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1.1 Introduction 
The initial aim of this work was to examine the use of polypyrrole (PPy), a well-
known conducting polymer, for the uptake and release of a cationic species, 
dopamine (DA). DA was chosen as it represents a large family of amine-based 
drugs. Therefore, if appropriate PPy films could be electrosynthesised and used 
in the controlled delivery of DA, then the concept could be used more widely in 
the field of controlled drug delivery.  
 
In Chapter 3, the growth of PPy films in the presence of various dopant anions, 
including a large anionic cyclodextrin (CD), sulfonated β-cyclodextrin (Sβ-CD) is 
explored. Although Sβ-CD doped PPy films have been reported in the recent 
literature, there has been very little work devoted to the characterisation of 
these films. Accordingly, much of Chapter 3 is devoted to the unique redox 
properties of the Sβ-CD doped PPy films.   
 
With the growth of the PPy films achieved, Chapter 4, shows the drug release 
profiles of the protonated DA and reveals that in the case of the polymer films 
doped with the anionic Sβ-CD, there is a substantial increase in the amount of 
DA released in comparison to other polymer films. In order to explain the 
enhanced release profiles, the well-known supramolecular complexation 
properties of cyclodextrins were considered. However, on searching the 
literature no reports on the complexation of DA with anionic cyclodextrins were 
found and consequently this was studied in detail. These findings are presented 
in Chapter 5, where the host-guest interactions between DA and the anionic Sβ-
CD are examined using a variety of techniques, both spectroscopic and 
electrochemical.  
 
In Chapter 6 the technique of electrospinning is introduced. Details on how it is 
used to fabricate nanostructured biodegradable polymer films with a high 
surface area are provided. The approaches used to deposit the Sβ-CD doped PPy 
films onto the nanostructured biodegradable film are then considered and 
discussed. It is shown that cyclic voltammetry was the most successful 
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approach. Moreover, it was possible to control the amount of PPy deposited and 
to maintain the nanostructured fiber substrate by varying the number of cycles. 
These high surface area Sβ-CD doped PPy films are promising for the uptake 
and liberation of DA.  
 
In this introductory chapter, the concept of controlled drug release is firstly 
introduced. This is then followed with information on conducting polymers, 
particularly PPy and the current state-of-art in using PPy in drug delivery. The 
technique of electrospinning is then introduced and linked to DDS. The next 
section is devoted to cyclodextrins, as it is the Sβ-CD doped PPy films that give 
the best controlled release properties. Finally, the chapter ends with a short 
account of the properties of DA and its delivery.  
 
1.1.1 Controlled drug release 
In the early 1970s, controlled release systems first materialised. Since then, the 
number and the areas in which a controlled release system is utilised have 
significantly increased. These systems have been used in areas such as 
cosmetics1, food2, and pesticides3. Controlled release systems are focused on 
obtaining the release of the proposed material, over a certain time without an 
external influence from any other potential release factor.4 Polymeric materials 
have been previously investigated for controlled release as they can be easily 
manufactured and their composition can be finely tuned.5 Polymers used in 
controlled release systems can be natural or synthetic and release can be 
achieved through the engineering of the polymer substrates, i.e., the 
degradation of poly(D,L – lactide-co-glycolide)  (PLGA) can be controlled through 
the polymer composition, higher ratios of PLA lead to a higher degradation 
rate.6 
 
Another important research area under consideration is the development of 
controlled drug delivery systems (DDS).7, 8 In 1980, controlled DDS were 
virtually unknown, yet in 2005, almost 100 million people globally were using 
some form of polymer based DDS.8 The aim of a DDS is to supply the drug in its 
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therapeutically active form to a specific target in the body when the drug is 
required. In the current administration process there is a critical concentration 
needed in order to achieve the drug’s maximum therapeutic effect. If the 
concentration goes beyond the maximum level, toxicity problems come into 
play. Conversely, if the concentration administered is below the minimum level 
the effect of the drug is not observed. The use of these DDS could potentially 
eliminate these problems as the release would be of a controlled manner.  
 
Santini et al.7 compared the release profiles of both conventional and controlled 
methods, as illustrated in Figure 1.1. With conventional methods of drug 
delivery, outlined in Figure 1.1(A), i.e., oral administration or injections, drug 
levels rise after initial administration, which could lead to potential toxicity 
problems, and then decrease until the next dosage, which has consequences on 
the efficiency of the dosage. The other schematic, Figure 1.1(B), demonstrates 
the effectiveness of a controlled release system. After dosage, the drug level in 
the blood remains constant, between the maximum and minimum levels, for a 
certain period of time. 
 
 
 
 
Figure 1.1: Drug levels in the blood with (A) conventional drug dosage (B) controlled 
delivery dosage, taken from Santini et al.7 
 
 
Maximum doping level
Minimum effective level
Dose                     Dose Dose
Time 
D
ru
g 
le
v
el
Maximum doping level
Minimum effective level
Dose
Time 
D
ru
g 
le
v
el
(A)                              (B) 
Introduction and literature review  Chapter 1 
- 5 - 
In recent years, polymeric materials have been examined and shown to provide 
an alternate means of delivering drugs. Implanted polymeric pellets or 
microspheres localise therapy to specific anatomic sites, providing a continuous 
sustained release of drugs while minimising systemic exposure.9 Polymers that 
display a physiochemical response to stimuli have been broadly researched for 
controlled release systems. Various stimuli include pH, temperature and the 
application of an electrical field.10 According to Langer11, polymeric DDS should 
i) maintain a constant drug level ii) reduce harmful side effects iii) minimise the 
amount of drug needed and iv) decrease the amount of doses which will have a 
pronounced effect on the patient.  
 
The original polymeric controlled DDS was based on a non-biodegradable 
polymer, silicone rubber, which was designed and tested by Folkman and 
Long.12 They loaded a silicone capsule (Silastic*) with a number of different 
drugs for the treatment of heart block and successfully implanted and 
monitored their effects over a number of days.  
 
In more recent years there has been considerable interest in the development of 
new and efficient DDS, particularly with the growth of sophisticated drugs that 
are based on DNA and proteins.5, 13 Currently, there are several materials under 
consideration in drug delivery, for example dendrimers14, nanoparticles15 and 
hydrogels16. The most promising opportunities in controlled DDS are in the area 
of responsive polymeric materials, with the possibility of implantable devices 
being used to deliver drugs. Murdan17 exhaustively reviewed the use of 
hydrogels as ‘smart’ drug delivery devices. He showed that hydrogels could be 
engineered for various medicinal treatments depending on the patients needs, 
for example, pain relief. In the body, drug release can only be accomplished if 
the drug carrier responds to some class of stimuli, be it chemical, physical or 
biological. Conversely, an implanted ‘smart’ drug delivery device should be non-
responsive to all other types of stimulus, once inside the body. A way of 
achieving this form of control is through an electrical stimulus.17 A number of in 
vivo devices, in the form of iontophoresis, have already been used for this type 
of controlled release.17, 18 Murdan presented a case where hydrogels loaded 
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with a bioactive compound, were implanted at a target site and the drug 
liberated through the application of an electrical field. In utilising such a system, 
many advantages including, minimal drug usage and lowering toxicity problems 
can be achieved. However, a problem arising with the application of an electrical 
stimuli to polymeric materials like, hydrogels, is that they experience deswelling 
or bending, which affects the drug release.17  
 
To overcome these problems, conducting polymers (CPs) are also receiving 
much attention in the field of biomedical research, for the application of 
controlled DDS, due to their light weight, good biocompatibility and ability to 
function at body temperature. In particular, conducting polymers exhibit a 
reversible electrochemical response. These reversible oxidation-reduction 
reactions are attractive for a responsive DDS, as a change in the net charge on a 
conducting polymer film during its reduction or oxidation requires ions to flow 
into or out of the film. This, in turn, allows the polymer film to bind and expel 
ions in response to electrical signals. Controlled release of drugs from polymers 
offers many advantages over conventional methods including better control of 
the drug level administered resulting in fewer side effects, local drug delivery, 
decreased requirements for the total amount of drug and protection of drugs 
which are rapidly destroyed by the body. However, in order to devise a suitable 
technology, the polymeric material must be responsive, i.e., it must be capable of 
altering so that the drug is released in a controlled fashion when needed. 
 
1.1.2 Conducting polymers 
A polymer is a large molecule made up of smaller repeating units. The name 
comes from the Greek poly, meaning ‘many’, and mer, meaning ‘part’. They are 
built up from simple molecules called monomers ‘single part’. Polymers are 
produced through a method known as polymerisation. This polymerisation step 
can be achieved through chemical or electrochemical methods. Originally 
polymers with the basic carbon chains were considered only as insulators.19 The 
first real interest in conducting polymers can be attributed to Walatka et al.20 in 
1973 with the report of highly conducting polysulfur nitride (SN)x. Meanwhile 
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and towards the late 1970s , MacDiarmid, Shirakawa and Heeger enhanced the 
discovery of the semi-conducting and metallic properties of the chemically 
synthesised organic polyacetylene.21-24 As is well known, the Nobel Prize in 
Chemistry was awarded to Alan J.Heeger, Alan G. MacDiarmid and Hideki 
Shirakawa in 2000 for the discovery and development of conducting polymers 
(CPs).21-24 In the following years, a wide range of polymeric organic species have 
been prepared as stable inherent films on inert electrodes via both chemical 
oxidation and electropolymerisation from aqueous and organic solution.25 
 
CPs are organic materials, which generally are comprised simply of C, H and 
simple heteroatoms such as N and S. Common examples include PPy, polyaniline 
and polythiophene which are shown in Figure 1.2. These and a number of other 
conducting polymers have been used in a variety of applications ranging from 
corrosion protection of materials, sensors to many biomedical applications, 
such as tissue engineering, nerve cell regeneration and drug delivery.26-29 
 
 
 
 
Figure 1.2: Chemical structures of (A) polypyrrole (B) polyaniline and (C) 
polythiophene. All polymers are shown in the dedoped state. 
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In, general materials are classed depending on their electrical conductivity, ĸ, 
where the electrical conductivity of insulators < semiconductors < conductors. 
Bredas and Street30 explained this phenomenon in terms of the band gap 
structure. Figure 1.3 illustrates the difference in each material using the band 
gap theory. The highest occupied molecular orbital is equivalent to the valence 
band (VB), while the lowest unoccupied molecular orbital may be equated to the 
conduction band (CB). The difference between each band is known as the band 
gap energy (Eg) and it is this energy gap that establishes the electrical 
properties of a material. If Eg > 10 eV, it is difficult to excite electrons into the 
conduction band and an insulator is formed. If Eg ~ 1.0 eV then thermal energy is 
sufficient to promote the electrons into the conduction band and a 
semiconductor is formed. If the gap vanishes, with overlap of the valence and 
conduction band, as shown in Figure 1.3, metallic conduction is observed. For 
most doped CPs the band gap energy is generally close to 1.0 eV, and 
consequently, CPs can be classified as semi-conductors. 
 
As pointed out by Bredas and Street30, the conductivity observed upon doping of 
the CPs was originally thought to be from the formation of unfilled electronic 
bands, however this idea was quickly dissipated upon experimental analysis of 
PPy and polyacetylene and now it is recognised that the conductivity is due to 
the formation of polarons and bipolarons, which are more energetically    
favoured.30, 31 
 
The π-bonded system of CPs, which comprises of alternating single and double 
bonds, enabling the delocalisation of electrons along the polymer backbone, is 
related to the conductivity of the system. The conductivity of these materials 
arises from a state of relative oxidation or reduction. In these states the polymer 
either loses (oxidation) or gains (reduction) an electron. Generally, it is said that 
this process occurs in 1 in every 4 monomer units.32 In this state the polymer is 
electronically charged and requires the introduction of counter ions (dopants) 
to compensate and reform the charge neutrality. The oxidation of the polymer in 
which an electron is removed from a π-bond, gives rise to a new energy state, 
which leaves the remaining electron in a non-bonding orbital. This energy level 
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is higher than the valence band and behaves like a heavily doped 
semiconductor.32 The extent of doping can be controlled during the 
polymerisation of the polymers. 
 
 
 
 
Figure 1.3: Schematic of the difference in band gap for Insulators, semi-conductors and 
metals (conductors). 
 
 
1.1.2.1 Polymerisation methods 
CPs are synthesised through a method known as oxidative polymerisation. This 
can be generated chemically or electrochemically. Chemical polymerisation 
involves the use of a chemical oxidant, such as ammonium peroxydisulfate 
(APS), ferric ions, permanganate, dichromate anions or hydrogen peroxide.  The 
oxidants not only oxidise the monomer but provide dopant anions to neutralise 
the positive charges formed on the polymer backbone.33 In the presence of these 
oxidants, the monomers are oxidised and chemically active cation radicals are 
formed which further react with the monomer and generate the desired 
polymer. An advantage of vapour phase chemical polymerisation of CPs is that 
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pyrrole leads to further doping after polymerisation and this gives rise to an 
increase in conductivity.35 
 
The electrochemical deposition is a simple and reproducible technique where 
the dopant is present in the electrolyte during polymerisation. It is generally 
performed in a conventional three electrode set up, described later in Chapter 2, 
where current is passed through a solution containing the monomer in the 
presence of a dopant (electrolyte). The CP is deposited at the positively charged 
working electrode or anode.27 Polymerisation is initiated through the oxidation 
of the monomer which forms a mobile charge carrier known as a polaron 
(radical cation), that can react with another monomer or polaron to form a 
bipolaron (radical dication) which leads to the formation of the insoluble 
polymer chain and deposition of the polymer onto the working electrode.36  
 
In his book ‘Conducting Polymers’ published in 1986, Alcacer commented on the 
possibility of using CPs to make artificial muscles or perhaps even modification 
for the brain; little did he realise the extent to which these materials have been 
extensively researched, over the past 20 years.32 Since their discovery, the 
preparation and characterisation of these materials has evolved substantially 
through the use of electrochemistry. The majority of research is significantly 
based in this area due to the ease and control of synthesis of these electronically 
CPs.19 Reviews on the development of CPs show the various areas to where they 
can be applied. The applications are ongoing.37-40 However, in the case of DDS, 
CPs, in particular PPy, are widely researched for the controlled release of 
therapeutically active compunds.41-45 During oxidative polymerisation, a dopant 
molecule, with an overall anionic charge, is used to compensate for the positive 
charges originating from the oxidation of the monomer. It is during this process 
that the concept of drug delivery originated. Burgmayer and Murray46 observed 
changes in the ionic permeability of PPy redox membranes using a voltage-
controlled electrochemical reaction. This led to further investigations into the 
application of CPs in DDS. 
 
Introduction and literature review  Chapter 1 
- 11 - 
1.1.2.2 Polypyrrole 
1.1.2.2.1 Historical background of polypyrrole  
In 1968 Dall’Olio and colleagues prepared black films of an oxypyrrole on 
platinum by the electrochemical polymerisation of pyrrole from a solution of 
sulfuric acid.47 In 1979 Diaz with the help of colleagues modified Dall’Olio’s 
approach and demonstrated that polymerising pyrrole onto platinum in 
acetonitrile led to a black, adherent film.48 Elemental analysis showed that the 
monomer unit was retained in the polymer. PPy in general, was poorly 
crystalline, and its ideal structure was a planar (α-ά)-bonded chain in which the 
orientation of the pyrrole molecules alternate.25 
The monomer unit, pyrrole, is shown in Figure 1.4. PPy is an organic material 
comprised simply of C, H and a simple N heteroatom, but is highly conducting. It 
is an inherently conductive polymer due to interchain hopping of electrons. PPy 
can be synthesised both chemically49 and electrochemically48. The 
electrochemical synthesis method is a one step synthesis method and allows the 
simple deposition of polymer films where its surface charge characteristics can 
easily be modified by changing the dopant anion (A-) that is incorporated into 
the material during synthesis. In a cell containing an aqueous or non-aqueous 
solution of the monomer, PPy forms a (semi) conducting film on the working 
electrode; the film grown is in the oxidised form and can be reduced to the non-
conducting insulating form by stepping the potential to more negative values. 
The potential cycling can be repeated many times between the insulating and 
(semi) conducting forms without a loss of the electroactivity of the film.25 
 
 
 
Figure 1.4: Schematic illustration of a monomer unit of pyrrole. 
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PPy in its neutral form is weakly coloured while the oxidised form is a deep 
blue/black. The switching of the state of the film not only changes its 
conductivity but it is also accompanied by a marked colour change, termed 
electrochromism.36 Materials such as PPy are important in terms of future 
technological impact as it may be possible to develop them to replace more 
expensive, often toxic, metallic conductors commonly employed in the 
electronics industry.25 
 
1.1.2.2.2 Polymerisation mechanism of pyrrole 
Although there are still various opinions on the mechanistic features of the 
electropolymerisation of pyrrole, the mechanism proposed by Diaz and his 
colleagues48 and later used by Baker and Reynolds is in good agreement with 
many experimental reports.50 The mechanism is demonstrated in Figure 1.5.  
 
The initial step is the generation of the radical cation. This cation has different 
resonance forms, as shown in Figure 1.5. In the next step in the chemical case, 
the radical cation then attacks another monomer molecule, generating a dimer 
radical cation. In the electrochemical case, the concentrations of radical cations 
is much larger than that of neutral monomers in the vicinity of the electrode 
where reactions are occurring, and radical-radical coupling leads to a radical 
dication. This coupling between the two pyrrole radicals results in the 
formation of a bond between the two α positions to give the radical dication, as 
highlighted in Figure 1.5. This is then followed by the loss of two protons, 
generating a neutral dimer. This dimer is then oxidised into a radical cation, 
where the unpaired electron is delocalised over the dimer. The radical dimer 
then couples with the radical monomer to form a trimer. The polymerisation 
thus progressing in this fashion to completion.  
 
The controversy in the mechanism of electropolymerisation is not surprising 
given that many factors, such as the nature of the electrolyte, ionic strength, pH, 
temperature and potential are important and can influence the mechanism of 
the reaction. 
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Figure 1.5: Mechanism of electrochemical polymerisation of pyrrole.50 
 
1.1.2.2.3 Biocompatibility 
PPy is one of the most widely researched conductive polymers. The fact that it 
can form biologically compatible matrices is one of the prominent reasons for 
the extensive research on the use of PPy in the field of biological applications.51 
Wang et al.52 acknowledged the reality that PPy had showed very good in vitro 
biocompatibility,29, 53, 54 but they wanted to evaluate further the in vivo 
biocompatibility prospects. They demonstrated that in comparison to no PPy, 
the presence of PPy/biodegradable composites stimulated no abnormal tissue 
response and had no affect on the degradation behaviour of the biodegradable 
materials. In 1994, PPy was one of the first conducting polymers investigated 
for its effect on mammalian cells.55 Since then, PPy is known to be 
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biocompatible, so it can be placed in the body without having adverse effects. It 
has been shown, in particular, to support cell growth and adhesion of 
endothelial cells.29, 55-57 Schmidt et al.29 also demonstrated that PPy was a 
suitable material for both in vitro nerve cell culture and in vivo implantation. 
PPy was electrochemically deposited onto ITO-conductive borosilicate glass. 
Moreover, the application of an external electrical stimulus through the polymer 
film resulted in enhanced neurite outgrowth. The median neurite length for PC-
12 cells grown on PPy film subjected to an electrical stimulus increased nearly 
two-fold compared with cells grown on PPy without the application of a 
constant potential. The group also investigated PPy in vivo and their studies 
showed that PPy promotes little negative tissue and inflammatory response. 
Due to the good biocompatible factor, studies on the application of an electric 
field to the PPy have also shown cell compatibility.29 In some important 
applications, such as biological sensors and actuators for medical devices it is a 
very attractive trait and some recent applications show that PPy can enhanced 
nerve cell regeneration and tissue engineering.27  
 
1.1.2.2.4 Electroactivity of polypyrrole 
PPy can be easily switched between the neutral, partially oxidised and fully 
oxidised states, as shown in Figure 1.6.  In its neutral state PPy exists as an 
insulator where the conduction band is empty as all the electrons remain in the 
valence band. Upon oxidation, an electron is removed from a π-bond (valence 
band) and a polaron is formed. The separation of the positive charge and the 
unpaired electron decreases during continual oxidation as the number of 
polarons increases. This in turn gives rise to the formation of a bipolaron, as 
depicted in Figure 1.6(C), and the polymer is now in its fully oxidised state. 
 
During oxidation and the generation of positive charge an influx of anions into 
the polymer matrix is observed in order to maintain charge balance.  This can be 
represented in Equation 1.1, where PPyo refers to the neutral (reduced) 
polymer, PPy+ refers to the oxidised polymer and A- refers to the anionic dopant. 
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PPy0  +  A-    PPy+A- + e-     1.1 
 
 
Typical anionic dopants are chlorides, bromides, iodides, perchlorates, nitrates, 
sulfates and para-toluene sulfonates.58-64 The extent of oxidation/reduction is 
given by the doping level and this is generally expressed as the ratio of dopant 
anions, A-, incorporated per monomer unit. For example, 1 A- per 4 monomer 
units gives a doping level of 0.25 or 25%. The maximum doping level achievable 
with PPy is 0.33 or 33%, i.e., 1 A- per 3 pyrrole units. It is important to point out 
that doping may not always be uniform; there can be islands with high doping 
levels surrounding by regions with a much lower doping level. 
 
 
  
 
 
 
Figure 1.6: Electronic structures of (A) neutral PPy, (B) polaron in partially doped PPy 
and (C) bipolaron in fully doped (oxidised) PPy.36 
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The electrochemical switching of PPy films is accompanied by movement of 
counter or dopant ions in and out of the polymer matrix to maintain the charge 
neutrality, as shown in Section 1.1.2.3.4. Consequently, PPy films are attractive 
for the controlled release of drug molecules. The concept of using PPy 
membranes for the uptake and release of ions was introduced, in the early 
1980s, by Burgmayer and Murray46.  They demonstrated that these polymeric 
films could be exchanged from their oxidised state to their neutral state. PPy has 
been seriously considered for drug delivery due to these unique redox 
properties. PPy gives a responsive material needed in order for the uptake and 
release of the drug to be controlled; in its oxidised state anions are 
electrostatically bound to the polymer film. These properties allow the 
controlled transport of ions. The uptake of these ions can occur in two ways. 
The first is where the bioactive molecule exists as an anion and is involved in 
the doping process of the polymeric material during polymerisation, Figure 1.7 
(A). Some anions that have been researched include adenosine tri phosphate 
(ATP)65, salicylate26, and dexamethasome26. These anions are electrostatically 
entrapped into the polymer matrix during the growth process upon application 
of an anodic potential. The anions are consequently liberated during the 
reduction of the polymer.  
 
 
 
 
Figure 1.7: Interconversion between oxidation and reduction states of PPy (PPy). (A) 
Anion (A-) incorporation and release which is notably observed in small mobile anions 
(e.g. Cl-) while, (B) Cation (C+) insertion and liberation from polymer films doped with 
larger anions  (e.g. DDS-) which remain entrapped in the polymer matrix. 
In the second case, cations can be incorporated into the system, Figure 1.7 (B), if 
the properties of the polymer film are modified.66 This is achieved through the 
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initial inclusion of a large anion which remains entrapped in the polymer matrix 
and thus the polymer behaves as a cation exchanger, where, the charge of the 
polymer system can only be compensated through the uptake of cations. The 
cations are therefore, taken in during the reduction of the polymer and released 
upon oxidation. Figure 1.7 demonstrates both these concepts. 
 
Miller and Zhou67 previously reported the release of dopamine from a poly(N-
methlypyrrole)/poly(styrenesulfonate) (PNMP/PSS) polymer based on the 
properties of these redox polymers. Immobilisation of PSS, a large anion, allows 
the uptake and release of the cation upon appropriate application of a potential. 
They achieved the release of dopamine using potential control, while more 
recently, Hepel and Mahdavi66 demonstrated the controlled release of a cationic 
species, chloropromazine, from a composite polymer film based on the same 
principles. They reported the development of a new composite conducting 
polymer, PPy/melanin, which performed as a cation binder and releaser. The 
modification of the polymer films, to enable the predominant cationic exchange 
properties of the CP, is an interesting way of improving the uptake and release 
of cationic species from these attractive materials. 
 
New ways of improving the controlled release of drugs are continually being 
sought after.  Lately, Abidan et al.41 reported on a method to prepare 
conducting-polymer nanotubes that can be used for controlled drug release. 
They introduced a method known as electrospinning to fabricate a nanofibrous 
mat in which the drug to be delivered had previously been incorporated; 
followed by electrochemical deposition of PPy films around the drug-loaded, 
electrospun biodegradable polymers. The drug release was achieved through 
the electrical stimulation of the PPy nanotubes. 
 
 
 
1.1.2.2.6 The application of Nanotechnology in drug delivery 
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Nanotechnology, although dating back to much earlier times, gained 
considerable attention in the early 1990s and has been the focus of much 
research over the last number of years. The introduction of nanotechnology into 
a controlled DDS has been shown to enhance many physical and chemical 
properties and overall has been used to increase the surface area of materials. 
This, in turn, leads to an increase in the amount of drug released from various 
materials. Many groups have introduced nanotechnology in various forms to 
improve on the drug delivery of a number of bioactive compounds, including 
nanoparticles15, micellar systems68 and nanofibers69. Polymeric nanofibers are 
gaining substantial interest for various applications including drug delivery69, 70. 
Several techniques have been employed for the production of nanofibers such 
as template synthesis71, self assembly72 and drawing73. One technique, in 
particular that is receiving considerable interest in this field, is 
electrospinning.74-77 Electrospinning has been introduced to achieve nanoscale 
membranes and fibres from various polymeric materials.78 
 
1.1.2.2.7 The application of Electrospinning to drug delivery 
Although electrospinning was first reported by Formhals79 in 1934 it has only 
been explored further in recent times.80, 81 In 1996, Reneker and Chun restored 
interest in the electrospinning technique by demonstrating the possibility of 
electrospinning a wide range of organic polymers.81 Since then the technique of 
electrospinning has become extremely useful in a variety of applications.82-85 
Electrospinning is a simple and inexpensive means for the formation of nano- to 
micron polymer fibers. 
 
This technique involves the application of a high electric field between a 
polymer fluid and a grounded electrode. When the polymer solution is subjected 
to an external electric field at a critical point the forces overcome the surface 
tension of the polymer solution to form a droplet with a conical shape, i.e., the 
Taylor cone.83, 86 The fluid is drawn into a jet which undergoes a whipping 
motion. Volatile solvents are used to dissolve the polymer as the subsequent 
evaporation from the liquid jet results in solid fibers. A more detailed 
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description of this technique is provided in Chapter 2, Section 2.4.5. In the 
majority of cases the fibers deposit randomly on the grounded collector. 
However, many groups have investigated the use of rotating collector plates to 
produce aligned nanofibers.87 Figure 1.8 illustrates a typical SEM micrograph of 
an electrospun fiber mat of PLGA fibers. 
 
This production of nanofibers allows these polymers to be used in a wide 
variety of applications including, tissue engineering (muscles, skin, cartilage and 
bones), wound healing and sutures, biosensors and DDS. Shin et al.88 studied the 
use of PLGA nanofiber scaffold for cartilage reconstruction, while, Kim and 
colleagues incorporated antibiotics in the fibrous matrix for use in wound 
dressings.89 Other groups have also prepared ultrafine polymers via 
electrospinning for skin regeneration.74 
 
 
 
 
Figure 1.8: A typical SEM image of electrospun PLGA nanofibers. 
 
 
Another attractive feature of using this electrospinning technique is that 
biodegradable polymeric materials, such as poly(lactic acid) (PLA) and poly(D,L – 
lactide-co-glycolide) (PLGA) can be used as a biomedical controlled release 
system. These biodegradable polymers can be electrospun in the presence of 
varying amounts of the required medication. They can then be placed in the 
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body and the drug release achieved through the modification of the polymer 
matrix’s morphology, porosity and composition.89 These biodegradable 
polymers have FDA approval for biomedical and drug delivery use.90-93 In 
comparison to other delivery forms, the electrospun nanofibers can 
conveniently incorporate the therapeutic compound during the electrospinning 
process.94 Many drugs have been incorporated into PLGA electrospun polymer 
matrices, in order to achieve delivery of the therapeutic drug,  including, 
tetracycline hydrochloride95 and mefoxin89. In these cases, the drug release was 
monitored and a burst release was observed and was attributed to the high 
surface area-to-volume ratio of the electrospun material. This is a disadvantage. 
In the last few years a small number of groups have deposited electroactive 
polymers, such as PPy, onto previously electrospun fibers in order to enhance 
the electrochemical properties57 of the material. Also, electrospun fibers have 
been used as a template in order to obtain a high surface area in the hope of 
achieving a greater uptake and release of drugs.41 
 
Another method of improving the DDS of conducting polymers is the use of 
various dopants during polymerisation of the polymer films. The 
functionalisation of PPy films with large anionic dopants is not new to this field 
of research. It has been well reported that the use of large anionic dopants 
during the electrochemical polymerisation of monomers leads to these bulky 
negatively charged groups being immobilised within the polymer matrix.96 In 
fact, these polymers, with their cationic exchange properties, have been used to 
incorporate various cationic groups for various applications. For example Fan 
and Bard in the late 1980s demonstrated the uptake of a positively charge 
Ru(NH3)63+ and methylviologen in PPy/Nafion films.97 
 
However, the generation of PPy films in the presence of negatively charged 
cyclodextrins is a new concept.98-100 There has been very little work reported on 
the electropolymerisation of pyrrole in the presence of anionic cyclodextrins. 
Indeed, much of the current published work is unreliable as very high potentials 
in the vicinity of 1.8 V vs. SCE were used to form the polymers.100, 101 It is very 
well known that these high potentials give rise to the overoxidation of PPy and a 
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considerable loss in its conductivity.59 The incorporation of cyclodextrins into 
conducting polymers provides a unique way of combining the unique host-guest 
complexation properties of cyclodextrins with the stability, high conductivity 
and ease of preparation of conducting polymers.  
 
1.1.3 Cyclodextrins 
1.1.3.1 History and structural properties of cyclodextrins  
Cyclodextrins (CD) are macrocyclic oligosaccharides composed of α-D-
glucopyranoside units linked by α-(1,4) bonds. They were first discovered by 
Villiers in 1891102, while in 1904, Schardinger103 further developed the cyclic 
structures hence; CDs are sometimes referred to as Schardinger dextrins. 
However, it was only in the mid 1970s that the structure and chemical 
properties of natural cyclodextrins were fully characterised.104
 
Cyclodextrins 
have developed quickly over the past two decades and have become an 
important branch of host-guest chemistry, specifically due to their ability to be 
involved in several practical applications.105 The main interest in cyclodextrins 
lies in their ability to form inclusion complexes with a variety of compounds. 
Host-guest chemistry is the study of these inclusion phenomena, where the 
‘host’ molecules are capable of including smaller ‘guest’ molecules through non-
covalent interactions. 
 
CDs are obtained through enzymatic degradation of starch in the presence of a 
glycosyl transferase, a type of amylase.106 Many organisms contain glycosyl 
transferase, however, in general it is obtained from Bacillus megaterium, 
Bacillus stereothermophilus and Bacillus macerans.106, 107 They are generally 
made up of glucopyranoside units of 4C1 chair conformation which leads to a 
truncated cone shape encasing a cavity.108 Figure 1.9 shows the structures of the 
most common CD members; α-, β- and γ-CD, which include 6, 7 and 8 repeating 
glucopyranoside units, respectively. These units orientate themselves in a cyclic 
manner offering a typical conical or truncated cone structure with a relatively 
hydrophobic interior and hydrophilic exterior.109 This structural property gives 
cyclodextrins good water solubility and the ability to hold appropriately sized 
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used for many applications including, drug delivery to enhance the solubility, 
stability and bioavailability of drug molecules.108, 112
 
 
Table 1.1: Approximate geometric dimensions of the three common CDs.106  
 
 
 
 
 
Cyclodextrin x / nm y / nm Cavity volume / Å3 
α 0.49 0.78 174 
β 0.62 0.78 262 
γ 0.79 0.78 427 
 
 
Cyclodextrins can also be chemically modified to replace the hydroxyl groups on 
both the primary and secondary rims of the CDs, with a variety of appropriate 
alkyl groups (R). It has been reported that this can improve binding affinity.108 
In the research presented here, a negatively charged cyclodextrin with a 
number of sulfonated groups present on the outer rims was used, sulfonated β-
CD (Sβ-CD). Sβ-CD is obtained by substitution of either primary or secondary 
hydrogen of the hydroxyl group of β-CD with a sulfonate group. Sβ-CD has an 
average of 7-11 substituents per CD and, therefore, has between 7-11 negative 
charges associated with it, which are counterbalanced with sodium ions, as 
illustrated in Figure 1.10.113 It is reported that β-CD and Sβ-CD have the same 
ring structure, differing only in the substituent located on the rims of the CD 
ring.14 Although Sβ-CD has the same ring structure as other derivativsed CDs the 
presence of the substituent on the ring contributes to its chiral discrimination 
properties.114 A major area in which these sulfonated CDs are being utilised is 
chromatography, or more specifically capillary electrophoresis, for the 
enantiomeric separation of acidic and basic compounds. In enantiomeric 
separation, using neutral CDs, they are not appropriate for neutral racemates as 
the complex has no electrophoretic mobilities.115 Therefore, the use of charged 
   x   
 y 
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CDs is now been widely researched for the separation of neutral compounds. It 
has been reported that the use of these sulfonated CDs for the enantiomeric 
separation of chiral compounds is highly effective as a result of the anionic 
charges.116, 117  
 
A number of groups have also characterised the Sβ-CD.115, 117 Figure 1.11 
illustrates a single glucose unit of an Sβ-CD (comprised of 7 units). On the 
primary ring there are 7 potential substitution sites corresponding to the C-6 
positions, while, on the secondary rim there are 14, represented by the C-2 and 
C-3 positions. Amini and co-workers117 reported that substitution of these CDs 
is predominantly at the C-2 and C-6 positions, while, Chen et al.115 confirmed 
nearly complete sulfation at the C-6 position of the primary hydroxyl groups 
and partial sulfation at the C-2 secondary hydroxyl groups. They also reported 
no substitution at the C-3 positions. From these reports it can be stated that 
almost the entire primary rim is sulfonated and some of the secondary rim. Due 
to this phenomenon and the fact that the sulfation brings with it negative 
charges these CDs are good candidates for the doping of CPs.  
 
 
R = SO3-Na+ or H ~ 7-11 SO3-Na+ groups. 
 
Figure 1.10: Structural and schematic representation of sulfonated β-cyclodextrin (Sβ-
CD). The arrows point to the primary and secondary rims, respectively.118 
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Figure 1.11: Chemical structure of Sβ-CD, depicting the numbering carbons. 
 
1.1.3.2 Inclusion complexation 
Cyclodextrins (CD) form a group of cyclic oligosaccharides that contain cavities 
in which guest molecules can be encapsulated.108, 109 It is well known that the 
size of the compounds are important and compounds are only capable of 
including into the cavity of the CD if they are within the dimensions of the CD 
cavity.119 In aqueous media, the cavity is filled with water molecules, which 
becomes displaced by the guest through complexation, as illustrated in Figure 
1.12. The guest molecule, xylene, displaces the water molecules and forms an 
inclusion complex with the CD. 
 
 
 
Figure 1.12: Schematic representation of xylene forming a complex with a β-
cyclodextrin. The small circles represent water molecules taken from Szjetli.109  
 
 
During the formation of an inclusion complex the chemical and the physical 
properties of the guest molecule change and can be monitored using a number 
of techniques. Various spectroscopic and electrochemical techniques can be 
used to confirm complexation, including fluorescence, UV-visible spectroscopy 
(UV), Nuclear magnetic resonance (NMR) and electrochemical studies. These 
changes attributed to the complexation can be used to evaluate the apparent 
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binding or formation constant (Kf). However, prior to the determination of the 
Kf  value the stoichiometry of the host-guest complex must be established.120 
This is obtained by the well known continuous variation or Job’s method which 
is described in more detail in Chapter 2, Section 2.6.1.1.121 Generally, inclusion 
complexes form a ratio of 1:1, 1:2 and sometimes 2:1 (CD:guest).122  
 
NMR is also a useful tool for the study of complexation due to its quantitative 
information and assuming the guest enters the cavity, NMR, can be also used to 
locate the protons involved in complexation.87 Many groups have studied the 
complexation properties with the neutral β-CD and monitored the changes in 
the chemical shifts for both the CD, and the guest. However, in the case of the 
modified CD used in this research, the NMR spectral data are too difficult to 
differentiate so the chemical shift of the guest is followed.120, 123-126 Bratu and 
colleagues125 studied the chemical shift changes observed when Fenbufen was 
in the presence of a neutral β-CD. They noticed an up-field shift of the guest 
protons, some more pronounced than others, and suggested that the 
complexation was initiated through the benzene moiety of the guest.               
Cruz et al.127 also used NMR to quantitatively evaluate the binding constant of 
the complexation of doxepin and a neutral β-CD.  
 
If a guest absorbs light in the UV or visible region then the inclusion 
phenomenon can be followed and subsequently, evaluated by UV.106 This 
technique can be used to confirm complexation and indeed obtain the formation 
constant associated with the inclusion complex. In the majority of cases the 
guest that absorbs in the UV-vis region experiences changes in the intensity and 
the position of the absorption bands in the presence of the CD. These spectral 
changes can be used to determine the Kf constants. Generally, a Hiedlebrand-
Benesi modified equation is used to evaluate the Kf constants.119, 128, 129 Ramaraj 
and co-workers130 monitored the changes attained during the complexation 
formation of a number of aromatic amines and nitro compounds in the presence 
of a neutral β-CD. They observed an increase in the intensity of the bands in all 
cases. Dang et al.119 observed shifts of the absorption bands to longer 
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wavelengths in the case of 1,4 benzoquinone (BQ) and 9,10 anthraquinone (AQ) 
in the presence of a neutral β-CD. 
 
Electrochemical techniques can also be performed on the complexation 
properties of CDs. If the guest is electroactive the peak current and potential can 
be followed for the free state and compared to the complexed state of the guest 
in question. Two features are generally observed during these electrochemical 
observations if an inclusion complex is found. Firstly, a decrease in the peak 
current can be seen, and, attributed to a decrease in the diffusion of the bulky 
CD complex as opposed to the more mobile free guest. Secondly, a shift in the 
peak potential is observed if the complexed species is included in the cavity, as 
it is harder to oxidise or reduce while located in the cavity. Once again based on 
these variations a number of equations can be used to verify the formation 
constant.129, 131, 132 Coutouli-Argyropoulou and his group133 reported the effect 
of complexation on the electrochemical properties of ferrocence derivatives and 
showed shifts, in both the peak current and peak potential, when higher 
concentrations of a neutral β-CD were added. Yanez et al.131 showed similar 
observations for nifedipine (NF) and nicardipine (NC) and estimated apparent 
formation constants of 135 and 357, respectively. 
 
Complexation studies of DA have been previously demonstrated in the presence 
of a neutral β-CD by Zhou et al.134 using UV and fluorescence spectroscopy. 
From the fluorescence technique, utilising a Hiedlebrand-Benesi modified 
equation, a Kf value of 95.06 was estimated. The degree of the complexation can 
vary over a wide range due to the stability of the complex, as it depends on a 
number of factors. In the next section a discussion on the main driving forces, 
involved in this complexation process are dealt with. 
 
1.1.3.3 Driving forces in the inclusion complexation process 
There are many reviews and books written on the driving forces behind the 
inclusion complexation abilities of cyclodextrins, not all agree, some refer to the 
predominantly hydrophobic affects while others state that it is a collection of  a 
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number of weaker interactions (H-bonding, van der Waals, electrostatic 
interactions).106, 108, 111, 135, 136 Either way the majority agree that the size of the 
cavity and shape of the guest are important factors in the complexation process. 
The most widely studied possible driving forces include  
 
 Hydrogen bonding  
 Electrostatic interaction 
 Van der Waals 
 Hydrophobic effect 
 
Hydrogen bonding is an interaction between an electronegative donor, a 
hydrogen and an electronegative acceptor.136 Various groups have 
demonstrated the importance of hydrogen bonding in the solid state, illustrating 
crystal structures defining the hydrogen bonding between the guest and the 
hydroxyls of the CDs.137 However, during the complexation of the CD and guest, 
in aqueous solution, the subject is still arguable as few direct measurements of 
hydrogen bonding have been made, as water molecules can compete with CDs 
to form hydrogen bonding with guest molecules. However, many groups will 
still argue over the significance of hydrogen bonding. 
 
Electrostatic interaction occurs when molecules of opposite charges interact. 
There are three types of electrostatic interactions, ion-ion interaction, ion-
dipole interaction and dipole-dipole interaction.136 Matsui and Okimoto138 
reported that ion-ion interaction is only eligible in the case of modified CDs, 
where as ion-dipole is considered more favourably due to the fact that CDs are 
polar molecules however as with hydrogen bonding, in aqueous media, the 
interaction between the guest and water will also be strong.136 Therefore, it is 
the case of dipole-dipole interaction that is mostly considered during 
complexation. 
 
Van der Waals forces or London dispersion forces are made up of dipole 
induced dipole contributions or the coordination of the electronic motion in the 
CD and guest. As CDs are known to have large dipole moments it is logical that 
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these induction forces are important in complexation. Experimental evidence 
has shown that the stability of the complex increases with an increase in 
polarisability. Also, as the polarisability of water is lower than the organic 
components of the CD cavity, van der Waals forces have an encouraging 
donation to the stability of the complex due to a stronger interaction of the CD 
and guest over the water and guest.136 CDs have also been reported to form 
stable inclusion complexes in organic solvents like DMF and DMSO confirming 
the importance of van der Waals forces.139 
 
The hydrophobic interaction which is entropically favourable, due to the 
expulsion of water, leads to the aggregation of non-polar solutes in aqueous 
solution.136 As reviewed by Connors135 the ‘classical’ hydrophobic interaction is 
said to be ‘entropy driven’ and a positive entropy and enthalpy is associated for 
the interaction between two non polar molecules. However, experimental 
studies in the complexation of CD and guests, show negative enthalpy and 
entropy changes,111 which have been suggested to indicate that these 
interactions are not a dominant force.  
 
Mosinger et al.122 reported that the formation of an inclusion complex is based 
on the electrostatic, van der Waals and π-π interactions, where, steric affects 
and Hydrogen bonding are inevitable. Chao and co-workers124 investigated the 
formation of an inclusion complex with β-CD and caffeic acid, they reported that 
the weak forces of hydrogen bonding, van der Waals, hydrophobic and 
electrostatic interactions simultaneously governed the process. 
 
Rekharsky and Inoue111 reviewed the complexation of cyclodextrins and stated 
that the interactions involved in the inclusion complexation of aromatic guests 
with CDs could not be simply put down to a hydrophobic effect. They 
established that complexation could be accounted for, through dipole-dipole 
interactions. In saying that, Tabushi and his group140 questioned the role of 
hydrogen bonding in the complexation process and reported that no dramatic 
changes of binding were observed, when a modified CD, incapable of hydrogen 
bonding, was compared to an unmodified CD. They concluded that the 
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involvement of hydrogen bonding was negligible and hydrophobic interactions 
dominated the process. Zia et al.113 investigated the complexation ability of a 
negatively charged CD (~7 negative sites) with a number of neutral and charged 
guest molecules. They accounted for the increase in the binding affinity, for the 
oppositely charged guest and CD, to be predominantly hydrophobic, due to the 
additional interaction sites provided by the negatively charged CD. Okimoto and 
colleagues141 also clearly observed stronger interactions occurring between a 
CD and guest with opposite charges. 
 
The understanding of these complexation processes is complicated, however, it 
is generally found that van der Waals forces and hydrophobic interactions are 
regarded as the main driving forces for CD complexation, while, electrostatic 
interactions and hydrogen bonding can be significantly considered in some 
inclusion complexation studies. Nevertheless, these attractive features of CDs 
allow them to be used in a wide range of applications including, the food 
industry142. However, the pharmaceutical industry is the most widely 
researched area in recent times, specifically in drug formulation and DDS.143 
 
1.1.3.4 Applications of CDs in DDS  
Due to their biocompatibility and their ability to form inclusion complexes, CDs 
have been studied for the use in DDS. They have been considered as drug 
carriers, as CDs have the potential to act as hydrophobic carriers and control the 
release of a variety of drugs.118  Many reviews have recently been published, 
describing the role of CDs in DDS.112, 118, 144-147 Irie and Uekama144 reviewed the 
role of CDs in peptide and protein delivery and summarised that CDs were able 
to eliminate a number of undesirable properties of drug formulations, as they 
form inclusion complexes with the desired drugs, which increase the drug 
delivery through a number of routes of administration. More recently, Li et al.145 
examined the recent progress in the preparation of inclusion complexes 
between CDs and various polymers as supramolecular biomaterials for drug 
and gene delivery. They demonstrated the promising field in the self assembly 
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of inclusion complexes between CDs and biodegradable polymers as injectable 
DDS.  
 
Ferancova and Labuda148 also reviewed the use of CDs as electrode modifiers. 
They summarised the many ways CDs can be immobilised onto electrode 
surfaces. As discussed in an earlier section, Section 1.1.4.2., the incorporation of 
CDs, as dopants, during the electrochemical polymerisation of CPs was 
demonstrated to examine the use of these modified electrodes to deliver neutral 
drugs.98 Formulating these materials, correlates the attractive features of both 
the CDs and the CPs. Bidan et al.98 examined the need for a new DDS that was 
not limited to charged drugs. They produced polymer films in the presence of an 
anionic CD and successfully delivered neutral compounds using these novel 
materials.         
 
Also briefly discussed in Section 1.1.4.2, was the reports made by a number of 
groups on the polymerisation of CPs in the presence of CDs.100, 101, 149 These 
groups have reportedly polymerised pyrrole at potentials usually shown to 
overoxidise the CP film.59 Due to this, these papers are unreliable in their 
reports. 
 
1.1.4 Drug release: Controlled release of dopamine 
DA is a neurotransmitter produced naturally in the brain. It is well documented 
that a common factor in neurodegenerative diseases such as Parkinson’s (PD) 
and Schizophrenia is a significant lack of the presence of DA in the substantia 
nigra (mid brain).150-152 In particular, PD is a slowly progressive disorder known 
to occur due to the damage of the basal ganglia.150-152 The disease affects 
movement, muscle control and balance. Studies on the brains of deceased 
Parkinson sufferers show a substantial loss of dopamine, particularly, in the 
substantia nigra. The function of the substantia nigra is to produce DA and 
manage the release of essential neurotransmitters that help control movement 
and coordination. Sufferers usually show symptoms such as tremors, slowness 
of movement and impaired balance and coordination. Prolonged loss of DA 
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gives rise to symptoms such as difficulty in walking, talking, or completing other 
simple tasks.150-152  
 
DA belongs to the well known catecholamine family. These molecules are 
electroactive and therefore their oxidation can be followed using 
electrochemistry, in particular, electrochemical methods such as cyclic 
voltammetry and rotational disc voltammetry. The electrochemical mechanism 
of oxidation is still not fully agreed; with various groups arguing that the 
mechanism goes through an ECE step rather than a CE step. For example, 
Hawley et al.153 have reported that the electrochemical oxidation of dopamine in 
aqueous solution proceeds through two types of steps, electrochemical (E) and 
chemical (C). The ECE mechanism is presented in Scheme 1.1. 
 
The first step in the oxidation of dopamine (A) involves the loss of both protons 
and electrons to form the o-dopaminoquinone (B). The oxidised, o-
dopaminoquinone undergoes a 1,4-Michael addition, which results in a 
intramolecular cyclisation reaction which produces leucodopaminochrome (C). 
This product is easily oxidised through an electrochemical step to form 
dopaminochrome (D).153, 154 
 
Controlled release studies of DA have been previously investigated.67, 155-158 
McRae-Degueurce et al.156 encapsulated DA into a thermoplastic polyester 
excipient: PLGA. They found that it was possible to deliver significant amounts 
of DA for prolonged periods of time by injecting the microencapsulated DA 
directly into the brain. Uludag and colleagues157 also examined the release of 
many therapeutic agents, including DA, from microencapsulated mammalian 
cells. The mammalian cells and tissues were entrapped in polymeric 
microcapsules containing the desired bioactive agent. 
 
Introduction and literature review  Chapter 1 
- 33 - 
 
 
 
Scheme 1.1: The proposed oxidative pathway for dopamine. 
 
 
In both these cases the release was based on diffusion from the polymeric 
materials. It is, therefore, difficult to maintain any control over the amount of 
DA released. Miller67 and Zhou158 and co-workers investigated the use of CPs to 
deliver DA. They introduced the concept of using large immobile dopants, which 
remain entrapped inside the cavity during polymerisation, to bind and 
successfully liberate DA from the polymer films.  
This is the basis of the work performed in this thesis. As outlined at the start of 
this chapter, the idea of this research is to develop PPy films for the uptake and 
release of DA, using a large immobile anionic cyclodextrin. The cyclodextrin, in 
addition to its large size and immobility, has unique host-guest complexation 
properties and this offers the prospects of inclusion complexation between the 
DA and the CD to enhance the drug delivery. If this can be achieved it could 
potentially serve as a model system in DDS and could be extended to various 
other cationic drug molecules.  
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1.1 Introduction 
The initial aim of this work was to examine the use of polypyrrole (PPy), a well-
known conducting polymer, for the uptake and release of a cationic species, 
dopamine (DA). DA was chosen as it represents a large family of amine-based 
drugs. Therefore, if appropriate PPy films could be electrosynthesised and used 
in the controlled delivery of DA, then the concept could be used more widely in 
the field of controlled drug delivery.  
 
In Chapter 3, the growth of PPy films in the presence of various dopant anions, 
including a large anionic cyclodextrin (CD), sulfonated β-cyclodextrin (Sβ-CD) is 
explored. Although Sβ-CD doped PPy films have been reported in the recent 
literature, there has been very little work devoted to the characterisation of 
these films. Accordingly, much of Chapter 3 is devoted to the unique redox 
properties of the Sβ-CD doped PPy films.   
 
With the growth of the PPy films achieved, Chapter 4, shows the drug release 
profiles of the protonated DA and reveals that in the case of the polymer films 
doped with the anionic Sβ-CD, there is a substantial increase in the amount of 
DA released in comparison to other polymer films. In order to explain the 
enhanced release profiles, the well-known supramolecular complexation 
properties of cyclodextrins were considered. However, on searching the 
literature no reports on the complexation of DA with anionic cyclodextrins were 
found and consequently this was studied in detail. These findings are presented 
in Chapter 5, where the host-guest interactions between DA and the anionic Sβ-
CD are examined using a variety of techniques, both spectroscopic and 
electrochemical.  
 
In Chapter 6 the technique of electrospinning is introduced. Details on how it is 
used to fabricate nanostructured biodegradable polymer films with a high 
surface area are provided. The approaches used to deposit the Sβ-CD doped PPy 
films onto the nanostructured biodegradable film are then considered and 
discussed. It is shown that cyclic voltammetry was the most successful 
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approach. Moreover, it was possible to control the amount of PPy deposited and 
to maintain the nanostructured fiber substrate by varying the number of cycles. 
These high surface area Sβ-CD doped PPy films are promising for the uptake 
and liberation of DA.  
 
In this introductory chapter, the concept of controlled drug release is firstly 
introduced. This is then followed with information on conducting polymers, 
particularly PPy and the current state-of-art in using PPy in drug delivery. The 
technique of electrospinning is then introduced and linked to DDS. The next 
section is devoted to cyclodextrins, as it is the Sβ-CD doped PPy films that give 
the best controlled release properties. Finally, the chapter ends with a short 
account of the properties of DA and its delivery.  
 
1.1.1 Controlled drug release 
In the early 1970s, controlled release systems first materialised. Since then, the 
number and the areas in which a controlled release system is utilised have 
significantly increased. These systems have been used in areas such as 
cosmetics1, food2, and pesticides3. Controlled release systems are focused on 
obtaining the release of the proposed material, over a certain time without an 
external influence from any other potential release factor.4 Polymeric materials 
have been previously investigated for controlled release as they can be easily 
manufactured and their composition can be finely tuned.5 Polymers used in 
controlled release systems can be natural or synthetic and release can be 
achieved through the engineering of the polymer substrates, i.e., the 
degradation of poly(D,L – lactide-co-glycolide)  (PLGA) can be controlled through 
the polymer composition, higher ratios of PLA lead to a higher degradation 
rate.6 
 
Another important research area under consideration is the development of 
controlled drug delivery systems (DDS).7, 8 In 1980, controlled DDS were 
virtually unknown, yet in 2005, almost 100 million people globally were using 
some form of polymer based DDS.8 The aim of a DDS is to supply the drug in its 
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therapeutically active form to a specific target in the body when the drug is 
required. In the current administration process there is a critical concentration 
needed in order to achieve the drug’s maximum therapeutic effect. If the 
concentration goes beyond the maximum level, toxicity problems come into 
play. Conversely, if the concentration administered is below the minimum level 
the effect of the drug is not observed. The use of these DDS could potentially 
eliminate these problems as the release would be of a controlled manner.  
 
Santini et al.7 compared the release profiles of both conventional and controlled 
methods, as illustrated in Figure 1.1. With conventional methods of drug 
delivery, outlined in Figure 1.1(A), i.e., oral administration or injections, drug 
levels rise after initial administration, which could lead to potential toxicity 
problems, and then decrease until the next dosage, which has consequences on 
the efficiency of the dosage. The other schematic, Figure 1.1(B), demonstrates 
the effectiveness of a controlled release system. After dosage, the drug level in 
the blood remains constant, between the maximum and minimum levels, for a 
certain period of time. 
 
 
 
 
Figure 1.1: Drug levels in the blood with (A) conventional drug dosage (B) controlled 
delivery dosage, taken from Santini et al.7 
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In recent years, polymeric materials have been examined and shown to provide 
an alternate means of delivering drugs. Implanted polymeric pellets or 
microspheres localise therapy to specific anatomic sites, providing a continuous 
sustained release of drugs while minimising systemic exposure.9 Polymers that 
display a physiochemical response to stimuli have been broadly researched for 
controlled release systems. Various stimuli include pH, temperature and the 
application of an electrical field.10 According to Langer11, polymeric DDS should 
i) maintain a constant drug level ii) reduce harmful side effects iii) minimise the 
amount of drug needed and iv) decrease the amount of doses which will have a 
pronounced effect on the patient.  
 
The original polymeric controlled DDS was based on a non-biodegradable 
polymer, silicone rubber, which was designed and tested by Folkman and 
Long.12 They loaded a silicone capsule (Silastic*) with a number of different 
drugs for the treatment of heart block and successfully implanted and 
monitored their effects over a number of days.  
 
In more recent years there has been considerable interest in the development of 
new and efficient DDS, particularly with the growth of sophisticated drugs that 
are based on DNA and proteins.5, 13 Currently, there are several materials under 
consideration in drug delivery, for example dendrimers14, nanoparticles15 and 
hydrogels16. The most promising opportunities in controlled DDS are in the area 
of responsive polymeric materials, with the possibility of implantable devices 
being used to deliver drugs. Murdan17 exhaustively reviewed the use of 
hydrogels as ‘smart’ drug delivery devices. He showed that hydrogels could be 
engineered for various medicinal treatments depending on the patients needs, 
for example, pain relief. In the body, drug release can only be accomplished if 
the drug carrier responds to some class of stimuli, be it chemical, physical or 
biological. Conversely, an implanted ‘smart’ drug delivery device should be non-
responsive to all other types of stimulus, once inside the body. A way of 
achieving this form of control is through an electrical stimulus.17 A number of in 
vivo devices, in the form of iontophoresis, have already been used for this type 
of controlled release.17, 18 Murdan presented a case where hydrogels loaded 
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with a bioactive compound, were implanted at a target site and the drug 
liberated through the application of an electrical field. In utilising such a system, 
many advantages including, minimal drug usage and lowering toxicity problems 
can be achieved. However, a problem arising with the application of an electrical 
stimuli to polymeric materials like, hydrogels, is that they experience deswelling 
or bending, which affects the drug release.17  
 
To overcome these problems, conducting polymers (CPs) are also receiving 
much attention in the field of biomedical research, for the application of 
controlled DDS, due to their light weight, good biocompatibility and ability to 
function at body temperature. In particular, conducting polymers exhibit a 
reversible electrochemical response. These reversible oxidation-reduction 
reactions are attractive for a responsive DDS, as a change in the net charge on a 
conducting polymer film during its reduction or oxidation requires ions to flow 
into or out of the film. This, in turn, allows the polymer film to bind and expel 
ions in response to electrical signals. Controlled release of drugs from polymers 
offers many advantages over conventional methods including better control of 
the drug level administered resulting in fewer side effects, local drug delivery, 
decreased requirements for the total amount of drug and protection of drugs 
which are rapidly destroyed by the body. However, in order to devise a suitable 
technology, the polymeric material must be responsive, i.e., it must be capable of 
altering so that the drug is released in a controlled fashion when needed. 
 
1.1.2 Conducting polymers 
A polymer is a large molecule made up of smaller repeating units. The name 
comes from the Greek poly, meaning ‘many’, and mer, meaning ‘part’. They are 
built up from simple molecules called monomers ‘single part’. Polymers are 
produced through a method known as polymerisation. This polymerisation step 
can be achieved through chemical or electrochemical methods. Originally 
polymers with the basic carbon chains were considered only as insulators.19 The 
first real interest in conducting polymers can be attributed to Walatka et al.20 in 
1973 with the report of highly conducting polysulfur nitride (SN)x. Meanwhile 
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and towards the late 1970s , MacDiarmid, Shirakawa and Heeger enhanced the 
discovery of the semi-conducting and metallic properties of the chemically 
synthesised organic polyacetylene.21-24 As is well known, the Nobel Prize in 
Chemistry was awarded to Alan J.Heeger, Alan G. MacDiarmid and Hideki 
Shirakawa in 2000 for the discovery and development of conducting polymers 
(CPs).21-24 In the following years, a wide range of polymeric organic species have 
been prepared as stable inherent films on inert electrodes via both chemical 
oxidation and electropolymerisation from aqueous and organic solution.25 
 
CPs are organic materials, which generally are comprised simply of C, H and 
simple heteroatoms such as N and S. Common examples include PPy, polyaniline 
and polythiophene which are shown in Figure 1.2. These and a number of other 
conducting polymers have been used in a variety of applications ranging from 
corrosion protection of materials, sensors to many biomedical applications, 
such as tissue engineering, nerve cell regeneration and drug delivery.26-29 
 
 
 
 
Figure 1.2: Chemical structures of (A) polypyrrole (B) polyaniline and (C) 
polythiophene. All polymers are shown in the dedoped state. 
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In, general materials are classed depending on their electrical conductivity, ĸ, 
where the electrical conductivity of insulators < semiconductors < conductors. 
Bredas and Street30 explained this phenomenon in terms of the band gap 
structure. Figure 1.3 illustrates the difference in each material using the band 
gap theory. The highest occupied molecular orbital is equivalent to the valence 
band (VB), while the lowest unoccupied molecular orbital may be equated to the 
conduction band (CB). The difference between each band is known as the band 
gap energy (Eg) and it is this energy gap that establishes the electrical 
properties of a material. If Eg > 10 eV, it is difficult to excite electrons into the 
conduction band and an insulator is formed. If Eg ~ 1.0 eV then thermal energy is 
sufficient to promote the electrons into the conduction band and a 
semiconductor is formed. If the gap vanishes, with overlap of the valence and 
conduction band, as shown in Figure 1.3, metallic conduction is observed. For 
most doped CPs the band gap energy is generally close to 1.0 eV, and 
consequently, CPs can be classified as semi-conductors. 
 
As pointed out by Bredas and Street30, the conductivity observed upon doping of 
the CPs was originally thought to be from the formation of unfilled electronic 
bands, however this idea was quickly dissipated upon experimental analysis of 
PPy and polyacetylene and now it is recognised that the conductivity is due to 
the formation of polarons and bipolarons, which are more energetically    
favoured.30, 31 
 
The π-bonded system of CPs, which comprises of alternating single and double 
bonds, enabling the delocalisation of electrons along the polymer backbone, is 
related to the conductivity of the system. The conductivity of these materials 
arises from a state of relative oxidation or reduction. In these states the polymer 
either loses (oxidation) or gains (reduction) an electron. Generally, it is said that 
this process occurs in 1 in every 4 monomer units.32 In this state the polymer is 
electronically charged and requires the introduction of counter ions (dopants) 
to compensate and reform the charge neutrality. The oxidation of the polymer in 
which an electron is removed from a π-bond, gives rise to a new energy state, 
which leaves the remaining electron in a non-bonding orbital. This energy level 
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is higher than the valence band and behaves like a heavily doped 
semiconductor.32 The extent of doping can be controlled during the 
polymerisation of the polymers. 
 
 
 
 
Figure 1.3: Schematic of the difference in band gap for Insulators, semi-conductors and 
metals (conductors). 
 
 
1.1.2.1 Polymerisation methods 
CPs are synthesised through a method known as oxidative polymerisation. This 
can be generated chemically or electrochemically. Chemical polymerisation 
involves the use of a chemical oxidant, such as ammonium peroxydisulfate 
(APS), ferric ions, permanganate, dichromate anions or hydrogen peroxide.  The 
oxidants not only oxidise the monomer but provide dopant anions to neutralise 
the positive charges formed on the polymer backbone.33 In the presence of these 
oxidants, the monomers are oxidised and chemically active cation radicals are 
formed which further react with the monomer and generate the desired 
polymer. An advantage of vapour phase chemical polymerisation of CPs is that 
the polymerisation occurs almost exclusively on the preferred surface and a 
higher surface area can be attained.34 Vapour phase chemical polymerisation of 
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pyrrole leads to further doping after polymerisation and this gives rise to an 
increase in conductivity.35 
 
The electrochemical deposition is a simple and reproducible technique where 
the dopant is present in the electrolyte during polymerisation. It is generally 
performed in a conventional three electrode set up, described later in Chapter 2, 
where current is passed through a solution containing the monomer in the 
presence of a dopant (electrolyte). The CP is deposited at the positively charged 
working electrode or anode.27 Polymerisation is initiated through the oxidation 
of the monomer which forms a mobile charge carrier known as a polaron 
(radical cation), that can react with another monomer or polaron to form a 
bipolaron (radical dication) which leads to the formation of the insoluble 
polymer chain and deposition of the polymer onto the working electrode.36  
 
In his book ‘Conducting Polymers’ published in 1986, Alcacer commented on the 
possibility of using CPs to make artificial muscles or perhaps even modification 
for the brain; little did he realise the extent to which these materials have been 
extensively researched, over the past 20 years.32 Since their discovery, the 
preparation and characterisation of these materials has evolved substantially 
through the use of electrochemistry. The majority of research is significantly 
based in this area due to the ease and control of synthesis of these electronically 
CPs.19 Reviews on the development of CPs show the various areas to where they 
can be applied. The applications are ongoing.37-40 However, in the case of DDS, 
CPs, in particular PPy, are widely researched for the controlled release of 
therapeutically active compunds.41-45 During oxidative polymerisation, a dopant 
molecule, with an overall anionic charge, is used to compensate for the positive 
charges originating from the oxidation of the monomer. It is during this process 
that the concept of drug delivery originated. Burgmayer and Murray46 observed 
changes in the ionic permeability of PPy redox membranes using a voltage-
controlled electrochemical reaction. This led to further investigations into the 
application of CPs in DDS. 
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1.1.2.2 Polypyrrole 
1.1.2.2.1 Historical background of polypyrrole  
In 1968 Dall’Olio and colleagues prepared black films of an oxypyrrole on 
platinum by the electrochemical polymerisation of pyrrole from a solution of 
sulfuric acid.47 In 1979 Diaz with the help of colleagues modified Dall’Olio’s 
approach and demonstrated that polymerising pyrrole onto platinum in 
acetonitrile led to a black, adherent film.48 Elemental analysis showed that the 
monomer unit was retained in the polymer. PPy in general, was poorly 
crystalline, and its ideal structure was a planar (α-ά)-bonded chain in which the 
orientation of the pyrrole molecules alternate.25 
The monomer unit, pyrrole, is shown in Figure 1.4. PPy is an organic material 
comprised simply of C, H and a simple N heteroatom, but is highly conducting. It 
is an inherently conductive polymer due to interchain hopping of electrons. PPy 
can be synthesised both chemically49 and electrochemically48. The 
electrochemical synthesis method is a one step synthesis method and allows the 
simple deposition of polymer films where its surface charge characteristics can 
easily be modified by changing the dopant anion (A-) that is incorporated into 
the material during synthesis. In a cell containing an aqueous or non-aqueous 
solution of the monomer, PPy forms a (semi) conducting film on the working 
electrode; the film grown is in the oxidised form and can be reduced to the non-
conducting insulating form by stepping the potential to more negative values. 
The potential cycling can be repeated many times between the insulating and 
(semi) conducting forms without a loss of the electroactivity of the film.25 
 
 
 
Figure 1.4: Schematic illustration of a monomer unit of pyrrole. 
 
H
N
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PPy in its neutral form is weakly coloured while the oxidised form is a deep 
blue/black. The switching of the state of the film not only changes its 
conductivity but it is also accompanied by a marked colour change, termed 
electrochromism.36 Materials such as PPy are important in terms of future 
technological impact as it may be possible to develop them to replace more 
expensive, often toxic, metallic conductors commonly employed in the 
electronics industry.25 
 
1.1.2.2.2 Polymerisation mechanism of pyrrole 
Although there are still various opinions on the mechanistic features of the 
electropolymerisation of pyrrole, the mechanism proposed by Diaz and his 
colleagues48 and later used by Baker and Reynolds is in good agreement with 
many experimental reports.50 The mechanism is demonstrated in Figure 1.5.  
 
The initial step is the generation of the radical cation. This cation has different 
resonance forms, as shown in Figure 1.5. In the next step in the chemical case, 
the radical cation then attacks another monomer molecule, generating a dimer 
radical cation. In the electrochemical case, the concentrations of radical cations 
is much larger than that of neutral monomers in the vicinity of the electrode 
where reactions are occurring, and radical-radical coupling leads to a radical 
dication. This coupling between the two pyrrole radicals results in the 
formation of a bond between the two α positions to give the radical dication, as 
highlighted in Figure 1.5. This is then followed by the loss of two protons, 
generating a neutral dimer. This dimer is then oxidised into a radical cation, 
where the unpaired electron is delocalised over the dimer. The radical dimer 
then couples with the radical monomer to form a trimer. The polymerisation 
thus progressing in this fashion to completion.  
 
The controversy in the mechanism of electropolymerisation is not surprising 
given that many factors, such as the nature of the electrolyte, ionic strength, pH, 
temperature and potential are important and can influence the mechanism of 
the reaction. 
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Figure 1.5: Mechanism of electrochemical polymerisation of pyrrole.50 
 
1.1.2.2.3 Biocompatibility 
PPy is one of the most widely researched conductive polymers. The fact that it 
can form biologically compatible matrices is one of the prominent reasons for 
the extensive research on the use of PPy in the field of biological applications.51 
Wang et al.52 acknowledged the reality that PPy had showed very good in vitro 
biocompatibility,29, 53, 54 but they wanted to evaluate further the in vivo 
biocompatibility prospects. They demonstrated that in comparison to no PPy, 
the presence of PPy/biodegradable composites stimulated no abnormal tissue 
response and had no affect on the degradation behaviour of the biodegradable 
materials. In 1994, PPy was one of the first conducting polymers investigated 
for its effect on mammalian cells.55 Since then, PPy is known to be 
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biocompatible, so it can be placed in the body without having adverse effects. It 
has been shown, in particular, to support cell growth and adhesion of 
endothelial cells.29, 55-57 Schmidt et al.29 also demonstrated that PPy was a 
suitable material for both in vitro nerve cell culture and in vivo implantation. 
PPy was electrochemically deposited onto ITO-conductive borosilicate glass. 
Moreover, the application of an external electrical stimulus through the polymer 
film resulted in enhanced neurite outgrowth. The median neurite length for PC-
12 cells grown on PPy film subjected to an electrical stimulus increased nearly 
two-fold compared with cells grown on PPy without the application of a 
constant potential. The group also investigated PPy in vivo and their studies 
showed that PPy promotes little negative tissue and inflammatory response. 
Due to the good biocompatible factor, studies on the application of an electric 
field to the PPy have also shown cell compatibility.29 In some important 
applications, such as biological sensors and actuators for medical devices it is a 
very attractive trait and some recent applications show that PPy can enhanced 
nerve cell regeneration and tissue engineering.27  
 
1.1.2.2.4 Electroactivity of polypyrrole 
PPy can be easily switched between the neutral, partially oxidised and fully 
oxidised states, as shown in Figure 1.6.  In its neutral state PPy exists as an 
insulator where the conduction band is empty as all the electrons remain in the 
valence band. Upon oxidation, an electron is removed from a π-bond (valence 
band) and a polaron is formed. The separation of the positive charge and the 
unpaired electron decreases during continual oxidation as the number of 
polarons increases. This in turn gives rise to the formation of a bipolaron, as 
depicted in Figure 1.6(C), and the polymer is now in its fully oxidised state. 
 
During oxidation and the generation of positive charge an influx of anions into 
the polymer matrix is observed in order to maintain charge balance.  This can be 
represented in Equation 1.1, where PPyo refers to the neutral (reduced) 
polymer, PPy+ refers to the oxidised polymer and A- refers to the anionic dopant. 
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PPy0  +  A-    PPy+A- + e-     1.1 
 
 
Typical anionic dopants are chlorides, bromides, iodides, perchlorates, nitrates, 
sulfates and para-toluene sulfonates.58-64 The extent of oxidation/reduction is 
given by the doping level and this is generally expressed as the ratio of dopant 
anions, A-, incorporated per monomer unit. For example, 1 A- per 4 monomer 
units gives a doping level of 0.25 or 25%. The maximum doping level achievable 
with PPy is 0.33 or 33%, i.e., 1 A- per 3 pyrrole units. It is important to point out 
that doping may not always be uniform; there can be islands with high doping 
levels surrounding by regions with a much lower doping level. 
 
 
  
 
 
 
Figure 1.6: Electronic structures of (A) neutral PPy, (B) polaron in partially doped PPy 
and (C) bipolaron in fully doped (oxidised) PPy.36 
1.1.2.2.5 Polypyrrole and drug delivery 
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
- e-
- e-
(A) 
 
 
 
 
 
(B) 
 
 
 
 
(C) 
 
Introduction and literature review  Chapter 1 
- 16 - 
The electrochemical switching of PPy films is accompanied by movement of 
counter or dopant ions in and out of the polymer matrix to maintain the charge 
neutrality, as shown in Section 1.1.2.3.4. Consequently, PPy films are attractive 
for the controlled release of drug molecules. The concept of using PPy 
membranes for the uptake and release of ions was introduced, in the early 
1980s, by Burgmayer and Murray46.  They demonstrated that these polymeric 
films could be exchanged from their oxidised state to their neutral state. PPy has 
been seriously considered for drug delivery due to these unique redox 
properties. PPy gives a responsive material needed in order for the uptake and 
release of the drug to be controlled; in its oxidised state anions are 
electrostatically bound to the polymer film. These properties allow the 
controlled transport of ions. The uptake of these ions can occur in two ways. 
The first is where the bioactive molecule exists as an anion and is involved in 
the doping process of the polymeric material during polymerisation, Figure 1.7 
(A). Some anions that have been researched include adenosine tri phosphate 
(ATP)65, salicylate26, and dexamethasome26. These anions are electrostatically 
entrapped into the polymer matrix during the growth process upon application 
of an anodic potential. The anions are consequently liberated during the 
reduction of the polymer.  
 
 
 
 
Figure 1.7: Interconversion between oxidation and reduction states of PPy (PPy). (A) 
Anion (A-) incorporation and release which is notably observed in small mobile anions 
(e.g. Cl-) while, (B) Cation (C+) insertion and liberation from polymer films doped with 
larger anions  (e.g. DDS-) which remain entrapped in the polymer matrix. 
In the second case, cations can be incorporated into the system, Figure 1.7 (B), if 
the properties of the polymer film are modified.66 This is achieved through the 
Reduction
Oxidation
N
H
N
H
N
H
A- A
-C+
N
H
N
H
N
H
A-
Reduction
Oxidation
N
H
N
H
N
H
+ A-
+ C+
N
H
N
H
N
H
(A) 
 
 
 
(B) 
Introduction and literature review  Chapter 1 
- 17 - 
initial inclusion of a large anion which remains entrapped in the polymer matrix 
and thus the polymer behaves as a cation exchanger, where, the charge of the 
polymer system can only be compensated through the uptake of cations. The 
cations are therefore, taken in during the reduction of the polymer and released 
upon oxidation. Figure 1.7 demonstrates both these concepts. 
 
Miller and Zhou67 previously reported the release of dopamine from a poly(N-
methlypyrrole)/poly(styrenesulfonate) (PNMP/PSS) polymer based on the 
properties of these redox polymers. Immobilisation of PSS, a large anion, allows 
the uptake and release of the cation upon appropriate application of a potential. 
They achieved the release of dopamine using potential control, while more 
recently, Hepel and Mahdavi66 demonstrated the controlled release of a cationic 
species, chloropromazine, from a composite polymer film based on the same 
principles. They reported the development of a new composite conducting 
polymer, PPy/melanin, which performed as a cation binder and releaser. The 
modification of the polymer films, to enable the predominant cationic exchange 
properties of the CP, is an interesting way of improving the uptake and release 
of cationic species from these attractive materials. 
 
New ways of improving the controlled release of drugs are continually being 
sought after.  Lately, Abidan et al.41 reported on a method to prepare 
conducting-polymer nanotubes that can be used for controlled drug release. 
They introduced a method known as electrospinning to fabricate a nanofibrous 
mat in which the drug to be delivered had previously been incorporated; 
followed by electrochemical deposition of PPy films around the drug-loaded, 
electrospun biodegradable polymers. The drug release was achieved through 
the electrical stimulation of the PPy nanotubes. 
 
 
 
1.1.2.2.6 The application of Nanotechnology in drug delivery 
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Nanotechnology, although dating back to much earlier times, gained 
considerable attention in the early 1990s and has been the focus of much 
research over the last number of years. The introduction of nanotechnology into 
a controlled DDS has been shown to enhance many physical and chemical 
properties and overall has been used to increase the surface area of materials. 
This, in turn, leads to an increase in the amount of drug released from various 
materials. Many groups have introduced nanotechnology in various forms to 
improve on the drug delivery of a number of bioactive compounds, including 
nanoparticles15, micellar systems68 and nanofibers69. Polymeric nanofibers are 
gaining substantial interest for various applications including drug delivery69, 70. 
Several techniques have been employed for the production of nanofibers such 
as template synthesis71, self assembly72 and drawing73. One technique, in 
particular that is receiving considerable interest in this field, is 
electrospinning.74-77 Electrospinning has been introduced to achieve nanoscale 
membranes and fibres from various polymeric materials.78 
 
1.1.2.2.7 The application of Electrospinning to drug delivery 
Although electrospinning was first reported by Formhals79 in 1934 it has only 
been explored further in recent times.80, 81 In 1996, Reneker and Chun restored 
interest in the electrospinning technique by demonstrating the possibility of 
electrospinning a wide range of organic polymers.81 Since then the technique of 
electrospinning has become extremely useful in a variety of applications.82-85 
Electrospinning is a simple and inexpensive means for the formation of nano- to 
micron polymer fibers. 
 
This technique involves the application of a high electric field between a 
polymer fluid and a grounded electrode. When the polymer solution is subjected 
to an external electric field at a critical point the forces overcome the surface 
tension of the polymer solution to form a droplet with a conical shape, i.e., the 
Taylor cone.83, 86 The fluid is drawn into a jet which undergoes a whipping 
motion. Volatile solvents are used to dissolve the polymer as the subsequent 
evaporation from the liquid jet results in solid fibers. A more detailed 
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description of this technique is provided in Chapter 2, Section 2.4.5. In the 
majority of cases the fibers deposit randomly on the grounded collector. 
However, many groups have investigated the use of rotating collector plates to 
produce aligned nanofibers.87 Figure 1.8 illustrates a typical SEM micrograph of 
an electrospun fiber mat of PLGA fibers. 
 
This production of nanofibers allows these polymers to be used in a wide 
variety of applications including, tissue engineering (muscles, skin, cartilage and 
bones), wound healing and sutures, biosensors and DDS. Shin et al.88 studied the 
use of PLGA nanofiber scaffold for cartilage reconstruction, while, Kim and 
colleagues incorporated antibiotics in the fibrous matrix for use in wound 
dressings.89 Other groups have also prepared ultrafine polymers via 
electrospinning for skin regeneration.74 
 
 
 
 
Figure 1.8: A typical SEM image of electrospun PLGA nanofibers. 
 
 
Another attractive feature of using this electrospinning technique is that 
biodegradable polymeric materials, such as poly(lactic acid) (PLA) and poly(D,L – 
lactide-co-glycolide) (PLGA) can be used as a biomedical controlled release 
system. These biodegradable polymers can be electrospun in the presence of 
varying amounts of the required medication. They can then be placed in the 
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body and the drug release achieved through the modification of the polymer 
matrix’s morphology, porosity and composition.89 These biodegradable 
polymers have FDA approval for biomedical and drug delivery use.90-93 In 
comparison to other delivery forms, the electrospun nanofibers can 
conveniently incorporate the therapeutic compound during the electrospinning 
process.94 Many drugs have been incorporated into PLGA electrospun polymer 
matrices, in order to achieve delivery of the therapeutic drug,  including, 
tetracycline hydrochloride95 and mefoxin89. In these cases, the drug release was 
monitored and a burst release was observed and was attributed to the high 
surface area-to-volume ratio of the electrospun material. This is a disadvantage. 
In the last few years a small number of groups have deposited electroactive 
polymers, such as PPy, onto previously electrospun fibers in order to enhance 
the electrochemical properties57 of the material. Also, electrospun fibers have 
been used as a template in order to obtain a high surface area in the hope of 
achieving a greater uptake and release of drugs.41 
 
Another method of improving the DDS of conducting polymers is the use of 
various dopants during polymerisation of the polymer films. The 
functionalisation of PPy films with large anionic dopants is not new to this field 
of research. It has been well reported that the use of large anionic dopants 
during the electrochemical polymerisation of monomers leads to these bulky 
negatively charged groups being immobilised within the polymer matrix.96 In 
fact, these polymers, with their cationic exchange properties, have been used to 
incorporate various cationic groups for various applications. For example Fan 
and Bard in the late 1980s demonstrated the uptake of a positively charge 
Ru(NH3)63+ and methylviologen in PPy/Nafion films.97 
 
However, the generation of PPy films in the presence of negatively charged 
cyclodextrins is a new concept.98-100 There has been very little work reported on 
the electropolymerisation of pyrrole in the presence of anionic cyclodextrins. 
Indeed, much of the current published work is unreliable as very high potentials 
in the vicinity of 1.8 V vs. SCE were used to form the polymers.100, 101 It is very 
well known that these high potentials give rise to the overoxidation of PPy and a 
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considerable loss in its conductivity.59 The incorporation of cyclodextrins into 
conducting polymers provides a unique way of combining the unique host-guest 
complexation properties of cyclodextrins with the stability, high conductivity 
and ease of preparation of conducting polymers.  
 
1.1.3 Cyclodextrins 
1.1.3.1 History and structural properties of cyclodextrins  
Cyclodextrins (CD) are macrocyclic oligosaccharides composed of α-D-
glucopyranoside units linked by α-(1,4) bonds. They were first discovered by 
Villiers in 1891102, while in 1904, Schardinger103 further developed the cyclic 
structures hence; CDs are sometimes referred to as Schardinger dextrins. 
However, it was only in the mid 1970s that the structure and chemical 
properties of natural cyclodextrins were fully characterised.104
 
Cyclodextrins 
have developed quickly over the past two decades and have become an 
important branch of host-guest chemistry, specifically due to their ability to be 
involved in several practical applications.105 The main interest in cyclodextrins 
lies in their ability to form inclusion complexes with a variety of compounds. 
Host-guest chemistry is the study of these inclusion phenomena, where the 
‘host’ molecules are capable of including smaller ‘guest’ molecules through non-
covalent interactions. 
 
CDs are obtained through enzymatic degradation of starch in the presence of a 
glycosyl transferase, a type of amylase.106 Many organisms contain glycosyl 
transferase, however, in general it is obtained from Bacillus megaterium, 
Bacillus stereothermophilus and Bacillus macerans.106, 107 They are generally 
made up of glucopyranoside units of 4C1 chair conformation which leads to a 
truncated cone shape encasing a cavity.108 Figure 1.9 shows the structures of the 
most common CD members; α-, β- and γ-CD, which include 6, 7 and 8 repeating 
glucopyranoside units, respectively. These units orientate themselves in a cyclic 
manner offering a typical conical or truncated cone structure with a relatively 
hydrophobic interior and hydrophilic exterior.109 This structural property gives 
cyclodextrins good water solubility and the ability to hold appropriately sized 
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used for many applications including, drug delivery to enhance the solubility, 
stability and bioavailability of drug molecules.108, 112
 
 
Table 1.1: Approximate geometric dimensions of the three common CDs.106  
 
 
 
 
 
Cyclodextrin x / nm y / nm Cavity volume / Å3 
α 0.49 0.78 174 
β 0.62 0.78 262 
γ 0.79 0.78 427 
 
 
Cyclodextrins can also be chemically modified to replace the hydroxyl groups on 
both the primary and secondary rims of the CDs, with a variety of appropriate 
alkyl groups (R). It has been reported that this can improve binding affinity.108 
In the research presented here, a negatively charged cyclodextrin with a 
number of sulfonated groups present on the outer rims was used, sulfonated β-
CD (Sβ-CD). Sβ-CD is obtained by substitution of either primary or secondary 
hydrogen of the hydroxyl group of β-CD with a sulfonate group. Sβ-CD has an 
average of 7-11 substituents per CD and, therefore, has between 7-11 negative 
charges associated with it, which are counterbalanced with sodium ions, as 
illustrated in Figure 1.10.113 It is reported that β-CD and Sβ-CD have the same 
ring structure, differing only in the substituent located on the rims of the CD 
ring.14 Although Sβ-CD has the same ring structure as other derivativsed CDs the 
presence of the substituent on the ring contributes to its chiral discrimination 
properties.114 A major area in which these sulfonated CDs are being utilised is 
chromatography, or more specifically capillary electrophoresis, for the 
enantiomeric separation of acidic and basic compounds. In enantiomeric 
separation, using neutral CDs, they are not appropriate for neutral racemates as 
the complex has no electrophoretic mobilities.115 Therefore, the use of charged 
   x   
 y 
Introduction and literature review  Chapter 1 
- 24 - 
CDs is now been widely researched for the separation of neutral compounds. It 
has been reported that the use of these sulfonated CDs for the enantiomeric 
separation of chiral compounds is highly effective as a result of the anionic 
charges.116, 117  
 
A number of groups have also characterised the Sβ-CD.115, 117 Figure 1.11 
illustrates a single glucose unit of an Sβ-CD (comprised of 7 units). On the 
primary ring there are 7 potential substitution sites corresponding to the C-6 
positions, while, on the secondary rim there are 14, represented by the C-2 and 
C-3 positions. Amini and co-workers117 reported that substitution of these CDs 
is predominantly at the C-2 and C-6 positions, while, Chen et al.115 confirmed 
nearly complete sulfation at the C-6 position of the primary hydroxyl groups 
and partial sulfation at the C-2 secondary hydroxyl groups. They also reported 
no substitution at the C-3 positions. From these reports it can be stated that 
almost the entire primary rim is sulfonated and some of the secondary rim. Due 
to this phenomenon and the fact that the sulfation brings with it negative 
charges these CDs are good candidates for the doping of CPs.  
 
 
R = SO3-Na+ or H ~ 7-11 SO3-Na+ groups. 
 
Figure 1.10: Structural and schematic representation of sulfonated β-cyclodextrin (Sβ-
CD). The arrows point to the primary and secondary rims, respectively.118 
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Figure 1.11: Chemical structure of Sβ-CD, depicting the numbering carbons. 
 
1.1.3.2 Inclusion complexation 
Cyclodextrins (CD) form a group of cyclic oligosaccharides that contain cavities 
in which guest molecules can be encapsulated.108, 109 It is well known that the 
size of the compounds are important and compounds are only capable of 
including into the cavity of the CD if they are within the dimensions of the CD 
cavity.119 In aqueous media, the cavity is filled with water molecules, which 
becomes displaced by the guest through complexation, as illustrated in Figure 
1.12. The guest molecule, xylene, displaces the water molecules and forms an 
inclusion complex with the CD. 
 
 
 
Figure 1.12: Schematic representation of xylene forming a complex with a β-
cyclodextrin. The small circles represent water molecules taken from Szjetli.109  
 
 
During the formation of an inclusion complex the chemical and the physical 
properties of the guest molecule change and can be monitored using a number 
of techniques. Various spectroscopic and electrochemical techniques can be 
used to confirm complexation, including fluorescence, UV-visible spectroscopy 
(UV), Nuclear magnetic resonance (NMR) and electrochemical studies. These 
changes attributed to the complexation can be used to evaluate the apparent 
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binding or formation constant (Kf). However, prior to the determination of the 
Kf  value the stoichiometry of the host-guest complex must be established.120 
This is obtained by the well known continuous variation or Job’s method which 
is described in more detail in Chapter 2, Section 2.6.1.1.121 Generally, inclusion 
complexes form a ratio of 1:1, 1:2 and sometimes 2:1 (CD:guest).122  
 
NMR is also a useful tool for the study of complexation due to its quantitative 
information and assuming the guest enters the cavity, NMR, can be also used to 
locate the protons involved in complexation.87 Many groups have studied the 
complexation properties with the neutral β-CD and monitored the changes in 
the chemical shifts for both the CD, and the guest. However, in the case of the 
modified CD used in this research, the NMR spectral data are too difficult to 
differentiate so the chemical shift of the guest is followed.120, 123-126 Bratu and 
colleagues125 studied the chemical shift changes observed when Fenbufen was 
in the presence of a neutral β-CD. They noticed an up-field shift of the guest 
protons, some more pronounced than others, and suggested that the 
complexation was initiated through the benzene moiety of the guest.               
Cruz et al.127 also used NMR to quantitatively evaluate the binding constant of 
the complexation of doxepin and a neutral β-CD.  
 
If a guest absorbs light in the UV or visible region then the inclusion 
phenomenon can be followed and subsequently, evaluated by UV.106 This 
technique can be used to confirm complexation and indeed obtain the formation 
constant associated with the inclusion complex. In the majority of cases the 
guest that absorbs in the UV-vis region experiences changes in the intensity and 
the position of the absorption bands in the presence of the CD. These spectral 
changes can be used to determine the Kf constants. Generally, a Hiedlebrand-
Benesi modified equation is used to evaluate the Kf constants.119, 128, 129 Ramaraj 
and co-workers130 monitored the changes attained during the complexation 
formation of a number of aromatic amines and nitro compounds in the presence 
of a neutral β-CD. They observed an increase in the intensity of the bands in all 
cases. Dang et al.119 observed shifts of the absorption bands to longer 
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wavelengths in the case of 1,4 benzoquinone (BQ) and 9,10 anthraquinone (AQ) 
in the presence of a neutral β-CD. 
 
Electrochemical techniques can also be performed on the complexation 
properties of CDs. If the guest is electroactive the peak current and potential can 
be followed for the free state and compared to the complexed state of the guest 
in question. Two features are generally observed during these electrochemical 
observations if an inclusion complex is found. Firstly, a decrease in the peak 
current can be seen, and, attributed to a decrease in the diffusion of the bulky 
CD complex as opposed to the more mobile free guest. Secondly, a shift in the 
peak potential is observed if the complexed species is included in the cavity, as 
it is harder to oxidise or reduce while located in the cavity. Once again based on 
these variations a number of equations can be used to verify the formation 
constant.129, 131, 132 Coutouli-Argyropoulou and his group133 reported the effect 
of complexation on the electrochemical properties of ferrocence derivatives and 
showed shifts, in both the peak current and peak potential, when higher 
concentrations of a neutral β-CD were added. Yanez et al.131 showed similar 
observations for nifedipine (NF) and nicardipine (NC) and estimated apparent 
formation constants of 135 and 357, respectively. 
 
Complexation studies of DA have been previously demonstrated in the presence 
of a neutral β-CD by Zhou et al.134 using UV and fluorescence spectroscopy. 
From the fluorescence technique, utilising a Hiedlebrand-Benesi modified 
equation, a Kf value of 95.06 was estimated. The degree of the complexation can 
vary over a wide range due to the stability of the complex, as it depends on a 
number of factors. In the next section a discussion on the main driving forces, 
involved in this complexation process are dealt with. 
 
1.1.3.3 Driving forces in the inclusion complexation process 
There are many reviews and books written on the driving forces behind the 
inclusion complexation abilities of cyclodextrins, not all agree, some refer to the 
predominantly hydrophobic affects while others state that it is a collection of  a 
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number of weaker interactions (H-bonding, van der Waals, electrostatic 
interactions).106, 108, 111, 135, 136 Either way the majority agree that the size of the 
cavity and shape of the guest are important factors in the complexation process. 
The most widely studied possible driving forces include  
 
 Hydrogen bonding  
 Electrostatic interaction 
 Van der Waals 
 Hydrophobic effect 
 
Hydrogen bonding is an interaction between an electronegative donor, a 
hydrogen and an electronegative acceptor.136 Various groups have 
demonstrated the importance of hydrogen bonding in the solid state, illustrating 
crystal structures defining the hydrogen bonding between the guest and the 
hydroxyls of the CDs.137 However, during the complexation of the CD and guest, 
in aqueous solution, the subject is still arguable as few direct measurements of 
hydrogen bonding have been made, as water molecules can compete with CDs 
to form hydrogen bonding with guest molecules. However, many groups will 
still argue over the significance of hydrogen bonding. 
 
Electrostatic interaction occurs when molecules of opposite charges interact. 
There are three types of electrostatic interactions, ion-ion interaction, ion-
dipole interaction and dipole-dipole interaction.136 Matsui and Okimoto138 
reported that ion-ion interaction is only eligible in the case of modified CDs, 
where as ion-dipole is considered more favourably due to the fact that CDs are 
polar molecules however as with hydrogen bonding, in aqueous media, the 
interaction between the guest and water will also be strong.136 Therefore, it is 
the case of dipole-dipole interaction that is mostly considered during 
complexation. 
 
Van der Waals forces or London dispersion forces are made up of dipole 
induced dipole contributions or the coordination of the electronic motion in the 
CD and guest. As CDs are known to have large dipole moments it is logical that 
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these induction forces are important in complexation. Experimental evidence 
has shown that the stability of the complex increases with an increase in 
polarisability. Also, as the polarisability of water is lower than the organic 
components of the CD cavity, van der Waals forces have an encouraging 
donation to the stability of the complex due to a stronger interaction of the CD 
and guest over the water and guest.136 CDs have also been reported to form 
stable inclusion complexes in organic solvents like DMF and DMSO confirming 
the importance of van der Waals forces.139 
 
The hydrophobic interaction which is entropically favourable, due to the 
expulsion of water, leads to the aggregation of non-polar solutes in aqueous 
solution.136 As reviewed by Connors135 the ‘classical’ hydrophobic interaction is 
said to be ‘entropy driven’ and a positive entropy and enthalpy is associated for 
the interaction between two non polar molecules. However, experimental 
studies in the complexation of CD and guests, show negative enthalpy and 
entropy changes,111 which have been suggested to indicate that these 
interactions are not a dominant force.  
 
Mosinger et al.122 reported that the formation of an inclusion complex is based 
on the electrostatic, van der Waals and π-π interactions, where, steric affects 
and Hydrogen bonding are inevitable. Chao and co-workers124 investigated the 
formation of an inclusion complex with β-CD and caffeic acid, they reported that 
the weak forces of hydrogen bonding, van der Waals, hydrophobic and 
electrostatic interactions simultaneously governed the process. 
 
Rekharsky and Inoue111 reviewed the complexation of cyclodextrins and stated 
that the interactions involved in the inclusion complexation of aromatic guests 
with CDs could not be simply put down to a hydrophobic effect. They 
established that complexation could be accounted for, through dipole-dipole 
interactions. In saying that, Tabushi and his group140 questioned the role of 
hydrogen bonding in the complexation process and reported that no dramatic 
changes of binding were observed, when a modified CD, incapable of hydrogen 
bonding, was compared to an unmodified CD. They concluded that the 
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involvement of hydrogen bonding was negligible and hydrophobic interactions 
dominated the process. Zia et al.113 investigated the complexation ability of a 
negatively charged CD (~7 negative sites) with a number of neutral and charged 
guest molecules. They accounted for the increase in the binding affinity, for the 
oppositely charged guest and CD, to be predominantly hydrophobic, due to the 
additional interaction sites provided by the negatively charged CD. Okimoto and 
colleagues141 also clearly observed stronger interactions occurring between a 
CD and guest with opposite charges. 
 
The understanding of these complexation processes is complicated, however, it 
is generally found that van der Waals forces and hydrophobic interactions are 
regarded as the main driving forces for CD complexation, while, electrostatic 
interactions and hydrogen bonding can be significantly considered in some 
inclusion complexation studies. Nevertheless, these attractive features of CDs 
allow them to be used in a wide range of applications including, the food 
industry142. However, the pharmaceutical industry is the most widely 
researched area in recent times, specifically in drug formulation and DDS.143 
 
1.1.3.4 Applications of CDs in DDS  
Due to their biocompatibility and their ability to form inclusion complexes, CDs 
have been studied for the use in DDS. They have been considered as drug 
carriers, as CDs have the potential to act as hydrophobic carriers and control the 
release of a variety of drugs.118  Many reviews have recently been published, 
describing the role of CDs in DDS.112, 118, 144-147 Irie and Uekama144 reviewed the 
role of CDs in peptide and protein delivery and summarised that CDs were able 
to eliminate a number of undesirable properties of drug formulations, as they 
form inclusion complexes with the desired drugs, which increase the drug 
delivery through a number of routes of administration. More recently, Li et al.145 
examined the recent progress in the preparation of inclusion complexes 
between CDs and various polymers as supramolecular biomaterials for drug 
and gene delivery. They demonstrated the promising field in the self assembly 
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of inclusion complexes between CDs and biodegradable polymers as injectable 
DDS.  
 
Ferancova and Labuda148 also reviewed the use of CDs as electrode modifiers. 
They summarised the many ways CDs can be immobilised onto electrode 
surfaces. As discussed in an earlier section, Section 1.1.4.2., the incorporation of 
CDs, as dopants, during the electrochemical polymerisation of CPs was 
demonstrated to examine the use of these modified electrodes to deliver neutral 
drugs.98 Formulating these materials, correlates the attractive features of both 
the CDs and the CPs. Bidan et al.98 examined the need for a new DDS that was 
not limited to charged drugs. They produced polymer films in the presence of an 
anionic CD and successfully delivered neutral compounds using these novel 
materials.         
 
Also briefly discussed in Section 1.1.4.2, was the reports made by a number of 
groups on the polymerisation of CPs in the presence of CDs.100, 101, 149 These 
groups have reportedly polymerised pyrrole at potentials usually shown to 
overoxidise the CP film.59 Due to this, these papers are unreliable in their 
reports. 
 
1.1.4 Drug release: Controlled release of dopamine 
DA is a neurotransmitter produced naturally in the brain. It is well documented 
that a common factor in neurodegenerative diseases such as Parkinson’s (PD) 
and Schizophrenia is a significant lack of the presence of DA in the substantia 
nigra (mid brain).150-152 In particular, PD is a slowly progressive disorder known 
to occur due to the damage of the basal ganglia.150-152 The disease affects 
movement, muscle control and balance. Studies on the brains of deceased 
Parkinson sufferers show a substantial loss of dopamine, particularly, in the 
substantia nigra. The function of the substantia nigra is to produce DA and 
manage the release of essential neurotransmitters that help control movement 
and coordination. Sufferers usually show symptoms such as tremors, slowness 
of movement and impaired balance and coordination. Prolonged loss of DA 
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gives rise to symptoms such as difficulty in walking, talking, or completing other 
simple tasks.150-152  
 
DA belongs to the well known catecholamine family. These molecules are 
electroactive and therefore their oxidation can be followed using 
electrochemistry, in particular, electrochemical methods such as cyclic 
voltammetry and rotational disc voltammetry. The electrochemical mechanism 
of oxidation is still not fully agreed; with various groups arguing that the 
mechanism goes through an ECE step rather than a CE step. For example, 
Hawley et al.153 have reported that the electrochemical oxidation of dopamine in 
aqueous solution proceeds through two types of steps, electrochemical (E) and 
chemical (C). The ECE mechanism is presented in Scheme 1.1. 
 
The first step in the oxidation of dopamine (A) involves the loss of both protons 
and electrons to form the o-dopaminoquinone (B). The oxidised, o-
dopaminoquinone undergoes a 1,4-Michael addition, which results in a 
intramolecular cyclisation reaction which produces leucodopaminochrome (C). 
This product is easily oxidised through an electrochemical step to form 
dopaminochrome (D).153, 154 
 
Controlled release studies of DA have been previously investigated.67, 155-158 
McRae-Degueurce et al.156 encapsulated DA into a thermoplastic polyester 
excipient: PLGA. They found that it was possible to deliver significant amounts 
of DA for prolonged periods of time by injecting the microencapsulated DA 
directly into the brain. Uludag and colleagues157 also examined the release of 
many therapeutic agents, including DA, from microencapsulated mammalian 
cells. The mammalian cells and tissues were entrapped in polymeric 
microcapsules containing the desired bioactive agent. 
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Scheme 1.1: The proposed oxidative pathway for dopamine. 
 
 
In both these cases the release was based on diffusion from the polymeric 
materials. It is, therefore, difficult to maintain any control over the amount of 
DA released. Miller67 and Zhou158 and co-workers investigated the use of CPs to 
deliver DA. They introduced the concept of using large immobile dopants, which 
remain entrapped inside the cavity during polymerisation, to bind and 
successfully liberate DA from the polymer films.  
This is the basis of the work performed in this thesis. As outlined at the start of 
this chapter, the idea of this research is to develop PPy films for the uptake and 
release of DA, using a large immobile anionic cyclodextrin. The cyclodextrin, in 
addition to its large size and immobility, has unique host-guest complexation 
properties and this offers the prospects of inclusion complexation between the 
DA and the CD to enhance the drug delivery. If this can be achieved it could 
potentially serve as a model system in DDS and could be extended to various 
other cationic drug molecules.  
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1.1 Introduction 
The initial aim of this work was to examine the use of polypyrrole (PPy), a well-
known conducting polymer, for the uptake and release of a cationic species, 
dopamine (DA). DA was chosen as it represents a large family of amine-based 
drugs. Therefore, if appropriate PPy films could be electrosynthesised and used 
in the controlled delivery of DA, then the concept could be used more widely in 
the field of controlled drug delivery.  
 
In Chapter 3, the growth of PPy films in the presence of various dopant anions, 
including a large anionic cyclodextrin (CD), sulfonated β-cyclodextrin (Sβ-CD) is 
explored. Although Sβ-CD doped PPy films have been reported in the recent 
literature, there has been very little work devoted to the characterisation of 
these films. Accordingly, much of Chapter 3 is devoted to the unique redox 
properties of the Sβ-CD doped PPy films.   
 
With the growth of the PPy films achieved, Chapter 4, shows the drug release 
profiles of the protonated DA and reveals that in the case of the polymer films 
doped with the anionic Sβ-CD, there is a substantial increase in the amount of 
DA released in comparison to other polymer films. In order to explain the 
enhanced release profiles, the well-known supramolecular complexation 
properties of cyclodextrins were considered. However, on searching the 
literature no reports on the complexation of DA with anionic cyclodextrins were 
found and consequently this was studied in detail. These findings are presented 
in Chapter 5, where the host-guest interactions between DA and the anionic Sβ-
CD are examined using a variety of techniques, both spectroscopic and 
electrochemical.  
 
In Chapter 6 the technique of electrospinning is introduced. Details on how it is 
used to fabricate nanostructured biodegradable polymer films with a high 
surface area are provided. The approaches used to deposit the Sβ-CD doped PPy 
films onto the nanostructured biodegradable film are then considered and 
discussed. It is shown that cyclic voltammetry was the most successful 
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approach. Moreover, it was possible to control the amount of PPy deposited and 
to maintain the nanostructured fiber substrate by varying the number of cycles. 
These high surface area Sβ-CD doped PPy films are promising for the uptake 
and liberation of DA.  
 
In this introductory chapter, the concept of controlled drug release is firstly 
introduced. This is then followed with information on conducting polymers, 
particularly PPy and the current state-of-art in using PPy in drug delivery. The 
technique of electrospinning is then introduced and linked to DDS. The next 
section is devoted to cyclodextrins, as it is the Sβ-CD doped PPy films that give 
the best controlled release properties. Finally, the chapter ends with a short 
account of the properties of DA and its delivery.  
 
1.1.1 Controlled drug release 
In the early 1970s, controlled release systems first materialised. Since then, the 
number and the areas in which a controlled release system is utilised have 
significantly increased. These systems have been used in areas such as 
cosmetics1, food2, and pesticides3. Controlled release systems are focused on 
obtaining the release of the proposed material, over a certain time without an 
external influence from any other potential release factor.4 Polymeric materials 
have been previously investigated for controlled release as they can be easily 
manufactured and their composition can be finely tuned.5 Polymers used in 
controlled release systems can be natural or synthetic and release can be 
achieved through the engineering of the polymer substrates, i.e., the 
degradation of poly(D,L – lactide-co-glycolide)  (PLGA) can be controlled through 
the polymer composition, higher ratios of PLA lead to a higher degradation 
rate.6 
 
Another important research area under consideration is the development of 
controlled drug delivery systems (DDS).7, 8 In 1980, controlled DDS were 
virtually unknown, yet in 2005, almost 100 million people globally were using 
some form of polymer based DDS.8 The aim of a DDS is to supply the drug in its 
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therapeutically active form to a specific target in the body when the drug is 
required. In the current administration process there is a critical concentration 
needed in order to achieve the drug’s maximum therapeutic effect. If the 
concentration goes beyond the maximum level, toxicity problems come into 
play. Conversely, if the concentration administered is below the minimum level 
the effect of the drug is not observed. The use of these DDS could potentially 
eliminate these problems as the release would be of a controlled manner.  
 
Santini et al.7 compared the release profiles of both conventional and controlled 
methods, as illustrated in Figure 1.1. With conventional methods of drug 
delivery, outlined in Figure 1.1(A), i.e., oral administration or injections, drug 
levels rise after initial administration, which could lead to potential toxicity 
problems, and then decrease until the next dosage, which has consequences on 
the efficiency of the dosage. The other schematic, Figure 1.1(B), demonstrates 
the effectiveness of a controlled release system. After dosage, the drug level in 
the blood remains constant, between the maximum and minimum levels, for a 
certain period of time. 
 
 
 
 
Figure 1.1: Drug levels in the blood with (A) conventional drug dosage (B) controlled 
delivery dosage, taken from Santini et al.7 
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In recent years, polymeric materials have been examined and shown to provide 
an alternate means of delivering drugs. Implanted polymeric pellets or 
microspheres localise therapy to specific anatomic sites, providing a continuous 
sustained release of drugs while minimising systemic exposure.9 Polymers that 
display a physiochemical response to stimuli have been broadly researched for 
controlled release systems. Various stimuli include pH, temperature and the 
application of an electrical field.10 According to Langer11, polymeric DDS should 
i) maintain a constant drug level ii) reduce harmful side effects iii) minimise the 
amount of drug needed and iv) decrease the amount of doses which will have a 
pronounced effect on the patient.  
 
The original polymeric controlled DDS was based on a non-biodegradable 
polymer, silicone rubber, which was designed and tested by Folkman and 
Long.12 They loaded a silicone capsule (Silastic*) with a number of different 
drugs for the treatment of heart block and successfully implanted and 
monitored their effects over a number of days.  
 
In more recent years there has been considerable interest in the development of 
new and efficient DDS, particularly with the growth of sophisticated drugs that 
are based on DNA and proteins.5, 13 Currently, there are several materials under 
consideration in drug delivery, for example dendrimers14, nanoparticles15 and 
hydrogels16. The most promising opportunities in controlled DDS are in the area 
of responsive polymeric materials, with the possibility of implantable devices 
being used to deliver drugs. Murdan17 exhaustively reviewed the use of 
hydrogels as ‘smart’ drug delivery devices. He showed that hydrogels could be 
engineered for various medicinal treatments depending on the patients needs, 
for example, pain relief. In the body, drug release can only be accomplished if 
the drug carrier responds to some class of stimuli, be it chemical, physical or 
biological. Conversely, an implanted ‘smart’ drug delivery device should be non-
responsive to all other types of stimulus, once inside the body. A way of 
achieving this form of control is through an electrical stimulus.17 A number of in 
vivo devices, in the form of iontophoresis, have already been used for this type 
of controlled release.17, 18 Murdan presented a case where hydrogels loaded 
Introduction and literature review  Chapter 1 
- 6 - 
with a bioactive compound, were implanted at a target site and the drug 
liberated through the application of an electrical field. In utilising such a system, 
many advantages including, minimal drug usage and lowering toxicity problems 
can be achieved. However, a problem arising with the application of an electrical 
stimuli to polymeric materials like, hydrogels, is that they experience deswelling 
or bending, which affects the drug release.17  
 
To overcome these problems, conducting polymers (CPs) are also receiving 
much attention in the field of biomedical research, for the application of 
controlled DDS, due to their light weight, good biocompatibility and ability to 
function at body temperature. In particular, conducting polymers exhibit a 
reversible electrochemical response. These reversible oxidation-reduction 
reactions are attractive for a responsive DDS, as a change in the net charge on a 
conducting polymer film during its reduction or oxidation requires ions to flow 
into or out of the film. This, in turn, allows the polymer film to bind and expel 
ions in response to electrical signals. Controlled release of drugs from polymers 
offers many advantages over conventional methods including better control of 
the drug level administered resulting in fewer side effects, local drug delivery, 
decreased requirements for the total amount of drug and protection of drugs 
which are rapidly destroyed by the body. However, in order to devise a suitable 
technology, the polymeric material must be responsive, i.e., it must be capable of 
altering so that the drug is released in a controlled fashion when needed. 
 
1.1.2 Conducting polymers 
A polymer is a large molecule made up of smaller repeating units. The name 
comes from the Greek poly, meaning ‘many’, and mer, meaning ‘part’. They are 
built up from simple molecules called monomers ‘single part’. Polymers are 
produced through a method known as polymerisation. This polymerisation step 
can be achieved through chemical or electrochemical methods. Originally 
polymers with the basic carbon chains were considered only as insulators.19 The 
first real interest in conducting polymers can be attributed to Walatka et al.20 in 
1973 with the report of highly conducting polysulfur nitride (SN)x. Meanwhile 
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and towards the late 1970s , MacDiarmid, Shirakawa and Heeger enhanced the 
discovery of the semi-conducting and metallic properties of the chemically 
synthesised organic polyacetylene.21-24 As is well known, the Nobel Prize in 
Chemistry was awarded to Alan J.Heeger, Alan G. MacDiarmid and Hideki 
Shirakawa in 2000 for the discovery and development of conducting polymers 
(CPs).21-24 In the following years, a wide range of polymeric organic species have 
been prepared as stable inherent films on inert electrodes via both chemical 
oxidation and electropolymerisation from aqueous and organic solution.25 
 
CPs are organic materials, which generally are comprised simply of C, H and 
simple heteroatoms such as N and S. Common examples include PPy, polyaniline 
and polythiophene which are shown in Figure 1.2. These and a number of other 
conducting polymers have been used in a variety of applications ranging from 
corrosion protection of materials, sensors to many biomedical applications, 
such as tissue engineering, nerve cell regeneration and drug delivery.26-29 
 
 
 
 
Figure 1.2: Chemical structures of (A) polypyrrole (B) polyaniline and (C) 
polythiophene. All polymers are shown in the dedoped state. 
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In, general materials are classed depending on their electrical conductivity, ĸ, 
where the electrical conductivity of insulators < semiconductors < conductors. 
Bredas and Street30 explained this phenomenon in terms of the band gap 
structure. Figure 1.3 illustrates the difference in each material using the band 
gap theory. The highest occupied molecular orbital is equivalent to the valence 
band (VB), while the lowest unoccupied molecular orbital may be equated to the 
conduction band (CB). The difference between each band is known as the band 
gap energy (Eg) and it is this energy gap that establishes the electrical 
properties of a material. If Eg > 10 eV, it is difficult to excite electrons into the 
conduction band and an insulator is formed. If Eg ~ 1.0 eV then thermal energy is 
sufficient to promote the electrons into the conduction band and a 
semiconductor is formed. If the gap vanishes, with overlap of the valence and 
conduction band, as shown in Figure 1.3, metallic conduction is observed. For 
most doped CPs the band gap energy is generally close to 1.0 eV, and 
consequently, CPs can be classified as semi-conductors. 
 
As pointed out by Bredas and Street30, the conductivity observed upon doping of 
the CPs was originally thought to be from the formation of unfilled electronic 
bands, however this idea was quickly dissipated upon experimental analysis of 
PPy and polyacetylene and now it is recognised that the conductivity is due to 
the formation of polarons and bipolarons, which are more energetically    
favoured.30, 31 
 
The π-bonded system of CPs, which comprises of alternating single and double 
bonds, enabling the delocalisation of electrons along the polymer backbone, is 
related to the conductivity of the system. The conductivity of these materials 
arises from a state of relative oxidation or reduction. In these states the polymer 
either loses (oxidation) or gains (reduction) an electron. Generally, it is said that 
this process occurs in 1 in every 4 monomer units.32 In this state the polymer is 
electronically charged and requires the introduction of counter ions (dopants) 
to compensate and reform the charge neutrality. The oxidation of the polymer in 
which an electron is removed from a π-bond, gives rise to a new energy state, 
which leaves the remaining electron in a non-bonding orbital. This energy level 
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is higher than the valence band and behaves like a heavily doped 
semiconductor.32 The extent of doping can be controlled during the 
polymerisation of the polymers. 
 
 
 
 
Figure 1.3: Schematic of the difference in band gap for Insulators, semi-conductors and 
metals (conductors). 
 
 
1.1.2.1 Polymerisation methods 
CPs are synthesised through a method known as oxidative polymerisation. This 
can be generated chemically or electrochemically. Chemical polymerisation 
involves the use of a chemical oxidant, such as ammonium peroxydisulfate 
(APS), ferric ions, permanganate, dichromate anions or hydrogen peroxide.  The 
oxidants not only oxidise the monomer but provide dopant anions to neutralise 
the positive charges formed on the polymer backbone.33 In the presence of these 
oxidants, the monomers are oxidised and chemically active cation radicals are 
formed which further react with the monomer and generate the desired 
polymer. An advantage of vapour phase chemical polymerisation of CPs is that 
the polymerisation occurs almost exclusively on the preferred surface and a 
higher surface area can be attained.34 Vapour phase chemical polymerisation of 
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pyrrole leads to further doping after polymerisation and this gives rise to an 
increase in conductivity.35 
 
The electrochemical deposition is a simple and reproducible technique where 
the dopant is present in the electrolyte during polymerisation. It is generally 
performed in a conventional three electrode set up, described later in Chapter 2, 
where current is passed through a solution containing the monomer in the 
presence of a dopant (electrolyte). The CP is deposited at the positively charged 
working electrode or anode.27 Polymerisation is initiated through the oxidation 
of the monomer which forms a mobile charge carrier known as a polaron 
(radical cation), that can react with another monomer or polaron to form a 
bipolaron (radical dication) which leads to the formation of the insoluble 
polymer chain and deposition of the polymer onto the working electrode.36  
 
In his book ‘Conducting Polymers’ published in 1986, Alcacer commented on the 
possibility of using CPs to make artificial muscles or perhaps even modification 
for the brain; little did he realise the extent to which these materials have been 
extensively researched, over the past 20 years.32 Since their discovery, the 
preparation and characterisation of these materials has evolved substantially 
through the use of electrochemistry. The majority of research is significantly 
based in this area due to the ease and control of synthesis of these electronically 
CPs.19 Reviews on the development of CPs show the various areas to where they 
can be applied. The applications are ongoing.37-40 However, in the case of DDS, 
CPs, in particular PPy, are widely researched for the controlled release of 
therapeutically active compunds.41-45 During oxidative polymerisation, a dopant 
molecule, with an overall anionic charge, is used to compensate for the positive 
charges originating from the oxidation of the monomer. It is during this process 
that the concept of drug delivery originated. Burgmayer and Murray46 observed 
changes in the ionic permeability of PPy redox membranes using a voltage-
controlled electrochemical reaction. This led to further investigations into the 
application of CPs in DDS. 
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1.1.2.2 Polypyrrole 
1.1.2.2.1 Historical background of polypyrrole  
In 1968 Dall’Olio and colleagues prepared black films of an oxypyrrole on 
platinum by the electrochemical polymerisation of pyrrole from a solution of 
sulfuric acid.47 In 1979 Diaz with the help of colleagues modified Dall’Olio’s 
approach and demonstrated that polymerising pyrrole onto platinum in 
acetonitrile led to a black, adherent film.48 Elemental analysis showed that the 
monomer unit was retained in the polymer. PPy in general, was poorly 
crystalline, and its ideal structure was a planar (α-ά)-bonded chain in which the 
orientation of the pyrrole molecules alternate.25 
The monomer unit, pyrrole, is shown in Figure 1.4. PPy is an organic material 
comprised simply of C, H and a simple N heteroatom, but is highly conducting. It 
is an inherently conductive polymer due to interchain hopping of electrons. PPy 
can be synthesised both chemically49 and electrochemically48. The 
electrochemical synthesis method is a one step synthesis method and allows the 
simple deposition of polymer films where its surface charge characteristics can 
easily be modified by changing the dopant anion (A-) that is incorporated into 
the material during synthesis. In a cell containing an aqueous or non-aqueous 
solution of the monomer, PPy forms a (semi) conducting film on the working 
electrode; the film grown is in the oxidised form and can be reduced to the non-
conducting insulating form by stepping the potential to more negative values. 
The potential cycling can be repeated many times between the insulating and 
(semi) conducting forms without a loss of the electroactivity of the film.25 
 
 
 
Figure 1.4: Schematic illustration of a monomer unit of pyrrole. 
 
H
N
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PPy in its neutral form is weakly coloured while the oxidised form is a deep 
blue/black. The switching of the state of the film not only changes its 
conductivity but it is also accompanied by a marked colour change, termed 
electrochromism.36 Materials such as PPy are important in terms of future 
technological impact as it may be possible to develop them to replace more 
expensive, often toxic, metallic conductors commonly employed in the 
electronics industry.25 
 
1.1.2.2.2 Polymerisation mechanism of pyrrole 
Although there are still various opinions on the mechanistic features of the 
electropolymerisation of pyrrole, the mechanism proposed by Diaz and his 
colleagues48 and later used by Baker and Reynolds is in good agreement with 
many experimental reports.50 The mechanism is demonstrated in Figure 1.5.  
 
The initial step is the generation of the radical cation. This cation has different 
resonance forms, as shown in Figure 1.5. In the next step in the chemical case, 
the radical cation then attacks another monomer molecule, generating a dimer 
radical cation. In the electrochemical case, the concentrations of radical cations 
is much larger than that of neutral monomers in the vicinity of the electrode 
where reactions are occurring, and radical-radical coupling leads to a radical 
dication. This coupling between the two pyrrole radicals results in the 
formation of a bond between the two α positions to give the radical dication, as 
highlighted in Figure 1.5. This is then followed by the loss of two protons, 
generating a neutral dimer. This dimer is then oxidised into a radical cation, 
where the unpaired electron is delocalised over the dimer. The radical dimer 
then couples with the radical monomer to form a trimer. The polymerisation 
thus progressing in this fashion to completion.  
 
The controversy in the mechanism of electropolymerisation is not surprising 
given that many factors, such as the nature of the electrolyte, ionic strength, pH, 
temperature and potential are important and can influence the mechanism of 
the reaction. 
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Figure 1.5: Mechanism of electrochemical polymerisation of pyrrole.50 
 
1.1.2.2.3 Biocompatibility 
PPy is one of the most widely researched conductive polymers. The fact that it 
can form biologically compatible matrices is one of the prominent reasons for 
the extensive research on the use of PPy in the field of biological applications.51 
Wang et al.52 acknowledged the reality that PPy had showed very good in vitro 
biocompatibility,29, 53, 54 but they wanted to evaluate further the in vivo 
biocompatibility prospects. They demonstrated that in comparison to no PPy, 
the presence of PPy/biodegradable composites stimulated no abnormal tissue 
response and had no affect on the degradation behaviour of the biodegradable 
materials. In 1994, PPy was one of the first conducting polymers investigated 
for its effect on mammalian cells.55 Since then, PPy is known to be 
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biocompatible, so it can be placed in the body without having adverse effects. It 
has been shown, in particular, to support cell growth and adhesion of 
endothelial cells.29, 55-57 Schmidt et al.29 also demonstrated that PPy was a 
suitable material for both in vitro nerve cell culture and in vivo implantation. 
PPy was electrochemically deposited onto ITO-conductive borosilicate glass. 
Moreover, the application of an external electrical stimulus through the polymer 
film resulted in enhanced neurite outgrowth. The median neurite length for PC-
12 cells grown on PPy film subjected to an electrical stimulus increased nearly 
two-fold compared with cells grown on PPy without the application of a 
constant potential. The group also investigated PPy in vivo and their studies 
showed that PPy promotes little negative tissue and inflammatory response. 
Due to the good biocompatible factor, studies on the application of an electric 
field to the PPy have also shown cell compatibility.29 In some important 
applications, such as biological sensors and actuators for medical devices it is a 
very attractive trait and some recent applications show that PPy can enhanced 
nerve cell regeneration and tissue engineering.27  
 
1.1.2.2.4 Electroactivity of polypyrrole 
PPy can be easily switched between the neutral, partially oxidised and fully 
oxidised states, as shown in Figure 1.6.  In its neutral state PPy exists as an 
insulator where the conduction band is empty as all the electrons remain in the 
valence band. Upon oxidation, an electron is removed from a π-bond (valence 
band) and a polaron is formed. The separation of the positive charge and the 
unpaired electron decreases during continual oxidation as the number of 
polarons increases. This in turn gives rise to the formation of a bipolaron, as 
depicted in Figure 1.6(C), and the polymer is now in its fully oxidised state. 
 
During oxidation and the generation of positive charge an influx of anions into 
the polymer matrix is observed in order to maintain charge balance.  This can be 
represented in Equation 1.1, where PPyo refers to the neutral (reduced) 
polymer, PPy+ refers to the oxidised polymer and A- refers to the anionic dopant. 
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PPy0  +  A-    PPy+A- + e-     1.1 
 
 
Typical anionic dopants are chlorides, bromides, iodides, perchlorates, nitrates, 
sulfates and para-toluene sulfonates.58-64 The extent of oxidation/reduction is 
given by the doping level and this is generally expressed as the ratio of dopant 
anions, A-, incorporated per monomer unit. For example, 1 A- per 4 monomer 
units gives a doping level of 0.25 or 25%. The maximum doping level achievable 
with PPy is 0.33 or 33%, i.e., 1 A- per 3 pyrrole units. It is important to point out 
that doping may not always be uniform; there can be islands with high doping 
levels surrounding by regions with a much lower doping level. 
 
 
  
 
 
 
Figure 1.6: Electronic structures of (A) neutral PPy, (B) polaron in partially doped PPy 
and (C) bipolaron in fully doped (oxidised) PPy.36 
1.1.2.2.5 Polypyrrole and drug delivery 
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The electrochemical switching of PPy films is accompanied by movement of 
counter or dopant ions in and out of the polymer matrix to maintain the charge 
neutrality, as shown in Section 1.1.2.3.4. Consequently, PPy films are attractive 
for the controlled release of drug molecules. The concept of using PPy 
membranes for the uptake and release of ions was introduced, in the early 
1980s, by Burgmayer and Murray46.  They demonstrated that these polymeric 
films could be exchanged from their oxidised state to their neutral state. PPy has 
been seriously considered for drug delivery due to these unique redox 
properties. PPy gives a responsive material needed in order for the uptake and 
release of the drug to be controlled; in its oxidised state anions are 
electrostatically bound to the polymer film. These properties allow the 
controlled transport of ions. The uptake of these ions can occur in two ways. 
The first is where the bioactive molecule exists as an anion and is involved in 
the doping process of the polymeric material during polymerisation, Figure 1.7 
(A). Some anions that have been researched include adenosine tri phosphate 
(ATP)65, salicylate26, and dexamethasome26. These anions are electrostatically 
entrapped into the polymer matrix during the growth process upon application 
of an anodic potential. The anions are consequently liberated during the 
reduction of the polymer.  
 
 
 
 
Figure 1.7: Interconversion between oxidation and reduction states of PPy (PPy). (A) 
Anion (A-) incorporation and release which is notably observed in small mobile anions 
(e.g. Cl-) while, (B) Cation (C+) insertion and liberation from polymer films doped with 
larger anions  (e.g. DDS-) which remain entrapped in the polymer matrix. 
In the second case, cations can be incorporated into the system, Figure 1.7 (B), if 
the properties of the polymer film are modified.66 This is achieved through the 
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initial inclusion of a large anion which remains entrapped in the polymer matrix 
and thus the polymer behaves as a cation exchanger, where, the charge of the 
polymer system can only be compensated through the uptake of cations. The 
cations are therefore, taken in during the reduction of the polymer and released 
upon oxidation. Figure 1.7 demonstrates both these concepts. 
 
Miller and Zhou67 previously reported the release of dopamine from a poly(N-
methlypyrrole)/poly(styrenesulfonate) (PNMP/PSS) polymer based on the 
properties of these redox polymers. Immobilisation of PSS, a large anion, allows 
the uptake and release of the cation upon appropriate application of a potential. 
They achieved the release of dopamine using potential control, while more 
recently, Hepel and Mahdavi66 demonstrated the controlled release of a cationic 
species, chloropromazine, from a composite polymer film based on the same 
principles. They reported the development of a new composite conducting 
polymer, PPy/melanin, which performed as a cation binder and releaser. The 
modification of the polymer films, to enable the predominant cationic exchange 
properties of the CP, is an interesting way of improving the uptake and release 
of cationic species from these attractive materials. 
 
New ways of improving the controlled release of drugs are continually being 
sought after.  Lately, Abidan et al.41 reported on a method to prepare 
conducting-polymer nanotubes that can be used for controlled drug release. 
They introduced a method known as electrospinning to fabricate a nanofibrous 
mat in which the drug to be delivered had previously been incorporated; 
followed by electrochemical deposition of PPy films around the drug-loaded, 
electrospun biodegradable polymers. The drug release was achieved through 
the electrical stimulation of the PPy nanotubes. 
 
 
 
1.1.2.2.6 The application of Nanotechnology in drug delivery 
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Nanotechnology, although dating back to much earlier times, gained 
considerable attention in the early 1990s and has been the focus of much 
research over the last number of years. The introduction of nanotechnology into 
a controlled DDS has been shown to enhance many physical and chemical 
properties and overall has been used to increase the surface area of materials. 
This, in turn, leads to an increase in the amount of drug released from various 
materials. Many groups have introduced nanotechnology in various forms to 
improve on the drug delivery of a number of bioactive compounds, including 
nanoparticles15, micellar systems68 and nanofibers69. Polymeric nanofibers are 
gaining substantial interest for various applications including drug delivery69, 70. 
Several techniques have been employed for the production of nanofibers such 
as template synthesis71, self assembly72 and drawing73. One technique, in 
particular that is receiving considerable interest in this field, is 
electrospinning.74-77 Electrospinning has been introduced to achieve nanoscale 
membranes and fibres from various polymeric materials.78 
 
1.1.2.2.7 The application of Electrospinning to drug delivery 
Although electrospinning was first reported by Formhals79 in 1934 it has only 
been explored further in recent times.80, 81 In 1996, Reneker and Chun restored 
interest in the electrospinning technique by demonstrating the possibility of 
electrospinning a wide range of organic polymers.81 Since then the technique of 
electrospinning has become extremely useful in a variety of applications.82-85 
Electrospinning is a simple and inexpensive means for the formation of nano- to 
micron polymer fibers. 
 
This technique involves the application of a high electric field between a 
polymer fluid and a grounded electrode. When the polymer solution is subjected 
to an external electric field at a critical point the forces overcome the surface 
tension of the polymer solution to form a droplet with a conical shape, i.e., the 
Taylor cone.83, 86 The fluid is drawn into a jet which undergoes a whipping 
motion. Volatile solvents are used to dissolve the polymer as the subsequent 
evaporation from the liquid jet results in solid fibers. A more detailed 
Introduction and literature review  Chapter 1 
- 19 - 
description of this technique is provided in Chapter 2, Section 2.4.5. In the 
majority of cases the fibers deposit randomly on the grounded collector. 
However, many groups have investigated the use of rotating collector plates to 
produce aligned nanofibers.87 Figure 1.8 illustrates a typical SEM micrograph of 
an electrospun fiber mat of PLGA fibers. 
 
This production of nanofibers allows these polymers to be used in a wide 
variety of applications including, tissue engineering (muscles, skin, cartilage and 
bones), wound healing and sutures, biosensors and DDS. Shin et al.88 studied the 
use of PLGA nanofiber scaffold for cartilage reconstruction, while, Kim and 
colleagues incorporated antibiotics in the fibrous matrix for use in wound 
dressings.89 Other groups have also prepared ultrafine polymers via 
electrospinning for skin regeneration.74 
 
 
 
 
Figure 1.8: A typical SEM image of electrospun PLGA nanofibers. 
 
 
Another attractive feature of using this electrospinning technique is that 
biodegradable polymeric materials, such as poly(lactic acid) (PLA) and poly(D,L – 
lactide-co-glycolide) (PLGA) can be used as a biomedical controlled release 
system. These biodegradable polymers can be electrospun in the presence of 
varying amounts of the required medication. They can then be placed in the 
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body and the drug release achieved through the modification of the polymer 
matrix’s morphology, porosity and composition.89 These biodegradable 
polymers have FDA approval for biomedical and drug delivery use.90-93 In 
comparison to other delivery forms, the electrospun nanofibers can 
conveniently incorporate the therapeutic compound during the electrospinning 
process.94 Many drugs have been incorporated into PLGA electrospun polymer 
matrices, in order to achieve delivery of the therapeutic drug,  including, 
tetracycline hydrochloride95 and mefoxin89. In these cases, the drug release was 
monitored and a burst release was observed and was attributed to the high 
surface area-to-volume ratio of the electrospun material. This is a disadvantage. 
In the last few years a small number of groups have deposited electroactive 
polymers, such as PPy, onto previously electrospun fibers in order to enhance 
the electrochemical properties57 of the material. Also, electrospun fibers have 
been used as a template in order to obtain a high surface area in the hope of 
achieving a greater uptake and release of drugs.41 
 
Another method of improving the DDS of conducting polymers is the use of 
various dopants during polymerisation of the polymer films. The 
functionalisation of PPy films with large anionic dopants is not new to this field 
of research. It has been well reported that the use of large anionic dopants 
during the electrochemical polymerisation of monomers leads to these bulky 
negatively charged groups being immobilised within the polymer matrix.96 In 
fact, these polymers, with their cationic exchange properties, have been used to 
incorporate various cationic groups for various applications. For example Fan 
and Bard in the late 1980s demonstrated the uptake of a positively charge 
Ru(NH3)63+ and methylviologen in PPy/Nafion films.97 
 
However, the generation of PPy films in the presence of negatively charged 
cyclodextrins is a new concept.98-100 There has been very little work reported on 
the electropolymerisation of pyrrole in the presence of anionic cyclodextrins. 
Indeed, much of the current published work is unreliable as very high potentials 
in the vicinity of 1.8 V vs. SCE were used to form the polymers.100, 101 It is very 
well known that these high potentials give rise to the overoxidation of PPy and a 
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considerable loss in its conductivity.59 The incorporation of cyclodextrins into 
conducting polymers provides a unique way of combining the unique host-guest 
complexation properties of cyclodextrins with the stability, high conductivity 
and ease of preparation of conducting polymers.  
 
1.1.3 Cyclodextrins 
1.1.3.1 History and structural properties of cyclodextrins  
Cyclodextrins (CD) are macrocyclic oligosaccharides composed of α-D-
glucopyranoside units linked by α-(1,4) bonds. They were first discovered by 
Villiers in 1891102, while in 1904, Schardinger103 further developed the cyclic 
structures hence; CDs are sometimes referred to as Schardinger dextrins. 
However, it was only in the mid 1970s that the structure and chemical 
properties of natural cyclodextrins were fully characterised.104
 
Cyclodextrins 
have developed quickly over the past two decades and have become an 
important branch of host-guest chemistry, specifically due to their ability to be 
involved in several practical applications.105 The main interest in cyclodextrins 
lies in their ability to form inclusion complexes with a variety of compounds. 
Host-guest chemistry is the study of these inclusion phenomena, where the 
‘host’ molecules are capable of including smaller ‘guest’ molecules through non-
covalent interactions. 
 
CDs are obtained through enzymatic degradation of starch in the presence of a 
glycosyl transferase, a type of amylase.106 Many organisms contain glycosyl 
transferase, however, in general it is obtained from Bacillus megaterium, 
Bacillus stereothermophilus and Bacillus macerans.106, 107 They are generally 
made up of glucopyranoside units of 4C1 chair conformation which leads to a 
truncated cone shape encasing a cavity.108 Figure 1.9 shows the structures of the 
most common CD members; α-, β- and γ-CD, which include 6, 7 and 8 repeating 
glucopyranoside units, respectively. These units orientate themselves in a cyclic 
manner offering a typical conical or truncated cone structure with a relatively 
hydrophobic interior and hydrophilic exterior.109 This structural property gives 
cyclodextrins good water solubility and the ability to hold appropriately sized 
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used for many applications including, drug delivery to enhance the solubility, 
stability and bioavailability of drug molecules.108, 112
 
 
Table 1.1: Approximate geometric dimensions of the three common CDs.106  
 
 
 
 
 
Cyclodextrin x / nm y / nm Cavity volume / Å3 
α 0.49 0.78 174 
β 0.62 0.78 262 
γ 0.79 0.78 427 
 
 
Cyclodextrins can also be chemically modified to replace the hydroxyl groups on 
both the primary and secondary rims of the CDs, with a variety of appropriate 
alkyl groups (R). It has been reported that this can improve binding affinity.108 
In the research presented here, a negatively charged cyclodextrin with a 
number of sulfonated groups present on the outer rims was used, sulfonated β-
CD (Sβ-CD). Sβ-CD is obtained by substitution of either primary or secondary 
hydrogen of the hydroxyl group of β-CD with a sulfonate group. Sβ-CD has an 
average of 7-11 substituents per CD and, therefore, has between 7-11 negative 
charges associated with it, which are counterbalanced with sodium ions, as 
illustrated in Figure 1.10.113 It is reported that β-CD and Sβ-CD have the same 
ring structure, differing only in the substituent located on the rims of the CD 
ring.14 Although Sβ-CD has the same ring structure as other derivativsed CDs the 
presence of the substituent on the ring contributes to its chiral discrimination 
properties.114 A major area in which these sulfonated CDs are being utilised is 
chromatography, or more specifically capillary electrophoresis, for the 
enantiomeric separation of acidic and basic compounds. In enantiomeric 
separation, using neutral CDs, they are not appropriate for neutral racemates as 
the complex has no electrophoretic mobilities.115 Therefore, the use of charged 
   x   
 y 
Introduction and literature review  Chapter 1 
- 24 - 
CDs is now been widely researched for the separation of neutral compounds. It 
has been reported that the use of these sulfonated CDs for the enantiomeric 
separation of chiral compounds is highly effective as a result of the anionic 
charges.116, 117  
 
A number of groups have also characterised the Sβ-CD.115, 117 Figure 1.11 
illustrates a single glucose unit of an Sβ-CD (comprised of 7 units). On the 
primary ring there are 7 potential substitution sites corresponding to the C-6 
positions, while, on the secondary rim there are 14, represented by the C-2 and 
C-3 positions. Amini and co-workers117 reported that substitution of these CDs 
is predominantly at the C-2 and C-6 positions, while, Chen et al.115 confirmed 
nearly complete sulfation at the C-6 position of the primary hydroxyl groups 
and partial sulfation at the C-2 secondary hydroxyl groups. They also reported 
no substitution at the C-3 positions. From these reports it can be stated that 
almost the entire primary rim is sulfonated and some of the secondary rim. Due 
to this phenomenon and the fact that the sulfation brings with it negative 
charges these CDs are good candidates for the doping of CPs.  
 
 
R = SO3-Na+ or H ~ 7-11 SO3-Na+ groups. 
 
Figure 1.10: Structural and schematic representation of sulfonated β-cyclodextrin (Sβ-
CD). The arrows point to the primary and secondary rims, respectively.118 
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Figure 1.11: Chemical structure of Sβ-CD, depicting the numbering carbons. 
 
1.1.3.2 Inclusion complexation 
Cyclodextrins (CD) form a group of cyclic oligosaccharides that contain cavities 
in which guest molecules can be encapsulated.108, 109 It is well known that the 
size of the compounds are important and compounds are only capable of 
including into the cavity of the CD if they are within the dimensions of the CD 
cavity.119 In aqueous media, the cavity is filled with water molecules, which 
becomes displaced by the guest through complexation, as illustrated in Figure 
1.12. The guest molecule, xylene, displaces the water molecules and forms an 
inclusion complex with the CD. 
 
 
 
Figure 1.12: Schematic representation of xylene forming a complex with a β-
cyclodextrin. The small circles represent water molecules taken from Szjetli.109  
 
 
During the formation of an inclusion complex the chemical and the physical 
properties of the guest molecule change and can be monitored using a number 
of techniques. Various spectroscopic and electrochemical techniques can be 
used to confirm complexation, including fluorescence, UV-visible spectroscopy 
(UV), Nuclear magnetic resonance (NMR) and electrochemical studies. These 
changes attributed to the complexation can be used to evaluate the apparent 
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binding or formation constant (Kf). However, prior to the determination of the 
Kf  value the stoichiometry of the host-guest complex must be established.120 
This is obtained by the well known continuous variation or Job’s method which 
is described in more detail in Chapter 2, Section 2.6.1.1.121 Generally, inclusion 
complexes form a ratio of 1:1, 1:2 and sometimes 2:1 (CD:guest).122  
 
NMR is also a useful tool for the study of complexation due to its quantitative 
information and assuming the guest enters the cavity, NMR, can be also used to 
locate the protons involved in complexation.87 Many groups have studied the 
complexation properties with the neutral β-CD and monitored the changes in 
the chemical shifts for both the CD, and the guest. However, in the case of the 
modified CD used in this research, the NMR spectral data are too difficult to 
differentiate so the chemical shift of the guest is followed.120, 123-126 Bratu and 
colleagues125 studied the chemical shift changes observed when Fenbufen was 
in the presence of a neutral β-CD. They noticed an up-field shift of the guest 
protons, some more pronounced than others, and suggested that the 
complexation was initiated through the benzene moiety of the guest.               
Cruz et al.127 also used NMR to quantitatively evaluate the binding constant of 
the complexation of doxepin and a neutral β-CD.  
 
If a guest absorbs light in the UV or visible region then the inclusion 
phenomenon can be followed and subsequently, evaluated by UV.106 This 
technique can be used to confirm complexation and indeed obtain the formation 
constant associated with the inclusion complex. In the majority of cases the 
guest that absorbs in the UV-vis region experiences changes in the intensity and 
the position of the absorption bands in the presence of the CD. These spectral 
changes can be used to determine the Kf constants. Generally, a Hiedlebrand-
Benesi modified equation is used to evaluate the Kf constants.119, 128, 129 Ramaraj 
and co-workers130 monitored the changes attained during the complexation 
formation of a number of aromatic amines and nitro compounds in the presence 
of a neutral β-CD. They observed an increase in the intensity of the bands in all 
cases. Dang et al.119 observed shifts of the absorption bands to longer 
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wavelengths in the case of 1,4 benzoquinone (BQ) and 9,10 anthraquinone (AQ) 
in the presence of a neutral β-CD. 
 
Electrochemical techniques can also be performed on the complexation 
properties of CDs. If the guest is electroactive the peak current and potential can 
be followed for the free state and compared to the complexed state of the guest 
in question. Two features are generally observed during these electrochemical 
observations if an inclusion complex is found. Firstly, a decrease in the peak 
current can be seen, and, attributed to a decrease in the diffusion of the bulky 
CD complex as opposed to the more mobile free guest. Secondly, a shift in the 
peak potential is observed if the complexed species is included in the cavity, as 
it is harder to oxidise or reduce while located in the cavity. Once again based on 
these variations a number of equations can be used to verify the formation 
constant.129, 131, 132 Coutouli-Argyropoulou and his group133 reported the effect 
of complexation on the electrochemical properties of ferrocence derivatives and 
showed shifts, in both the peak current and peak potential, when higher 
concentrations of a neutral β-CD were added. Yanez et al.131 showed similar 
observations for nifedipine (NF) and nicardipine (NC) and estimated apparent 
formation constants of 135 and 357, respectively. 
 
Complexation studies of DA have been previously demonstrated in the presence 
of a neutral β-CD by Zhou et al.134 using UV and fluorescence spectroscopy. 
From the fluorescence technique, utilising a Hiedlebrand-Benesi modified 
equation, a Kf value of 95.06 was estimated. The degree of the complexation can 
vary over a wide range due to the stability of the complex, as it depends on a 
number of factors. In the next section a discussion on the main driving forces, 
involved in this complexation process are dealt with. 
 
1.1.3.3 Driving forces in the inclusion complexation process 
There are many reviews and books written on the driving forces behind the 
inclusion complexation abilities of cyclodextrins, not all agree, some refer to the 
predominantly hydrophobic affects while others state that it is a collection of  a 
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number of weaker interactions (H-bonding, van der Waals, electrostatic 
interactions).106, 108, 111, 135, 136 Either way the majority agree that the size of the 
cavity and shape of the guest are important factors in the complexation process. 
The most widely studied possible driving forces include  
 
 Hydrogen bonding  
 Electrostatic interaction 
 Van der Waals 
 Hydrophobic effect 
 
Hydrogen bonding is an interaction between an electronegative donor, a 
hydrogen and an electronegative acceptor.136 Various groups have 
demonstrated the importance of hydrogen bonding in the solid state, illustrating 
crystal structures defining the hydrogen bonding between the guest and the 
hydroxyls of the CDs.137 However, during the complexation of the CD and guest, 
in aqueous solution, the subject is still arguable as few direct measurements of 
hydrogen bonding have been made, as water molecules can compete with CDs 
to form hydrogen bonding with guest molecules. However, many groups will 
still argue over the significance of hydrogen bonding. 
 
Electrostatic interaction occurs when molecules of opposite charges interact. 
There are three types of electrostatic interactions, ion-ion interaction, ion-
dipole interaction and dipole-dipole interaction.136 Matsui and Okimoto138 
reported that ion-ion interaction is only eligible in the case of modified CDs, 
where as ion-dipole is considered more favourably due to the fact that CDs are 
polar molecules however as with hydrogen bonding, in aqueous media, the 
interaction between the guest and water will also be strong.136 Therefore, it is 
the case of dipole-dipole interaction that is mostly considered during 
complexation. 
 
Van der Waals forces or London dispersion forces are made up of dipole 
induced dipole contributions or the coordination of the electronic motion in the 
CD and guest. As CDs are known to have large dipole moments it is logical that 
Introduction and literature review  Chapter 1 
- 29 - 
these induction forces are important in complexation. Experimental evidence 
has shown that the stability of the complex increases with an increase in 
polarisability. Also, as the polarisability of water is lower than the organic 
components of the CD cavity, van der Waals forces have an encouraging 
donation to the stability of the complex due to a stronger interaction of the CD 
and guest over the water and guest.136 CDs have also been reported to form 
stable inclusion complexes in organic solvents like DMF and DMSO confirming 
the importance of van der Waals forces.139 
 
The hydrophobic interaction which is entropically favourable, due to the 
expulsion of water, leads to the aggregation of non-polar solutes in aqueous 
solution.136 As reviewed by Connors135 the ‘classical’ hydrophobic interaction is 
said to be ‘entropy driven’ and a positive entropy and enthalpy is associated for 
the interaction between two non polar molecules. However, experimental 
studies in the complexation of CD and guests, show negative enthalpy and 
entropy changes,111 which have been suggested to indicate that these 
interactions are not a dominant force.  
 
Mosinger et al.122 reported that the formation of an inclusion complex is based 
on the electrostatic, van der Waals and π-π interactions, where, steric affects 
and Hydrogen bonding are inevitable. Chao and co-workers124 investigated the 
formation of an inclusion complex with β-CD and caffeic acid, they reported that 
the weak forces of hydrogen bonding, van der Waals, hydrophobic and 
electrostatic interactions simultaneously governed the process. 
 
Rekharsky and Inoue111 reviewed the complexation of cyclodextrins and stated 
that the interactions involved in the inclusion complexation of aromatic guests 
with CDs could not be simply put down to a hydrophobic effect. They 
established that complexation could be accounted for, through dipole-dipole 
interactions. In saying that, Tabushi and his group140 questioned the role of 
hydrogen bonding in the complexation process and reported that no dramatic 
changes of binding were observed, when a modified CD, incapable of hydrogen 
bonding, was compared to an unmodified CD. They concluded that the 
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involvement of hydrogen bonding was negligible and hydrophobic interactions 
dominated the process. Zia et al.113 investigated the complexation ability of a 
negatively charged CD (~7 negative sites) with a number of neutral and charged 
guest molecules. They accounted for the increase in the binding affinity, for the 
oppositely charged guest and CD, to be predominantly hydrophobic, due to the 
additional interaction sites provided by the negatively charged CD. Okimoto and 
colleagues141 also clearly observed stronger interactions occurring between a 
CD and guest with opposite charges. 
 
The understanding of these complexation processes is complicated, however, it 
is generally found that van der Waals forces and hydrophobic interactions are 
regarded as the main driving forces for CD complexation, while, electrostatic 
interactions and hydrogen bonding can be significantly considered in some 
inclusion complexation studies. Nevertheless, these attractive features of CDs 
allow them to be used in a wide range of applications including, the food 
industry142. However, the pharmaceutical industry is the most widely 
researched area in recent times, specifically in drug formulation and DDS.143 
 
1.1.3.4 Applications of CDs in DDS  
Due to their biocompatibility and their ability to form inclusion complexes, CDs 
have been studied for the use in DDS. They have been considered as drug 
carriers, as CDs have the potential to act as hydrophobic carriers and control the 
release of a variety of drugs.118  Many reviews have recently been published, 
describing the role of CDs in DDS.112, 118, 144-147 Irie and Uekama144 reviewed the 
role of CDs in peptide and protein delivery and summarised that CDs were able 
to eliminate a number of undesirable properties of drug formulations, as they 
form inclusion complexes with the desired drugs, which increase the drug 
delivery through a number of routes of administration. More recently, Li et al.145 
examined the recent progress in the preparation of inclusion complexes 
between CDs and various polymers as supramolecular biomaterials for drug 
and gene delivery. They demonstrated the promising field in the self assembly 
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of inclusion complexes between CDs and biodegradable polymers as injectable 
DDS.  
 
Ferancova and Labuda148 also reviewed the use of CDs as electrode modifiers. 
They summarised the many ways CDs can be immobilised onto electrode 
surfaces. As discussed in an earlier section, Section 1.1.4.2., the incorporation of 
CDs, as dopants, during the electrochemical polymerisation of CPs was 
demonstrated to examine the use of these modified electrodes to deliver neutral 
drugs.98 Formulating these materials, correlates the attractive features of both 
the CDs and the CPs. Bidan et al.98 examined the need for a new DDS that was 
not limited to charged drugs. They produced polymer films in the presence of an 
anionic CD and successfully delivered neutral compounds using these novel 
materials.         
 
Also briefly discussed in Section 1.1.4.2, was the reports made by a number of 
groups on the polymerisation of CPs in the presence of CDs.100, 101, 149 These 
groups have reportedly polymerised pyrrole at potentials usually shown to 
overoxidise the CP film.59 Due to this, these papers are unreliable in their 
reports. 
 
1.1.4 Drug release: Controlled release of dopamine 
DA is a neurotransmitter produced naturally in the brain. It is well documented 
that a common factor in neurodegenerative diseases such as Parkinson’s (PD) 
and Schizophrenia is a significant lack of the presence of DA in the substantia 
nigra (mid brain).150-152 In particular, PD is a slowly progressive disorder known 
to occur due to the damage of the basal ganglia.150-152 The disease affects 
movement, muscle control and balance. Studies on the brains of deceased 
Parkinson sufferers show a substantial loss of dopamine, particularly, in the 
substantia nigra. The function of the substantia nigra is to produce DA and 
manage the release of essential neurotransmitters that help control movement 
and coordination. Sufferers usually show symptoms such as tremors, slowness 
of movement and impaired balance and coordination. Prolonged loss of DA 
Introduction and literature review  Chapter 1 
- 32 - 
gives rise to symptoms such as difficulty in walking, talking, or completing other 
simple tasks.150-152  
 
DA belongs to the well known catecholamine family. These molecules are 
electroactive and therefore their oxidation can be followed using 
electrochemistry, in particular, electrochemical methods such as cyclic 
voltammetry and rotational disc voltammetry. The electrochemical mechanism 
of oxidation is still not fully agreed; with various groups arguing that the 
mechanism goes through an ECE step rather than a CE step. For example, 
Hawley et al.153 have reported that the electrochemical oxidation of dopamine in 
aqueous solution proceeds through two types of steps, electrochemical (E) and 
chemical (C). The ECE mechanism is presented in Scheme 1.1. 
 
The first step in the oxidation of dopamine (A) involves the loss of both protons 
and electrons to form the o-dopaminoquinone (B). The oxidised, o-
dopaminoquinone undergoes a 1,4-Michael addition, which results in a 
intramolecular cyclisation reaction which produces leucodopaminochrome (C). 
This product is easily oxidised through an electrochemical step to form 
dopaminochrome (D).153, 154 
 
Controlled release studies of DA have been previously investigated.67, 155-158 
McRae-Degueurce et al.156 encapsulated DA into a thermoplastic polyester 
excipient: PLGA. They found that it was possible to deliver significant amounts 
of DA for prolonged periods of time by injecting the microencapsulated DA 
directly into the brain. Uludag and colleagues157 also examined the release of 
many therapeutic agents, including DA, from microencapsulated mammalian 
cells. The mammalian cells and tissues were entrapped in polymeric 
microcapsules containing the desired bioactive agent. 
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Scheme 1.1: The proposed oxidative pathway for dopamine. 
 
 
In both these cases the release was based on diffusion from the polymeric 
materials. It is, therefore, difficult to maintain any control over the amount of 
DA released. Miller67 and Zhou158 and co-workers investigated the use of CPs to 
deliver DA. They introduced the concept of using large immobile dopants, which 
remain entrapped inside the cavity during polymerisation, to bind and 
successfully liberate DA from the polymer films.  
This is the basis of the work performed in this thesis. As outlined at the start of 
this chapter, the idea of this research is to develop PPy films for the uptake and 
release of DA, using a large immobile anionic cyclodextrin. The cyclodextrin, in 
addition to its large size and immobility, has unique host-guest complexation 
properties and this offers the prospects of inclusion complexation between the 
DA and the CD to enhance the drug delivery. If this can be achieved it could 
potentially serve as a model system in DDS and could be extended to various 
other cationic drug molecules.  
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1.1 Introduction 
The initial aim of this work was to examine the use of polypyrrole (PPy), a well-
known conducting polymer, for the uptake and release of a cationic species, 
dopamine (DA). DA was chosen as it represents a large family of amine-based 
drugs. Therefore, if appropriate PPy films could be electrosynthesised and used 
in the controlled delivery of DA, then the concept could be used more widely in 
the field of controlled drug delivery.  
 
In Chapter 3, the growth of PPy films in the presence of various dopant anions, 
including a large anionic cyclodextrin (CD), sulfonated β-cyclodextrin (Sβ-CD) is 
explored. Although Sβ-CD doped PPy films have been reported in the recent 
literature, there has been very little work devoted to the characterisation of 
these films. Accordingly, much of Chapter 3 is devoted to the unique redox 
properties of the Sβ-CD doped PPy films.   
 
With the growth of the PPy films achieved, Chapter 4, shows the drug release 
profiles of the protonated DA and reveals that in the case of the polymer films 
doped with the anionic Sβ-CD, there is a substantial increase in the amount of 
DA released in comparison to other polymer films. In order to explain the 
enhanced release profiles, the well-known supramolecular complexation 
properties of cyclodextrins were considered. However, on searching the 
literature no reports on the complexation of DA with anionic cyclodextrins were 
found and consequently this was studied in detail. These findings are presented 
in Chapter 5, where the host-guest interactions between DA and the anionic Sβ-
CD are examined using a variety of techniques, both spectroscopic and 
electrochemical.  
 
In Chapter 6 the technique of electrospinning is introduced. Details on how it is 
used to fabricate nanostructured biodegradable polymer films with a high 
surface area are provided. The approaches used to deposit the Sβ-CD doped PPy 
films onto the nanostructured biodegradable film are then considered and 
discussed. It is shown that cyclic voltammetry was the most successful 
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approach. Moreover, it was possible to control the amount of PPy deposited and 
to maintain the nanostructured fiber substrate by varying the number of cycles. 
These high surface area Sβ-CD doped PPy films are promising for the uptake 
and liberation of DA.  
 
In this introductory chapter, the concept of controlled drug release is firstly 
introduced. This is then followed with information on conducting polymers, 
particularly PPy and the current state-of-art in using PPy in drug delivery. The 
technique of electrospinning is then introduced and linked to DDS. The next 
section is devoted to cyclodextrins, as it is the Sβ-CD doped PPy films that give 
the best controlled release properties. Finally, the chapter ends with a short 
account of the properties of DA and its delivery.  
 
1.1.1 Controlled drug release 
In the early 1970s, controlled release systems first materialised. Since then, the 
number and the areas in which a controlled release system is utilised have 
significantly increased. These systems have been used in areas such as 
cosmetics1, food2, and pesticides3. Controlled release systems are focused on 
obtaining the release of the proposed material, over a certain time without an 
external influence from any other potential release factor.4 Polymeric materials 
have been previously investigated for controlled release as they can be easily 
manufactured and their composition can be finely tuned.5 Polymers used in 
controlled release systems can be natural or synthetic and release can be 
achieved through the engineering of the polymer substrates, i.e., the 
degradation of poly(D,L – lactide-co-glycolide)  (PLGA) can be controlled through 
the polymer composition, higher ratios of PLA lead to a higher degradation 
rate.6 
 
Another important research area under consideration is the development of 
controlled drug delivery systems (DDS).7, 8 In 1980, controlled DDS were 
virtually unknown, yet in 2005, almost 100 million people globally were using 
some form of polymer based DDS.8 The aim of a DDS is to supply the drug in its 
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therapeutically active form to a specific target in the body when the drug is 
required. In the current administration process there is a critical concentration 
needed in order to achieve the drug’s maximum therapeutic effect. If the 
concentration goes beyond the maximum level, toxicity problems come into 
play. Conversely, if the concentration administered is below the minimum level 
the effect of the drug is not observed. The use of these DDS could potentially 
eliminate these problems as the release would be of a controlled manner.  
 
Santini et al.7 compared the release profiles of both conventional and controlled 
methods, as illustrated in Figure 1.1. With conventional methods of drug 
delivery, outlined in Figure 1.1(A), i.e., oral administration or injections, drug 
levels rise after initial administration, which could lead to potential toxicity 
problems, and then decrease until the next dosage, which has consequences on 
the efficiency of the dosage. The other schematic, Figure 1.1(B), demonstrates 
the effectiveness of a controlled release system. After dosage, the drug level in 
the blood remains constant, between the maximum and minimum levels, for a 
certain period of time. 
 
 
 
 
Figure 1.1: Drug levels in the blood with (A) conventional drug dosage (B) controlled 
delivery dosage, taken from Santini et al.7 
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In recent years, polymeric materials have been examined and shown to provide 
an alternate means of delivering drugs. Implanted polymeric pellets or 
microspheres localise therapy to specific anatomic sites, providing a continuous 
sustained release of drugs while minimising systemic exposure.9 Polymers that 
display a physiochemical response to stimuli have been broadly researched for 
controlled release systems. Various stimuli include pH, temperature and the 
application of an electrical field.10 According to Langer11, polymeric DDS should 
i) maintain a constant drug level ii) reduce harmful side effects iii) minimise the 
amount of drug needed and iv) decrease the amount of doses which will have a 
pronounced effect on the patient.  
 
The original polymeric controlled DDS was based on a non-biodegradable 
polymer, silicone rubber, which was designed and tested by Folkman and 
Long.12 They loaded a silicone capsule (Silastic*) with a number of different 
drugs for the treatment of heart block and successfully implanted and 
monitored their effects over a number of days.  
 
In more recent years there has been considerable interest in the development of 
new and efficient DDS, particularly with the growth of sophisticated drugs that 
are based on DNA and proteins.5, 13 Currently, there are several materials under 
consideration in drug delivery, for example dendrimers14, nanoparticles15 and 
hydrogels16. The most promising opportunities in controlled DDS are in the area 
of responsive polymeric materials, with the possibility of implantable devices 
being used to deliver drugs. Murdan17 exhaustively reviewed the use of 
hydrogels as ‘smart’ drug delivery devices. He showed that hydrogels could be 
engineered for various medicinal treatments depending on the patients needs, 
for example, pain relief. In the body, drug release can only be accomplished if 
the drug carrier responds to some class of stimuli, be it chemical, physical or 
biological. Conversely, an implanted ‘smart’ drug delivery device should be non-
responsive to all other types of stimulus, once inside the body. A way of 
achieving this form of control is through an electrical stimulus.17 A number of in 
vivo devices, in the form of iontophoresis, have already been used for this type 
of controlled release.17, 18 Murdan presented a case where hydrogels loaded 
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with a bioactive compound, were implanted at a target site and the drug 
liberated through the application of an electrical field. In utilising such a system, 
many advantages including, minimal drug usage and lowering toxicity problems 
can be achieved. However, a problem arising with the application of an electrical 
stimuli to polymeric materials like, hydrogels, is that they experience deswelling 
or bending, which affects the drug release.17  
 
To overcome these problems, conducting polymers (CPs) are also receiving 
much attention in the field of biomedical research, for the application of 
controlled DDS, due to their light weight, good biocompatibility and ability to 
function at body temperature. In particular, conducting polymers exhibit a 
reversible electrochemical response. These reversible oxidation-reduction 
reactions are attractive for a responsive DDS, as a change in the net charge on a 
conducting polymer film during its reduction or oxidation requires ions to flow 
into or out of the film. This, in turn, allows the polymer film to bind and expel 
ions in response to electrical signals. Controlled release of drugs from polymers 
offers many advantages over conventional methods including better control of 
the drug level administered resulting in fewer side effects, local drug delivery, 
decreased requirements for the total amount of drug and protection of drugs 
which are rapidly destroyed by the body. However, in order to devise a suitable 
technology, the polymeric material must be responsive, i.e., it must be capable of 
altering so that the drug is released in a controlled fashion when needed. 
 
1.1.2 Conducting polymers 
A polymer is a large molecule made up of smaller repeating units. The name 
comes from the Greek poly, meaning ‘many’, and mer, meaning ‘part’. They are 
built up from simple molecules called monomers ‘single part’. Polymers are 
produced through a method known as polymerisation. This polymerisation step 
can be achieved through chemical or electrochemical methods. Originally 
polymers with the basic carbon chains were considered only as insulators.19 The 
first real interest in conducting polymers can be attributed to Walatka et al.20 in 
1973 with the report of highly conducting polysulfur nitride (SN)x. Meanwhile 
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and towards the late 1970s , MacDiarmid, Shirakawa and Heeger enhanced the 
discovery of the semi-conducting and metallic properties of the chemically 
synthesised organic polyacetylene.21-24 As is well known, the Nobel Prize in 
Chemistry was awarded to Alan J.Heeger, Alan G. MacDiarmid and Hideki 
Shirakawa in 2000 for the discovery and development of conducting polymers 
(CPs).21-24 In the following years, a wide range of polymeric organic species have 
been prepared as stable inherent films on inert electrodes via both chemical 
oxidation and electropolymerisation from aqueous and organic solution.25 
 
CPs are organic materials, which generally are comprised simply of C, H and 
simple heteroatoms such as N and S. Common examples include PPy, polyaniline 
and polythiophene which are shown in Figure 1.2. These and a number of other 
conducting polymers have been used in a variety of applications ranging from 
corrosion protection of materials, sensors to many biomedical applications, 
such as tissue engineering, nerve cell regeneration and drug delivery.26-29 
 
 
 
 
Figure 1.2: Chemical structures of (A) polypyrrole (B) polyaniline and (C) 
polythiophene. All polymers are shown in the dedoped state. 
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In, general materials are classed depending on their electrical conductivity, ĸ, 
where the electrical conductivity of insulators < semiconductors < conductors. 
Bredas and Street30 explained this phenomenon in terms of the band gap 
structure. Figure 1.3 illustrates the difference in each material using the band 
gap theory. The highest occupied molecular orbital is equivalent to the valence 
band (VB), while the lowest unoccupied molecular orbital may be equated to the 
conduction band (CB). The difference between each band is known as the band 
gap energy (Eg) and it is this energy gap that establishes the electrical 
properties of a material. If Eg > 10 eV, it is difficult to excite electrons into the 
conduction band and an insulator is formed. If Eg ~ 1.0 eV then thermal energy is 
sufficient to promote the electrons into the conduction band and a 
semiconductor is formed. If the gap vanishes, with overlap of the valence and 
conduction band, as shown in Figure 1.3, metallic conduction is observed. For 
most doped CPs the band gap energy is generally close to 1.0 eV, and 
consequently, CPs can be classified as semi-conductors. 
 
As pointed out by Bredas and Street30, the conductivity observed upon doping of 
the CPs was originally thought to be from the formation of unfilled electronic 
bands, however this idea was quickly dissipated upon experimental analysis of 
PPy and polyacetylene and now it is recognised that the conductivity is due to 
the formation of polarons and bipolarons, which are more energetically    
favoured.30, 31 
 
The π-bonded system of CPs, which comprises of alternating single and double 
bonds, enabling the delocalisation of electrons along the polymer backbone, is 
related to the conductivity of the system. The conductivity of these materials 
arises from a state of relative oxidation or reduction. In these states the polymer 
either loses (oxidation) or gains (reduction) an electron. Generally, it is said that 
this process occurs in 1 in every 4 monomer units.32 In this state the polymer is 
electronically charged and requires the introduction of counter ions (dopants) 
to compensate and reform the charge neutrality. The oxidation of the polymer in 
which an electron is removed from a π-bond, gives rise to a new energy state, 
which leaves the remaining electron in a non-bonding orbital. This energy level 
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is higher than the valence band and behaves like a heavily doped 
semiconductor.32 The extent of doping can be controlled during the 
polymerisation of the polymers. 
 
 
 
 
Figure 1.3: Schematic of the difference in band gap for Insulators, semi-conductors and 
metals (conductors). 
 
 
1.1.2.1 Polymerisation methods 
CPs are synthesised through a method known as oxidative polymerisation. This 
can be generated chemically or electrochemically. Chemical polymerisation 
involves the use of a chemical oxidant, such as ammonium peroxydisulfate 
(APS), ferric ions, permanganate, dichromate anions or hydrogen peroxide.  The 
oxidants not only oxidise the monomer but provide dopant anions to neutralise 
the positive charges formed on the polymer backbone.33 In the presence of these 
oxidants, the monomers are oxidised and chemically active cation radicals are 
formed which further react with the monomer and generate the desired 
polymer. An advantage of vapour phase chemical polymerisation of CPs is that 
the polymerisation occurs almost exclusively on the preferred surface and a 
higher surface area can be attained.34 Vapour phase chemical polymerisation of 
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pyrrole leads to further doping after polymerisation and this gives rise to an 
increase in conductivity.35 
 
The electrochemical deposition is a simple and reproducible technique where 
the dopant is present in the electrolyte during polymerisation. It is generally 
performed in a conventional three electrode set up, described later in Chapter 2, 
where current is passed through a solution containing the monomer in the 
presence of a dopant (electrolyte). The CP is deposited at the positively charged 
working electrode or anode.27 Polymerisation is initiated through the oxidation 
of the monomer which forms a mobile charge carrier known as a polaron 
(radical cation), that can react with another monomer or polaron to form a 
bipolaron (radical dication) which leads to the formation of the insoluble 
polymer chain and deposition of the polymer onto the working electrode.36  
 
In his book ‘Conducting Polymers’ published in 1986, Alcacer commented on the 
possibility of using CPs to make artificial muscles or perhaps even modification 
for the brain; little did he realise the extent to which these materials have been 
extensively researched, over the past 20 years.32 Since their discovery, the 
preparation and characterisation of these materials has evolved substantially 
through the use of electrochemistry. The majority of research is significantly 
based in this area due to the ease and control of synthesis of these electronically 
CPs.19 Reviews on the development of CPs show the various areas to where they 
can be applied. The applications are ongoing.37-40 However, in the case of DDS, 
CPs, in particular PPy, are widely researched for the controlled release of 
therapeutically active compunds.41-45 During oxidative polymerisation, a dopant 
molecule, with an overall anionic charge, is used to compensate for the positive 
charges originating from the oxidation of the monomer. It is during this process 
that the concept of drug delivery originated. Burgmayer and Murray46 observed 
changes in the ionic permeability of PPy redox membranes using a voltage-
controlled electrochemical reaction. This led to further investigations into the 
application of CPs in DDS. 
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1.1.2.2 Polypyrrole 
1.1.2.2.1 Historical background of polypyrrole  
In 1968 Dall’Olio and colleagues prepared black films of an oxypyrrole on 
platinum by the electrochemical polymerisation of pyrrole from a solution of 
sulfuric acid.47 In 1979 Diaz with the help of colleagues modified Dall’Olio’s 
approach and demonstrated that polymerising pyrrole onto platinum in 
acetonitrile led to a black, adherent film.48 Elemental analysis showed that the 
monomer unit was retained in the polymer. PPy in general, was poorly 
crystalline, and its ideal structure was a planar (α-ά)-bonded chain in which the 
orientation of the pyrrole molecules alternate.25 
The monomer unit, pyrrole, is shown in Figure 1.4. PPy is an organic material 
comprised simply of C, H and a simple N heteroatom, but is highly conducting. It 
is an inherently conductive polymer due to interchain hopping of electrons. PPy 
can be synthesised both chemically49 and electrochemically48. The 
electrochemical synthesis method is a one step synthesis method and allows the 
simple deposition of polymer films where its surface charge characteristics can 
easily be modified by changing the dopant anion (A-) that is incorporated into 
the material during synthesis. In a cell containing an aqueous or non-aqueous 
solution of the monomer, PPy forms a (semi) conducting film on the working 
electrode; the film grown is in the oxidised form and can be reduced to the non-
conducting insulating form by stepping the potential to more negative values. 
The potential cycling can be repeated many times between the insulating and 
(semi) conducting forms without a loss of the electroactivity of the film.25 
 
 
 
Figure 1.4: Schematic illustration of a monomer unit of pyrrole. 
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PPy in its neutral form is weakly coloured while the oxidised form is a deep 
blue/black. The switching of the state of the film not only changes its 
conductivity but it is also accompanied by a marked colour change, termed 
electrochromism.36 Materials such as PPy are important in terms of future 
technological impact as it may be possible to develop them to replace more 
expensive, often toxic, metallic conductors commonly employed in the 
electronics industry.25 
 
1.1.2.2.2 Polymerisation mechanism of pyrrole 
Although there are still various opinions on the mechanistic features of the 
electropolymerisation of pyrrole, the mechanism proposed by Diaz and his 
colleagues48 and later used by Baker and Reynolds is in good agreement with 
many experimental reports.50 The mechanism is demonstrated in Figure 1.5.  
 
The initial step is the generation of the radical cation. This cation has different 
resonance forms, as shown in Figure 1.5. In the next step in the chemical case, 
the radical cation then attacks another monomer molecule, generating a dimer 
radical cation. In the electrochemical case, the concentrations of radical cations 
is much larger than that of neutral monomers in the vicinity of the electrode 
where reactions are occurring, and radical-radical coupling leads to a radical 
dication. This coupling between the two pyrrole radicals results in the 
formation of a bond between the two α positions to give the radical dication, as 
highlighted in Figure 1.5. This is then followed by the loss of two protons, 
generating a neutral dimer. This dimer is then oxidised into a radical cation, 
where the unpaired electron is delocalised over the dimer. The radical dimer 
then couples with the radical monomer to form a trimer. The polymerisation 
thus progressing in this fashion to completion.  
 
The controversy in the mechanism of electropolymerisation is not surprising 
given that many factors, such as the nature of the electrolyte, ionic strength, pH, 
temperature and potential are important and can influence the mechanism of 
the reaction. 
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Figure 1.5: Mechanism of electrochemical polymerisation of pyrrole.50 
 
1.1.2.2.3 Biocompatibility 
PPy is one of the most widely researched conductive polymers. The fact that it 
can form biologically compatible matrices is one of the prominent reasons for 
the extensive research on the use of PPy in the field of biological applications.51 
Wang et al.52 acknowledged the reality that PPy had showed very good in vitro 
biocompatibility,29, 53, 54 but they wanted to evaluate further the in vivo 
biocompatibility prospects. They demonstrated that in comparison to no PPy, 
the presence of PPy/biodegradable composites stimulated no abnormal tissue 
response and had no affect on the degradation behaviour of the biodegradable 
materials. In 1994, PPy was one of the first conducting polymers investigated 
for its effect on mammalian cells.55 Since then, PPy is known to be 
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biocompatible, so it can be placed in the body without having adverse effects. It 
has been shown, in particular, to support cell growth and adhesion of 
endothelial cells.29, 55-57 Schmidt et al.29 also demonstrated that PPy was a 
suitable material for both in vitro nerve cell culture and in vivo implantation. 
PPy was electrochemically deposited onto ITO-conductive borosilicate glass. 
Moreover, the application of an external electrical stimulus through the polymer 
film resulted in enhanced neurite outgrowth. The median neurite length for PC-
12 cells grown on PPy film subjected to an electrical stimulus increased nearly 
two-fold compared with cells grown on PPy without the application of a 
constant potential. The group also investigated PPy in vivo and their studies 
showed that PPy promotes little negative tissue and inflammatory response. 
Due to the good biocompatible factor, studies on the application of an electric 
field to the PPy have also shown cell compatibility.29 In some important 
applications, such as biological sensors and actuators for medical devices it is a 
very attractive trait and some recent applications show that PPy can enhanced 
nerve cell regeneration and tissue engineering.27  
 
1.1.2.2.4 Electroactivity of polypyrrole 
PPy can be easily switched between the neutral, partially oxidised and fully 
oxidised states, as shown in Figure 1.6.  In its neutral state PPy exists as an 
insulator where the conduction band is empty as all the electrons remain in the 
valence band. Upon oxidation, an electron is removed from a π-bond (valence 
band) and a polaron is formed. The separation of the positive charge and the 
unpaired electron decreases during continual oxidation as the number of 
polarons increases. This in turn gives rise to the formation of a bipolaron, as 
depicted in Figure 1.6(C), and the polymer is now in its fully oxidised state. 
 
During oxidation and the generation of positive charge an influx of anions into 
the polymer matrix is observed in order to maintain charge balance.  This can be 
represented in Equation 1.1, where PPyo refers to the neutral (reduced) 
polymer, PPy+ refers to the oxidised polymer and A- refers to the anionic dopant. 
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PPy0  +  A-    PPy+A- + e-     1.1 
 
 
Typical anionic dopants are chlorides, bromides, iodides, perchlorates, nitrates, 
sulfates and para-toluene sulfonates.58-64 The extent of oxidation/reduction is 
given by the doping level and this is generally expressed as the ratio of dopant 
anions, A-, incorporated per monomer unit. For example, 1 A- per 4 monomer 
units gives a doping level of 0.25 or 25%. The maximum doping level achievable 
with PPy is 0.33 or 33%, i.e., 1 A- per 3 pyrrole units. It is important to point out 
that doping may not always be uniform; there can be islands with high doping 
levels surrounding by regions with a much lower doping level. 
 
 
  
 
 
 
Figure 1.6: Electronic structures of (A) neutral PPy, (B) polaron in partially doped PPy 
and (C) bipolaron in fully doped (oxidised) PPy.36 
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The electrochemical switching of PPy films is accompanied by movement of 
counter or dopant ions in and out of the polymer matrix to maintain the charge 
neutrality, as shown in Section 1.1.2.3.4. Consequently, PPy films are attractive 
for the controlled release of drug molecules. The concept of using PPy 
membranes for the uptake and release of ions was introduced, in the early 
1980s, by Burgmayer and Murray46.  They demonstrated that these polymeric 
films could be exchanged from their oxidised state to their neutral state. PPy has 
been seriously considered for drug delivery due to these unique redox 
properties. PPy gives a responsive material needed in order for the uptake and 
release of the drug to be controlled; in its oxidised state anions are 
electrostatically bound to the polymer film. These properties allow the 
controlled transport of ions. The uptake of these ions can occur in two ways. 
The first is where the bioactive molecule exists as an anion and is involved in 
the doping process of the polymeric material during polymerisation, Figure 1.7 
(A). Some anions that have been researched include adenosine tri phosphate 
(ATP)65, salicylate26, and dexamethasome26. These anions are electrostatically 
entrapped into the polymer matrix during the growth process upon application 
of an anodic potential. The anions are consequently liberated during the 
reduction of the polymer.  
 
 
 
 
Figure 1.7: Interconversion between oxidation and reduction states of PPy (PPy). (A) 
Anion (A-) incorporation and release which is notably observed in small mobile anions 
(e.g. Cl-) while, (B) Cation (C+) insertion and liberation from polymer films doped with 
larger anions  (e.g. DDS-) which remain entrapped in the polymer matrix. 
In the second case, cations can be incorporated into the system, Figure 1.7 (B), if 
the properties of the polymer film are modified.66 This is achieved through the 
Reduction
Oxidation
N
H
N
H
N
H
A- A
-C+
N
H
N
H
N
H
A-
Reduction
Oxidation
N
H
N
H
N
H
+ A-
+ C+
N
H
N
H
N
H
(A) 
 
 
 
(B) 
Introduction and literature review  Chapter 1 
- 17 - 
initial inclusion of a large anion which remains entrapped in the polymer matrix 
and thus the polymer behaves as a cation exchanger, where, the charge of the 
polymer system can only be compensated through the uptake of cations. The 
cations are therefore, taken in during the reduction of the polymer and released 
upon oxidation. Figure 1.7 demonstrates both these concepts. 
 
Miller and Zhou67 previously reported the release of dopamine from a poly(N-
methlypyrrole)/poly(styrenesulfonate) (PNMP/PSS) polymer based on the 
properties of these redox polymers. Immobilisation of PSS, a large anion, allows 
the uptake and release of the cation upon appropriate application of a potential. 
They achieved the release of dopamine using potential control, while more 
recently, Hepel and Mahdavi66 demonstrated the controlled release of a cationic 
species, chloropromazine, from a composite polymer film based on the same 
principles. They reported the development of a new composite conducting 
polymer, PPy/melanin, which performed as a cation binder and releaser. The 
modification of the polymer films, to enable the predominant cationic exchange 
properties of the CP, is an interesting way of improving the uptake and release 
of cationic species from these attractive materials. 
 
New ways of improving the controlled release of drugs are continually being 
sought after.  Lately, Abidan et al.41 reported on a method to prepare 
conducting-polymer nanotubes that can be used for controlled drug release. 
They introduced a method known as electrospinning to fabricate a nanofibrous 
mat in which the drug to be delivered had previously been incorporated; 
followed by electrochemical deposition of PPy films around the drug-loaded, 
electrospun biodegradable polymers. The drug release was achieved through 
the electrical stimulation of the PPy nanotubes. 
 
 
 
1.1.2.2.6 The application of Nanotechnology in drug delivery 
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Nanotechnology, although dating back to much earlier times, gained 
considerable attention in the early 1990s and has been the focus of much 
research over the last number of years. The introduction of nanotechnology into 
a controlled DDS has been shown to enhance many physical and chemical 
properties and overall has been used to increase the surface area of materials. 
This, in turn, leads to an increase in the amount of drug released from various 
materials. Many groups have introduced nanotechnology in various forms to 
improve on the drug delivery of a number of bioactive compounds, including 
nanoparticles15, micellar systems68 and nanofibers69. Polymeric nanofibers are 
gaining substantial interest for various applications including drug delivery69, 70. 
Several techniques have been employed for the production of nanofibers such 
as template synthesis71, self assembly72 and drawing73. One technique, in 
particular that is receiving considerable interest in this field, is 
electrospinning.74-77 Electrospinning has been introduced to achieve nanoscale 
membranes and fibres from various polymeric materials.78 
 
1.1.2.2.7 The application of Electrospinning to drug delivery 
Although electrospinning was first reported by Formhals79 in 1934 it has only 
been explored further in recent times.80, 81 In 1996, Reneker and Chun restored 
interest in the electrospinning technique by demonstrating the possibility of 
electrospinning a wide range of organic polymers.81 Since then the technique of 
electrospinning has become extremely useful in a variety of applications.82-85 
Electrospinning is a simple and inexpensive means for the formation of nano- to 
micron polymer fibers. 
 
This technique involves the application of a high electric field between a 
polymer fluid and a grounded electrode. When the polymer solution is subjected 
to an external electric field at a critical point the forces overcome the surface 
tension of the polymer solution to form a droplet with a conical shape, i.e., the 
Taylor cone.83, 86 The fluid is drawn into a jet which undergoes a whipping 
motion. Volatile solvents are used to dissolve the polymer as the subsequent 
evaporation from the liquid jet results in solid fibers. A more detailed 
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description of this technique is provided in Chapter 2, Section 2.4.5. In the 
majority of cases the fibers deposit randomly on the grounded collector. 
However, many groups have investigated the use of rotating collector plates to 
produce aligned nanofibers.87 Figure 1.8 illustrates a typical SEM micrograph of 
an electrospun fiber mat of PLGA fibers. 
 
This production of nanofibers allows these polymers to be used in a wide 
variety of applications including, tissue engineering (muscles, skin, cartilage and 
bones), wound healing and sutures, biosensors and DDS. Shin et al.88 studied the 
use of PLGA nanofiber scaffold for cartilage reconstruction, while, Kim and 
colleagues incorporated antibiotics in the fibrous matrix for use in wound 
dressings.89 Other groups have also prepared ultrafine polymers via 
electrospinning for skin regeneration.74 
 
 
 
 
Figure 1.8: A typical SEM image of electrospun PLGA nanofibers. 
 
 
Another attractive feature of using this electrospinning technique is that 
biodegradable polymeric materials, such as poly(lactic acid) (PLA) and poly(D,L – 
lactide-co-glycolide) (PLGA) can be used as a biomedical controlled release 
system. These biodegradable polymers can be electrospun in the presence of 
varying amounts of the required medication. They can then be placed in the 
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body and the drug release achieved through the modification of the polymer 
matrix’s morphology, porosity and composition.89 These biodegradable 
polymers have FDA approval for biomedical and drug delivery use.90-93 In 
comparison to other delivery forms, the electrospun nanofibers can 
conveniently incorporate the therapeutic compound during the electrospinning 
process.94 Many drugs have been incorporated into PLGA electrospun polymer 
matrices, in order to achieve delivery of the therapeutic drug,  including, 
tetracycline hydrochloride95 and mefoxin89. In these cases, the drug release was 
monitored and a burst release was observed and was attributed to the high 
surface area-to-volume ratio of the electrospun material. This is a disadvantage. 
In the last few years a small number of groups have deposited electroactive 
polymers, such as PPy, onto previously electrospun fibers in order to enhance 
the electrochemical properties57 of the material. Also, electrospun fibers have 
been used as a template in order to obtain a high surface area in the hope of 
achieving a greater uptake and release of drugs.41 
 
Another method of improving the DDS of conducting polymers is the use of 
various dopants during polymerisation of the polymer films. The 
functionalisation of PPy films with large anionic dopants is not new to this field 
of research. It has been well reported that the use of large anionic dopants 
during the electrochemical polymerisation of monomers leads to these bulky 
negatively charged groups being immobilised within the polymer matrix.96 In 
fact, these polymers, with their cationic exchange properties, have been used to 
incorporate various cationic groups for various applications. For example Fan 
and Bard in the late 1980s demonstrated the uptake of a positively charge 
Ru(NH3)63+ and methylviologen in PPy/Nafion films.97 
 
However, the generation of PPy films in the presence of negatively charged 
cyclodextrins is a new concept.98-100 There has been very little work reported on 
the electropolymerisation of pyrrole in the presence of anionic cyclodextrins. 
Indeed, much of the current published work is unreliable as very high potentials 
in the vicinity of 1.8 V vs. SCE were used to form the polymers.100, 101 It is very 
well known that these high potentials give rise to the overoxidation of PPy and a 
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considerable loss in its conductivity.59 The incorporation of cyclodextrins into 
conducting polymers provides a unique way of combining the unique host-guest 
complexation properties of cyclodextrins with the stability, high conductivity 
and ease of preparation of conducting polymers.  
 
1.1.3 Cyclodextrins 
1.1.3.1 History and structural properties of cyclodextrins  
Cyclodextrins (CD) are macrocyclic oligosaccharides composed of α-D-
glucopyranoside units linked by α-(1,4) bonds. They were first discovered by 
Villiers in 1891102, while in 1904, Schardinger103 further developed the cyclic 
structures hence; CDs are sometimes referred to as Schardinger dextrins. 
However, it was only in the mid 1970s that the structure and chemical 
properties of natural cyclodextrins were fully characterised.104
 
Cyclodextrins 
have developed quickly over the past two decades and have become an 
important branch of host-guest chemistry, specifically due to their ability to be 
involved in several practical applications.105 The main interest in cyclodextrins 
lies in their ability to form inclusion complexes with a variety of compounds. 
Host-guest chemistry is the study of these inclusion phenomena, where the 
‘host’ molecules are capable of including smaller ‘guest’ molecules through non-
covalent interactions. 
 
CDs are obtained through enzymatic degradation of starch in the presence of a 
glycosyl transferase, a type of amylase.106 Many organisms contain glycosyl 
transferase, however, in general it is obtained from Bacillus megaterium, 
Bacillus stereothermophilus and Bacillus macerans.106, 107 They are generally 
made up of glucopyranoside units of 4C1 chair conformation which leads to a 
truncated cone shape encasing a cavity.108 Figure 1.9 shows the structures of the 
most common CD members; α-, β- and γ-CD, which include 6, 7 and 8 repeating 
glucopyranoside units, respectively. These units orientate themselves in a cyclic 
manner offering a typical conical or truncated cone structure with a relatively 
hydrophobic interior and hydrophilic exterior.109 This structural property gives 
cyclodextrins good water solubility and the ability to hold appropriately sized 
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used for many applications including, drug delivery to enhance the solubility, 
stability and bioavailability of drug molecules.108, 112
 
 
Table 1.1: Approximate geometric dimensions of the three common CDs.106  
 
 
 
 
 
Cyclodextrin x / nm y / nm Cavity volume / Å3 
α 0.49 0.78 174 
β 0.62 0.78 262 
γ 0.79 0.78 427 
 
 
Cyclodextrins can also be chemically modified to replace the hydroxyl groups on 
both the primary and secondary rims of the CDs, with a variety of appropriate 
alkyl groups (R). It has been reported that this can improve binding affinity.108 
In the research presented here, a negatively charged cyclodextrin with a 
number of sulfonated groups present on the outer rims was used, sulfonated β-
CD (Sβ-CD). Sβ-CD is obtained by substitution of either primary or secondary 
hydrogen of the hydroxyl group of β-CD with a sulfonate group. Sβ-CD has an 
average of 7-11 substituents per CD and, therefore, has between 7-11 negative 
charges associated with it, which are counterbalanced with sodium ions, as 
illustrated in Figure 1.10.113 It is reported that β-CD and Sβ-CD have the same 
ring structure, differing only in the substituent located on the rims of the CD 
ring.14 Although Sβ-CD has the same ring structure as other derivativsed CDs the 
presence of the substituent on the ring contributes to its chiral discrimination 
properties.114 A major area in which these sulfonated CDs are being utilised is 
chromatography, or more specifically capillary electrophoresis, for the 
enantiomeric separation of acidic and basic compounds. In enantiomeric 
separation, using neutral CDs, they are not appropriate for neutral racemates as 
the complex has no electrophoretic mobilities.115 Therefore, the use of charged 
   x   
 y 
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CDs is now been widely researched for the separation of neutral compounds. It 
has been reported that the use of these sulfonated CDs for the enantiomeric 
separation of chiral compounds is highly effective as a result of the anionic 
charges.116, 117  
 
A number of groups have also characterised the Sβ-CD.115, 117 Figure 1.11 
illustrates a single glucose unit of an Sβ-CD (comprised of 7 units). On the 
primary ring there are 7 potential substitution sites corresponding to the C-6 
positions, while, on the secondary rim there are 14, represented by the C-2 and 
C-3 positions. Amini and co-workers117 reported that substitution of these CDs 
is predominantly at the C-2 and C-6 positions, while, Chen et al.115 confirmed 
nearly complete sulfation at the C-6 position of the primary hydroxyl groups 
and partial sulfation at the C-2 secondary hydroxyl groups. They also reported 
no substitution at the C-3 positions. From these reports it can be stated that 
almost the entire primary rim is sulfonated and some of the secondary rim. Due 
to this phenomenon and the fact that the sulfation brings with it negative 
charges these CDs are good candidates for the doping of CPs.  
 
 
R = SO3-Na+ or H ~ 7-11 SO3-Na+ groups. 
 
Figure 1.10: Structural and schematic representation of sulfonated β-cyclodextrin (Sβ-
CD). The arrows point to the primary and secondary rims, respectively.118 
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Figure 1.11: Chemical structure of Sβ-CD, depicting the numbering carbons. 
 
1.1.3.2 Inclusion complexation 
Cyclodextrins (CD) form a group of cyclic oligosaccharides that contain cavities 
in which guest molecules can be encapsulated.108, 109 It is well known that the 
size of the compounds are important and compounds are only capable of 
including into the cavity of the CD if they are within the dimensions of the CD 
cavity.119 In aqueous media, the cavity is filled with water molecules, which 
becomes displaced by the guest through complexation, as illustrated in Figure 
1.12. The guest molecule, xylene, displaces the water molecules and forms an 
inclusion complex with the CD. 
 
 
 
Figure 1.12: Schematic representation of xylene forming a complex with a β-
cyclodextrin. The small circles represent water molecules taken from Szjetli.109  
 
 
During the formation of an inclusion complex the chemical and the physical 
properties of the guest molecule change and can be monitored using a number 
of techniques. Various spectroscopic and electrochemical techniques can be 
used to confirm complexation, including fluorescence, UV-visible spectroscopy 
(UV), Nuclear magnetic resonance (NMR) and electrochemical studies. These 
changes attributed to the complexation can be used to evaluate the apparent 
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binding or formation constant (Kf). However, prior to the determination of the 
Kf  value the stoichiometry of the host-guest complex must be established.120 
This is obtained by the well known continuous variation or Job’s method which 
is described in more detail in Chapter 2, Section 2.6.1.1.121 Generally, inclusion 
complexes form a ratio of 1:1, 1:2 and sometimes 2:1 (CD:guest).122  
 
NMR is also a useful tool for the study of complexation due to its quantitative 
information and assuming the guest enters the cavity, NMR, can be also used to 
locate the protons involved in complexation.87 Many groups have studied the 
complexation properties with the neutral β-CD and monitored the changes in 
the chemical shifts for both the CD, and the guest. However, in the case of the 
modified CD used in this research, the NMR spectral data are too difficult to 
differentiate so the chemical shift of the guest is followed.120, 123-126 Bratu and 
colleagues125 studied the chemical shift changes observed when Fenbufen was 
in the presence of a neutral β-CD. They noticed an up-field shift of the guest 
protons, some more pronounced than others, and suggested that the 
complexation was initiated through the benzene moiety of the guest.               
Cruz et al.127 also used NMR to quantitatively evaluate the binding constant of 
the complexation of doxepin and a neutral β-CD.  
 
If a guest absorbs light in the UV or visible region then the inclusion 
phenomenon can be followed and subsequently, evaluated by UV.106 This 
technique can be used to confirm complexation and indeed obtain the formation 
constant associated with the inclusion complex. In the majority of cases the 
guest that absorbs in the UV-vis region experiences changes in the intensity and 
the position of the absorption bands in the presence of the CD. These spectral 
changes can be used to determine the Kf constants. Generally, a Hiedlebrand-
Benesi modified equation is used to evaluate the Kf constants.119, 128, 129 Ramaraj 
and co-workers130 monitored the changes attained during the complexation 
formation of a number of aromatic amines and nitro compounds in the presence 
of a neutral β-CD. They observed an increase in the intensity of the bands in all 
cases. Dang et al.119 observed shifts of the absorption bands to longer 
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wavelengths in the case of 1,4 benzoquinone (BQ) and 9,10 anthraquinone (AQ) 
in the presence of a neutral β-CD. 
 
Electrochemical techniques can also be performed on the complexation 
properties of CDs. If the guest is electroactive the peak current and potential can 
be followed for the free state and compared to the complexed state of the guest 
in question. Two features are generally observed during these electrochemical 
observations if an inclusion complex is found. Firstly, a decrease in the peak 
current can be seen, and, attributed to a decrease in the diffusion of the bulky 
CD complex as opposed to the more mobile free guest. Secondly, a shift in the 
peak potential is observed if the complexed species is included in the cavity, as 
it is harder to oxidise or reduce while located in the cavity. Once again based on 
these variations a number of equations can be used to verify the formation 
constant.129, 131, 132 Coutouli-Argyropoulou and his group133 reported the effect 
of complexation on the electrochemical properties of ferrocence derivatives and 
showed shifts, in both the peak current and peak potential, when higher 
concentrations of a neutral β-CD were added. Yanez et al.131 showed similar 
observations for nifedipine (NF) and nicardipine (NC) and estimated apparent 
formation constants of 135 and 357, respectively. 
 
Complexation studies of DA have been previously demonstrated in the presence 
of a neutral β-CD by Zhou et al.134 using UV and fluorescence spectroscopy. 
From the fluorescence technique, utilising a Hiedlebrand-Benesi modified 
equation, a Kf value of 95.06 was estimated. The degree of the complexation can 
vary over a wide range due to the stability of the complex, as it depends on a 
number of factors. In the next section a discussion on the main driving forces, 
involved in this complexation process are dealt with. 
 
1.1.3.3 Driving forces in the inclusion complexation process 
There are many reviews and books written on the driving forces behind the 
inclusion complexation abilities of cyclodextrins, not all agree, some refer to the 
predominantly hydrophobic affects while others state that it is a collection of  a 
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number of weaker interactions (H-bonding, van der Waals, electrostatic 
interactions).106, 108, 111, 135, 136 Either way the majority agree that the size of the 
cavity and shape of the guest are important factors in the complexation process. 
The most widely studied possible driving forces include  
 
 Hydrogen bonding  
 Electrostatic interaction 
 Van der Waals 
 Hydrophobic effect 
 
Hydrogen bonding is an interaction between an electronegative donor, a 
hydrogen and an electronegative acceptor.136 Various groups have 
demonstrated the importance of hydrogen bonding in the solid state, illustrating 
crystal structures defining the hydrogen bonding between the guest and the 
hydroxyls of the CDs.137 However, during the complexation of the CD and guest, 
in aqueous solution, the subject is still arguable as few direct measurements of 
hydrogen bonding have been made, as water molecules can compete with CDs 
to form hydrogen bonding with guest molecules. However, many groups will 
still argue over the significance of hydrogen bonding. 
 
Electrostatic interaction occurs when molecules of opposite charges interact. 
There are three types of electrostatic interactions, ion-ion interaction, ion-
dipole interaction and dipole-dipole interaction.136 Matsui and Okimoto138 
reported that ion-ion interaction is only eligible in the case of modified CDs, 
where as ion-dipole is considered more favourably due to the fact that CDs are 
polar molecules however as with hydrogen bonding, in aqueous media, the 
interaction between the guest and water will also be strong.136 Therefore, it is 
the case of dipole-dipole interaction that is mostly considered during 
complexation. 
 
Van der Waals forces or London dispersion forces are made up of dipole 
induced dipole contributions or the coordination of the electronic motion in the 
CD and guest. As CDs are known to have large dipole moments it is logical that 
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these induction forces are important in complexation. Experimental evidence 
has shown that the stability of the complex increases with an increase in 
polarisability. Also, as the polarisability of water is lower than the organic 
components of the CD cavity, van der Waals forces have an encouraging 
donation to the stability of the complex due to a stronger interaction of the CD 
and guest over the water and guest.136 CDs have also been reported to form 
stable inclusion complexes in organic solvents like DMF and DMSO confirming 
the importance of van der Waals forces.139 
 
The hydrophobic interaction which is entropically favourable, due to the 
expulsion of water, leads to the aggregation of non-polar solutes in aqueous 
solution.136 As reviewed by Connors135 the ‘classical’ hydrophobic interaction is 
said to be ‘entropy driven’ and a positive entropy and enthalpy is associated for 
the interaction between two non polar molecules. However, experimental 
studies in the complexation of CD and guests, show negative enthalpy and 
entropy changes,111 which have been suggested to indicate that these 
interactions are not a dominant force.  
 
Mosinger et al.122 reported that the formation of an inclusion complex is based 
on the electrostatic, van der Waals and π-π interactions, where, steric affects 
and Hydrogen bonding are inevitable. Chao and co-workers124 investigated the 
formation of an inclusion complex with β-CD and caffeic acid, they reported that 
the weak forces of hydrogen bonding, van der Waals, hydrophobic and 
electrostatic interactions simultaneously governed the process. 
 
Rekharsky and Inoue111 reviewed the complexation of cyclodextrins and stated 
that the interactions involved in the inclusion complexation of aromatic guests 
with CDs could not be simply put down to a hydrophobic effect. They 
established that complexation could be accounted for, through dipole-dipole 
interactions. In saying that, Tabushi and his group140 questioned the role of 
hydrogen bonding in the complexation process and reported that no dramatic 
changes of binding were observed, when a modified CD, incapable of hydrogen 
bonding, was compared to an unmodified CD. They concluded that the 
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involvement of hydrogen bonding was negligible and hydrophobic interactions 
dominated the process. Zia et al.113 investigated the complexation ability of a 
negatively charged CD (~7 negative sites) with a number of neutral and charged 
guest molecules. They accounted for the increase in the binding affinity, for the 
oppositely charged guest and CD, to be predominantly hydrophobic, due to the 
additional interaction sites provided by the negatively charged CD. Okimoto and 
colleagues141 also clearly observed stronger interactions occurring between a 
CD and guest with opposite charges. 
 
The understanding of these complexation processes is complicated, however, it 
is generally found that van der Waals forces and hydrophobic interactions are 
regarded as the main driving forces for CD complexation, while, electrostatic 
interactions and hydrogen bonding can be significantly considered in some 
inclusion complexation studies. Nevertheless, these attractive features of CDs 
allow them to be used in a wide range of applications including, the food 
industry142. However, the pharmaceutical industry is the most widely 
researched area in recent times, specifically in drug formulation and DDS.143 
 
1.1.3.4 Applications of CDs in DDS  
Due to their biocompatibility and their ability to form inclusion complexes, CDs 
have been studied for the use in DDS. They have been considered as drug 
carriers, as CDs have the potential to act as hydrophobic carriers and control the 
release of a variety of drugs.118  Many reviews have recently been published, 
describing the role of CDs in DDS.112, 118, 144-147 Irie and Uekama144 reviewed the 
role of CDs in peptide and protein delivery and summarised that CDs were able 
to eliminate a number of undesirable properties of drug formulations, as they 
form inclusion complexes with the desired drugs, which increase the drug 
delivery through a number of routes of administration. More recently, Li et al.145 
examined the recent progress in the preparation of inclusion complexes 
between CDs and various polymers as supramolecular biomaterials for drug 
and gene delivery. They demonstrated the promising field in the self assembly 
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of inclusion complexes between CDs and biodegradable polymers as injectable 
DDS.  
 
Ferancova and Labuda148 also reviewed the use of CDs as electrode modifiers. 
They summarised the many ways CDs can be immobilised onto electrode 
surfaces. As discussed in an earlier section, Section 1.1.4.2., the incorporation of 
CDs, as dopants, during the electrochemical polymerisation of CPs was 
demonstrated to examine the use of these modified electrodes to deliver neutral 
drugs.98 Formulating these materials, correlates the attractive features of both 
the CDs and the CPs. Bidan et al.98 examined the need for a new DDS that was 
not limited to charged drugs. They produced polymer films in the presence of an 
anionic CD and successfully delivered neutral compounds using these novel 
materials.         
 
Also briefly discussed in Section 1.1.4.2, was the reports made by a number of 
groups on the polymerisation of CPs in the presence of CDs.100, 101, 149 These 
groups have reportedly polymerised pyrrole at potentials usually shown to 
overoxidise the CP film.59 Due to this, these papers are unreliable in their 
reports. 
 
1.1.4 Drug release: Controlled release of dopamine 
DA is a neurotransmitter produced naturally in the brain. It is well documented 
that a common factor in neurodegenerative diseases such as Parkinson’s (PD) 
and Schizophrenia is a significant lack of the presence of DA in the substantia 
nigra (mid brain).150-152 In particular, PD is a slowly progressive disorder known 
to occur due to the damage of the basal ganglia.150-152 The disease affects 
movement, muscle control and balance. Studies on the brains of deceased 
Parkinson sufferers show a substantial loss of dopamine, particularly, in the 
substantia nigra. The function of the substantia nigra is to produce DA and 
manage the release of essential neurotransmitters that help control movement 
and coordination. Sufferers usually show symptoms such as tremors, slowness 
of movement and impaired balance and coordination. Prolonged loss of DA 
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gives rise to symptoms such as difficulty in walking, talking, or completing other 
simple tasks.150-152  
 
DA belongs to the well known catecholamine family. These molecules are 
electroactive and therefore their oxidation can be followed using 
electrochemistry, in particular, electrochemical methods such as cyclic 
voltammetry and rotational disc voltammetry. The electrochemical mechanism 
of oxidation is still not fully agreed; with various groups arguing that the 
mechanism goes through an ECE step rather than a CE step. For example, 
Hawley et al.153 have reported that the electrochemical oxidation of dopamine in 
aqueous solution proceeds through two types of steps, electrochemical (E) and 
chemical (C). The ECE mechanism is presented in Scheme 1.1. 
 
The first step in the oxidation of dopamine (A) involves the loss of both protons 
and electrons to form the o-dopaminoquinone (B). The oxidised, o-
dopaminoquinone undergoes a 1,4-Michael addition, which results in a 
intramolecular cyclisation reaction which produces leucodopaminochrome (C). 
This product is easily oxidised through an electrochemical step to form 
dopaminochrome (D).153, 154 
 
Controlled release studies of DA have been previously investigated.67, 155-158 
McRae-Degueurce et al.156 encapsulated DA into a thermoplastic polyester 
excipient: PLGA. They found that it was possible to deliver significant amounts 
of DA for prolonged periods of time by injecting the microencapsulated DA 
directly into the brain. Uludag and colleagues157 also examined the release of 
many therapeutic agents, including DA, from microencapsulated mammalian 
cells. The mammalian cells and tissues were entrapped in polymeric 
microcapsules containing the desired bioactive agent. 
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Scheme 1.1: The proposed oxidative pathway for dopamine. 
 
 
In both these cases the release was based on diffusion from the polymeric 
materials. It is, therefore, difficult to maintain any control over the amount of 
DA released. Miller67 and Zhou158 and co-workers investigated the use of CPs to 
deliver DA. They introduced the concept of using large immobile dopants, which 
remain entrapped inside the cavity during polymerisation, to bind and 
successfully liberate DA from the polymer films.  
This is the basis of the work performed in this thesis. As outlined at the start of 
this chapter, the idea of this research is to develop PPy films for the uptake and 
release of DA, using a large immobile anionic cyclodextrin. The cyclodextrin, in 
addition to its large size and immobility, has unique host-guest complexation 
properties and this offers the prospects of inclusion complexation between the 
DA and the CD to enhance the drug delivery. If this can be achieved it could 
potentially serve as a model system in DDS and could be extended to various 
other cationic drug molecules.  
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1.1 Introduction 
The initial aim of this work was to examine the use of polypyrrole (PPy), a well-
known conducting polymer, for the uptake and release of a cationic species, 
dopamine (DA). DA was chosen as it represents a large family of amine-based 
drugs. Therefore, if appropriate PPy films could be electrosynthesised and used 
in the controlled delivery of DA, then the concept could be used more widely in 
the field of controlled drug delivery.  
 
In Chapter 3, the growth of PPy films in the presence of various dopant anions, 
including a large anionic cyclodextrin (CD), sulfonated β-cyclodextrin (Sβ-CD) is 
explored. Although Sβ-CD doped PPy films have been reported in the recent 
literature, there has been very little work devoted to the characterisation of 
these films. Accordingly, much of Chapter 3 is devoted to the unique redox 
properties of the Sβ-CD doped PPy films.   
 
With the growth of the PPy films achieved, Chapter 4, shows the drug release 
profiles of the protonated DA and reveals that in the case of the polymer films 
doped with the anionic Sβ-CD, there is a substantial increase in the amount of 
DA released in comparison to other polymer films. In order to explain the 
enhanced release profiles, the well-known supramolecular complexation 
properties of cyclodextrins were considered. However, on searching the 
literature no reports on the complexation of DA with anionic cyclodextrins were 
found and consequently this was studied in detail. These findings are presented 
in Chapter 5, where the host-guest interactions between DA and the anionic Sβ-
CD are examined using a variety of techniques, both spectroscopic and 
electrochemical.  
 
In Chapter 6 the technique of electrospinning is introduced. Details on how it is 
used to fabricate nanostructured biodegradable polymer films with a high 
surface area are provided. The approaches used to deposit the Sβ-CD doped PPy 
films onto the nanostructured biodegradable film are then considered and 
discussed. It is shown that cyclic voltammetry was the most successful 
Introduction and literature review  Chapter 1 
- 3 - 
approach. Moreover, it was possible to control the amount of PPy deposited and 
to maintain the nanostructured fiber substrate by varying the number of cycles. 
These high surface area Sβ-CD doped PPy films are promising for the uptake 
and liberation of DA.  
 
In this introductory chapter, the concept of controlled drug release is firstly 
introduced. This is then followed with information on conducting polymers, 
particularly PPy and the current state-of-art in using PPy in drug delivery. The 
technique of electrospinning is then introduced and linked to DDS. The next 
section is devoted to cyclodextrins, as it is the Sβ-CD doped PPy films that give 
the best controlled release properties. Finally, the chapter ends with a short 
account of the properties of DA and its delivery.  
 
1.1.1 Controlled drug release 
In the early 1970s, controlled release systems first materialised. Since then, the 
number and the areas in which a controlled release system is utilised have 
significantly increased. These systems have been used in areas such as 
cosmetics1, food2, and pesticides3. Controlled release systems are focused on 
obtaining the release of the proposed material, over a certain time without an 
external influence from any other potential release factor.4 Polymeric materials 
have been previously investigated for controlled release as they can be easily 
manufactured and their composition can be finely tuned.5 Polymers used in 
controlled release systems can be natural or synthetic and release can be 
achieved through the engineering of the polymer substrates, i.e., the 
degradation of poly(D,L – lactide-co-glycolide)  (PLGA) can be controlled through 
the polymer composition, higher ratios of PLA lead to a higher degradation 
rate.6 
 
Another important research area under consideration is the development of 
controlled drug delivery systems (DDS).7, 8 In 1980, controlled DDS were 
virtually unknown, yet in 2005, almost 100 million people globally were using 
some form of polymer based DDS.8 The aim of a DDS is to supply the drug in its 
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therapeutically active form to a specific target in the body when the drug is 
required. In the current administration process there is a critical concentration 
needed in order to achieve the drug’s maximum therapeutic effect. If the 
concentration goes beyond the maximum level, toxicity problems come into 
play. Conversely, if the concentration administered is below the minimum level 
the effect of the drug is not observed. The use of these DDS could potentially 
eliminate these problems as the release would be of a controlled manner.  
 
Santini et al.7 compared the release profiles of both conventional and controlled 
methods, as illustrated in Figure 1.1. With conventional methods of drug 
delivery, outlined in Figure 1.1(A), i.e., oral administration or injections, drug 
levels rise after initial administration, which could lead to potential toxicity 
problems, and then decrease until the next dosage, which has consequences on 
the efficiency of the dosage. The other schematic, Figure 1.1(B), demonstrates 
the effectiveness of a controlled release system. After dosage, the drug level in 
the blood remains constant, between the maximum and minimum levels, for a 
certain period of time. 
 
 
 
 
Figure 1.1: Drug levels in the blood with (A) conventional drug dosage (B) controlled 
delivery dosage, taken from Santini et al.7 
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In recent years, polymeric materials have been examined and shown to provide 
an alternate means of delivering drugs. Implanted polymeric pellets or 
microspheres localise therapy to specific anatomic sites, providing a continuous 
sustained release of drugs while minimising systemic exposure.9 Polymers that 
display a physiochemical response to stimuli have been broadly researched for 
controlled release systems. Various stimuli include pH, temperature and the 
application of an electrical field.10 According to Langer11, polymeric DDS should 
i) maintain a constant drug level ii) reduce harmful side effects iii) minimise the 
amount of drug needed and iv) decrease the amount of doses which will have a 
pronounced effect on the patient.  
 
The original polymeric controlled DDS was based on a non-biodegradable 
polymer, silicone rubber, which was designed and tested by Folkman and 
Long.12 They loaded a silicone capsule (Silastic*) with a number of different 
drugs for the treatment of heart block and successfully implanted and 
monitored their effects over a number of days.  
 
In more recent years there has been considerable interest in the development of 
new and efficient DDS, particularly with the growth of sophisticated drugs that 
are based on DNA and proteins.5, 13 Currently, there are several materials under 
consideration in drug delivery, for example dendrimers14, nanoparticles15 and 
hydrogels16. The most promising opportunities in controlled DDS are in the area 
of responsive polymeric materials, with the possibility of implantable devices 
being used to deliver drugs. Murdan17 exhaustively reviewed the use of 
hydrogels as ‘smart’ drug delivery devices. He showed that hydrogels could be 
engineered for various medicinal treatments depending on the patients needs, 
for example, pain relief. In the body, drug release can only be accomplished if 
the drug carrier responds to some class of stimuli, be it chemical, physical or 
biological. Conversely, an implanted ‘smart’ drug delivery device should be non-
responsive to all other types of stimulus, once inside the body. A way of 
achieving this form of control is through an electrical stimulus.17 A number of in 
vivo devices, in the form of iontophoresis, have already been used for this type 
of controlled release.17, 18 Murdan presented a case where hydrogels loaded 
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with a bioactive compound, were implanted at a target site and the drug 
liberated through the application of an electrical field. In utilising such a system, 
many advantages including, minimal drug usage and lowering toxicity problems 
can be achieved. However, a problem arising with the application of an electrical 
stimuli to polymeric materials like, hydrogels, is that they experience deswelling 
or bending, which affects the drug release.17  
 
To overcome these problems, conducting polymers (CPs) are also receiving 
much attention in the field of biomedical research, for the application of 
controlled DDS, due to their light weight, good biocompatibility and ability to 
function at body temperature. In particular, conducting polymers exhibit a 
reversible electrochemical response. These reversible oxidation-reduction 
reactions are attractive for a responsive DDS, as a change in the net charge on a 
conducting polymer film during its reduction or oxidation requires ions to flow 
into or out of the film. This, in turn, allows the polymer film to bind and expel 
ions in response to electrical signals. Controlled release of drugs from polymers 
offers many advantages over conventional methods including better control of 
the drug level administered resulting in fewer side effects, local drug delivery, 
decreased requirements for the total amount of drug and protection of drugs 
which are rapidly destroyed by the body. However, in order to devise a suitable 
technology, the polymeric material must be responsive, i.e., it must be capable of 
altering so that the drug is released in a controlled fashion when needed. 
 
1.1.2 Conducting polymers 
A polymer is a large molecule made up of smaller repeating units. The name 
comes from the Greek poly, meaning ‘many’, and mer, meaning ‘part’. They are 
built up from simple molecules called monomers ‘single part’. Polymers are 
produced through a method known as polymerisation. This polymerisation step 
can be achieved through chemical or electrochemical methods. Originally 
polymers with the basic carbon chains were considered only as insulators.19 The 
first real interest in conducting polymers can be attributed to Walatka et al.20 in 
1973 with the report of highly conducting polysulfur nitride (SN)x. Meanwhile 
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and towards the late 1970s , MacDiarmid, Shirakawa and Heeger enhanced the 
discovery of the semi-conducting and metallic properties of the chemically 
synthesised organic polyacetylene.21-24 As is well known, the Nobel Prize in 
Chemistry was awarded to Alan J.Heeger, Alan G. MacDiarmid and Hideki 
Shirakawa in 2000 for the discovery and development of conducting polymers 
(CPs).21-24 In the following years, a wide range of polymeric organic species have 
been prepared as stable inherent films on inert electrodes via both chemical 
oxidation and electropolymerisation from aqueous and organic solution.25 
 
CPs are organic materials, which generally are comprised simply of C, H and 
simple heteroatoms such as N and S. Common examples include PPy, polyaniline 
and polythiophene which are shown in Figure 1.2. These and a number of other 
conducting polymers have been used in a variety of applications ranging from 
corrosion protection of materials, sensors to many biomedical applications, 
such as tissue engineering, nerve cell regeneration and drug delivery.26-29 
 
 
 
 
Figure 1.2: Chemical structures of (A) polypyrrole (B) polyaniline and (C) 
polythiophene. All polymers are shown in the dedoped state. 
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In, general materials are classed depending on their electrical conductivity, ĸ, 
where the electrical conductivity of insulators < semiconductors < conductors. 
Bredas and Street30 explained this phenomenon in terms of the band gap 
structure. Figure 1.3 illustrates the difference in each material using the band 
gap theory. The highest occupied molecular orbital is equivalent to the valence 
band (VB), while the lowest unoccupied molecular orbital may be equated to the 
conduction band (CB). The difference between each band is known as the band 
gap energy (Eg) and it is this energy gap that establishes the electrical 
properties of a material. If Eg > 10 eV, it is difficult to excite electrons into the 
conduction band and an insulator is formed. If Eg ~ 1.0 eV then thermal energy is 
sufficient to promote the electrons into the conduction band and a 
semiconductor is formed. If the gap vanishes, with overlap of the valence and 
conduction band, as shown in Figure 1.3, metallic conduction is observed. For 
most doped CPs the band gap energy is generally close to 1.0 eV, and 
consequently, CPs can be classified as semi-conductors. 
 
As pointed out by Bredas and Street30, the conductivity observed upon doping of 
the CPs was originally thought to be from the formation of unfilled electronic 
bands, however this idea was quickly dissipated upon experimental analysis of 
PPy and polyacetylene and now it is recognised that the conductivity is due to 
the formation of polarons and bipolarons, which are more energetically    
favoured.30, 31 
 
The π-bonded system of CPs, which comprises of alternating single and double 
bonds, enabling the delocalisation of electrons along the polymer backbone, is 
related to the conductivity of the system. The conductivity of these materials 
arises from a state of relative oxidation or reduction. In these states the polymer 
either loses (oxidation) or gains (reduction) an electron. Generally, it is said that 
this process occurs in 1 in every 4 monomer units.32 In this state the polymer is 
electronically charged and requires the introduction of counter ions (dopants) 
to compensate and reform the charge neutrality. The oxidation of the polymer in 
which an electron is removed from a π-bond, gives rise to a new energy state, 
which leaves the remaining electron in a non-bonding orbital. This energy level 
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is higher than the valence band and behaves like a heavily doped 
semiconductor.32 The extent of doping can be controlled during the 
polymerisation of the polymers. 
 
 
 
 
Figure 1.3: Schematic of the difference in band gap for Insulators, semi-conductors and 
metals (conductors). 
 
 
1.1.2.1 Polymerisation methods 
CPs are synthesised through a method known as oxidative polymerisation. This 
can be generated chemically or electrochemically. Chemical polymerisation 
involves the use of a chemical oxidant, such as ammonium peroxydisulfate 
(APS), ferric ions, permanganate, dichromate anions or hydrogen peroxide.  The 
oxidants not only oxidise the monomer but provide dopant anions to neutralise 
the positive charges formed on the polymer backbone.33 In the presence of these 
oxidants, the monomers are oxidised and chemically active cation radicals are 
formed which further react with the monomer and generate the desired 
polymer. An advantage of vapour phase chemical polymerisation of CPs is that 
the polymerisation occurs almost exclusively on the preferred surface and a 
higher surface area can be attained.34 Vapour phase chemical polymerisation of 
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pyrrole leads to further doping after polymerisation and this gives rise to an 
increase in conductivity.35 
 
The electrochemical deposition is a simple and reproducible technique where 
the dopant is present in the electrolyte during polymerisation. It is generally 
performed in a conventional three electrode set up, described later in Chapter 2, 
where current is passed through a solution containing the monomer in the 
presence of a dopant (electrolyte). The CP is deposited at the positively charged 
working electrode or anode.27 Polymerisation is initiated through the oxidation 
of the monomer which forms a mobile charge carrier known as a polaron 
(radical cation), that can react with another monomer or polaron to form a 
bipolaron (radical dication) which leads to the formation of the insoluble 
polymer chain and deposition of the polymer onto the working electrode.36  
 
In his book ‘Conducting Polymers’ published in 1986, Alcacer commented on the 
possibility of using CPs to make artificial muscles or perhaps even modification 
for the brain; little did he realise the extent to which these materials have been 
extensively researched, over the past 20 years.32 Since their discovery, the 
preparation and characterisation of these materials has evolved substantially 
through the use of electrochemistry. The majority of research is significantly 
based in this area due to the ease and control of synthesis of these electronically 
CPs.19 Reviews on the development of CPs show the various areas to where they 
can be applied. The applications are ongoing.37-40 However, in the case of DDS, 
CPs, in particular PPy, are widely researched for the controlled release of 
therapeutically active compunds.41-45 During oxidative polymerisation, a dopant 
molecule, with an overall anionic charge, is used to compensate for the positive 
charges originating from the oxidation of the monomer. It is during this process 
that the concept of drug delivery originated. Burgmayer and Murray46 observed 
changes in the ionic permeability of PPy redox membranes using a voltage-
controlled electrochemical reaction. This led to further investigations into the 
application of CPs in DDS. 
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1.1.2.2 Polypyrrole 
1.1.2.2.1 Historical background of polypyrrole  
In 1968 Dall’Olio and colleagues prepared black films of an oxypyrrole on 
platinum by the electrochemical polymerisation of pyrrole from a solution of 
sulfuric acid.47 In 1979 Diaz with the help of colleagues modified Dall’Olio’s 
approach and demonstrated that polymerising pyrrole onto platinum in 
acetonitrile led to a black, adherent film.48 Elemental analysis showed that the 
monomer unit was retained in the polymer. PPy in general, was poorly 
crystalline, and its ideal structure was a planar (α-ά)-bonded chain in which the 
orientation of the pyrrole molecules alternate.25 
The monomer unit, pyrrole, is shown in Figure 1.4. PPy is an organic material 
comprised simply of C, H and a simple N heteroatom, but is highly conducting. It 
is an inherently conductive polymer due to interchain hopping of electrons. PPy 
can be synthesised both chemically49 and electrochemically48. The 
electrochemical synthesis method is a one step synthesis method and allows the 
simple deposition of polymer films where its surface charge characteristics can 
easily be modified by changing the dopant anion (A-) that is incorporated into 
the material during synthesis. In a cell containing an aqueous or non-aqueous 
solution of the monomer, PPy forms a (semi) conducting film on the working 
electrode; the film grown is in the oxidised form and can be reduced to the non-
conducting insulating form by stepping the potential to more negative values. 
The potential cycling can be repeated many times between the insulating and 
(semi) conducting forms without a loss of the electroactivity of the film.25 
 
 
 
Figure 1.4: Schematic illustration of a monomer unit of pyrrole. 
 
H
N
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PPy in its neutral form is weakly coloured while the oxidised form is a deep 
blue/black. The switching of the state of the film not only changes its 
conductivity but it is also accompanied by a marked colour change, termed 
electrochromism.36 Materials such as PPy are important in terms of future 
technological impact as it may be possible to develop them to replace more 
expensive, often toxic, metallic conductors commonly employed in the 
electronics industry.25 
 
1.1.2.2.2 Polymerisation mechanism of pyrrole 
Although there are still various opinions on the mechanistic features of the 
electropolymerisation of pyrrole, the mechanism proposed by Diaz and his 
colleagues48 and later used by Baker and Reynolds is in good agreement with 
many experimental reports.50 The mechanism is demonstrated in Figure 1.5.  
 
The initial step is the generation of the radical cation. This cation has different 
resonance forms, as shown in Figure 1.5. In the next step in the chemical case, 
the radical cation then attacks another monomer molecule, generating a dimer 
radical cation. In the electrochemical case, the concentrations of radical cations 
is much larger than that of neutral monomers in the vicinity of the electrode 
where reactions are occurring, and radical-radical coupling leads to a radical 
dication. This coupling between the two pyrrole radicals results in the 
formation of a bond between the two α positions to give the radical dication, as 
highlighted in Figure 1.5. This is then followed by the loss of two protons, 
generating a neutral dimer. This dimer is then oxidised into a radical cation, 
where the unpaired electron is delocalised over the dimer. The radical dimer 
then couples with the radical monomer to form a trimer. The polymerisation 
thus progressing in this fashion to completion.  
 
The controversy in the mechanism of electropolymerisation is not surprising 
given that many factors, such as the nature of the electrolyte, ionic strength, pH, 
temperature and potential are important and can influence the mechanism of 
the reaction. 
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Figure 1.5: Mechanism of electrochemical polymerisation of pyrrole.50 
 
1.1.2.2.3 Biocompatibility 
PPy is one of the most widely researched conductive polymers. The fact that it 
can form biologically compatible matrices is one of the prominent reasons for 
the extensive research on the use of PPy in the field of biological applications.51 
Wang et al.52 acknowledged the reality that PPy had showed very good in vitro 
biocompatibility,29, 53, 54 but they wanted to evaluate further the in vivo 
biocompatibility prospects. They demonstrated that in comparison to no PPy, 
the presence of PPy/biodegradable composites stimulated no abnormal tissue 
response and had no affect on the degradation behaviour of the biodegradable 
materials. In 1994, PPy was one of the first conducting polymers investigated 
for its effect on mammalian cells.55 Since then, PPy is known to be 
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biocompatible, so it can be placed in the body without having adverse effects. It 
has been shown, in particular, to support cell growth and adhesion of 
endothelial cells.29, 55-57 Schmidt et al.29 also demonstrated that PPy was a 
suitable material for both in vitro nerve cell culture and in vivo implantation. 
PPy was electrochemically deposited onto ITO-conductive borosilicate glass. 
Moreover, the application of an external electrical stimulus through the polymer 
film resulted in enhanced neurite outgrowth. The median neurite length for PC-
12 cells grown on PPy film subjected to an electrical stimulus increased nearly 
two-fold compared with cells grown on PPy without the application of a 
constant potential. The group also investigated PPy in vivo and their studies 
showed that PPy promotes little negative tissue and inflammatory response. 
Due to the good biocompatible factor, studies on the application of an electric 
field to the PPy have also shown cell compatibility.29 In some important 
applications, such as biological sensors and actuators for medical devices it is a 
very attractive trait and some recent applications show that PPy can enhanced 
nerve cell regeneration and tissue engineering.27  
 
1.1.2.2.4 Electroactivity of polypyrrole 
PPy can be easily switched between the neutral, partially oxidised and fully 
oxidised states, as shown in Figure 1.6.  In its neutral state PPy exists as an 
insulator where the conduction band is empty as all the electrons remain in the 
valence band. Upon oxidation, an electron is removed from a π-bond (valence 
band) and a polaron is formed. The separation of the positive charge and the 
unpaired electron decreases during continual oxidation as the number of 
polarons increases. This in turn gives rise to the formation of a bipolaron, as 
depicted in Figure 1.6(C), and the polymer is now in its fully oxidised state. 
 
During oxidation and the generation of positive charge an influx of anions into 
the polymer matrix is observed in order to maintain charge balance.  This can be 
represented in Equation 1.1, where PPyo refers to the neutral (reduced) 
polymer, PPy+ refers to the oxidised polymer and A- refers to the anionic dopant. 
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PPy0  +  A-    PPy+A- + e-     1.1 
 
 
Typical anionic dopants are chlorides, bromides, iodides, perchlorates, nitrates, 
sulfates and para-toluene sulfonates.58-64 The extent of oxidation/reduction is 
given by the doping level and this is generally expressed as the ratio of dopant 
anions, A-, incorporated per monomer unit. For example, 1 A- per 4 monomer 
units gives a doping level of 0.25 or 25%. The maximum doping level achievable 
with PPy is 0.33 or 33%, i.e., 1 A- per 3 pyrrole units. It is important to point out 
that doping may not always be uniform; there can be islands with high doping 
levels surrounding by regions with a much lower doping level. 
 
 
  
 
 
 
Figure 1.6: Electronic structures of (A) neutral PPy, (B) polaron in partially doped PPy 
and (C) bipolaron in fully doped (oxidised) PPy.36 
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The electrochemical switching of PPy films is accompanied by movement of 
counter or dopant ions in and out of the polymer matrix to maintain the charge 
neutrality, as shown in Section 1.1.2.3.4. Consequently, PPy films are attractive 
for the controlled release of drug molecules. The concept of using PPy 
membranes for the uptake and release of ions was introduced, in the early 
1980s, by Burgmayer and Murray46.  They demonstrated that these polymeric 
films could be exchanged from their oxidised state to their neutral state. PPy has 
been seriously considered for drug delivery due to these unique redox 
properties. PPy gives a responsive material needed in order for the uptake and 
release of the drug to be controlled; in its oxidised state anions are 
electrostatically bound to the polymer film. These properties allow the 
controlled transport of ions. The uptake of these ions can occur in two ways. 
The first is where the bioactive molecule exists as an anion and is involved in 
the doping process of the polymeric material during polymerisation, Figure 1.7 
(A). Some anions that have been researched include adenosine tri phosphate 
(ATP)65, salicylate26, and dexamethasome26. These anions are electrostatically 
entrapped into the polymer matrix during the growth process upon application 
of an anodic potential. The anions are consequently liberated during the 
reduction of the polymer.  
 
 
 
 
Figure 1.7: Interconversion between oxidation and reduction states of PPy (PPy). (A) 
Anion (A-) incorporation and release which is notably observed in small mobile anions 
(e.g. Cl-) while, (B) Cation (C+) insertion and liberation from polymer films doped with 
larger anions  (e.g. DDS-) which remain entrapped in the polymer matrix. 
In the second case, cations can be incorporated into the system, Figure 1.7 (B), if 
the properties of the polymer film are modified.66 This is achieved through the 
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initial inclusion of a large anion which remains entrapped in the polymer matrix 
and thus the polymer behaves as a cation exchanger, where, the charge of the 
polymer system can only be compensated through the uptake of cations. The 
cations are therefore, taken in during the reduction of the polymer and released 
upon oxidation. Figure 1.7 demonstrates both these concepts. 
 
Miller and Zhou67 previously reported the release of dopamine from a poly(N-
methlypyrrole)/poly(styrenesulfonate) (PNMP/PSS) polymer based on the 
properties of these redox polymers. Immobilisation of PSS, a large anion, allows 
the uptake and release of the cation upon appropriate application of a potential. 
They achieved the release of dopamine using potential control, while more 
recently, Hepel and Mahdavi66 demonstrated the controlled release of a cationic 
species, chloropromazine, from a composite polymer film based on the same 
principles. They reported the development of a new composite conducting 
polymer, PPy/melanin, which performed as a cation binder and releaser. The 
modification of the polymer films, to enable the predominant cationic exchange 
properties of the CP, is an interesting way of improving the uptake and release 
of cationic species from these attractive materials. 
 
New ways of improving the controlled release of drugs are continually being 
sought after.  Lately, Abidan et al.41 reported on a method to prepare 
conducting-polymer nanotubes that can be used for controlled drug release. 
They introduced a method known as electrospinning to fabricate a nanofibrous 
mat in which the drug to be delivered had previously been incorporated; 
followed by electrochemical deposition of PPy films around the drug-loaded, 
electrospun biodegradable polymers. The drug release was achieved through 
the electrical stimulation of the PPy nanotubes. 
 
 
 
1.1.2.2.6 The application of Nanotechnology in drug delivery 
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Nanotechnology, although dating back to much earlier times, gained 
considerable attention in the early 1990s and has been the focus of much 
research over the last number of years. The introduction of nanotechnology into 
a controlled DDS has been shown to enhance many physical and chemical 
properties and overall has been used to increase the surface area of materials. 
This, in turn, leads to an increase in the amount of drug released from various 
materials. Many groups have introduced nanotechnology in various forms to 
improve on the drug delivery of a number of bioactive compounds, including 
nanoparticles15, micellar systems68 and nanofibers69. Polymeric nanofibers are 
gaining substantial interest for various applications including drug delivery69, 70. 
Several techniques have been employed for the production of nanofibers such 
as template synthesis71, self assembly72 and drawing73. One technique, in 
particular that is receiving considerable interest in this field, is 
electrospinning.74-77 Electrospinning has been introduced to achieve nanoscale 
membranes and fibres from various polymeric materials.78 
 
1.1.2.2.7 The application of Electrospinning to drug delivery 
Although electrospinning was first reported by Formhals79 in 1934 it has only 
been explored further in recent times.80, 81 In 1996, Reneker and Chun restored 
interest in the electrospinning technique by demonstrating the possibility of 
electrospinning a wide range of organic polymers.81 Since then the technique of 
electrospinning has become extremely useful in a variety of applications.82-85 
Electrospinning is a simple and inexpensive means for the formation of nano- to 
micron polymer fibers. 
 
This technique involves the application of a high electric field between a 
polymer fluid and a grounded electrode. When the polymer solution is subjected 
to an external electric field at a critical point the forces overcome the surface 
tension of the polymer solution to form a droplet with a conical shape, i.e., the 
Taylor cone.83, 86 The fluid is drawn into a jet which undergoes a whipping 
motion. Volatile solvents are used to dissolve the polymer as the subsequent 
evaporation from the liquid jet results in solid fibers. A more detailed 
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description of this technique is provided in Chapter 2, Section 2.4.5. In the 
majority of cases the fibers deposit randomly on the grounded collector. 
However, many groups have investigated the use of rotating collector plates to 
produce aligned nanofibers.87 Figure 1.8 illustrates a typical SEM micrograph of 
an electrospun fiber mat of PLGA fibers. 
 
This production of nanofibers allows these polymers to be used in a wide 
variety of applications including, tissue engineering (muscles, skin, cartilage and 
bones), wound healing and sutures, biosensors and DDS. Shin et al.88 studied the 
use of PLGA nanofiber scaffold for cartilage reconstruction, while, Kim and 
colleagues incorporated antibiotics in the fibrous matrix for use in wound 
dressings.89 Other groups have also prepared ultrafine polymers via 
electrospinning for skin regeneration.74 
 
 
 
 
Figure 1.8: A typical SEM image of electrospun PLGA nanofibers. 
 
 
Another attractive feature of using this electrospinning technique is that 
biodegradable polymeric materials, such as poly(lactic acid) (PLA) and poly(D,L – 
lactide-co-glycolide) (PLGA) can be used as a biomedical controlled release 
system. These biodegradable polymers can be electrospun in the presence of 
varying amounts of the required medication. They can then be placed in the 
Introduction and literature review  Chapter 1 
- 20 - 
body and the drug release achieved through the modification of the polymer 
matrix’s morphology, porosity and composition.89 These biodegradable 
polymers have FDA approval for biomedical and drug delivery use.90-93 In 
comparison to other delivery forms, the electrospun nanofibers can 
conveniently incorporate the therapeutic compound during the electrospinning 
process.94 Many drugs have been incorporated into PLGA electrospun polymer 
matrices, in order to achieve delivery of the therapeutic drug,  including, 
tetracycline hydrochloride95 and mefoxin89. In these cases, the drug release was 
monitored and a burst release was observed and was attributed to the high 
surface area-to-volume ratio of the electrospun material. This is a disadvantage. 
In the last few years a small number of groups have deposited electroactive 
polymers, such as PPy, onto previously electrospun fibers in order to enhance 
the electrochemical properties57 of the material. Also, electrospun fibers have 
been used as a template in order to obtain a high surface area in the hope of 
achieving a greater uptake and release of drugs.41 
 
Another method of improving the DDS of conducting polymers is the use of 
various dopants during polymerisation of the polymer films. The 
functionalisation of PPy films with large anionic dopants is not new to this field 
of research. It has been well reported that the use of large anionic dopants 
during the electrochemical polymerisation of monomers leads to these bulky 
negatively charged groups being immobilised within the polymer matrix.96 In 
fact, these polymers, with their cationic exchange properties, have been used to 
incorporate various cationic groups for various applications. For example Fan 
and Bard in the late 1980s demonstrated the uptake of a positively charge 
Ru(NH3)63+ and methylviologen in PPy/Nafion films.97 
 
However, the generation of PPy films in the presence of negatively charged 
cyclodextrins is a new concept.98-100 There has been very little work reported on 
the electropolymerisation of pyrrole in the presence of anionic cyclodextrins. 
Indeed, much of the current published work is unreliable as very high potentials 
in the vicinity of 1.8 V vs. SCE were used to form the polymers.100, 101 It is very 
well known that these high potentials give rise to the overoxidation of PPy and a 
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considerable loss in its conductivity.59 The incorporation of cyclodextrins into 
conducting polymers provides a unique way of combining the unique host-guest 
complexation properties of cyclodextrins with the stability, high conductivity 
and ease of preparation of conducting polymers.  
 
1.1.3 Cyclodextrins 
1.1.3.1 History and structural properties of cyclodextrins  
Cyclodextrins (CD) are macrocyclic oligosaccharides composed of α-D-
glucopyranoside units linked by α-(1,4) bonds. They were first discovered by 
Villiers in 1891102, while in 1904, Schardinger103 further developed the cyclic 
structures hence; CDs are sometimes referred to as Schardinger dextrins. 
However, it was only in the mid 1970s that the structure and chemical 
properties of natural cyclodextrins were fully characterised.104
 
Cyclodextrins 
have developed quickly over the past two decades and have become an 
important branch of host-guest chemistry, specifically due to their ability to be 
involved in several practical applications.105 The main interest in cyclodextrins 
lies in their ability to form inclusion complexes with a variety of compounds. 
Host-guest chemistry is the study of these inclusion phenomena, where the 
‘host’ molecules are capable of including smaller ‘guest’ molecules through non-
covalent interactions. 
 
CDs are obtained through enzymatic degradation of starch in the presence of a 
glycosyl transferase, a type of amylase.106 Many organisms contain glycosyl 
transferase, however, in general it is obtained from Bacillus megaterium, 
Bacillus stereothermophilus and Bacillus macerans.106, 107 They are generally 
made up of glucopyranoside units of 4C1 chair conformation which leads to a 
truncated cone shape encasing a cavity.108 Figure 1.9 shows the structures of the 
most common CD members; α-, β- and γ-CD, which include 6, 7 and 8 repeating 
glucopyranoside units, respectively. These units orientate themselves in a cyclic 
manner offering a typical conical or truncated cone structure with a relatively 
hydrophobic interior and hydrophilic exterior.109 This structural property gives 
cyclodextrins good water solubility and the ability to hold appropriately sized 
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used for many applications including, drug delivery to enhance the solubility, 
stability and bioavailability of drug molecules.108, 112
 
 
Table 1.1: Approximate geometric dimensions of the three common CDs.106  
 
 
 
 
 
Cyclodextrin x / nm y / nm Cavity volume / Å3 
α 0.49 0.78 174 
β 0.62 0.78 262 
γ 0.79 0.78 427 
 
 
Cyclodextrins can also be chemically modified to replace the hydroxyl groups on 
both the primary and secondary rims of the CDs, with a variety of appropriate 
alkyl groups (R). It has been reported that this can improve binding affinity.108 
In the research presented here, a negatively charged cyclodextrin with a 
number of sulfonated groups present on the outer rims was used, sulfonated β-
CD (Sβ-CD). Sβ-CD is obtained by substitution of either primary or secondary 
hydrogen of the hydroxyl group of β-CD with a sulfonate group. Sβ-CD has an 
average of 7-11 substituents per CD and, therefore, has between 7-11 negative 
charges associated with it, which are counterbalanced with sodium ions, as 
illustrated in Figure 1.10.113 It is reported that β-CD and Sβ-CD have the same 
ring structure, differing only in the substituent located on the rims of the CD 
ring.14 Although Sβ-CD has the same ring structure as other derivativsed CDs the 
presence of the substituent on the ring contributes to its chiral discrimination 
properties.114 A major area in which these sulfonated CDs are being utilised is 
chromatography, or more specifically capillary electrophoresis, for the 
enantiomeric separation of acidic and basic compounds. In enantiomeric 
separation, using neutral CDs, they are not appropriate for neutral racemates as 
the complex has no electrophoretic mobilities.115 Therefore, the use of charged 
   x   
 y 
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CDs is now been widely researched for the separation of neutral compounds. It 
has been reported that the use of these sulfonated CDs for the enantiomeric 
separation of chiral compounds is highly effective as a result of the anionic 
charges.116, 117  
 
A number of groups have also characterised the Sβ-CD.115, 117 Figure 1.11 
illustrates a single glucose unit of an Sβ-CD (comprised of 7 units). On the 
primary ring there are 7 potential substitution sites corresponding to the C-6 
positions, while, on the secondary rim there are 14, represented by the C-2 and 
C-3 positions. Amini and co-workers117 reported that substitution of these CDs 
is predominantly at the C-2 and C-6 positions, while, Chen et al.115 confirmed 
nearly complete sulfation at the C-6 position of the primary hydroxyl groups 
and partial sulfation at the C-2 secondary hydroxyl groups. They also reported 
no substitution at the C-3 positions. From these reports it can be stated that 
almost the entire primary rim is sulfonated and some of the secondary rim. Due 
to this phenomenon and the fact that the sulfation brings with it negative 
charges these CDs are good candidates for the doping of CPs.  
 
 
R = SO3-Na+ or H ~ 7-11 SO3-Na+ groups. 
 
Figure 1.10: Structural and schematic representation of sulfonated β-cyclodextrin (Sβ-
CD). The arrows point to the primary and secondary rims, respectively.118 
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Figure 1.11: Chemical structure of Sβ-CD, depicting the numbering carbons. 
 
1.1.3.2 Inclusion complexation 
Cyclodextrins (CD) form a group of cyclic oligosaccharides that contain cavities 
in which guest molecules can be encapsulated.108, 109 It is well known that the 
size of the compounds are important and compounds are only capable of 
including into the cavity of the CD if they are within the dimensions of the CD 
cavity.119 In aqueous media, the cavity is filled with water molecules, which 
becomes displaced by the guest through complexation, as illustrated in Figure 
1.12. The guest molecule, xylene, displaces the water molecules and forms an 
inclusion complex with the CD. 
 
 
 
Figure 1.12: Schematic representation of xylene forming a complex with a β-
cyclodextrin. The small circles represent water molecules taken from Szjetli.109  
 
 
During the formation of an inclusion complex the chemical and the physical 
properties of the guest molecule change and can be monitored using a number 
of techniques. Various spectroscopic and electrochemical techniques can be 
used to confirm complexation, including fluorescence, UV-visible spectroscopy 
(UV), Nuclear magnetic resonance (NMR) and electrochemical studies. These 
changes attributed to the complexation can be used to evaluate the apparent 
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binding or formation constant (Kf). However, prior to the determination of the 
Kf  value the stoichiometry of the host-guest complex must be established.120 
This is obtained by the well known continuous variation or Job’s method which 
is described in more detail in Chapter 2, Section 2.6.1.1.121 Generally, inclusion 
complexes form a ratio of 1:1, 1:2 and sometimes 2:1 (CD:guest).122  
 
NMR is also a useful tool for the study of complexation due to its quantitative 
information and assuming the guest enters the cavity, NMR, can be also used to 
locate the protons involved in complexation.87 Many groups have studied the 
complexation properties with the neutral β-CD and monitored the changes in 
the chemical shifts for both the CD, and the guest. However, in the case of the 
modified CD used in this research, the NMR spectral data are too difficult to 
differentiate so the chemical shift of the guest is followed.120, 123-126 Bratu and 
colleagues125 studied the chemical shift changes observed when Fenbufen was 
in the presence of a neutral β-CD. They noticed an up-field shift of the guest 
protons, some more pronounced than others, and suggested that the 
complexation was initiated through the benzene moiety of the guest.               
Cruz et al.127 also used NMR to quantitatively evaluate the binding constant of 
the complexation of doxepin and a neutral β-CD.  
 
If a guest absorbs light in the UV or visible region then the inclusion 
phenomenon can be followed and subsequently, evaluated by UV.106 This 
technique can be used to confirm complexation and indeed obtain the formation 
constant associated with the inclusion complex. In the majority of cases the 
guest that absorbs in the UV-vis region experiences changes in the intensity and 
the position of the absorption bands in the presence of the CD. These spectral 
changes can be used to determine the Kf constants. Generally, a Hiedlebrand-
Benesi modified equation is used to evaluate the Kf constants.119, 128, 129 Ramaraj 
and co-workers130 monitored the changes attained during the complexation 
formation of a number of aromatic amines and nitro compounds in the presence 
of a neutral β-CD. They observed an increase in the intensity of the bands in all 
cases. Dang et al.119 observed shifts of the absorption bands to longer 
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wavelengths in the case of 1,4 benzoquinone (BQ) and 9,10 anthraquinone (AQ) 
in the presence of a neutral β-CD. 
 
Electrochemical techniques can also be performed on the complexation 
properties of CDs. If the guest is electroactive the peak current and potential can 
be followed for the free state and compared to the complexed state of the guest 
in question. Two features are generally observed during these electrochemical 
observations if an inclusion complex is found. Firstly, a decrease in the peak 
current can be seen, and, attributed to a decrease in the diffusion of the bulky 
CD complex as opposed to the more mobile free guest. Secondly, a shift in the 
peak potential is observed if the complexed species is included in the cavity, as 
it is harder to oxidise or reduce while located in the cavity. Once again based on 
these variations a number of equations can be used to verify the formation 
constant.129, 131, 132 Coutouli-Argyropoulou and his group133 reported the effect 
of complexation on the electrochemical properties of ferrocence derivatives and 
showed shifts, in both the peak current and peak potential, when higher 
concentrations of a neutral β-CD were added. Yanez et al.131 showed similar 
observations for nifedipine (NF) and nicardipine (NC) and estimated apparent 
formation constants of 135 and 357, respectively. 
 
Complexation studies of DA have been previously demonstrated in the presence 
of a neutral β-CD by Zhou et al.134 using UV and fluorescence spectroscopy. 
From the fluorescence technique, utilising a Hiedlebrand-Benesi modified 
equation, a Kf value of 95.06 was estimated. The degree of the complexation can 
vary over a wide range due to the stability of the complex, as it depends on a 
number of factors. In the next section a discussion on the main driving forces, 
involved in this complexation process are dealt with. 
 
1.1.3.3 Driving forces in the inclusion complexation process 
There are many reviews and books written on the driving forces behind the 
inclusion complexation abilities of cyclodextrins, not all agree, some refer to the 
predominantly hydrophobic affects while others state that it is a collection of  a 
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number of weaker interactions (H-bonding, van der Waals, electrostatic 
interactions).106, 108, 111, 135, 136 Either way the majority agree that the size of the 
cavity and shape of the guest are important factors in the complexation process. 
The most widely studied possible driving forces include  
 
 Hydrogen bonding  
 Electrostatic interaction 
 Van der Waals 
 Hydrophobic effect 
 
Hydrogen bonding is an interaction between an electronegative donor, a 
hydrogen and an electronegative acceptor.136 Various groups have 
demonstrated the importance of hydrogen bonding in the solid state, illustrating 
crystal structures defining the hydrogen bonding between the guest and the 
hydroxyls of the CDs.137 However, during the complexation of the CD and guest, 
in aqueous solution, the subject is still arguable as few direct measurements of 
hydrogen bonding have been made, as water molecules can compete with CDs 
to form hydrogen bonding with guest molecules. However, many groups will 
still argue over the significance of hydrogen bonding. 
 
Electrostatic interaction occurs when molecules of opposite charges interact. 
There are three types of electrostatic interactions, ion-ion interaction, ion-
dipole interaction and dipole-dipole interaction.136 Matsui and Okimoto138 
reported that ion-ion interaction is only eligible in the case of modified CDs, 
where as ion-dipole is considered more favourably due to the fact that CDs are 
polar molecules however as with hydrogen bonding, in aqueous media, the 
interaction between the guest and water will also be strong.136 Therefore, it is 
the case of dipole-dipole interaction that is mostly considered during 
complexation. 
 
Van der Waals forces or London dispersion forces are made up of dipole 
induced dipole contributions or the coordination of the electronic motion in the 
CD and guest. As CDs are known to have large dipole moments it is logical that 
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these induction forces are important in complexation. Experimental evidence 
has shown that the stability of the complex increases with an increase in 
polarisability. Also, as the polarisability of water is lower than the organic 
components of the CD cavity, van der Waals forces have an encouraging 
donation to the stability of the complex due to a stronger interaction of the CD 
and guest over the water and guest.136 CDs have also been reported to form 
stable inclusion complexes in organic solvents like DMF and DMSO confirming 
the importance of van der Waals forces.139 
 
The hydrophobic interaction which is entropically favourable, due to the 
expulsion of water, leads to the aggregation of non-polar solutes in aqueous 
solution.136 As reviewed by Connors135 the ‘classical’ hydrophobic interaction is 
said to be ‘entropy driven’ and a positive entropy and enthalpy is associated for 
the interaction between two non polar molecules. However, experimental 
studies in the complexation of CD and guests, show negative enthalpy and 
entropy changes,111 which have been suggested to indicate that these 
interactions are not a dominant force.  
 
Mosinger et al.122 reported that the formation of an inclusion complex is based 
on the electrostatic, van der Waals and π-π interactions, where, steric affects 
and Hydrogen bonding are inevitable. Chao and co-workers124 investigated the 
formation of an inclusion complex with β-CD and caffeic acid, they reported that 
the weak forces of hydrogen bonding, van der Waals, hydrophobic and 
electrostatic interactions simultaneously governed the process. 
 
Rekharsky and Inoue111 reviewed the complexation of cyclodextrins and stated 
that the interactions involved in the inclusion complexation of aromatic guests 
with CDs could not be simply put down to a hydrophobic effect. They 
established that complexation could be accounted for, through dipole-dipole 
interactions. In saying that, Tabushi and his group140 questioned the role of 
hydrogen bonding in the complexation process and reported that no dramatic 
changes of binding were observed, when a modified CD, incapable of hydrogen 
bonding, was compared to an unmodified CD. They concluded that the 
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involvement of hydrogen bonding was negligible and hydrophobic interactions 
dominated the process. Zia et al.113 investigated the complexation ability of a 
negatively charged CD (~7 negative sites) with a number of neutral and charged 
guest molecules. They accounted for the increase in the binding affinity, for the 
oppositely charged guest and CD, to be predominantly hydrophobic, due to the 
additional interaction sites provided by the negatively charged CD. Okimoto and 
colleagues141 also clearly observed stronger interactions occurring between a 
CD and guest with opposite charges. 
 
The understanding of these complexation processes is complicated, however, it 
is generally found that van der Waals forces and hydrophobic interactions are 
regarded as the main driving forces for CD complexation, while, electrostatic 
interactions and hydrogen bonding can be significantly considered in some 
inclusion complexation studies. Nevertheless, these attractive features of CDs 
allow them to be used in a wide range of applications including, the food 
industry142. However, the pharmaceutical industry is the most widely 
researched area in recent times, specifically in drug formulation and DDS.143 
 
1.1.3.4 Applications of CDs in DDS  
Due to their biocompatibility and their ability to form inclusion complexes, CDs 
have been studied for the use in DDS. They have been considered as drug 
carriers, as CDs have the potential to act as hydrophobic carriers and control the 
release of a variety of drugs.118  Many reviews have recently been published, 
describing the role of CDs in DDS.112, 118, 144-147 Irie and Uekama144 reviewed the 
role of CDs in peptide and protein delivery and summarised that CDs were able 
to eliminate a number of undesirable properties of drug formulations, as they 
form inclusion complexes with the desired drugs, which increase the drug 
delivery through a number of routes of administration. More recently, Li et al.145 
examined the recent progress in the preparation of inclusion complexes 
between CDs and various polymers as supramolecular biomaterials for drug 
and gene delivery. They demonstrated the promising field in the self assembly 
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of inclusion complexes between CDs and biodegradable polymers as injectable 
DDS.  
 
Ferancova and Labuda148 also reviewed the use of CDs as electrode modifiers. 
They summarised the many ways CDs can be immobilised onto electrode 
surfaces. As discussed in an earlier section, Section 1.1.4.2., the incorporation of 
CDs, as dopants, during the electrochemical polymerisation of CPs was 
demonstrated to examine the use of these modified electrodes to deliver neutral 
drugs.98 Formulating these materials, correlates the attractive features of both 
the CDs and the CPs. Bidan et al.98 examined the need for a new DDS that was 
not limited to charged drugs. They produced polymer films in the presence of an 
anionic CD and successfully delivered neutral compounds using these novel 
materials.         
 
Also briefly discussed in Section 1.1.4.2, was the reports made by a number of 
groups on the polymerisation of CPs in the presence of CDs.100, 101, 149 These 
groups have reportedly polymerised pyrrole at potentials usually shown to 
overoxidise the CP film.59 Due to this, these papers are unreliable in their 
reports. 
 
1.1.4 Drug release: Controlled release of dopamine 
DA is a neurotransmitter produced naturally in the brain. It is well documented 
that a common factor in neurodegenerative diseases such as Parkinson’s (PD) 
and Schizophrenia is a significant lack of the presence of DA in the substantia 
nigra (mid brain).150-152 In particular, PD is a slowly progressive disorder known 
to occur due to the damage of the basal ganglia.150-152 The disease affects 
movement, muscle control and balance. Studies on the brains of deceased 
Parkinson sufferers show a substantial loss of dopamine, particularly, in the 
substantia nigra. The function of the substantia nigra is to produce DA and 
manage the release of essential neurotransmitters that help control movement 
and coordination. Sufferers usually show symptoms such as tremors, slowness 
of movement and impaired balance and coordination. Prolonged loss of DA 
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gives rise to symptoms such as difficulty in walking, talking, or completing other 
simple tasks.150-152  
 
DA belongs to the well known catecholamine family. These molecules are 
electroactive and therefore their oxidation can be followed using 
electrochemistry, in particular, electrochemical methods such as cyclic 
voltammetry and rotational disc voltammetry. The electrochemical mechanism 
of oxidation is still not fully agreed; with various groups arguing that the 
mechanism goes through an ECE step rather than a CE step. For example, 
Hawley et al.153 have reported that the electrochemical oxidation of dopamine in 
aqueous solution proceeds through two types of steps, electrochemical (E) and 
chemical (C). The ECE mechanism is presented in Scheme 1.1. 
 
The first step in the oxidation of dopamine (A) involves the loss of both protons 
and electrons to form the o-dopaminoquinone (B). The oxidised, o-
dopaminoquinone undergoes a 1,4-Michael addition, which results in a 
intramolecular cyclisation reaction which produces leucodopaminochrome (C). 
This product is easily oxidised through an electrochemical step to form 
dopaminochrome (D).153, 154 
 
Controlled release studies of DA have been previously investigated.67, 155-158 
McRae-Degueurce et al.156 encapsulated DA into a thermoplastic polyester 
excipient: PLGA. They found that it was possible to deliver significant amounts 
of DA for prolonged periods of time by injecting the microencapsulated DA 
directly into the brain. Uludag and colleagues157 also examined the release of 
many therapeutic agents, including DA, from microencapsulated mammalian 
cells. The mammalian cells and tissues were entrapped in polymeric 
microcapsules containing the desired bioactive agent. 
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Scheme 1.1: The proposed oxidative pathway for dopamine. 
 
 
In both these cases the release was based on diffusion from the polymeric 
materials. It is, therefore, difficult to maintain any control over the amount of 
DA released. Miller67 and Zhou158 and co-workers investigated the use of CPs to 
deliver DA. They introduced the concept of using large immobile dopants, which 
remain entrapped inside the cavity during polymerisation, to bind and 
successfully liberate DA from the polymer films.  
This is the basis of the work performed in this thesis. As outlined at the start of 
this chapter, the idea of this research is to develop PPy films for the uptake and 
release of DA, using a large immobile anionic cyclodextrin. The cyclodextrin, in 
addition to its large size and immobility, has unique host-guest complexation 
properties and this offers the prospects of inclusion complexation between the 
DA and the CD to enhance the drug delivery. If this can be achieved it could 
potentially serve as a model system in DDS and could be extended to various 
other cationic drug molecules.  
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2.1  Introduction 
The experimental techniques and procedures employed in this study are 
outlined in this chapter. Firstly, a description of the electrochemical 
instrumentation and the electrochemical set-up are provided. Then, the 
techniques used in the preparation of the polymer samples are introduced, 
however specific details on concentrations or experimental parameters are not 
provided, as these are given in a separate experimental section in Chapters 3, 4, 
5 and 6. General information on the characterisation of the samples is presented 
in Section 2.5. Again, specific details are not given, rather an overview of how 
the technique was used to characterise the sample is provided. Finally, a 
summary of the theories and related equations employed in this work is 
provided in Section 2.6.  
 
2.2  Electrochemical set up   
2.2.1 Electrochemical apparatus 
Electrochemical experiments such as potentiostatic, galvanostatic, cyclic 
voltammetry (CV), open-circuit potential and electrochemical quartz crystal 
microbalance (EQCM) measurements were carried out using one of three 
potentiostats; a Solartron (Model SI 1285), an eDAQ Potentiostat or a CHi440 
instrument (Model EA160). Each system was controlled by a computer and the 
various software packages used were CorrWare for WindowsTM, Version 2.1, 
eDAQ Echem Version 2.0.2 and CHi440 software Version 1.0.0.1, respectively. A 
schematic of the electrochemical equipment is shown in Figure 2.1. In all cases, 
experiments were carried out using a conventional three-electrode system, as 
described in Section 2.2.2.  
Experimental  Chapter 2 
- 42 - 
 
 
Figure 2.1: Experimental set up used to record all electrochemical measurements. 
 
2.2.2 The electrochemical cell 
The electrochemical cell shown in Figure 2.2 is a standard three-electrode cell 
consisting of a working electrode (WE), an auxiliary or counter electrode (CE) 
and a reference electrode (RE). A standard calomel electrode (SCE) was utilised 
for the majority of this work, except in the case of the work carried out for the 
release of dopamine (DA) from the nanofiber substrates where, a silver / silver 
chloride (Ag/AgCl) electrode (3.0 mol dm-3 NaCl filling solution) was used.  The 
working electrode varied from one experiment to the next. For the bulk drug 
release studies, platinum wire was used. In the nanofiber studies, poly(D,L – 
lactide-co-glycolide) PLGA fibers mounted on a gold coated mylar substrate 
were examined, while in the complexation studies a glassy carbon (GC) 
electrode was employed. A platinum wire/mesh electrode was used as the 
auxiliary (counter) electrode. The electrodes were connected to the potentiostat 
using coloured wires and the experiments and the results were computer 
controlled, as shown in Figure 2.1. 
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Figure 2.2: Diagram of electrode and electrochemical cell. 
 
2.2.3 Electrode materials and preparation  
All electrode materials were purchased from Goodfellow Metals and Alfa Aesar. 
For the most part of the drug release study, platinum wire was used and for the 
CV techniques a platinum disc encased in Teflon and set in place using epoxy 
resin was used, a schematic of which is illustrated in Figure 2.3. In both cases 
the platinum wire and disc comprised of a purity grade of 99.9 % and had a 1 
mm and 4 mm diameter, respectively. The platinum wire was polished using 
1200 grade paper and rinsed well using distilled water, to generate a clean and 
smooth surface. The platinum disc electrode was polished using 1 µm diamond 
polish (Buehler MetaDi Monocrystalline Diamond suspension) on a Buehler 
micro-cloth and washed with distilled water to ensure a clean surface. The 
nanofiber study utilised Poly(D,L – lactide-co-glycolide) (PLGA 50:50) 
electrospun onto a gold coated mylar substrate.  
 
For the electrochemical complexation studies, a GC rod (4 mm) was utilised. 
This GC rod was similarly encased into a larger insulating Teflon sheath and set 
in place using epoxy resin, as observed with the platinum disc electrode. The 
electrical contact was achieved using a copper wire. A schematic is shown in 
Figure 2.3. For the GC surface, diameter of 4 mm, the electrode was polished as 
outlined above for the platinum disc electrode. 
Reference (SCE)
Auxilliary (Pt wire)
Working  
(Pt, Au or GC)
Electrolyte
Glass cell
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Figure 2.3: Schematic diagram of electrode assembly. 
 
2.3  Chemicals and purification 
For all reagents the highest analytical grade possible was purchased and used as 
received. With two exceptions, the first was the pyrrole monomer; it was 
purchased from Aldrich and purified by distillation. It was stored in the dark, in 
the fridge at low temperatures. Secondly, sulfonated β-cyclodextrin (Sβ-CD) 
sodium salt was purchased from Aldrich (substitution ca. 7-11 moles per mole 
of β-CD as reported by Aldrich). The molecular mass of this compound was 
calculated, assuming an average of 9 substituted sulfonated groups were 
present. During experimental analysis an impurity was discovered. Nuclear 
Magnetic Resonance spectroscopy (NMR) (technique described later in more 
detail in Section 2.5.6) and Mass spectrometry (MS) techniques were employed 
to determine the nature of the impurity as shown in Figure 2.4 (A) and (B), 
respectively. The NMR data were obtained using a 300 MHz Bruker instrument, 
in D20. Figure 2.4 (A) shows the 1H NMR spectra of a sample of Sβ-CD in 0.10 
mol dm-3 KCl in D2O. In this figure, the highlighted blue region corresponds to 
the protons of the impurity. The impurity was confirmed to be pyridine. Figure 
2.5 shows the chemical structure of pyridine. MS was also performed to 
determine the impurity present in the Sβ-CD,  on an Agilent Technologies 6200 
Series Accurate-Mass Time-of-Flight (TOF) LC/MS. MS is a technique used to 
Teflon  
Holder 
Electrical  
Connection 
Epoxy Resin 
Exposed Metal 
Surface 
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measure the weight of a molecule or fragments of it. In this study, the technique 
involves the ionisation of the sample. Samples were placed in an Agilent 1200 
series high powered liquid chromatogram (HPLC) and passed through a 
gradient mobile phase of acetronitrile/water/formic acid. This process purified 
and separated the sample. The sample was then delivered to the mass 
spectrometer, in order to detect the positive ions. The sample was sent through 
a skimmer, where the neutral ions where removed. Using an Agilent time of 
flight (TOF) system, the positive ions were then pulsed up the flight tube and 
with the help of a reflectron, divided and, consequently, monitored by a 
detector. A spectrum illustrating the abundance of each positive ion as a 
function of mass/charge (m/z) was recorded. Figure 2.4 (B) shows the data 
recorded for a sample of the Sβ-CD. Pyridine has a molar mass of 79.101 g mol-1. 
However, MS deals with the (M+H)+ peak. In Figure 2.4 (B), the peak highlighted 
at m/z ratio 80.400 is equivalent to a pyridine (M+H)+ peak. Table 2.1 illustrates 
both the calculated and the measured m/z ratio for the pyridine (M+H)+ peak, 
with a calculated error of ± 0.5 % which is within the % error governed by the 
RSC.  
 
 
(A) 
Hc      Hb  Ha 
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
6
0
1
.1
5
7.47.67.88.08.28.48.68.8 ppm
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Figure 2.4: (A) 1H NMR spectra of 1.0 x 10-2 mol dm-3 Sβ-CD in 0.1 mol dm-3 KCl in D2O. 
Highlighted in blue is the presence of the peaks corresponding to pyridine. (B) Mass 
spectrum of a sample of Sβ-CD. 
 
Table 2.1: Table of calculated and measured m/z ratios for Sβ-CD sample. 
 
 Calculated, m/z Measured, m/z % ppm error 
(M+H)+ 80.04948 80.04944 ± 0.5 
 
 
Figure 2.5: Structure of pyridine. (300 MHz, D2O): δ 7.45 (1H, m, a-H), δ 8.49 (2H, 
m, b-H), δ 7.84 (2H, m, c-H). 
(B) 
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Methods in purifying the salt were also carried out. A common way of removing 
pyridine is by dissolving the salt in toluene and rotary evaporating the solvent 
off. However, Sβ-CD is insoluble in this solvent system and the purification step 
was unsuccessful. However, the main concern with the impurity was the 
possible interaction of pyridine with the Sβ-CD and preventing the interaction of 
the Sβ-CD with the dopamine. To eliminate the possibility of interference a 
simple CV experiment was performed. Firstly, a 50 mL volume of a 5.0 x 10-4 
mol dm-3 DA solution was prepared in a citrate phosphate buffer, pH~3.2. This 
solution was divided in two sample cells, where 40 µL of pyridine was added to 
one of the cells. CV was run, using a three electrode set up as described in 
Section 2.2.2 with a GC as the working electrode, on the DA solution in the 
absence and presence of pyridine. The potential was swept from -0.250 to 0.800 
V vs. SCE at 50 mV s-1 for 10 cycles. Figure 2.6 shows the results obtained for the 
oxidation of DA in the absence and presence of 40 µL (2.0 x 10-2 mol dm-3) of 
pyridine.  
 
 
Figure 2.6: Cyclic voltammograms recorded in a citrate-phosphate buffer (pH ~ 3.2) 
at a GC electrode. Data were recorded in a 5.0 x 10-4 mol dm-3 DA solution in the 
 absence and       presence of pyridine. The potential was swept from -0.250 to 
0.800 V vs. SCE at 50 mV s-1. 
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From the data, identical voltammograms were recorded in the presence and 
absence of pyridine. It is evident that no interference is observed in the 
presence of a large excess of pyridine. In light of this, all results shown in the 
complexation studies are true for the inclusion complexation of DA with Sβ-CD. 
 
2.4  Preparation of polymer samples  
Using various techniques polypyrrole was electrochemically and chemically 
deposited on a number of substrates. Here, the techniques employed are briefly 
summarised. The solution preparation and other more detailed parameters are 
discussed in the results chapters. 
 
2.4.1 Potentiostatic techniques 
These studies were carried out by applying a constant potential to the electrode 
and then recording the current density as a function of time.  This technique 
was employed to electrochemically deposit polypyrrole on the desired 
substrate.  This involved applying an anodic potential of > 0.500 V vs. SCE to the 
electrode of interest in the polymer forming electrolyte.   
 
This technique was also used to incorporate and release the drugs by reducing 
and oxidising the polymer film. In the case of the cationic drugs, i.e., DA, the 
incorporation was achieved by imposing a potential of –0.900 V vs. SCE for a 
period of 30 min in a 0.1 mol dm-3 DA solution and, an applied potential of 0.100 
V vs. SCE for 60 min in a 0.1 mol dm-3 Na2S04 solution was required for the 
release.  
 
2.4.2 Galvanostatic techniques 
This technique was employed to electrochemically deposit polypyrrole onto the 
electrospun nanofibers on gold coated mylar. This technique involves the 
application of a constant current to the electrochemical cell. In the case of 
polypyrrole growth on the electrospun PLGA nanofibers a constant current of 1 
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mA cm-2 was applied and the potential was recorded as a function of time, or 
until a suitable charge was passed. 
 
2.4.3 Cyclic voltammetry 
This technique was utilised as an alternative technique to electrochemically 
deposit polypyrrole on particular substrates of interest. Cyclic voltammetry, 
(CV), involves sweeping the potential applied to the working electrode between 
two potential limits at a required scan rate, where the change in current is 
monitored.1 The resulting cyclic voltammogram is a plot of applied potential as 
a function of current. The working electrode serves as the surface where the 
electron transfer of the redox reaction takes place and the electrical current 
created is known as the faradic current. The CE balances this faradic process 
with an electron transfer in the opposite direction. (e.g., if oxidation takes place 
at the WE, reduction takes place at the CE). The redox reaction occurs within the 
potential range defined by the two chosen potential limits, and the potential at 
which the reduction or oxidation takes place provides qualitative information 
about the electroactive species under investigation. The working electrode can 
act as an electrochemical reductant or oxidant depending on the applied 
potential to the surface. As the applied potential becomes more negative, the 
electrode becomes a better reducing agent. Equally, as the applied potential 
becomes more positive, the electrode becomes a better oxidising agent. 
 
2.4.4 Vapour phase polymerisation 
Vapour phase polymerisation (VPP) was another technique employed for the 
deposition of polypyrrole onto various substrates. This technique is relatively 
simple and is useful for the deposition of polymers onto insulating substrates. In 
this case an oxidant, 40% Fe(III)/PTS made up in ethanol, was spin coated onto 
a desired substrate, flashed off using a heating mantle and placed in a chamber 
containing the monomer. The oxidant initiates polymerisation of the monomer 
which is followed by the formation of polypyrrole onto the surface. 
 
 
Experimental 
2.4.5 Electrospinning 
Electrospinning is a technique that was used to form nanostructured fibers onto 
a substrate which subsequently was used to polymerise pyrrole. In this 
technique, a strong electric field was employed to convert a polymer solution 
into solid fibers. The electrospinning apparatus
consisted of a high voltage power supply (Gamma High Voltage), a digital 
syringe pump (Kd Scientific
made of galvanised iron mounted on a stand. 
 
Figure 2.7: Schematic diagram of the Electrospinning set
 
 
In order to produce the electrospun fibers a h
needle containing the polymer solution, this
jet. A solid fiber is generated and is continuously stretched due to the 
electrostatic repulsions between the surface char
solvent. Intrinsic properties
(viscosity), elasticity, electrical conductivity, polarity and surface tension of 
solvent are all important in the formation of the fibers and are studied as 
detailed in Chapter 6. Operational properties
field, the distance from the spinneret and collector and the flow rate of the 
polymer were also taken into consideration. 
conducting substrate. This consists of a plastic sheet with a coating of gold.
side is conducting and the other insulating. It comes in large rolls and is easy to 
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 used is shown in Figure 2.7.
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use, flexible and can be shaped in various sizes to achieve uniform substrates. In 
the electrospinning process, samples were initially cut into 5 x 5 cm squares and 
clipped onto a metal template. 
 
2.5  Characterisation of samples 
Various techniques were used to characterise the polymers, confirm inclusion 
complexation and evaluate the amount of drug released from the polymer 
systems. 
 
2.5.1 EQCM measurements 
Additional information on the synthesis and electrochemical behaviour of the 
conducting polymers, as well as the drug release studies was obtained using an 
Electrochemical Quartz Crystal Microbalance (EQCM) technique.  The 
experiments were performed on a CHI400 EQCM, a schematic of which is shown 
in Figure 2.8. The equipment consisted of a quartz crystal oscillator, a frequency 
counter, a fast digital function generator, a high-resolution and high-speed data 
acquisition circuitry, a potentiostat, a galvanostat and a computer. EQCM 
measurements calculate the mass change occurring at the electrode surface by 
monitoring the changes in the resonant frequency (ƒ0) of an oscillating quartz 
crystal. The frequency is related to the mass through the Sauerbrey equation, 
Equation 2.1: 
 
Δ   2Δ	
  
 
where ƒ0 is the resonant frequency, ∆M is the mass change, A is the surface area 
of the electrode or film, 0.203 cm2, ρ is the density of quartz , 2.648 g cm-3, and µ 
is the shear modulus of quartz, 2.947 x 1011 g cm-1 s-2. In this equation the 
change in frequency (∆ƒ) is equal to minus the change in mass (∆m) per unit 
area (A) times a constant. The frequency, therefore, decreases as the mass 
increases.  
2.1 
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Figure 2.8: EQCM set-up. 
 
2.5.2 UV-visible spectroscopy 
UV-visible spectroscopy measures the amount of ultraviolet and visible light 
transmitted or absorbed by a sample placed in the spectrometer. The 
wavelength at which a chemical absorbs light is a function of its electronic 
structure and the intensity of the light absorption is related to the amount of the 
chemical between the light source and the detector, so a UV-visible spectrum 
can be used to identify some chemical species. Also, it is well suited for the 
quantitative study of association constants since the measured absorbance 
values are proportional to the respective concentration by the Beer-Lambert 
law.2 
 
A Varian Cary series spectrophotometer was used for all of the analysis on 
monitoring the drug release and complexation studies. It comprises a Xenon 
lamp and has a maximum scan rate of 24 000 nm per minute. This technique 
was employed to monitor the release of dopamine investigated in the drug 
delivery studies. Spectra were obtained and analysed to calculate the amount of 
drug released upon application of a reduction/oxidation or open-circuit 
potential. In all cases, a quartz crystal cuvette with a diameter of 1 cm was used. 
The drug concentration was investigated at the wavelength of maximum 
absorption, λmax of the drug. For example, the wavelength at 280 nm was 
monitored in the release studies of dopamine. To determine the concentration, 
or the amount of drug released, a calibration curve was firstly obtained. The 
Ref              CE
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amount of drug released can be determined by measuring the absorbance at a 
particular wavelength and applying the Beer-Lambert law, Equation 2.2.  
 
	    
 
where A is the absorbance, ε is the molar absorbtivity, b is the path length and c 
is the concentration of the compound in solution. From the linear relationship 
between concentration and absorbance a slope value can be obtained. When 
samples from the release of the drug were taken and the absorbance values 
were recorded, these values were expressed as concentration when used in 
conjunction with the Beer Lambert law and the slope value. For example, Figure 
2.9 shows a calibration curve of DA which has a λmax = 280 nm. The equation of 
this line is: 
 
      y = 2487.68 x                        
 
where y is the absorbance and x is the concentration.  
 
 
 
Figure 2.9: Calibration curve for dopamine in water. Absorbance as a function of 
concentration. From the data the slope was obtained. 
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2.5.3 Cyclic voltammetry 
This technique was utilised as an alternative technique to electrochemically 
deposit polypyrrole on particular substrates of interest. Secondly, it was used as 
an investigative tool to study the growth and the properties of the polymer.3 
Thirdly, it was used to determine the binding constants for DA and Sβ-CD. The 
scan rates employed in the specific experiments are illustrated in the figure 
captions or corresponding text in the results section.  
 
As detailed in Section 2.3.3, the CV experiment involves scanning the potential 
between two limits at a particular scan rate. It is particularly useful in studying 
the reversibility of a redox couple. For a simple redox couple, the 
voltammogram exhibits an oxidation wave, with a peak current, and a 
corresponding reduction wave, centred at a peak potential. 
 
For a reversible couple, the ratio of the reverse-to-forward peak currents, ipr/ipf, 
is unity, while the separation between the peak potentials is given by Equation 
2.3. Also, this peak separation is independent of the scan rate. Thus, the peak 
separation can be used to determine the number of electrons transferred, n, and 
as a criterion for the Nernstian behaviour: 
 
                 ∆       59 /                     2.3 
 
In addition, the peak current for a reversible couple is given by the Randles-
Sevcik equation: 
 
    /	 !/  "!/ 
 
 
where the constant, k, has a value of 2.69 x 105, ip is the peak current, n is the 
number of electrons transferred per mole of electroactive species; A is the area 
of the electrode in cm2; D is the diffusion coefficient in cm2 s-1; c is the 
concentration in mol cm-3; v is the scan rate of the potential in V s-1.4 The ip is 
linearly proportional to the concentration, c, of the electroactive species and the 
2.4 
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square root of the scan rate, ν1/2. Thus if linear plots of ip vs. ν1/2 are obtained the 
electrode reaction is under diffusion control, which is the mass transport of the 
electroactive species to the surface of the electrode across a concentration 
gradient.  Using Equation 2.4, the diffusion coefficients were evaluated from the 
slopes of the corresponding, ip vs. ν1/2 plots. 
 
However, the situation is very different when the redox reaction is slow or when 
it is coupled with a chemical reaction. For an irreversible process (slow electron 
exchange), the redox peaks are reduced in size and are separated by a large 
potential. Totally irreversible systems are characterised by a shift of the peak 
potential with the scan rate, as detailed in Equation 2.5: 
 
        $%&/'()*0.78  ln 1 23$4)567 8  ln $
9:;<
=> )!/?                            2.5 
 
where α is the transfer coefficient and n is the number of electrons involved in 
the charge-transfer step. Thus, Ep occurs at potentials higher than E0, with the 
overpotential related to the rate of the reaction, k0, and α. For quasi-reversible 
systems (with 10-1 > k0 > 10-5 cm s-1) the peaks exhibit a larger separation in 
peak potentials compared to the reversible redox system, Equation 2.3. 
 
2.5.4 Rotation disc voltammetry  
Rotation Disc Voltammetry, (RDV), was another technique employed in the 
determination of diffusion coefficients of DA in the absence and presence of Sβ-
CD. A schematic of the equipment involved is shown in Figure 2.11. A rotation 
disc electrode, similar to the electrode shown in Figure 2.3 was used for these 
studies. The RDV set up consists of an electrode attached to a rotor spindle via a 
suitable electrical contact. When the circular disc is rotated at a particular 
rotation speed in solution, fresh reactant is brought to the surface. A well 
defined flow pattern, shown in Figure 2.11 (B), is obtained where the rotating 
electrode acts as a ‘pump’, dragging the solution perpendicular to the electrode 
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surface which is subsequently thrown out in a radial direction on contact with 
the electrode surface.5 
 
 
          
 
Figure 2.11: Schematic diagram of electrode in the RDV set up. The patterns of flow to 
a rotating disc electrode (A) viewed from below the electrode face and (B) across its 
surface as viewed from the side. 
 
This technique has an advantage over cyclic voltammetry where the diffusion 
layer is time dependent. The thickness of the diffusion layer using RDV can be 
controlled by changing the rotation speed of the electrode. This approach leads 
to higher currents, greater sensitivity and reproducibility due to the increased 
transport of electroactive species to the electrode surface. The electrode is 
rotated at a known frequency, f, where the angular velocity, ω = 2πf/60. The 
rotation of the electrode must not be so fast as to cause turbulence in the 
solution, therefore ensuring laminar flow of the substrate to the electrode 
surface.1 Since the current is proportional to the concentration, the observed 
current should increase with the increase in ω. With this statement, the Levich 
equation is defined. This equation applies to the total mass-transport-limited 
Rotor spindle 
 
 
 
 
Electrode 
ω
z = 0
r = 0
(a)
(b)
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condition at the electrode surface. Using the Levich equation, for an 
electrochemical process the observed current is limited by diffusion, this 
current can be related to the rotation speed of the electrode, Equation 2.6. 
 
@  0.621(	 /CD!/EF!/ 
 
where,  
GHIJ  0.621(	 /CD!/E 
 
 
iL is the limiting current, n is the number of electrons transferred, F is Faraday’s 
constant (96485.3415 C mol-1), A is the surface area, D is the diffusion 
coefficient, cm2 s -1, ν is the kinematic viscosity, c is the concentration and ω is 
the rotational speed in rad s–1.  
 
In this thesis, the Levich equation was used to determine Df and Dc, which are 
the diffusion coefficients of DA obtained in the absence and presence of an 
excess of Sβ-CD, respectively. In this case, the limiting current was recorded as a 
function of the rotation rate for a solution of DA in the absence and presence of 
Sβ-CD. The limiting current is directly proportional to the square root of the 
rotation speed. The subsequent Levich plot, iL vs. ω
1/2
, should return a straight 
line through the origin whose slope can be used to estimate the diffusion 
coefficient. The diffusion coefficient, D can be obtained from the slopes if the 
parameters n and c are known. 
 
The Koutecky-Levich equation was also applied to the RDE data to evaluate the 
apparent rate constant, kDA, for the oxidation of DA, in the presence and absence 
of Sβ-CD. The Koutecky-Levich equation is a modification of the Levich equation 
and is generally used if the Levich plot, iL vs. ω1/2, deviates from linearity due to 
a kinetic limitation in the electron transfer reaction.1 In this instance the 
Koutecky-Levich plot, 1/iL vs. 1/ω1/2, was used to estimate the rate constants of 
the DA oxidation. The Koutecky-Levich equation is given by Equation 2.7: 
 
2.6 
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In this analysis, iL represents the measured limiting current, iK is the current of 
the electron transfer between the DA and the electrode and ilev is the Levich 
current, which corresponds to the mass transfer of DA in the solution. The iK is 
not influenced by the rotation rate, as expressed in Equation 2.8: 
 
                                                             2  (	4O                  2.8 
 
where n is the number of electrons transferred, F is Faraday’s constant 
(96485.3415 C mol-1), A is the surface area, kDA is the reaction rate constant, and 
c is the concentration. 
 
A plot of 1/iL against 1/ω1/2 should be linear. The rate constant, kDA, for DA in 
the absence and presence of Sβ-CD can be obtained from the intercept of the 
Koutecky-Levich plot, 1/iL vs. 1/ω1/2.  
 
2.5.5 Nuclear magnetic resonance  
Proton (1H) Nuclear Magnetic Resonance (NMR) is widely used for the 
determination of the structure of organic compounds. For the purpose of these 
studies it is the most effective structural tool for investigating the interaction 
between a cyclodextrin and a guest.6 
 
1H NMR is relative quantitative; the number of hydrogen nuclei can be 
measured by integrating the area under the peak. It also reveals the connectivity 
of the structure due to the coupling of the protons, and more importantly, for 
this research, the chemical shifts give a reliable indication of the local chemistry. 
Radio waves are used to study the energy level differences of 1H nuclei. 
Hydrogen nuclei have a nuclear spin of a half and so have two energy levels: 
they can be aligned either with or against the applied magnetic field. The 
2.7 
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chemical shift provides much information and is a measure of the shielding of 
the nucleus by the electrons around it.7 In these studies, 1H NMR was used to 
confirm the stoichiometry, the binding constant and the geometric factors 
involved in the complexation between DA and Sβ-CD. A change in the chemical 
shift of DA in the presence and absence of Sβ-CD allowed for the evaluation of 
the binding constants. 1H-NMR experiments were performed on a Bruker 300 
MHz NMR spectrometer at 293 K in D20. 1H NMR peak protons were reported in 
ppm relative to internal reference. 
 
2.5.6 Optical and scanning electron microscopy 
Optical and Scanning Electron Microscopy (SEM) allows the observation and 
characterisation of samples on a micrometer (µm) to a nanometer (nm) scale. 
Optical images were preformed on a Leica DMEP DFC-280 and an Olympus 
BX51M system using Leica application suite and Olympus DP Version 3.2, 
software, respectively. The majority of SEM images were obtained from a Joel 
840 SEM, while, the Energy dispersive X-ray Analysis (EDAX) and SEM analysis 
were performed on a Hitachi FE-Scanning Electron Microscope. The image 
processing and analysis to study the formation of fibers and the morphology of 
the polymers as a function of the various parameters applied were performed 
using both techniques.  
 
For the analysis of the growth and morphology of polypyrrole, images were 
obtained on various substrates, including platinum, gold, and Au coated mylar. 
For the electrospinning studies, samples were electrospun using various 
parameters and images were taken using both techniques. In the case of SEM, 
Au coated mylar was used as the substrate which was gold sputter coated prior 
to analysis using an Emitech K550x Gold Sputter Coater. Optical images were 
taken on glass slides, and Au coated mylar samples.  
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2.5.7 Solution properties 
Solution properties such as pH and ionic conductivity, were determined using 
an Orion model 720A pH meter and a Jenway 4510 conductivity meter, 
respectively. The equipment was calibrated each time prior to experimental 
analysis using buffered solutions, pH 7.0 and 4.0 obtained from Fluka, and 0.1 
mol dm-3 KCl from Sigma. Where necessary, the pH and conductivity of the 
solutions were adjusted by adding HCl / H2SO4 or NaOH. 
 
2.6  Theory of experimental techniques and equations used  
In order to understand various processes occurring many theories and related 
equations were used. The following is an overview of the theories where the 
background is also provided.  
 
2.6.1 Complexation studies 
In order to evaluate complexation between DA and Sβ-CD the formation 
constant was determined using four techniques: UV, CV, RDV and NMR. Also, the 
Job’s method was employed to distinguish the stoichiometric value of the 
complex. The related theory behind each of the equations used is described in 
this section. 
 
2.6.1.1 Job’s method 
Before any structural or associative measures are performed on a host-guest 
interaction, it is important to determine the stoichiometry of the complex. A 
common way to confirm this stoichiometric value is well known as the 
continuous variation or Job’s method.8-10 This method is an experimental mixing 
technique widely used in the determination of stoichiometric ratios of each 
constituent involved. This method can be applied to various analytical 
techniques, such as Fluorescence11, UV-visible spectroscopy12 and 1H NMR13, 14. 
In each method, the Job’s plot is based on the spectral change observed either 
for the guest or the host.  
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This method involves the preparation of a series of solutions where the sum of 
the guest [G] and host [H] concentrations is kept constant while changing the 
mole fraction. This is achieved by mixing different volumes of the two 
components, G and H, such that the overall volume remains the same along the 
series. Experimentally, some property (such as chemical shifts in the NMR or 
absorbance values in UV) whose value changes when the guest and host form a 
complex, is measured in each solution.2  
 
The data for the Job’s plot is generated by taking the product of the mole 
fraction with the change of the property from that of an equal concentration of 
free guest. This product is then plotted as a function of the mole fraction. The 
stoichiometry is determined from the x-coordinate at a maximum value of the 
Job’s curve.  
 
2.6.1.2 Formation constants 
In aqueous solutions, cyclodextrins and guest molecules are well known to form 
inclusion complexes.2, 15-19 An equilibrium is established between these species 
and is expressed as the complex formation, stability, equilibrium or binding 
constant, Kf. The formation constant for the inclusion complex has to be 
evaluated for the quantitative analysis.20 In complexation studies, a simple way 
of determining the formation constant for a 1:1 complex is based on the 
following equilibrium: 
 
P 8  Q R S 
 
with G representing the guest, H the host and C the complex. From here, the 
formation constant can be defined as: 
      
TU    *S?*P?*Q? 
 
where [G] and [H] are the equilibrium concentration of the guest and host, 
respectively. The encapsulation of a guest inside a CD cavity leads to alterations 
2.9 
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in the chemical and physical properties of the guest. In this instance it is feasible 
to calculate the formation constant by monitoring these changes. Depending on 
the experiment being performed, a certain property is monitored. For example, 
in UV-visible spectroscopy the absorbance change is monitored. In all of the 
following cases these methods are known as approximation methods, as each 
method includes one or more approximation. In all cases of evaluating the 
formation constant the concentration of the guest was held constant and the 
host concentration was varied. The two main approximations for these 
evaluations are (i) the host is in excess of the guest and (ii) the stoichiometric 
value is 1:1, for the G:H inclusion complex. 
2.6.1.2.1 UV-visible studies 
UV-visible spectroscopy is considered to be well suited for the quantitative 
study of the formation constant due to the measured absorbance being 
proportional to the concentrations because of the Beer-Lambert law.2 There are 
limitations but in cases where the absorbance of the guest increases upon 
complexation, a suitably modified Hiedelbrand-Benesi equation21 can be used to 
estimate the formation constant. In this study the modified Hiedelbrand-Benesi, 
Equation 2.11, reported by Dang and co-workers17 and Ibrahim et al.22 was used.  
 
 
		  	   
VWDV  V 8  
VWDV   V X 
1
TU*S ?  
 
A0 and A are the absorbencies of the free guest and the complex, respectively, εG 
and εH-G are the absorption coefficients of the guest and the complex, 
respectively. The formation constant expressed in Equation 2.11 implies that a 
Hiedelbrand-Benesi plot of A0/A0-A versus 1/[CD] should give a straight line, 
and from the slope and the intercept of the straight line plots, the Kf values can 
be obtained. 
 
 
 
2.11 
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2.6.1.2.2 Electrochemical studies 
The formation of an inclusion complex between a redox-active guest and 
cyclodextrin can be followed using electrochemical approaches such as CV and 
RDV. The peak current and peak potential of the redox-active guest is measured 
in the absence and presence of a large excess of CD. As the CD is large and bulky 
the included guest will diffuse more slowly than the free guest giving rise to a 
reduction in the peak current. Likewise, a higher applied potential is required to 
oxidise the included guest. These electrochemical changes attributed to the 
complexation of a guest in the presence of cyclodextrins are well discussed in 
the literature.17, 23, 24 The formation constant for the inclusion complex can be 
calculated using changes in the peak current data by using Equation 2.12, 
expressed as follows:22, 25, 26 
 
1
*GY  S ?   TU
$1  	)
$1   Z )
 TU 
 
Here, [Sβ-CD] is the concentration of sulfonated β-CD, i0 and i are the peak 
currents without and with CD. A is a proportional constant. This equation is 
valid when the concentration of the CD is in large excess of the guest and a 1:1 
relationship is obtained for the complex. 
 
In order to follow the changes in the oxidation potential of the guest as it is 
included in the cavity the RDV technique was used. For the RDV data, the 
equation originally proposed by Galus27 and used by Coutouli-Argyropoulou et 
al.16 and Ibrahim et al.22 was used, Equation 2.13. As mentioned in Section 2.5.3, 
the limiting currents obtained using the RDV scale linearly with the square root 
of the rotation frequency. The diffusion coefficient can be determined by means 
of the Levich equation. The half-wave potentials can also be evaluated from the 
RDV data. With these values, the formation constant can be evaluated using the 
following equation: 
  
[ (%&\ ]$!)  $!)U ^  ln$1 8 T*GY  S ?) 8 ln$  / U)!/  
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Here, F is Faraday’s constant (96485.3415 C mol-1), R is the gas constant and T is 
temperature in K, (E1/2)app and (E1/2)f are the half-wave potentials of the 
electroactive guest obtained in the presence and absence of the Sβ-CD, 
respectively, while Df and Dc are the diffusion coefficients of the guest obtained 
in the absence and in the presence of a large excess of Sβ-CD. Again this 
equation is only valid when the concentration of the CD is in excess of the guest 
and a 1:1 relationship is obtained for the stoichiometry of the complex. 
 
2.6.1.2.3 NMR studies 
As previously said NMR is a sensitive technique for monitoring the interactions 
between molecules. With this said, it is a good method for understanding the 
complexation in solution. NMR spectra of the Sβ-CD were too complicated to 
analyse due to the large number of functional groups and the low average 
molecular symmetry.2 In this case the property monitored for the host guest 
complexation was the chemical shift of the signals due to the guest. A NMR 
titration experiment can be performed to obtain structural and binding 
information on the complex. A spectrum of the free host and the free guest is 
measured, along with a number of solutions made up where the guest is held at 
a constant concentration and the host is varied. Upon complexation, the 
electronic environments of host and guest change, by monitoring the chemical 
shift of the guest, the structural conformation of the complex can be understood 
and the formation constant evaluated. The stability constant is determined 
under fast exchange; the rate of complexation is usually faster than the NMR 
time scale.2, 28 The formation constant is evaluated using a non-linear least 
square analysis obtained with the following relationships, described in Equation 
2.14.28 
 
  
_  _`   Δ_2 a   
  4%c 
                             
where  
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Here, δ is the observed chemical shift and δh is the chemical shift observed in 
the presence of Sβ-CD. R is the mole fraction. A plot of Δδ as a function of the 
concentration ratio of Sβ-CD is obtained for each proton. In this analysis, it is 
assumed that δ and δh are independent of concentration and temperature. This 
non-linear least squares data treatment of the NMR titration is widely 
applicable and is acceptable if a 1:1 stoichiometric value for the host and guest 
is obtained. 
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3.1 Introduction 
In the very early stages of polymer chemistry all carbon-based polymers were 
regarded as insulators.1 However, the discovery of the conducting polymer 
opened up many doors for the new age of polymer technology. Since their 
discovery in the 1970’s the preparation and characterisation of these materials 
has evolved substantially through the use of electrochemistry.  
 
Polypyrrole (PPy), a conducting polymer has been extensively researched for 
several applications, as discussed previously in Chapter 1. However, for the 
purpose of this research it is in the area of drug delivery that PPy finds its most 
attractive application.2-6 It is also well documented that chemically modified 
electrodes using cyclodextrins (CDs) offer a wide range of possibilities in the 
field of electrochemistry.7 CDs, as previously described in Chapter 1, are 
macrocyclic oligosaccharides built of α-D-glucopyranoside units linked by α-
(1,4) bonds. In this case the use of negatively charged CDs was investigated for 
the potential growth of the polymers and subsequent uptake and release of 
some pharmaceutically important compounds. However, there is little literature 
published on the electrochemical deposition of conducting polymers in the 
presence of the cyclodextrin used in this research, sulfonated β-cyclodextrin, 
(Sβ-CD).  
 
The present studies concentrate on the deposition of PPy in the presence of 
these charged CDs. The Sβ-CD is only soluble in aqueous media and as PPy is 
one of the few conducting polymers that can be prepared in aqueous solutions, 
it was the most promising polymer to work with. It is reported that PPy films 
can vary in their characteristics depending on the parameters applied during 
electrochemical polymerisation including dopant anion and thickness.8 In this 
chapter a preliminary investigation into the growth of the polymer films in the 
presence of various dopants specifically, in the presence of Sβ-CD, was 
investigated. Sβ-CD is a large anionic cyclodextrin with approximately 7-11 
anionic groups positioned around its cavity. 
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This chapter discusses the deposition of PPy in the presence of Sβ-CD which was 
achieved by a simple one-step electrochemical synthesis using both constant 
potential and cyclic voltammetry (CV) techniques. The film characterisation and 
consequently the redox properties of the polymer films were also analysed 
using CV. Electrochemical quartz crystal microgravimetry (EQCM) 
measurements were also obtained for the PPy/Sβ-CD films, to obtain 
information on its ion exchange properties.  
 
3.2 Experimental 
3.2.1 Materials 
3.2.1.1 Reagents 
Pyrrole monomer (98 %) was obtained from Aldrich and was purified by 
distillation prior to experimental procedures. It was stored in the dark in the 
fridge. Unless otherwise stated, 0.20 mol dm-3 (0.35 ml in 25 ml supporting 
electrolyte) of pyrrole was dissolved in the electrolyte solution for all 
electrochemical deposition experiments. Analytical reagents, sodium sulfate 
(Na2SO4), sulfonated β-cyclodextrin (Sβ-CD) sodium salt (substitution ca. 7-11 
moles per mole of β-CD as reported by Aldrich), sodium chloride (NaCl) and 
para-toluene-sulfonic (PTS) acid were purchased from Aldrich and used as 
received. Distilled water was used in all solution preparations. 
 
3.2.1.2 Electrodes and Instruments 
For the bulk experiments electrochemical deposition of PPy and analysis of the 
samples was carried out using a Solartron Model SI 1285 potentiostat. All 
measurements were made at room temperature. A platinum wire (99 %, 1 mm 
in diameter) electrode where the exposed surface area was recorded separately 
for every experiment was used for the deposition of PPy. A SCE and a platinum 
wire CE were also used in the electrode set up. For the CV experiments a 
platinum disc electrode encased in a Teflon holder, previously described in 
Chapter 2, Figure 2.3 was used with an exposed surface area of 0.1256 cm2. In 
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both cases, the wire and the disc electrode were polished using a 1 µm diamond 
polish and Buehler micro-cloth and rinsed well with distilled water to ensure a 
smooth surface finish, as outlined in Chapter 2. 
 
For the mass change analyses, electrochemical quartz crystal microgravimetry 
(EQCM) measurements were performed with a CHI440 instrument. The 
polymers were deposited onto polished Au quartz crystal electrodes (Cambria 
Scientific) with an exposed surface area of 0.203 cm2. The electrochemical cell 
consisted of a specially made Teflon holder in which the crystal was placed 
between two o-rings (CHI125), a picture of which is shown in Figure 3.1. The set 
up was completed using a platinum wire counter and a 3.0 mol dm-3 Ag/AgCl 
reference electrode. 
 
 
 
Figure 3.1: Picture of the Teflon holder including the o-rings where the crystal is 
placed during EQCM. 
 
The conductivity measurements were carried out using a Jenway 4510 
conductivity meter, while optical images were carried out of an Olympus BX51M 
system using Leica application suite and Olympus DP Version 3.2 and the EDAX 
and SEM were performed on a Hitachi FE-Scanning Electron Microscope. 
 
3.2.2 Procedures 
3.2.2.1 Polymer film preparation 
The synthesis of PPy was carried out using an electro-synthesis method, which 
deposited the polymer film at the working electrode. Polymers were prepared 
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in various electrolyte solutions containing 0.20 mol dm-3 pyrrole, unless 
otherwise stated. A summary of the various electrolytes used in the 
electrochemical deposition of PPy are given in Table 3.1. PPy was grown in a 
conventional three-electrode cell where a saturated calomel reference electrode 
(SCE) and a platinum wire counter electrode were used. A platinum wire (99 %, 
1 mm in diameter) electrode was used as the working electrode in the majority 
of cases. For the imaging analysis flat platinum or glassy carbon disc electrodes 
(SA = 0.1256 cm2) were utilised. For the CV characterisation the polymers were 
deposited onto Pt disc electrodes encased in Teflon (SA = 0.1256 cm2). 
 
 
Table 3.1: Summary of the electrolytes used for the deposition of PPy. 
 
Electrolyte Concentration / mol dm-3 
Sodium sulfate, Na2SO4 0.10, 0.05, 0.01 
Sodium chloride, NaCl 0.10, 0.05, 0.01 
para-toluene-sulfonic acid, PTS 0.10, 0.05, 0.01  
Sulfonated β-cyclodextrin, Sβ-CD 0.10, 0.05, 0.01 
 
To investigate if Sβ-CD was a suitable electrolyte to polymerise pyrrole, 
conductivity measurements on a series of Sβ-CD concentrations were obtained. 
A 2.0 x 10-2 mol dm-3 Sβ-CD solution was prepared in deionised water from 
which a series of solutions were generated by serial dilution to 2.0 x 10-5 mol 
dm-3. The conductivity of each solution was measured and corrected for the 
conductivity of deionised water, at 25 0C. PPy/Sβ-CD films were subsequently 
grown potentiostatically by applying a constant potential in the range of 0.600 
to 1.000 V vs. SCE, for a desired time or until a certain charge was passed. The 
growth solution was an aqueous pyrrole/Sβ-CD mixture with 0.20 mol dm-3 
pyrrole and 0.01 mol dm-3 Sβ-CD, unless otherwise stated. In this way Sβ-CD 
sodium salt is the only electrolyte present and so was incorporated into the 
growing PPy film as the charge balancing counter anion. Conductivity 
measurements were also performed on the supporting electrolytes used during 
the electrochemical polymerisation of pyrrole. 
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The various techniques employed included constant potential (V), and cyclic 
voltammetry (CV). For CV growth the potential was swept from 0.000 to 0.800 V 
vs. SCE at a scan rate of 50 mV s-1, where the cycle number was varied. For 
constant potential experiments, a potential in the range of 0.600 to 1.000 V vs. 
SCE was applied until a sufficient charge was passed.  
 
3.2.2.2 Film characterisation 
After electrochemical deposition, the PPy films were characterised using CV. A 
three electrode cell was used for all CV experiments. A platinum disc electrode, 
encased in Teflon, was used as the working electrode, a SCE and platinum wire 
was used as the reference and counter electrodes, respectively. The redox 
properties of the PPy films were monitored by cycling in a potential window of   
-0.900 to 0.900 V vs. SCE, in a monomer solution containing 0.20 mol dm-2 
pyrrole and the supporting electrolytes shown in Table 3.1, or in a monomer 
free electrolyte. 
 
For the optical images, polymers were synthesised onto an Au disc electrode 
from an aqueous solution of 0.10 mol dm-3 Na2SO4 or a 0.01 mol dm-3 Sβ-CD 
solution, in the presence of 0.20 mol dm-3 pyrrole at 0.900 V until a charge of 
0.3, 1.0 or 3.0 C cm-2 were passed. For the SEM and EDAX measurements, 
PPy/Sβ-CD polymers were electrochemically deposited from an aqueous 
solution of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD, onto flat Pt disc 
electrodes at 0.900 V vs. SCE to a charge of 3.0 C cm-2, unless otherwise stated. 
Samples were sputtered coated with gold prior to analysis. 
 
3.2.2.3 Electrochemical quartz crystal microgravimetry 
In the case of the EQCM measurements, PPy films were electrochemically 
deposited onto gold quartz crystal electrodes with an active surface area (SA) of 
0.2033 cm2, at an oxidation potential of 0.700 V vs. SCE from a solution of 0.20 
mol dm-3 pyrrole and 0.10 mol dm-3 Na2SO4 or 0.01 mol dm-3 Sβ-CD, 
respectively. All solutions were prepared using distilled water. A Pt wire was 
Polypyrrole, formation and characterisation  Chapter 3 
- 73 - 
used as a counter electrode while a 3.0 mol dm-3 Ag/AgCl electrode was used as 
the reference. 
 
The EQCM electrodes were placed in between two O-rings of the commercially 
designed Teflon holder, as shown in Figure 3.1. This setup was then connected 
to the external oscillator box which measured the frequency change. Unless 
otherwise stated, the charge passed during polymer formation was 1.50 x 10-2 C 
cm-2. For the EQCM measurements during CV experiments, films 
electrodeposited using Sβ-CD as the dopant were placed in a 0.10 mol dm-3 
Na2SO4 solution and cycled between -0.900 and 0.600 V vs. SCE at scan rates of 
50 and 5 mV s-1. The frequency shift, caused by changes in the mass during the 
electrochemical experiments, was measured using a frequency counter and 
related to mass using the Sauerbrey equation, Equation 2.1, Section 2.5.1. 
 
3.3 Results and Discussion 
3.3.1 Polymer synthesis 
It is well known that during electrochemical polymerisation of pyrrole (Py), 
positively charged chains of the polymer are created. In order to maintain 
charge neutrality anionic counter ions, or dopants, are taken up into the 
polymer film. The electropolymerisation of pyrrole can be represented by the 
simple scheme, depicted in Figures 3.2 and 3.3, where A- represents the counter 
ion.  
 
 
 
 
Figure 3.2: Schematic representation of the electrochemical polymerisation of pyrrole 
to form PPy, with the polymer presented in the reduced state. 
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Figure 3.3: Structure of partially doped PPy, A- represents the dopant anion. 
 
 
The PPy oxidation level is reported to be between 0.20 and 0.33 per monomer 
unit depending on the nature of the dopant anion. This means that for every 3 to 
4 monomer subunits a counter ion is needed to maintain charge neutrality, as 
indicated in Figure 3.3.9 Commonly, small mobile anions, such as chlorides, are 
used as dopants for the electrochemical deposition of PPy. When large anions 
are used, such as polystyrene sulfonate (PSS)10 or Nafion11, these bulky anions 
remain entrapped in the polymer film and are not involved in the redox 
reaction. This is also the case for the anionic dopant used in these studies,         
Sβ-CD.  
 
It is also important to point out the reason for choosing the β-CD over the α-CD 
or indeed the γ-CD. As mentioned in Chapter 1, the most common commercially 
available cyclodextrins are the α-CD, β-CD and the γ-CD which differ in the 
number of glucose units present, 6, 7 or 8, respectively. The cavity size depends 
on the number of glucose units, with the β-CD cavity being the most acceptable 
size for including compounds for drug delivery, whereas the α-CD is known to 
be insufficent in size for many drugs12, while the γ-CD is very expensive. It 
should also be highlighted that to the best of our knowledge there has been very 
little research shown on the electrochemical synthesis of PPy/Sβ-CD films and 
from the literature that was reviewed the polymerisation of the polymer films 
was continually deposited in the presence of an additional supporting 
electrolyte, lithium perchlorate (LiClO4).13 However, it must be pointed out that 
the work presented by Temsamani and colleagues13 shows the electrochemical 
synthesis of the polymers at extreme oxidation potentials cycled up as high as 
1.800 V vs. SCE. At these potentials, the PPy films are well known to over-
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oxidise.9 The over-oxidation of the PPy film is an irreversible process and leads 
to the degradation of the film which in turn leads to the loss of the redox 
activity, the conductivity and hence the electroactivity of the polymer.14, 15 For 
Temsamani and co-workers, these high potentials can only lead to increased 
porosity of the polymer film and, therefore, a higher affinity for the 
electrochemical activity of the electrode surface to be observed. In analysing 
their data presented in the papers, the CV plots illustrate redox activity more 
than likely attributed to the gold oxide forming from the gold substrate used 
during electrochemical deposition.  
 
An important factor in both the physical properties and the morphology of PPy 
films is the nature of the doping anion. It is documented that in general ~30 % 
of the weight of the polymer corresponds to the dopant.16 The dopant anion can 
be organic or inorganic. Some prime examples vary from the extensively used 
chloride anion to pharmaceutically important compounds, such as adenosine 5’-
triphosphate (ATP)17, 18 and dexamethasone6. They can also vary in size from 
para-toluene sulfonic acid (PTS)19, 20 to dodecylbenzenesulfonate (DBS)14, the 
size of the dopant can control the structure and porosity of the polymer.16 
Kassim et al.21 reported that the stability and mechanical properties of PPy films 
were enhanced in the presence of large anionic dopants over smaller ones. It is 
reported that PPy/SO4 films differ from PPy films doped with large entrapped 
dopants.22 
 
For the formation of the PPy films used in this study, two methods were 
employed; the first, CV, was used to determine the oxidation potential of the 
monomer in the presence of Sβ-CD and other dopants, for comparative 
purposes. The second method was constant potential polymerisation, which 
involved the application of a constant potential to the electrode in the presence 
of the monomer solution and supporting electrolyte.  
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3.3.1.1 Investigations on the growth of PPy in various dopant electrolytes 
To acknowledge that Sβ-CD is a suitable electrolyte for the polymerisation of 
pyrrole, conductivity measurements of Sβ-CD in varying concentrations were 
obtained. In the case of Sβ-CD the conductivity increases linearly with 
increasing concentration as shown in Figure 3.4, this is evidence of the presence 
of a strong electrolyte.23 A good linear correlation value of 0.997 was obtained 
for these data. Figure 3.5 shows the molar conductivity as a function of the 
square root of the Sβ-CD concentration. Although a linear plot was not obtained 
between the molar conductivity and the square root of concentration to satisfy 
the relationship, Λ = Λo -b√, which is characteristic of a strong electrolyte, the 
molar conductivity is high. Moreover, a near-linear relationship is observed as 
the limiting molar conductivity is approached, as opposed to the exponential 
relationship which is typical of weak electrolytes. This is a further indication for 
a strong electrolyte.  Therefore, it can be concluded that Sβ-CD is an appropriate 
electrolyte to dope the polymer and no other supporting electrolyte is 
necessary. 
 
 
 
 
Figure 3.4: Conductivity of Sβ-CD measured at 25 0C as a function of concentration. 
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Figure 3.5: Molar conductivity of Sβ-CD as a function of the square root of 
concentration. 
 
 
Figure 3.6 shows representative CV data for the electropolymerisation of 
pyrrole in NaCl, Na2SO4, PTS and Sβ-CD electrolytes. An oxidation wave 
corresponding to electron transfer and oxidation of the monomer is seen for all 
dopant anions. It is clearly evident that the oxidation potential of the monomer 
varies with the nature of the dopant. For example, the oxidation of pyrrole 
occurs at 0.530, 0.584, 0.589 and 0.595 V vs. SCE for the Sβ-CD, PTS, Na2SO4 and 
NaCl systems, respectively, indicating easier oxidation of the monomer in the 
Sβ-CD electrolyte. Furthermore, the rate of oxidation, as evidenced from the 
slope of the current-potential curve between 0.600 and 0.900 V vs. SCE, varies 
considerably with the nature of the dopants. The rate of oxidation is observed 
as: Sβ-CD > PTS > Na2SO4 > NaCl. Indeed, the rate of oxidation is 0.098 A V-1 for 
the Sβ-CD system compared to 0.023 A V-1 for the chloride system, a significant 
4-fold increase in the presence of the Sβ-CD anions. Again, this clearly indicates 
a higher rate of oxidation of the pyrrole monomer in the Sβ-CD electrolyte. 
According to the mobility of the anions this is an unusual result, as the mobility 
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of the anions would follow the opposite trend, i.e., NaCl > Na2SO4 >PTS > Sβ-CD. 
Furthermore, the Sβ-CD will have a much lower mobility than the other anions 
due to its large size. 
 
 
 
 
Figure 3.6: Cyclic voltammograms, first cycle, for the polymerisation of pyrrole in the 
presence of 0.20 mol dm-3 pyrrole and 0.05 mol dm-3 concentrations of various dopants.     
NaCl     Na2SO4        PTS      and Sβ-CD       . The potential was swept from 0.000 to 
0.900 V vs. SCE at a 50 mV s-1.    
 
 
Although the electrolytes are maintained at equal concentrations, the 
conductivity and ionic strength of the solutions will vary. The ionic strength of 
each solution was computed using Equation 3.1, where cA is the molar 
concentration of ion, A, and zA is the charge number of that ion, and the sum is 
taken over all ions in the solution.  
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These parameters are provided in Table 3.2. The high anionic charge on the Sβ-
CD, approximately 7-11 anionic sites, provides the solution with a high ionic 
strength and a higher conductivity which certainly will have some role to play in 
the higher rates of oxidation of the monomer and higher rates of 
electropolymerisation.  
 
Table 3.2: Conductivity measurements and ionic strength for each supporting 
electrolyte.  
 
 
Dopant / 0.05 mol dm-3 
 
 
Conductivity/ mS 
 
Ionic strength /         
mol dm-3 
Sβ-CD 21.40 2.25 
PTS 16.89 0.05 
Na2SO4 8.65 0.15 
NaCl 2.82 0.05 
 
 
Figure 3.7 illustrates the CV data obtained for the deposition of PPy films in the 
presence of Sβ-CD and in the presence of a 10-fold increase in the concentration 
of chloride (0.5 mol dm-3). Now, these two electrolytes have similar 
conductivities. In comparing these two voltammograms, there is very little 
difference between the traces. The oxidation of the monomer and subsequent 
currents reached are in close agreement. This verifies that conductivity is a 
major influence in the polymerisation of these polymers and accounts for the 
apparently higher rates observed with the Sβ-CD, Figure 3.6. 
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Figure 3.7: Cyclic voltammograms for the deposition of PPy, onto a Pt disk electrode in 
the presence of 0.20 mol dm-3 pyrrole and ♦0.01 mol dm-3 Sβ-CD and ♦0.10 mol dm-3 
NaCl. The potential was swept from 0.000 to 0.900 V vs. SCE. 
 
 
It is has been reported that a shift of the anodic potential in the positive 
direction, during the electrochemical polymerisation of pyrrole in the presence 
of a neutral β-cyclodextrin, is due to the formation of an inclusion complex 
between the monomer and the CD. For example, Arjomandi and Holze observed 
an increase in the oxidation potential of pyrrole in the presence of a neutral β-
CD in LiClO4.24 This was not observed in this work, as is clearly deduced from 
Figures 3.6 and 3.7, where there is no evidence of any anodic potential shift in 
the oxidation potential of pyrrole. However, this possibility was further 
investigated using NMR. Figure 3.8 shows the NMR spectra obtained for a 
sample of pyrrole monomer in the absence and presence of an excess of Sβ-CD. 
It has been well documented that if an inclusion complex is formed, a change in 
the chemical shift is observed.25 In the case presented here, no alteration in the 
chemical shift was observed, suggesting no complexation. Clearly, complexation 
does not occur between the Sβ-CD and the pyrrole monomer. 
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Figure 3.8: NMR spectra of ♦Py monomer ♦Py monomer with a 4-fold excess of Sβ-CD 
in D20. (300 MHz, D2O): δ 6.78 (2H, d, a-H), δ 6.23 (2H, d, b-H). 
 
In order to gain more information on the growth of PPy in the presence of Sβ-
CD, additional experiments were performed to probe the influence of the 
concentration of the Sβ-CD and the monomer on the rate of 
electropolymerisation.  
 
Figure 3.9 shows the CV data obtained for the electropolymerisation and 
simultaneous redox activities of the polymer film doped in the presence of 0.01 
mol dm-3 Sβ-CD. There is a clear change in the voltammograms as the cycle 
number increases, with an increase in the peak current, corresponding to the 
oxidation of the polymer, at ~ -0.2 V vs. SCE and an increase in the reduction 
peak, observed at ~ -0.6 V vs. SCE. This is consistent with the deposition of high 
amounts of conducting PPy. 
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Figure 3.9: CV of PPy/ Sβ-CD in the presence of 0.05 mol dm-3 pyrrole and 0.01 mol 
dm-3 Sβ-CD 
 
Figure 3.10 shows the current, measured at a potential of ~-0.2 V vs. SCE taken 
from the cyclic voltammograms depicted in Figure 3.9, plotted as a function of 
cycle number. The polymers were deposited onto platinum in the presence of 
increasing concentrations of Sβ-CD. It is clear that as the concentration of Sβ-CD 
is increased, the rate of oxidation of the monomer and the rate of polymer 
growth increase. Also, the current continues to increase with cycle number. The 
continued increase in current indicates that the deposited PPy is indeed 
conducting, even after 40 cycles of high rates of polymer growth.  
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Figure 3.10: Current as a function of cycle number for the growth of PPy on a Pt disc 
electrode, in the presence of 0.20 mol dm-3 pyrrole and varying concentration of Sβ-CD,        
0.01           0.05         and        0.10 mol dm-3. The voltammograms were recorded from        
-0.900 to 0.800 V vs. SCE at a 50 mV s-1. 
 
 
More detailed information on the rate of deposition of the polymer can be 
obtained by using the charge in the voltammograms where oxidation of the 
monomer is not contributing to the current. Figure 3.11 shows the integrated 
anodic charge of the oxidation peak shown in Figure 3.9, as a function of cycle 
number for varying concentrations of the monomer (Py) in the presence of a 
constant concentration of the Sβ-CD. In this case, the computed charge is 
dominated by the oxidation of the deposited polymer, and it can be taken as a 
measure of the amount of polymer deposited. It is clear from this figure that the 
amount of PPy deposited increases at a faster rate in the presence of higher 
concentrations of the monomer. The rate of growth, which can be measured 
from the slopes of the linear charge-time plots (charge-cycle number) were 
calculated as 1.63, 1.89, 1.91, and 2.13 C cm-2 s-1 for monomer concentrations of 
0.05, 0.10, 0.15 and 0.20 mol dm-3, respectively. These findings are in good 
agreement with literature reports where the monomer concentration is 
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important in the kinetics of polymer growth. Indeed, Kim et al.26 reported 
similar observations for the polymerisation of pyrrole in the presence of a large 
anion tetrabutylammonium perchlorate (TBAP).  
 
 
 
Figure 3.11: Accumulative anodic charge for the oxidation of the pyrrole monomer 
during electrochemical polymerisation in various pyrrole concentrations. The Sβ-CD 
concentration was held at 0.01 mol dm-3 and the pyrrole concentration was          0.20
 0.15       0.10 and         0.05 mol dm-3. The potential was swept from -0.900 V to 
0.800 V vs. SCE at 50 mV s-1. 
 
 
A similar analysis showing the influence of the concentration of the Sβ-CD is 
provided in Figure 3.12, where the charge integrated under the oxidation peak 
is plotted as a function of cycle number. Again, linear plots are obtained and the 
influence of the dopant anion can be seen by a comparison of the slopes of these 
plots. At the higher Sβ-CD concentration of 0.10 mol dm-3, the rate of growth is 
given as 8.74 C cm-2 s-1 compared to the value of 2.13 C cm-2 s-1 for the lower Sβ-
CD concentration, 0.01 mol dm-3. This highlights the significant role of the Sβ-CD 
anion in the deposition of PPy and is in good agreement with results obtained 
with smaller dopant anions, such as nitrates. 27  
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Figure 3.12: Accumulative anodic charge for the oxidation of the pyrrole monomer 
during electrochemical polymerisation in various Sβ-CD concentrations. The pyrrole 
concentration was held at 0.20 mol dm-3 and the Sβ-CD concentration was varied     
from      0.01         0.05 and         0.10    mol dm-3. The potential was swept from -0.900 V 
to 0.800 V vs. SCE at 50 mV s-1. 
 
3.3.1.2 Polymer synthesis using constant potential 
Baker and Reynolds10 have comprehensively discussed the mechanism behind 
the polymerisation of pyrrole during electrochemical oxidation at a constant 
potential, as previously discussed in Chapter 1. They report that the current-
time transients obtained during the polymerisation of pyrrole occur in three 
stages. The first stage described by Baker and Reynolds was the current spike 
whose decay is dependent on potential and is said to represent the electrode 
surface coverage with a monolayer thick polymer film. The second stage 
involves the rise in current lasting for a number of seconds and the third stage is 
represented by the continued current flow for the remainder of the 
electrochemical deposition. 
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The three stages described by Baker and Reynolds were observed during the 
potentiostatic deposition of the PPy films in the presence of 0.01 mol dm-3 Sβ-
CD. Figure 3.13 shows a typical current-time plot for the potentiostatic growth 
of PPy films onto a platinum electrode in the presence of 0.01 mol dm-3 Sβ-CD. 
The electrochemical deposition shown in this figure was achieved at 0.700 V vs. 
SCE. It is evident from this figure that the initial current spikes, which is 
associated with the nucleation process of the electrosynthesis of PPy, and this is 
followed by a rise in current until a plateau is reached. Many papers have also 
reported current-time plots for the electrochemical polymerisation of pyrrole 
showing this behaviour.28, 29 This typical result is in agreement with various 
other reports where the polymer film deposition onto the electrode surface is 
achieved through a mechanism generally accepted for the cathodic synthesis of 
a metal onto a particular substrate.29 
 
 
 
 
Figure 3.13: Current-time plot for the potentiostatic growth of PPy at 0.900 V vs. SCE 
to a charge of 1.0 C cm-2. Polymers were electrochemically deposited onto Pt wire in the 
presence of 0.2 mol dm-3 Py and 0.01 mol dm-3 Sβ-CD. 
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Figure 3.14 shows the current as a function of time for the polymerisation of 
0.20 mol dm-3 pyrrole in the presence of 0.01 mol dm-3 Sβ-CD at various 
oxidation potentials. It can be seen from this figure that the magnitude of the 
current increases as the deposition potential is made more positive. These 
observations are in agreement with the results recorded by Asavapiriyanont et 
al.28 for the potential deposition of PPy in the presence of aqueous KNO3 
solutions and demonstrate that the shape of the current-time transients 
correspond to immediate nucleation with three-dimensional growth. Reece et 
al.30 also commented on the increase in current observed as a result of 
increasing potential during the growth of PPy films, on platinum, in the 
presence of both α and β sulfonated cyclodextrins. 
 
 
 
 
Figure 3.14: Current as a function of time for the potentiostatic growth of PPy at 
various potentials to a charge of 1.00 C cm-2. Polymers were electrochemically 
deposited onto Pt wire in the presence of 0.20 mol dm-3 Py and 0.01 mol dm-3 Sβ-CD.  
       1.0 V,      0.9 V,       0.8 V,      0.7 V,      0.6 V and      0.5 V vs. SCE. 
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Figure 3.15 illustrates the steady-state current as a function of potential for the 
data shown in Figure 3.14. The slope of the current-potential trace for the lower 
potentials was recorded at 0.019 A cm-2 V-1 and 0.039 A cm-2 V-1 in the case of 
the higher potentials. Therefore, the rate of the reaction approximately doubles 
as the potential increases from 0.500 V to 0.700 V vs. SCE. 
 
 
 
 
Figure 3.15: Current as a function of potential applied during the 
electropolymerisation of pyrrole. Polymers were electrochemically deposited onto Pt 
wire in the presence of 0.20 mol dm-3 Py and 0.01 mol dm-3 Sβ-CD. 
 
3.3.2 Film characterisation 
3.3.2.1 Probing the redox properties using CV 
Cyclic voltammetry is a technique widely used for the characterisation of the 
electroactivity of conducting polymers.9 Redox properties of PPy films are 
associated with the exchange of ions, be they anionic, cationic, or both. These 
exchange properties are significantly dependent on the dopant used during 
polymerisation.14 The redox properties of a number of polymer films doped 
with various counter ions were investigated using CV. It is well demonstrated in 
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the literature that in the presence of large anionic dopants that are immobilised 
into the polymer films the first electrochemical reduction is due to the uptake of 
cations to compensate for the anions present from the bulky entrapped dopant 
in the polymer film. This is very different to the anion exchange properties of 
the classical polymer doped with small, mobile anions.31 
 
Figure 3.16 shows the CV data for the polymerisation of pyrrole and the 
subsequent redox activity of the film, in the presence of 0.20 mol dm-3 pyrrole 
and 0.01 mol dm-3 of Sβ-CD. The oxidation peak observed at ~ 0.5 V represents 
the oxidation of the monomer.  These PPy/Sβ-CD films only take up and release 
cations, which is due to the large bulky nature and immobility of the anionic 
cyclodextrin. The well defined broad reduction and oxidation peaks, which are 
highlighted in this figure, can be attributed to the uptake and release of Na+ 
cations.  
 
  
 
Figure 3.16: CV voltammogram, 20th cycle, at 50 mV s-1 recorded for PPy/Sβ-CD 
electrodes in 0.20 mol dm-3 pyrrole in the presence of 0.01 mol dm-3 Sβ-CD. Highlighted 
is the oxidation/reduction of the PPy film.  
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As reported in the literature, the properties of the dopant anions, such as size, 
charge and mobility, are very important in distinguishing the characteristics of 
the conducting polymer.22, 32 Figure 3.17 shows the CV data obtained for the 
electropolymerisation and simultaneous redox activities of the polymer film 
doped in the presence of various dopants at a concentration of 0.10 mol dm-3. It 
is obvious from these data that the redox activities of the PPy/Sβ-CD are far 
more superior and well-defined compared to the PPy/Cl and PPy/SO4 films. It 
has been well documented that the redox peaks corresponding to the chloride 
and sulfate dopants can be hard to distinguish and appear broad and give ill-
shaped cyclic voltammograms.22 
 
On the other hand, well defined redox peaks are visible with the PPy/Sβ-CD film, 
as evident in Figures 3.16 and 3.17. Interestingly, the reduction peak is sharper 
than the corresponding oxidation peak, indicating a considerable variation in 
the kinetics of the two processes. The broad oxidation peak indicates a slow 
conversion of the polymer from the reduced to oxidised state, while the sharper 
reduction peak indicates a faster rate of reduction. This is somewhat unusual as 
during oxidation of the polymer, the layer next to the electrode surface is 
oxidised first giving a conducting layer which facilitates oxidation of the 
adjacent layers until the conducting zone reaches the solution. Conversely, on 
reduction of the polymer, the layer adjacent to the electrode is reduced first to 
give an insulating interface, making the overall reduction process more difficult 
and slower. The sharper reduction wave is a clear indication that the 
incorporation of Na+ during the reduction of the polymer is a relatively fast 
process, PPyn+Sβ-CDn- + ne-  PPyoSβ-CDn-(nNa+), whereas the oxidation of the 
polymer is much slower due to a slow release of Na+, or alternatively the slow 
incorporation of anions, to balance the charge. 
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Figure 3.17: CV voltammograms of PPy films in the monomer solution containing the 
pyrrole monomer, 0.20 mol dm-3, in the presence of 0.10 mol dm-3         NaCl          Na2SO4 
and     NanSβ-CD. This analysis was obtained from cycle 20. The potential was swept 
from   -0.900 to 0.800 V vs. SCE at a scan rate of 50 mV s-1. 
 
3.3.2.3 Probing the redox properties using EQCM measurements 
Ion transport is the key phenomenon in the application of PPy for a drug 
delivery system. In order to comprehend the ion flow during the switching of 
the polymer and measure the mass changes involved during the electrochemical 
reactions at the solution-electrode interface, EQCM measurements were 
performed. This technique is one of the most common techniques used to follow 
the charging and discharging reactions that take place in conducting polymer 
films.10, 33  
 
Two different types of polymer systems were considered. The first is where a 
PPy film is doped with relatively small mobile anions, SO42-. The application of a 
positive potential generates an oxidised polymer film (creating positive charges 
on the PPy); this allows the incorporation and subsequent transfer of anions in 
order to maintain charge neutrality. Contrary to this, upon application of a 
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reduction potential, the PPy film becomes reduced and electrons flow into the 
film to neutralise the positive charges, expelling the anions from the polymer 
matrix. This type of polymer system is well known as an anion exchanger. 
However, in the case of large anionic dopants and the case discussed here, 
where the PPy film is doped with a bulky anionic dopant which remains 
immobilised in the polymer matrix, anions are not exchanged. Instead, cations 
are taken up during reduction of the polymer film in order to maintain charge 
neutrality, and hence these polymers acquire the term cation exchanger. 
 
Firstly, the growth of two separate polymer systems was investigated using 
EQCM. Figure 3.18 shows the plots of the change in mass of the oscillating 
quartz crystal as a function of the charge passed during the electrochemical 
synthesis of PPy/Sβ-CD and PPy/SO4 films. According to Syritski et al.34 who 
reported the EQCM measurements for various PPy films, the good linearity 
observed in both cases can be attributed to linear and homogenous film growth 
on the EQCM gold electrode.  
 
 
 
Figure 3.18: Mass as a function of charge passed for polymers electrochemically 
synthesised at a constant potential of 0.700 V vs. Ag/AgCl on gold EQCM electrodes in 
the presence of ♦0.10 mol dm-3 Na2S04 and ♦0.01 mol dm-3 Sβ-CD. 
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It is well known from the Sauerbrey equation, Equation 2.1, that a decrease in 
the resonating frequency is indicative of an increase in the mass of the 
electrode. Figure 3.19 shows the overall mass as a function of time for the 
growth of these two different polymers; the Sβ-CD-doped polymer was 
polymerised in the presence of 0.01 mol dm-3 Sβ-CD and the other in the 
presence of 0.10 mol dm-3 Na2SO4. In both cases the PPy films were 
electrochemically deposited at a potential of 0.700 V vs. Ag/AgCl to a final 
charge of 1.50 x 10-2 C cm-2. It is interesting to note from Figure 3.19, in the case 
of the Sβ-CD film that there is an induction time observed for approximately 7 s 
before the mass begins to increase, this is not seen with the sulfate system. This 
characteristic feature is probably due to the time that is needed for the large 
and bulky Sβ-CD anions to diffuse to the surface. However, it is clearly evident 
that once the induction time has elapsed, the growth rate increases significantly. 
 
 
 
 
Figure 3.19: Mass as a function of time for polymers electrochemically synthesised at 
0.700 V vs. Ag/AgCl on EQCM in the presence of ♦ 0.10 mol dm-3 Na2S04 and ♦0.01 mol 
dm-3 Sβ-CD until a charge of 1.50 x 10-2 C was passed. 
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EQCM measurements in conjunction with the CV technique were also carried 
out to study the mass change involved during the polarisation of the PPy/Sβ-CD 
films at different scan rates. This study was performed to understand the ion 
uptake and release capabilities of the polymer system. The films were firstly 
synthesised then washed with distilled water prior to being subjected to a 
monomer free 0.10 mol dm-3 Na2SO4 solution. The current, as well as the mass 
change, was recorded simultaneously while the samples were swept from a 
potential close to the original polymerisation potential, 0.600 V vs. Ag/AgCl, to a 
reduction potential, -0.900 V vs. Ag/AgCl, at a scan rate of 5 and 50 mV s-1.  
 
As described by Syritski et al.34  there are two types of behaviour for the 
reduction/oxidation of a PPy film, which is dependent on the dopant. Equation 
3.2, proposed by Syritski et al.34 illustrates the anticipated behaviour during 
reduction and oxidation of a polymer film doped with a large immobile dopant 
which remains entrapped into the polymer film, as in the case of the PPy/Sβ-CD 
film. After oxidative polymerisation of the monomer and subsequent doping to 
form the polymer film the cations are incorporated during the reduction 
process in order to compensate the negative charges (3.2 a). Accordingly, upon 
application of an oxidation potential the compensation of charge can be 
achieved by both cation expulsion and anion incorporation from the supporting 
electrolyte (3.2 b). 
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The expected results for these films, synthesised with the large immobilised 
anionic dopant, is for the film to behave as a cation exchanger. Figure 3.20 
shows the CV data for a PPy/Sβ-CD film cycled in 0.10 mol dm-3 Na2SO4, scanned 
at 50 mV s-1.  Again, as observed in Figures 3.16 and 3.17, a sharp reduction 
wave is seen, while the corresponding oxidation wave is much broader. 
However, in this figure, it is interesting to note that the first cycle is somewhat 
different from the subsequent cycles, due to the large influx of cations on the 
first reductive sweep. 
 
Tamm et al.22 discussed the voltammograms of PPy films doped with DBS and 
demonstrated similar results to those observed in Figure 3.20. They showed 
that the first cycle was not very reversible and that the subsequent cycles were 
considerably different to the first. They attributed this to the ‘break in’ 
phenomena. The ‘break in’ phenomena is the number of cycles needed to reach 
a steady state and can vary due to the scan rate, temperature and nature of 
supporting electrolyte. 
 
 
 
 
Figure 3.20: CV data for a PPy/Sβ-CD film cycled in a 0.10 mol dm-3 Na2SO4 aqueous 
solution. The potential was swept from 0.600 to -0.900 V vs. Ag/AgCl at 50 mV s-1. 
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In the case of DBS, and indeed the Sβ-CD, the nature of these anions in the 
polymer matrix allows them to become immobilised into the polymer film, 
which in turn requires only cations to achieve electroneutrality. The influx of 
the cations upon reduction of the polymer film in effect changes the structure of 
the polymer film and thus increases the mobility of ions in the film. Therefore, 
the changes observed between the first and the following cycles is believed to 
be due to this large initial cation uptake.22 Khalkhali et al.14 observed similar 
results when characterising PPy films electrochemically deposited in the 
presence of the large anionic dopant, DBS. They also attributed the oxidation 
and reduction of polymers synthesised in the presence of large immobilised 
dopants, to the movement of cations. 
 
Figure 3.21 shows the first cycle for both the cyclic voltammogram recorded at 
50 mV s-1 and the corresponding mass change involved during the cycling, in a 
monomer free 0.10 mol dm-3 Na2SO4 solution. The polymer was previously 
synthesised potentiostatically at 0.700 V vs. Ag/AgCl in the presence of 0.01 mol    
dm-3 Sβ-CD. The polymer was then cycled from 0.600 V vs. Ag/AgCl in the 
cathodic direction. It is evident from the mass change data that during the 
reduction scan an increase in the mass occurs, corresponding to the uptake of 
cations. This increase in mass is observed at ~0.1 V vs. Ag/AgCl and continues 
to increase, reaching a maximum rate, at potentials close to the reduction peak 
observed in the voltammogram. On the reverse cycle, the mass slowly decreases 
corresponding to the release of the cations. This corresponds to the behaviour 
of a cation exchanger. Assuming the mass change was predominantly due to the 
uptake of cations, the mass increase was ~ 5.8 x 10-8 moles of Na+.  On closer 
inspection of Figure 3.21, it can be seen that the rate of the mass increase 
(forward cycle) is considerably higher than the rate of the mass loss (reverse 
cycle), again highlighting the fact that the reduction process is faster than the 
oxidation process.  It is also noticeable from Figure 3.21, that a small mass 
increase occurs between 0.1 and 0.6 V vs. Ag/AgCl on the reverse scan. This is 
probably related to the uptake of sulfate anions from the supporting electrolyte, 
as outlined in Equation 3.2, or the intake of solvent water molecules.  
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Figure 3.21: CV data for the current (♦) and the mass change (♦) as a function of 
potential obtained for a PPy/Sβ-CD film cycled in a 0.10 mol dm-3 Na2SO4 aqueous 
solution. The potential was swept from 0.600 to -0.900 V vs. Ag/AgCl at a scan rate of 
50 mV s-1.  
 
 
As discussed previously, typical doping levels reported for PPy are in the ratio 
of 1:3 to 1:4 dopant:pyrrole.35 Previously, Reece, Ralph and Wallace using 
microanalytical data, suggested that the doping level of the PPy films doped 
with either the α or the β sulfonated CD, had a doping ratio of 1:4.5 slightly 
lower than the more commonly reported doping levels.30 Several groups have 
used EQCM data to quantify polymer systems and to give an approximate 
calculation of the doping level.34 In the results presented here, EQCM 
measurements along with Equation 3.3 a derivation of Faraday’s law, was used 
to estimate the doping levels.  In these equations, M is the total mass of the 
deposited polymer, Q is the charge reached, Mm is the mass of the monomer, 
Mdop is the mass of the dopant, x is the doping level and F is Faraday’s constant, 
95484.56 C mol-1. 
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Figure 3.22 demonstrates the experimental and theoretical results obtained for 
the growth of a PPy film doped with a small mobile chloride anion (0.10 mol   
dm-3 NaCl); slope values of 0.0032 g C-1 and 0.0035 g C-1 were extrapolated, 
respectively. In analysing the initial growth, highlighted in Figure 3.22, there 
was very good correlation between the experimental and the theoretical data. 
However, as the film thickness (charge) increased a deviation from the 
theoretical slope was observed. In evaluating these data using Equation 3.4, it 
was assumed that the maximum doping level of 0.33 was achieved. The slight 
deviation from the theoretical slope obtained was possibly due to the maximum 
doping level not being reached. Another reason for the lower experimental mass 
per unit charge is the formation of dimers or oligomers, which in turn consume 
the current and, consequently, the charge, but are not involved in the deposition 
of the polymer to give the corresponding mass increase. 
 
A good agreement between the theoretical and experimental mass was obtained 
in Figure 3.22, similar data were collected for the Sβ-CD-doped polymer and 
used in an attempt to estimate the doping level of the Sβ-CD.  As discussed 
earlier, the Sβ-CD is a cyclodextrin with 7-11 substituted anions present on the 
outer rims. Unlike the chloride model, which has only one anion involved in the 
doping process, the cyclodextrin is a complex molecule with a minimum of 7 
and a maximum of 11 anions possibly involved in the doping process. 
 
3.3 
 
 
 
3.4 
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Figure 3.22: Mass as a function of charge for the growth on a PPy/Cl film in the 
presence of 0.20 mol dm-3 pyrrole and 0.10 mol dm-3 NaCl. Polymers were deposited at 
0.700 V vs. Ag/AgCl until a charge of 1.5 x 10-2 C cm-2 was reached. ♦Theoretical and 
♦experimental data.  
 
In using Equation 3.4 to estimate the doping level for the PPy/Sβ-CD system, 
two hypotheses were necessary. In case 1, it was assumed that the maximum 
doping level of 0.33 was attained and that each sulfonated group participated in 
the doping process. Figure 3.23 shows the EQCM measurements, mass as a 
function of charge, obtained for the growth of a PPy/Sβ-CD polymer at 0.700 V 
vs. Ag/AgCl. The experimental and theoretical analysis, where the number of 
anions present on the CD and participating in the doping process was varied, 
are evaluated. In the case of the theoretical (Thl) trace, the estimated molar 
mass of the Sβ-CD, 2053.43 g, was used and each Sβ-CD provided only one 
anionic charge in the doping. It is obvious from these data displayed in Figure 
3.23 that there is a very large deviation from the theoretical and experimental 
slopes, 0.0033 g C-1 to 0.00041 g C-1, respectively. This clearly indicates that 
each Sβ-CD provides more than one sulfonated anion to dope the polymer. 
Equation 3.4 was then used to estimate the mass charge relationship assuming 
that each Sβ-CD provided from 1 to 11 anions in the doping process. These 
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theoretical plots are provided in Figure 3.23 and show increasing agreement 
between the theoretical and experimental data as each Sβ-CD provides a higher 
number of anions in the doping process. However, it is very clear from this plot 
that there is still a significant gap between the theoretical and experimental 
profiles assuming that each Sβ-CD provides 11 sulfonate groups to dope the 
polymer. Obviously, the doping level is considerably lower than 0.33, as is 
commonly obtained with other dopants. 
 
 
 
 
Figure 3.23: Mass as a function of charge for the growth on a PPy/Sβ-CD film in the 
presence of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD. Polymers were deposited 
at 0.700 V vs. Ag/AgCl until a charge of 1.5 x 10-2 C cm-2 was reached. ♦Theoretical and 
♦experimental data.  
 
In the second case, the assumption that 9 sulfonated groups were involved in 
the doping process was made and using Equation 3.2, the charge was calculated 
for a number of possible doping levels. Figure 3.24 illustrates the data obtained 
for each doping level. The theoretical (Thl) analysis is for the maximum doping 
level of 0.33, for an Sβ-CD with 9 sulfonated groups where all are involved in the 
doping process. In comparison to the data obtained in Figure 3.23, the slopes 
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are now in closer proximity, as the doping level decreases. A summary of the 
analysis in Figure 3.24 is given in Table 3.3. Using these data the doping level 
was estimated to be 0.083. 
 
 
 
 
Figure 3.24: Mass as a function of charge for the growth on a PPy/Sβ-CD film in the 
presence of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD. Polymers were deposited 
at 0.700 V vs. Ag/AgCl until a charge of 1.5 x 10-2 C cm-2 was reached. ♦Theoretical 
(assuming 9 sulfonated groups) and ♦experimental data.  
 
 
To summarise on these hypotheses, it was demonstrated that the maximum 
doping level, 0.33, with PPy films is not evident in the presence of the Sβ-CD. 
Due to the complexity of the Sβ-CD molecule, and the uncertainties in the 
amount of substituted groups, which is directly related to the number of anionic 
sulfonated groups present, it is difficult to define the level of doping. Although, 
Reece et al.30 approximated a value of 1:4.5 (Sβ-CD:Py) and also stated the 
difficulties in evaluating the doping level due to the unknown degree of sulfation 
of the CD, our approximations point in the direction of a much lower doping 
level of 1:12. However, based on the assumption that all sulfonated groups are 
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involved in the compensation of the charge, it is highly unlikely that the doping 
level is >0.10. At these levels it would mean that for approximately every 10 Py 
units 1 Sβ-CD would compensate for the charge. However, if all the sulfonated 
groups on the Sβ-CD were involved in charge balance this would not only place 
strain on the cyclodextrin but also on the polymer. Therefore, it is highly 
probable that some free sulfonated groups are present within the polymer. 
 
Clearly, the doping level is very different with these large polyanionic dopants. 
The doping level of 0.33, commonly found with small dopants, was not evident 
with the Sβ-CD. Although the true doping level could not be obtained, the doping 
levels estimated between 0.08 and 0.10 seem reasonable given the large size of 
the Sβ-CD dopant. 
 
 
Table 3.3: Evaluated slopes for the varying doping levels, assuming 9 anions are 
present on the Sβ-CD. 
 
 
Doping level 
 
 
Doping ratio (Py:Sβ-CD) 
 
Slope /g C-1 
Experimental Experimental 0.00042 
0.334 3:1 0.00063 
0.250 4:1 0.00057 
0.200 5:1 0.00053 
0.167 6:1 0.00050 
0.143 7:1 0.00048 
0.125 8:1 0.00047 
0.100 10:1 0.00044 
0.083 12:1 0.00042 
 
Next, an examination into the ion and solvent flux observed during cycling of the 
PPy/Sβ-CD was made using the EQCM data. Hillman et al.36, 37 examined the ion 
and solvent flux data as a function of potential for a poly(3,4-
ethylenedioxythiophene) PEDOT system. The simultaneous CV data and the 
EQCM measurements recorded were used to analyse the fluxes. Hillman and co-
Polypyrrole, formation and characterisation  Chapter 3 
- 103 - 
workers proposed the following equations for the flux of the anion, however in 
this case the equations are denoted for the cations, as the PPy/Sβ-CD film is a 
cation exchanger, Figure 3.21. Various approximations were used in these 
equations, including the films are permselective, the total mass change at any 
stage of the redox process is the sum of the contributions from cation and 
solvent transfers, ∆mA and ∆mS, respectively. Here, the time differentials are 
denoted by a prime. 
 
The mass contributions are related by Equation 3.5 where the total mass is 
given by the sum of the mass of the cations and solvent. 
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Using the electroneutrality conditions and Faraday’s law, the ion flux, jC, which 
express the individual species contributions, is given by Equation 3.6, 
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where MC and zC are the molar mass and charge number of the cation, 
respectively. The total mass flux, jT is then denoted as,  
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Therefore, by comparing both jC and jT, information on the solvent transfer can 
be obtained. The solvent flux is defined by Equation 3.8, where MS is the solvent 
molar mass.  
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Combining these equations gives the expression in Equation 3.9.  
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The data previously shown in Figure 3.20 were used to calculate the individual 
cation and solvent fluxes using Equations 3.5 to 3.9. It was shown earlier, Figure 
3.21, that this polymer acts as a cation exchanger. Therefore, contrary to 
Hillman, who evaluated the recorded data for the flux of the anion, these 
proposed equations were used for the analysis of the transport of the cation. 
Figure 3.25 demonstrates the flux of cations as a function of the potential 
applied during cycling in a 0.10 mol dm-3 Na2SO4 solution. From this figure an 
increase in the number of cations is evident as the potential is reduced; with a 
maximum flux occurring at ~-0.4 vs. Ag/AgCl, which corresponds to the 
cathodic peak previously observed for a PPy/Sβ-CD film, shown in Figure 3.20. 
 
In Figure 3.26 a comparison of the cation and solvent flux observed during the 
cycling of the PPy/Sβ-CD film is made. On comparing the flux of cation and 
solvent transport, it is clear that there is a higher flux of solvent. Also in 
comparing this graph and evaluating the moles of water and cations, 
approximately twice as much solvent is taken up by the polymer in comparison 
to the cation uptake. This evidence points to a large uptake of water into the 
polymer system. These studies also show that the reduced film is in the most 
solvated state. This is consistent with the simultaneous uptake of cations and 
water molecules on reduction of the film. Each cation is encased by a solvated 
cage and it is not surprising that both the cations and water molecules are 
incorporated simultaneously. 
 
Figure 3.27 shows the overall mass change involved during the solvent uptake. 
Upon reduction, there is an almost linear increase in the mass of the solvent 
taken into the polymer. On the reverse scan, there is a loss of the solvent, but 
this is a non-linear relationship, with the rate of loss being greater from -0.700 
to -0.400 V vs. Ag/AgCl. More solvent is incorporated again from 0.000 to 0.300 
V vs. Ag/AgCl. 
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Figure 3.25: Flux of the cationic species as a function of the potential. The potential 
was swept from 0.600 V to -0.900 V vs. Ag/AgCl at a scan rate of 50 mV s-1. 
 
 
  
 
Figure 3.26: Fluxes for the ♦ cation and ♦ solvent as a function of potential on cycling 
PPy/Sβ-CD films in 0.10 mol dm-3 Na2SO4 at 50 mV s-1. 
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Figure 3.27: Solvent mass as a function of potential on cycling PPy/Sβ-CD films in 0.10 
mol dm-3 Na2SO4 at 50 mV s-1. 
 
 
Using this analysis, proposed by Hillman et al.36, 37 it is evident that the polymer 
incorporates a substantial amount of water during reduction. This has been 
reported in the literature.22 In addition to the solvent influx with cations, it is 
likely that a considerable amount of water will remain in the cavity of the Sβ-CD. 
 
3.3.3 Analysis of the PPy/Sβ-CD films 
3.3.3.1 SEM and optical images 
Optical imaging techniques were performed on various polymers. PPy films 
were firstly synthesised, washed thoroughly with distilled water, dried and 
images recorded. The PPy films were polymerised in the presence of an aqueous 
sodium sulfate solution and an aqueous Sβ-CD solution. The optical images of 
both PPy films are shown in Figure 3.28. The typical cauliflower, globular 
morphology is evident in both cases. 
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Figure 3.28: Optical images of (A) PPy-SO4 and (B) PPy/Sβ-CD on Au. Polymers were 
electrochemically deposited from aqueous solutions of 0.10 mol dm-3 Na2SO4 and 0.01 
mol dm-3 Sβ-CD, in the presence of 0.20 mol dm-3 pyrrole, at 0.900 V vs. SCE to a charge 
of 3.0 C cm-2. 
 
 
In general, PPy films present a cauliflower-like morphology constituted by 
micro-spherical grains. It has been reported that this cauliflower structure is 
related to the dopant intercalation difficulty in the disordered polymeric 
chain.38, 39 It is also well documented that PPy films observe a cauliflower like 
morphology.30, 40 Figure 3.29 shows an SEM image of a PPy/Sβ-CD film 
potentiostatically grown at 0.900 V vs. SCE to a charge of 3.0 C cm-2 on a Pt disc, 
with the corresponding EDAX data shown in Figure 3.31. Interestingly, in the 
case of the Sβ-CD doped polymer, although the typical cauliflower morphology 
is clear, it behaves in a more organised manner as apparent from Figure 3.29. 
The polymer growth seems to lay itself in almost evenly distributed rows, as 
highlighted in Figure 3.29.  Other groups who have investigated the morphology 
of PPy films in the presence of cyclodextrins have also observed a different 
oriented, organisational mode in comparison to ‘typical’ PPy films.13, 41, 42 
 
Izaoumen et al.41 also reported this type of polymer arrangement for a PPy film 
electrochemically synthesised in the presence of a neutral β-cyclodextrin and 
LiClO4 supporting electrolyte solution. In their case the polymers were 
synthesised using CV. Figure 3.30 illustrates the SEM image obtained for their 
polymer film, the organisational feature is evident. Temsamani and co 
(A)            (B) 
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workers13 also demonstrated similar SEM images for the PPy/Sβ-CD polymers 
grown in the presence of LiClO4 supporting electrolyte. 
 
 
 
Figure 3.29: SEM micrographs of a PPy/Sβ-CD film electrochemical deposited onto a 
platinum disc electrode at a potential of 0.900 V to a charge of 3.0 C cm-2.  
 
 
 
Figure 3.30: SEM image of PPy/β-CD film obtained by CV growth (35 cycles) from a 
PPy/β-CD/LiClO4 solution taken from Izaoumen et al. 41 
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3.3.3.2 EDAX 
To confirm the incorporation of Sβ-CD into the polymer film EDAX 
measurements were performed, where PPy films were electrochemically 
deposited in the presence of 0.01 mol dm-3 Sβ-CD onto flat platinum disc 
electrodes. Figure 3.31 shows the data obtained when a polymer was 
synthesised at a potential of 0.900 V vs. SCE until a charge of 3.0 C cm-2 was 
passed. As is evident from the figure, EDAX analysis of the doped PPy film 
revealed the presence of sulfur which can only correspond to the incorporation 
of the Sβ-CD anions during electrochemical synthesis, as no other supporting 
electrolyte was used. 
 
 
 
 
Figure 3.31: EDAX spectra of a PPy/Sβ-CD a sample. Polymerisaed electrochemically at 
0.900 V vs. SCE to a charge of 3 C cm-2 onto a Pt disc. 
 
 
In the following chapter a study on the incorporation and release of a cationic 
drug, dopamine, using PPy films syntheised electrochemically in the presence of 
Na2SO4 or Sβ-CD are investigated.   
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3.4 Summary of results 
The synthesis and characterisation of PPy films through the use of 
electrochemistry was investigated in this chapter. Sβ-CD was established to be a 
suitable electrolyte, through conductivity measurements, for the 
electrochemical polymerisation of pyrrole. CV data recorded for the 
polymerisation of the pyrrole monomer in the presence of a number of dopants, 
including Sβ-CD, showed interesting results. These studies demonstrated that 
the Sβ-CD facilitated the oxidation of the monomer at lower anodic potentials in 
comparison to the smaller, more mobile dopants, such as the chloride anion. 
Also, the rate of electropolymerisation was much higher. However, it was 
verified that the major influence in the rate of electropolymerisation was the 
conductivity of the solution. The Sβ-CD has a 10 fold higher conductivity in 
comparison to an equimolar concentration of NaCl. Analysis of the CV data 
observed an increase in the current as the polymerisation step progressed, 
indicating that the polymer film retained its conductivity even at high rates of 
deposition. 
 
PPy/Sβ-CD films were also electrochemically deposited using a potentiostatic 
method. The current-time transients demonstrated the typical behaviour 
observed for the deposition of PPy films, corresponding to the nucleation of the 
polymer. The rate of the reaction was also investigated and was shown to 
increase by a factor of two as higher anodic potentials were applied during 
synthesis. 
 
The redox properties of the polymer films were examined using CV. In the case 
of the PPy/Sβ-CD films, the redox activity of the films was clearly observed in 
contrast to other polymer films doped with smaller anions. EQCM 
measurements also demonstrated the redox properties of the polymer films 
where an increase in mass was observed during the reduction of the polymer 
films, signifying cationic exchange properties. EQCM measurements were also 
recorded during the potentiostatic growth of the PPy/Sβ-CD films and showed a 
delayed rate of reaction at the initial polymerisation step. However, once this 
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induction time was overcome, the rate of polymer growth increased 
substantially. 
 
An evaluation into the doping level of the PPy/Sβ-CD films was initiated through 
an equation derived from Faraday’s law. Preliminary results verify that the 
doping level is not 0.33, which is generally observed for the doping of PPy films 
in the presence of chloride anions.  However, a doping level of 0.083 was 
estimated assuming 9 of the sulfonated groups on the cyclodextrin ring were all 
involved in the doping process. The participation of 9 sulfonated groups in the 
doping process is high and is unlikely as it would cause a substantial strain not 
only for the CD but for the overall composition of the polymers.  
 
Finally, it was shown that this PPy/Sβ-CD system has cationic exchange 
properties. An investigation into the cation and solvent fluxes was initiated 
through an analysis proposed by Hillman. It showed that a large amount of the 
mass change achieved during the potential cycling of the polymer film in a 0.10 
mol dm-3 Na2SO4 solution, was attributed to the uptake of water.  
 
EDAX and SEM analysis also confirmed the presence of the Sβ-CD in the polymer 
matrix and the morphology of the polymer. 
 
Temsamani and co-workers also suggested that these PPy/Sβ-CD films could be 
potentially useful for the extraction of cations due to the enhanced electrostatic 
effects from the sulfate moieties and also due to the fact that cyclodextrins are 
well known to form supramolecular inclusion formation complexes with various 
guest molecules.13 This property leads to the study of PPy/Sβ-CD films for the 
uptake and release of a cationic species. With this in mind, the use of these 
biocompatible films for an implantable drug delivery release system was 
investigated using dopamine as a model cationic drug. These findings are 
presented in Chapter 4. 
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4.1 Introduction 
An area that is of increased interest is the controlled delivery of drug molecules 
that have a direct therapeutic affect on living tissues and cells. Many people 
suffering from diseases, such as diabetes, go through everyday life having to 
endure the painful process of daily injections in order to keep their particular 
disease under control. Therefore, advances in the use of implantable medical 
devices to control the release of bioactive molecules are of huge interest.  In this 
chapter, an examination into the controlled release of dopamine (DA), a 
neurotransmitter, is investigated. For conditions such as Parkinson’s disease, 
there is no known cure. As presented in Chapter 1, Parkinson’s disease affects 
the levels of DA found in the substantia nigra. Logically, due to the discovery of 
low levels of DA, the first thought would be to administer a sufferer a quantity of 
dopamine; however, it is well reported that dopamine is too large to cross the 
blood brain barrier, and so alternative routes must be investigated.1-3 
 
Conducting polymers have been considered for use as a membrane for 
controlled drug delivery due to their distinctive properties which see the 
electrochemical switching of the polymer take place under various applied 
potentials.4-9 This redox switching from the oxidised or doped state 
(conductive) to the reduced or neutral state (non-conducting) of the polymer, 
requires the uptake and release of ions to maintain charge neutrality.10, 11 
Burgmayer and Murray12 showed that the ionic resistance of a polypyrrole film 
could be controlled by changing the applied potential, and therefore the 
oxidation state of the polymer, using electrochemical means.  
 
In this research and chapter, polypyrrole (PPy) was the conducting polymer 
investigated for its role as a drug delivery system (DDS). There are many 
attractive reasons for choosing these conducting polymers. Firstly, PPy films are 
biocompatible.9, 13-16 Secondly, PPy films are responsive materials and can be 
stimulated electrochemically to uptake and release ions. With this movement of 
ions, various groups have already investigated the prospect of using a number 
of anions to dope the polymer during electrochemical polymerisation, and upon 
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application of a reduction potential achieve the release of the anion. During 
electrochemical polymerisation, anionic species are incorporated into the 
polymer film to compensate the positive charge of the oxidised polypyrrole. 
Upon appropriate application of a potential, these anionic species can be 
released. In this way various anionic dopants, including possible pharmaceutical 
drugs, such as adenosine 5’-triphosphate (ATP)11, Heparin17 and 
Dexamethasone18 (Dex) can be released upon electrical stimulation.  
 
This research, however, investigates the role of a modified PPy electrode in the 
controlled drug delivery of a cationic species at physiological pH, DA. Equally, 
with the immobilisation of large anionic dopants which remain entrapped in the 
film, cations can potentially be incorporated and released upon application of 
appropriate reduction and oxidation potentials, respectively. The presence of 
the large anionic dopant could potentially allow the uptake and release of 
cations, such as DA, during appropriate electrochemical stimulation. 
 
This chapter gives an insight into the potential use of PPy films as a DDS, 
particularly for the delivery of DA. Various parameters were investigated, 
including a study on the potential applied during growth of the polymer, the 
thickness of the polymer film, the potentials employed during incorporation and 
release of the DA, pH of DA solution, as well as, concentration and variations in 
the nature of the anionic dopant. A variety of dopants were used, varying from 
simple mobile anions to an anionic cyclodextrin. 
4.2 Experimental 
4.2.1 Materials 
4.2.1.1 Reagents 
Pyrrole monomer (98 %) was obtained from Aldrich and was purified by 
distillation prior to use. It was stored in the dark in the freezer at -4 0C. Unless 
otherwise stated, 0.20 mol dm-3 (0.35 ml in 25 ml supporting electrolyte) 
pyrrole was dissolved in the electrolyte solution for the electrochemical 
deposition experiments. Analytical reagents, sodium sulfate (Na2SO4), dopamine 
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hydrochloride salt (DA), sulfonated β-cyclodextrin (Sβ-CD) sodium salt, sodium 
chloride (NaCl) and para-toluene-sulfonic acid (PTS) were purchased from 
Aldrich and used as received. In the case of altering the pH, a 0.1 mol dm-3 H2SO4 
or a 0.1 mol dm-3 NaOH solution was used to adjust the pH, accordingly. 
 
4.2.1.2 Electrodes and Instruments 
Electrochemical deposition of polypyrrole and analysis of the samples was 
carried out using a Solartron Model SI 1285 potentiostat. All measurements 
were made at room temperature. A platinum wire (99 %, 1 mm in diameter) 
electrode, where the exposed surface area was recorded separately for every 
experiment, was used for the deposition of polypyrrole and the successive 
uptake and release of DA. A saturated calomel reference electrode (SCE) and a 
platinum wire counter electrode (CE) were also used in the cell set up.  
 
Electrochemical quartz crystal microgravimetry (EQCM) measurements were 
carried out using a CHI440 instrument. The polymers were deposited onto 
polished Au quartz crystal electrodes (Cambria Scientific) with an exposed 
surface area of 0.203 cm2. The electrochemical cell consisted of a specially made 
Teflon holder in which the crystal was placed between two o-rings, a schematic 
of which is shown previously in Chapter 3, Figure 3.1. The set up was completed 
using a platinum wire counter electrode and a 3.0 mol dm-3 Ag|AgCl reference 
electrode. UV studies on the release of the DA were carried out on a Varian 
Instruments Cary 50 Conc UV-visible spectrophotometer using a 1 cm path 
length quartz crystal cuvette. 
 
4.2.2 Procedures 
4.2.2.1 Polymer film preparation 
PPy film fabrication was carried out using an electro-synthesis method, which 
deposited the polymer film at the working electrode (platinum wire). Polymers 
were prepared in various electrolyte solutions containing 0.20 mol dm-3 pyrrole. 
A summary of the various electrolytes used in the electrochemical deposition of 
Polypyrrole and drug delivery  Chapter 4 
- 118 - 
polypyrrole are given in Table 4.1. In all cases, distilled water was used to 
prepare the solutions. Electropolymerisation of the pyrrole monomer was 
achieved using a constant potential. The potentials applied for the deposition 
ranged from 0.500 to 1.000 V vs. SCE, and were applied until a certain constant 
charge was passed, to ensure uniform film thickness. 
 
Table 4.1: Electrolytes investigated in the deposition of polypyrrole. 
 
Electrolyte Concentration / mol dm-3 
Sodium sulfate, Na2SO4 0.10 
Sodium chloride, NaCl 0.10 
para-toluene-sulfonic acid, PTS 0.10  
Sulfonated β-cyclodextrin, Sβ-CD 0.01 
 
4.2.2.2 Incorporation of drug 
After polymerisation, the prepared polymer films were gently washed with 
distilled water and immersed in a 0.10 mol dm-3 DA solution, prepared in a 
supporting electrolyte of 0.10 mol dm-3 Na2SO4. In general, the DA incorporation 
step involved the application of a reduction potential of -0.900 V vs. SCE, for 30 
min. The polymer was then washed with distilled water and transferred to a 
fresh 0.10 mol dm-3 Na2SO4 solution and held at a reduction potential of -0.900 
V vs. SCE for 10 min in order to liberate any excess DA present on the surface of 
the polymer. 
 
4.2.2.3 Release of drug 
UV-visible spectroscopy was used to monitor the rate of release of the drug 
molecule, DA. To determine the concentration of the drug released for each 
experiment, a calibration curve was first prepared using DA concentrations 
ranging from 1.0 x 10-3 to 1.0 x 10-6 mol dm-3. The absorbance values measured 
during the drug release experiment were then converted to DA concentration 
using the calibration curve. A typical calibration curve is shown in Figure 2.9, 
Chapter 2. 
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For the PPy/SO4 system, the drug loaded polymers were transferred to a quartz 
crystal cuvette with 3 mL of 0.10 mol dm-3 Na2SO4 and then inserted in the UV 
spectrophotometer. Counter and reference electrodes, Pt and Ag wire, 
respectively, were placed in the cuvette, avoiding the path of the light beam. An 
oxidation potential of 0.100 V was applied for 60 min in order to release the 
drug. The samples were analysed over a spectral range of 500 to 200 nm every 
30 s over the period of 60 min. However, it proved difficult to eliminate slow 
release effects and a new method of analysing the amount of DA released from 
the PPy/Sβ-CD polymers was used. In this case, the electrochemical set up was 
transferred to 25 mL of 0.10 mol dm-3 Na2SO4 solution in a glass cell. To 
facilitate the mixing of the released drug with the release medium, the solution 
was agitated with a stirring bead. An oxidation potential of 0.100 V vs. SCE, 
unless otherwise stated, was applied for 60 min. To monitor release, 3.0 mL 
aliquots were sampled from the medium and ran in the UV spectrophotometer 
over a spectral range of 500 to 200 nm every 10 min over the period of 60 min, 
unless otherwise stated. After each sampling, the 3.0 mL aliquots were returned, 
so as not to distort the volume.  
 
4.2.2.4 Influence of varying parameters for the PPy/SO4 system 
4.2.2.4.1 Influence of varying the growth potential and charge  
The influence of the nature of the polypyrrole film was firstly examined. In these 
experiments, polymers were electrochemically deposited onto a platinum wire 
in the presence of 0.20 mol dm-3 pyrrole and 0.10 mol dm-3 Na2SO4 at different 
electropolymerisation potentials.  The oxidation potentials were varied from 
0.500 to 0.900 V vs. SCE, while maintaining a constant charge of 5.0 C cm-2. The 
thickness of the polymers, where the charges consumed were varied from 1.0 to 
10.0 C cm-2, was also examined. The incorporation and release of DA was then 
carried out as described in Sections 4.2.2.2 and 4.2.2.3, respectively. 
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4.2.2.4.2 Influence of varying the incorporation step 
In this study, the polypyrrole films were electrochemically deposited in the 
presence of 0.20 mol dm-3 pyrrole and 0.10 mol dm-3 Na2SO4, at 0.600 V to a 
charge of 5.0 C cm-2. They were then washed with distilled water and placed in a 
0.10 mol dm-3 DA solution made up in 0.10 mol dm-3 Na2SO4. The DA was 
incorporated into the polymer by immersing the electrochemical set up into the 
DA solution and applying various reduction potentials, in the range of -1.000 to  
-0.400 V vs. SCE, for 30 min. The release of the DA was achieved as explained in 
Section 4.2.2.3. 
 
The pH of the DA solution during the incorporation period was also studied to 
see if this parameter had any influence on the uptake and subsequent release of 
the DA. In this instance, the pH was adjusted using 0.10 mol dm-3 H2SO4 or NaOH 
to give a final pH in the range of 1.1 to 6.9. Again, the incorporation and release 
steps were carried out as detailed in Sections 4.2.2.2 and 4.2.2.3, respectively. 
 
4.2.2.4.3 Influence of varying the release step 
As described in Section 4.2.2.3, the release of DA was achieved through the 
application of an anodic potential. In examining this process for the PPy/SO4 
system, polymers were electrochemically deposited onto platinum wire, in the 
presence of 0.20 mol dm-3 pyrrole and 0.10 mol dm-3 Na2SO4, at 0.600 V vs. SCE 
to a charge of 1.0 C cm-2. DA was incorporated as detailed in Section 4.2.2.2 and 
the release achieved through varying the potential from 0.100 to 0.300 V vs. 
SCE.  
 
4.2.2.4.4 Influence of the nature of the dopant anion 
The final parameter varied in this section was the influence of the electrolyte 
solution in which the polymer was grown. In these experiments, polymers were 
electrochemically synthesised under a constant potential of 0.600 V vs. SCE to a 
charge of 5.0 C cm-2 in the presence of 0.20 mol dm-3 pyrrole and various dopant 
anions, Table 4.1. The uptake and release of DA was performed as outlined in 
Sections 4.2.2.2 and 4.2.2.3, respectively. 
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4.2.2.5 Influence of varying parameters for the PPy/Sβ-CD system 
Information on the characterisation of the redox properties of the PPy/Sβ-CD 
system was performed using cyclic voltammetry (CV). For the CV data, the 
polymers were deposited onto a platinum disc electrode using a constant 
potential of 0.700 V vs. SCE to a charge of 0.6 C cm-2 in the presence of 0.20 mol 
dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD. The polymer film, after careful washing, 
was then cycled through a potential window of 0.600 to -0.900 V at 50 mV s-1 for 
10 cycles. 
 
4.2.2.5.1 Influence of varying the growth potential and charge  
In this set of experiments, polymers were electrochemically deposited onto a 
platinum wire in the presence of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD 
dissolved in water.  The oxidation potentials employed for this deposition step 
were varied from 0.500 to 1.000 V vs. SCE, until a charge of 2.0 C cm-2 was 
passed. The thickness of the polymers, where the charges consumed were 
varied from 1.0 to 10.0 C cm-2, was also examined, in this case a constant 
potential of 0.900 V vs. SCE was applied to achieve electrochemical growth. The 
incorporation and release of DA was then carried out as described in Sections 
4.2.2.2 and 4.2.2.3, respectively. 
 
An investigation into the influence of a supporting electrolyte during polymer 
growth was also carried out. In this section, polymer films were synthesised at 
0.900 V vs. SCE to a charge of 1.0 C cm-2, in the presence of 0.20 mol dm-3 
pyrrole, where 0.01 mol dm-3 Sβ-CD was prepared in 0.10 mol dm-3 Na2SO4. 
Incorporation and release of DA was achieved, as previously outlined in Section 
4.2.2.2 and 4.2.2.3, respectively.  
 
4.2.2.5.2 Investigations into the oxidation of DA at thicker PPy/Sβ-CD films 
Oxidation of DA was observed on release from the thicker Sβ-CD-doped 
polypyrrole films. In order to gain an understanding of how the DA was 
oxidised, various experiments were performed, focussing on both the 
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incorporation and release steps, with the aim of identifying the point where 
oxidation of DA occurred.  
 
An electrochemical cell, in a quartz crystal cuvette, was set up in the UV 
spectrophotometer. In the cell, 0.5 mL of pyrrole was added to a 1.5 x 10-4 mol 
dm-3 DA solution in water, where a constant potential of 0.200 V vs. SCE was 
applied for 10 min. A UV spectrum was taken before and after the potential was 
applied to determine if the DA was oxidised during the applied potential step. 
 
CV experiments were also carried out. Polymers were synthesised in the 
presence of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD in water at 0.900 V 
vs. SCE to 1.0 C cm-2. Cyclic voltammograms were recorded in 0.10 mol dm-3 DA 
solution in 0.10 mol dm-3 Na2SO4 solution, at a scan rate of 50 mV s-1, for both a 
bare and the modified platinum electrode (SA = 0.479 cm2). 
 
KNO3 salt bridges were prepared using the method outlined by Shakhashiri.19 
The growth of the polymers was achieved, as described in Section 4.2.2.5.1, 
where the potential applied was 0.900 V vs. SCE and the polymers were grown 
to a thickness corresponding to a charge of 10.0 C cm-2. The incorporation and 
release steps were carried out as described in Sections 4.2.2.2 and 4.2.2.3, 
respectively, however the counter electrode was separated from the DA 
solution, in order to prevent the possible oxidation of DA at the counter 
electrode. 
 
4.2.2.5.3 Influence of varying the incorporation step 
In this step, all polymers were synthesised onto a platinum wire in the presence 
of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD in water, where a 0.900 V vs. 
SCE potential was applied until 2.0 C cm-2 of a charge was passed, unless 
otherwise stated. DA was incorporated by transferring the set up to a 0.10 mol 
dm-3 DA solution and applying various reduction potentials, ranging from -0.900 
to -0.400 V vs. SCE, for 30 min. In addition, the reduction period was varied by 
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changing the amount of time the polymers were subjected to a potential of           
-0.900 V vs. SCE.  
 
In all cases, the DA solution used for the incorporation stage was made up in the 
presence of a supporting electrolyte, 0.10 mol dm-3 Na2SO4. An examination into 
the presence of this supporting electrolyte was performed where its 
concentration was varied from 0.0 to 0.10 mol dm-3 Na2SO4. Polymers were 
prepared, DA was incorporated and released, as summarised previously. 
 
4.2.2.5.4 Influence of varying the release step 
In examining this process for the PPy/Sβ-CD system, the polymers were 
electrochemically deposited onto the platinum wire, in the presence of 0.20 mol  
dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD, polarised at 0.900 V vs. SCE to a charge of  
3.0 C cm-2, unless otherwise stated. DA was incorporated, as outlined in Section 
4.2.2.2, and the release was achieved by applying a potential from -0.300 to 
0.300 V vs. SCE. The amount of time allowed for the release was also varied 
from 30 to 720 min. 
 
4.2.2.6 EQCM measurements 
EQCM data were recorded for the uptake and release of DA in the PPy/Sβ-CD 
system. In the case of all the EQCM measurements, polypyrrole films were 
electrochemically deposited onto gold quartz crystal electrodes with an active 
surface area (SA) of 0.203 cm2, at an oxidation potential of 0.700 V vs. SCE from 
a solution of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD, until a charge of 
either 1.5 x 10-2 C or 3.6 x 10-2 C was passed. All solutions were prepared using 
distilled water. A Pt wire was used as a counter electrode, while a 3.0 mol dm-3 
Ag/AgCl electrode was used for the reference electrode. Once the polymers 
were prepared they were washed well with distilled water and immersed in a 
0.10 mol dm-3 DA solution prepared in distilled water.  
 
The DA was incorporated by applying a reduction potential of -0.900 V vs. SCE 
for either 100 or 600 s. The electrodes were again washed with distilled water 
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and transferred to a 0.10 mol dm-3 Na2SO4 solution where the release of the DA 
was achieved by applying 0.100 V vs. SCE for either 100 or 600 s.  
 
This technique, in conjunction with chronoamperometry, was also used to 
monitor the release of the DA during the switching of the potential. As outlined 
above the polymers were electrochemically deposited at an oxidation potential 
of 0.700 V vs. SCE from a solution of 0.20 mol dm-3 pyrrole and 0.01 mol  dm-3 
Sβ-CD until a charge of 1.5 x 10-2 C was passed. The polymers were then washed 
and immersed in a 0.10 mol dm-3 DA solution prepared in a 0.10 mol dm-3 
Na2SO4 supporting electrolyte and the potential was pulsed from -0.900 to 0.100 
V vs. SCE every 100 s. 
 
As described previously in Section 2.5.1, the frequency shift, caused by changes 
in the mass during the electrochemical experiments, was measured using a 
frequency counter. The resonant frequency shift, Δƒ, relates to the mass change, 
ΔM, in accordance with the Sauerbrey equation, Equation 4.1: 
 
Δ  
2Δ	


 
 
where ƒ0 is the resonant frequency, ∆M is the mass change, A is the surface area 
of the electrode or film, ρ is the density of quartz , 2.648 g cm-3, and µ is the 
shear modules of quartz, 2.947 x 1011 g cm-1 s-2. Only thin polymer films were 
used, and accordingly, the Sauerbrey equation is valid giving a very good 
estimate of the mass changes accompanying the release of DA. 
 
4.3 Results and Discussion 
4.3.1 Dopamine, a cationic model drug 
The objectives of any drug delivery system (DDS) are to incorporate a drug into 
a drug carrier and to deliver these drugs into the body in a controlled manner, 
at the target site, at a required time and at a particular concentration. The 
4.1 
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current methods of drug delivery exhibit specific problems that scientists are 
attempting to address. For example, the potencies and therapeutic properties of 
many drugs are limited, or otherwise reduced, because of the partial 
degradation that occurs before they reach a desired target in the body. Time-
release medications, upon intake, deliver treatment continuously. However, this 
can be a disadvantage as the drug can become unresponsive to the symptoms.  
 
Therefore, the goal of any DDS is to deploy drugs intact to specifically targeted 
areas which can be controlled by means of either a physiological or chemical 
trigger. Materials already under consideration are dendrimers20, liposomes21, 
and hydrogels22. Release mechanisms vary from diffusion, swelling and 
degradation of the DDS. Although these concepts of release are good, they are 
not very efficient as there is no way of controlling the amount of drug released. 
For example, in the case of diffusion, which is a slow process, there is no control 
of delivery or concentration to the site. The same can be said for the swelling 
and degradation processes. Accordingly, the challenge is to provide an ideal 
system which responds to a biological environment, i.e., deliver the drug when it 
is needed and switch off the delivery when it is no longer required.  Several 
other experimental drug delivery systems show exciting signs of promise, 
including those composed of electroactive polymers. In this chapter results are 
presented and discussed on electroactive PPy films for the controlled delivery of 
a well-known neurotransmitter, dopamine, DA. 
 
Dopamine, Figure 4.1, in an aqueous media pH~6, exists as a cationic species. As 
described in Chapter 1, dopamine is a neurotransmitter and is of considerable 
interest due to its use in the treatment of Parkinson’s disease. To deliver this 
cationic species, the PPy films were doped with a number of large anions, with 
particular focus on the use of the large anionic and immobile dopant, sulfonated 
β-cyclodextrin (Sβ-CD).  
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Figure 4.1: Structure of DA in its protonated state. 
 
Many authors have investigated the uptake and release of pharmaceutically 
important compounds from conducting polymer films and have monitored the 
release using various techniques, including cyclic voltammetry (CV)23, high 
powered liquid chromatography (HPLC)24, radio labelling15 in addition to the 
most common of all, and the technique employed in these studies, UV-visible 
spectroscopy (UV)25-27. As DA absorbs in the UV region, this technique was 
employed. Figure 4.2 shows the absorbance as a function of wavelength for a  
1.0 x 10-4 mol dm-3 DA solution in water. The DA compound absorbs between 
260 and 300 nm, with a λmax of 280 nm.  
 
However, DA is light and oxygen sensitive. As previously shown in Chapter 1, 
catecholamine compounds can undergo both electrochemical and chemical 
oxidation.28, 29 The oxidation of the catecholamine group has been documented 
to show changes in the UV spectral data, with the quinone showing a λmax of 310 
nm.28, 30 Therefore, an investigation into the time frame allowed for experiments 
to be carried out on the DA solutions, under normal conditions, were 
considered. Figure 4.3 shows the UV data obtained for a 1.0 x 10-4 mol dm-3 DA 
solution monitored over 240 min with exposure to air and light.  From this 
figure, the oxidation of DA is clearly observed from the increase in the 
absorbance at 310 nm. After 120 min, oxidation of DA was evident, while 
considerable oxidation is seen after 240 min. During the oxidation of DA a band 
at ~ 310 nm progressively increases in intensity until it overlaps the band 
observed at 280 nm, along with a band forming at ~ 470 nm and is 
characteristic of the chrome form of the oxidation product of the DA.30 This 
HO
HO
H
H
H
NH3
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oxidation limited the potentials that could be applied to release DA, Sections 
4.3.3.3 and 4.3.4.3, and its exposure to air and light, during the release steps.  
 
 
Figure 4.2: UV spectrum of 1.0 x 10-4 mol dm-3 DA in water. 
 
  
Figure 4.3: Absorbance plotted as a function of wavelength for 1 x 10-4 mol dm-3 DA in 
water over time. Absorbance spectra recorded after ♦ 60 ♦ 120 ♦ 180 and ♦ 240 min. 
Highlighted region indicates oxidation. 
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4.3.2 Polymer preparation 
In the 1980’s, research into the use of PPy films for the uptake and release of 
biochemical molecules was suggested and proved by Burgmayer and Murray12, 
and Miller et al.23 A decade later the research on these materials was focused on 
finding new composite films to uptake and release many different types of 
drugs.31 Recent studies have investigated the use of PPy for the uptake and 
release of more complex compounds, including proteins.15 It is well known that  
PPy films have the capabilities to incorporate and release chemical substances 
be it dyes32, anionic drugs5, 11, 18, 26 cationic species23 and proteins15. In all cases 
the release of the substances can be achieved using electrochemical stimulation.  
 
As discussed in Chapter 3, electrochemical deposition of the pyrrole monomer 
occurs during the oxidation of the monomer and the incorporation of anions or 
dopants to maintain charge neutrality. It has been well reported that anionic 
species such as ATP11 and salicylate5 can be simultaneously incorporated or 
doped during electrochemical polymerisation of the pyrrole. This is due to the 
fact that during the oxidation of the monomer cations (polarons and bipolarons) 
are produced along the polymer backbone and the inclusion of anions to 
compensate these charges involves the uptake of these anionic species. 
However, although it was attempted (results are not shown), DA is a cationic 
species and cannot act as a dopant during the polymerisation of pyrrole. 
Accordingly, in order to investigate the uptake and release of this cationic 
species, polymers were firstly electrochemically deposited onto the working 
electrode in the presence of various anions. After polymerisation, the polymers 
are in their fully oxidised state and when reduced in the presence of the cationic 
species in solution, some of these cations will be incorporated within the 
polymer matrix. They can be subsequently released upon application of an 
appropriate oxidation potential. Scheme 4.1 illustrates the mechanism and 
concept behind the binding and release of the cationic DA. 
 
The first system discussed here is the PPy/SO4 system; all experimental details 
are provided in Section 4.2.2.4. Different parameters were varied to optimise 
the uptake and release of DA.  
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Scheme 4.1: Processes involved during reduction and oxidation of the PPy film in the 
presence of the cationic DA, where A- represents an immobile dopant anion. 
 
4.3.3 Influence of varying parameters for PPy/SO4 system  
As previously mentioned, PPy has the ability to bind and release ions, due to its 
redox properties. During polymerisation of the monomer, where the polymer 
was doped with SO42- or HSO4- anions, the black polymer films were deposited 
onto the platinum wire. Figure 4.4 shows typical current-time transients 
recorded for the growth of a PPy/SO4 film in an aqueous solution. Two separate 
growth curves are presented which indicate a reasonably good reproducibility 
from experiment to experiment and is characteristic of the results obtained 
throughout these studies. These distinctive growth transients have been 
discussed in Chapter 3, Section 3.3.1. In this case, the polymer backbone is 
oxidised and anions, A-, are needed to compensate for the charge and 
consequently are incorporated into the polymer matrix, as demonstrated in 
Scheme 4.2. 
 
   	
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Scheme 4.2: Doping of PPy with anions, A-, during electropolymerisation in a solution 
of MA. 
 
Following the electrochemical synthesis, the polymer films were then washed 
with copious amounts of distilled water and transferred to the cationic DA 
solution, where a reduction potential was applied. Figure 4.5 shows a typical 
current-time transient for the reduction of the polymer film in the presence of 
the cationic DA solution with a supporting sulfate electrolyte at -0.900 V vs. SCE. 
Reduction 
 
Oxidation 
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There is an initial rapid decrease in the reduction current, which is followed by 
a slower rate of reduction until most of the PPy film is reduced. 
 
 
Figure 4.4: Current as a function of time for the electro-oxidation of pyrrole in the 
presence of 0.10 mol dm-3 Na2S04 at 0.750 V vs. SCE.  
 
 
Figure 4.5: Current as a function of time for the reduction of PPy/SO4 film in a solution 
of 0.10 mol dm-3 DA in 0.10 mol dm-3 Na2S04 at -0.900 V vs. SCE.  
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Subsequently, after reduction of the polymer films in the DA solution, the films 
were washed with 0.10 mol dm-3 Na2S04, and transferred to a cuvette placed in 
the UV spectrophotometer, where an oxidation potential was applied to 
stimulate the release of DA. Upon application of an anodic potential, the 
polymer film was re-oxidised and therefore any cations incorporated during the 
reduction step, should be released to maintain the charge neutrality, Scheme 
4.1. Figure 4.6 shows a representative current-time transient recorded when an 
oxidation potential of 0.200 V vs. SCE was applied to the PPy film. 
 
 
 
 
Figure 4.6: Current as a function of time for the oxidation of the PPy/SO4 film loaded 
with DA to achieve the release of DA into 0.10 mol dm-3 Na2S04 at 0.200 V vs. SCE.  
 
As detailed in Section 4.2, UV-visible spectroscopy was used to monitor the 
release of the DA as a function of time. As discussed earlier, Section 4.3.1, DA has 
a strong absorbance peak in the UV region at a λmax of 280 nm. Figure 4.7 
illustrates the spectral data obtained for the release of DA, from a PPy/SO4 
polymer film synthesised at 0.750 V vs. SCE to 1.0 C cm-2, where the 
incorporation of DA was achieved by applying a reduction potential of -0.900 V 
vs. SCE for 30 min and where the release was accomplished through the 
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application of an oxidation potential of 0.200 V vs. SCE. Release of DA was 
monitored over a 60 min period. Using the DA calibration curve, as detailed in 
Section 2.5.2, Figure 2.9, the amount of DA released was computed as a function 
of time. It is clear from Figure 4.7, that DA is indeed released from the PPy/SO4 
film and that the absorbance continues to increase with increasing time. 
 
Accordingly, as the DA was successfully incorporated and released, a number of 
parameters were varied in order to optimise the release of the DA from the 
prepared PPy/SO4 films. This included studies on the polymer thickness, the 
incorporation potential, the pH of the incorporating DA solution, the release 
potential and the dopant used during the electrochemical polymerisation of 
pyrrole.  
 
 
 
 
Figure 4.7: Absorbance as a function of wavelength for the release of the DA upon the 
application of an oxidation potential of 0.200 V vs. SCE to a PPy/SO4 film where DA 
was incorporated upon reduction of the film in 0.10 mol dm-3 DA/0.10 mol dm-3 Na2SO4 
at -0.900 V vs. SCE. Release medium was 0.10 mol dm-3 Na2S04. Data were recorded for 
60 min. Inset shows the release as a function of time. 
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4.3.3.1 Influence of varying the growth potential and charge of PPy/SO4 film 
The first parameter examined was the anodic potential applied during the 
deposition of the polypyrrole film from the sulfate solution. As previously 
mentioned, the pyrrole monomer oxidises to form a polymer chain which 
incorporates anions to neutralise the charge. In applying a number of oxidation 
potentials to the polypyrrole film, the physical and mechanical properties of the 
film can change. In this set of experiments, the polymers were synthesised in the 
presence of 0.20 mol dm-3 pyrrole and 0.10 mol dm-3 Na2S04, until a charge of 
5.0 C cm-2 was reached. The DA was incorporated and the procedures outlined 
in Section 4.2.2.4.1 were then used to achieve the release of the DA. Figure 4.8 
shows the amount of DA released after 60 min, upon application of an oxidation 
potential, 0.100 V vs SCE, to the PPy/S04/DA loaded film. It is clear from this 
figure that there is no significant change in the amount of DA released from the 
films grown at different potentials in the range between 0.500 and 0.900 V vs. 
SCE. The maximum amount of DA released is 50 nmol cm-2 and this occurs at a 
growth potential of 0.75 V vs. SCE. 
 
 
 
Figure 4.8: DA released as a function of the potential applied during electrochemical 
polymerisation of PPy/SO4 films grown to a charge of 5.0 C cm-2. DA was incorporated 
at -0.900 V vs. SCE and released at 0.100 V vs. SCE. 
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The thickness of the polymer films was also considered. The polymer films were 
electrochemically deposited to three different charges which were deposited at 
a constant potential of 0.600 V vs. SCE. The release of DA was achieved as 
described in Section 4.2.2.2. Figure 4.9 demonstrates the release of DA as a 
function of the charge reached during electrochemical deposition. It is evident 
from this figure that as the charge increases, which is proportional to the 
thickness of the film, the amount of DA released over 60 min increases 
considerably, reaching 200 nmol cm-2 for polymers grown to a charge of              
10.0 C cm-2. 
 
 
 
Figure 4.9: DA released as a function of the charge passed during the polymerisation of 
pyrrole at an oxidation potential of 0.600 V vs. SCE in 0.1 mol dm-3 Na2SO4. DA was 
incorporated at -0.900 V vs. SCE and released at 0.100 V vs. SCE for 60 min. 
 
4.3.3.2 Influence of varying the incorporation step 
Next, a series of experiments was carried out to optimise the incorporation of 
DA into the polypyrrole films. Both the potential used to reduce the polymer, i.e., 
the incorporation potential and the pH of the DA solution were varied. 
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4.3.3.2.1 Influence of varying the incorporation potential 
The incorporation potential was varied from -0.400 to -1.000 V vs. SCE. This 
step is an important one as it determines the amount of DA incorporated into 
the polymer film. Figure 4.10 shows the amount of DA released after oxidation 
of the PPy film, as described in Section 4.2.2.4.2, where the DA was incorporated 
at various reduction potentials. It is clear that as the incorporation potential is 
reduced to lower reduction potentials, greater amounts of DA are bound and on 
subsequent oxidation, the polymer film shows an increased release of DA.  
 
Figure 4.11 shows some of the corresponding current-time transients for these 
data. It is evident from this figure that the lower reduction potentials give rise to 
more efficient reduction of the polymer film, which in turn enables the ingress 
of the cationic DA. There is a three-fold increase in the amount of DA released 
on varying the reduction potential from -0.400 to -1.000 V vs. SCE, which 
indicates that not alone is DA incorporated, but the sulfate anions are not 
ejected on reduction. If these anions are lost, then the reduced polymer, PPyo, 
will not bind the cationic DA. 
 
 
 
Figure 4.10: DA released as a function of the potential applied to the polymer films 
during the reduction or incorporation step. 
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Figure 4.11: Current-time transients recorded for the reduction of the polypyrrole film 
in the DA solution. ♦ -0.200 V vs. SCE ♦-0.600 V vs. SCE ♦-1.000 V vs. SCE. 
 
4.3.3.2.2 Influence of varying the pH of the incorporating DA solution 
DA exists as a protonated species in aqueous media. Consequently, the influence 
of the pH of the incorporating DA solution was investigated. Figure 4.12 shows 
the DA released after 60 min from polymers which were synthesised as 
described in Section 4.2.2.4.2, but the pH of the DA solution was varied during 
the DA-incorporation step. From this figure it is evident that a change in the pH 
of the DA incorporation solution has no significant effect on the amount of DA 
incorporated or released from the polypyrrole films.  
 
This result is consistent with the fact that the amount of DA in its protonated 
form is reasonably constant over this pH range. The ratio of DA in the neutral 
and protonated states can be obtained by considering the Henderson 
Hasselbalch equation, Equation 4.2, and using HA+ to represent the protonated 
DA and A to indicate the neutral form (HA+  H+ + A). This relationship can be 
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arranged to give Equation 4.3, providing the ratio of the neutral to the 
protonated DA, in terms of the pH and pKa value of DA, which is 8.92. 
 
 
 
 
Figure 4.12: DA released, nmol cm-2, from the PPy/SO4 films as a function of the pH of 
the DA incorporation solution, 0.10 mol dm-3 DA and 0.10 mol dm-3 Na2SO4.  
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Using Equations 4.2 and 4.3, the ratio of protonated DA to the neutral DA can be 
computed and it remains essentially constant at 99.9% between the pH values 
from 1.0 to 6.0.  Therefore, it is not surprising that the amount of DA released 
remains essentially constant between pH values of 1.0 and 6.0, Figure 4.12. 
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4.3.3.3 Influence of varying the release step 
 4.3.3.3.1 Influence of varying the release potential 
In the final step of optimising the parameters for the delivery of DA from the 
PPy/SO4 system, the release process was investigated. This step involves the 
application of an anodic potential in order to re-oxidise the polymer film which, 
in turn, releases the cations from the polymer matrix. Once again, the polymers 
were electrochemically synthesised as outlined in Section 4.2.2.4.3, and the DA 
was incorporated using a potential of -0.900 V vs. SCE for 30 min. The release of 
the DA was then achieved by varying the oxidation potential. Figure 4.13 shows 
the UV spectral data obtained when various potentials were applied to the 
prepared polymers. It is apparent from these data that there is a considerable 
variation in the UV absorbance. This is due to the oxidation of the DA molecule 
as previously described. The DA is converted to the quinone form with applied 
potentials greater than 0.200 V vs. SCE. Therefore, the oxidation potential was 
limited to values ≤ 0.100 V vs. SCE to ensure that DA was released in its pure 
un-oxidised form.  
 
 
Figure 4.13: UV spectra of DA release from polymers grown to 1.0 C cm-2 from 0.20 
mol dm-3 pyrrole and 0.10 mol dm-3 Na2SO4 at 0.600 V vs. SCE. Release of the DA was 
achieved by applying    ♦ 0.100 ♦ 0.200 ♦ 0.300 V vs. SCE for 60 min. 
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4.3.3.4 Influence of varying electrolyte 
It has been reported that the use of different dopants can change the structure 
and porosity of polypyrrole.33 With this in mind, the dopant anion was varied to 
investigate its influence for the uptake and release of DA. Polymers were 
prepared using the experimental procedures outlined in Section 4.2.2.4.3, where 
the only variation was the dopant anion. The incorporation of the DA was 
accomplished by applying a reduction potential of -0.900 V vs. SCE in the 
presence of 0.10 mol dm-3 DA. Subsequent release of the DA, which was 
monitored using UV-visible spectroscopy, is shown in Figure 4.14 for each 
dopant. It should be pointed out that the concentration of Sβ-CD was 10 times 
lower than the concentration of the other dopant anions. Figure 4.15 shows 
representative UV absorption peaks centred at 280 nm for the DA release from 
each polymer composite after 60 min. It is clear that the release of DA from the 
PPy/Sβ-CD system is significantly improved in comparison to the DA released 
from the other PPy films.  There is no, or negligible release, of DA from the 
PPy/Cl system. This is probably connected with the fact that the chloride anion 
is a mobile dopant and as the oxidised polypyrrole film is reduced in the DA 
solution, the chloride anions are expelled, with little or no uptake of the cationic 
DA. The larger PTS and Sβ-CD are immobile and reduction of the polypyrrole is 
accompanied by the ingress of the cationic DA.  
 
Table 4.2 expresses the amount of DA released in nmol cm-2 as a function of the 
dopant anion used during the electrochemical synthesis. This reiterates that the 
amount of DA released is far superior from the PPy/Sβ-CD films when compared 
to the other films investigated. It is also important to point out that there is an 
increase in the stability of the DA released, Figure 4.15. Due to this significant 
improvement, the PPy/Sβ-CD system was explored in greater detail, the results 
of which are presented in Section 4.3.4.  
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Figure 4.14: UV data for the release of DA at 0.100 V vs. SCE from polymers prepared 
with the various anionic dopants shown in the plots. 
 
 
 
Figure 4.15: UV data for the release of DA at 0.100 V vs. SCE after 60 min from 
polymers prepared with the various anionic dopants:♦ NaCl ♦ Na2SO4 ♦ PTS ♦ Sβ-CD. 
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Table 4.2: DA released after 60 min from the various polymer films doped with 
different anions.  
 
 
Dopant 
 
DA release / nmol cm-2 
NaCl 5 
Na2SO4 60 
PTS 165 
Sβ-CD 404 
 
 
4.3.4 Influence of varying parameters for PPy/Sβ-CD system 
Due to the substantial increase in the amount of DA released when the polymer 
was doped with the large immobile anionic Sβ-CD dopant, this novel material 
for the uptake and subsequent release of DA was further investigated. Bidan et 
al.34 reported that during the electrochemical polymerisation of pyrrole in the 
presence of Sβ-CD anions, due to their size and immobility, they remain 
entrapped within the polymer matrix and as a consequence require the uptake 
of cations to compensate for the charge. Figure 4.16 shows a typical 
voltammogram of the redox properties of a PPy/Sβ-CD film. The nature of the 
ionic species exchanged during the cycling is evident. In the first segment of 
cycle 1, as the potential is cycled from an initial potential of 0.500 V vs. SCE to 
more negative values,  there is a pronounced cathodic peak at -0.556 V vs. SCE, 
which corresponds to the incorporation of the cationic species. Accordingly, the 
corresponding anodic peak at -0.322 V vs. SCE represents to the point where 
both cations and anions are expelled and inserted, respectively. It is also evident 
that this behavior, although slightly suppressed, is observed for the successive 
cycles, indicating that the ionic exchange is potential dependent, reversible and 
stable. Bidan and co-workers34 also reported similar observations of the 
PPy/Sβ-CD films cycled in the presence of 0.50 mol dm-3 LiCI04 aqueous 
solutions. 
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Therefore, when a reduction potential is applied to the PPy/Sβ-CD film, cations 
from the solution flow into the film to maintain the charge neutrality. Upon 
application of an oxidation potential, the process is reversed and the expulsion 
of the cations is observed. This behaviour has thus widened the use of these 
films for the application of drug delivery devices. An examination into the 
various stages of the synthesis and uptake and release was hence performed 
and these results are now presented. 
 
 
 
 
Figure 4.16: CV data recorded in 0.10 mol dm-3 Na2SO4 at 50 mV s-1 for a PPy/Sβ-CD 
film synthesised at 0.700 V vs. SCE from an aqueous solution containing 0.20 mol dm-3 
pyrrole and 0.01 mol dm-3 Sβ-CD to a charge of 0.6 C cm-2. ♦ Cycle 1 ♦ Cycles 2 – 10. 
 
4.3.4.1 Influence of varying the PPy film growth conditions 
4.3.4.1.1 Influence of varying potential applied upon growth of the polymer 
The first parameter studied for the uptake and release of DA from these PPy/Sβ-
CD films was the potential applied during the growth of the polymer films. The 
current-time transients recorded were previously shown in Chapter 3, Figure 
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3.11. This figure showed that as the anodic potential was increased during the 
potentiostatic growth, the currents increased, indicating a higher rate of 
electropolymerisation at the higher applied potentials. Figure 4.17 illustrates 
the maximum amount of DA released, from these PPy/Sβ-CD films synthesised, 
as a function of the deposition potential.  
 
There were two observations taken from this figure. The first is that the 
polymers synthesised at 1.000 V vs. SCE appear to observe a lower amount of 
DA released after 60 min, in comparison to the other PPy/Sβ-CD films. This is 
possibly due to the fact that at this high formation potential, the resistance of 
the films is high, as it is well known that polypyrrole films are easily over-
oxidised with potentials higher than 0.800 V vs. SCE. This high resistivity can 
lead to the loss of activity of the film and, therefore, a decrease in its 
conductivity.35 In turn, the amount of DA incorporated is suppressed.  
 
 
 
Figure 4.17: DA release from the PPy/Sβ-CD films electrochemically deposited onto 
platinum wire at various potentials. Polymers were synthesised using 0.20 mol dm-3 
pyrrole and 0.01 mol dm-3 Sβ-CD to a charge of 2.0 C cm-2. 
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The second observation is that polymers electropolymerised at 0.500 V vs. SCE 
also lead to a decreased amount of DA released. It is known that as the potential, 
applied during electropolymerisation, is increased it changes the physical and 
mechanical properties of the polymer structure; an increase in the porosity of 
the polymer is observed. Therefore, at this lower deposition potential the 
polymer matrix is not as porous as the polymers deposited at higher anodic 
potentials and, in turn, this gives rise to a decrease in the number of DA cations 
incorporated within the polymer composite. Furthermore, the doping levels are 
known to increase with increasing formation potential.36 At a formation 
potential of 0.500 V vs. SCE, lower levels of the sulfonated β-CD are 
incorporated as a dopant within the polymer matrix. Since it is the immobile Sβ-
CD dopant that gives rise to the ingress and incorporation of DA during the 
reduction of the polymer, a decrease in its concentration will lead to a reduction 
in the amount of DA incorporated and bound in the polymer.  
 
As 0.900 V vs. SCE yields the greatest DA release over a 60 min period, this 
potential was used to synthesise the polymers for the investigation of the 
influence of the polymer thickness and most subsequent experiments. 
 
4.3.4.1.2 Influence of varying polymer thickness 
In varying the thickness of the polymer films, as long as the constant potential 
applied allows for the further oxidation of the monomer, the only limitation in 
how thick a film can be grown is the availability of the pyrrole monomer.35 For 
this study, polymers were potentiostatically synthesised onto platinum wire 
from 0.2 mol dm-3 pyrrole where the thickness of the PPy films deposited at the 
working electrode was varied by holding the potential constant and changing 
the growth time. In these cases the potential was held at 0.900 V vs. SCE. The DA 
was incorporated, washed and released as described, in Section 4.2.2.5.1.  
 
Figure 4.18 shows the charge plotted as a function of time for the growth plots 
of the various PPy/Sβ-CD films used in this study. It can be seen that higher 
charges are measured with increasing polymerisation times, increasing in a 
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linear manner at a rate of 0.089 ± 0.001 C cm-2 s-1. In addition, there is very good 
reproducibility from experiment to experiment. Figure 4.19 shows the total 
amount of DA released after 60 min as a function of the charge to which the 
polymer films were synthesised. The figure shows a linear relationship between 
the DA released and the electropolymerisation charge. As observed with the 
PPy/SO4 films, it is the thickness of the PPy/Sβ-CD films which has the greatest 
effect on the amount of DA released.  
 
Figure 4.18 Charge as a function of time for the potentiostatic growth of PPy films from  
0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD where a potential of 0.900 V vs. SCE 
was applied. 
 
The amount of charge consumed as a function of their corresponding DA 
release, upon reduction and oxidation, of films grown to various thickness is 
shown in Figure 4.20 and 4.21, respectively. The final release amounts show a 
linear relationship with the charge consumed during both potential 
applications. Zhou et al.37 obtained similar findings for a polymer system 
investigating the release of dimethyldopamine (1H+) from a poly(N-
methylpyrrole)/poly(styrenesulfonate) (PMP+PSS-) film. They attributed these 
results to the fact that the release of the 1H+ was instigated electrochemically by 
the redox process. 
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Figure 4.19: DA release from the polymers potentiostatically grown at 0.900 V vs. SCE 
to various charges in the presence of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD 
where DA was incorporated and released upon application of -0.900 and 0.100 V vs. 
SCE, respectively. 
 
 
Figure 4.20: DA release as a function of the charge consumed during the incorporation 
of DA where polymers were potentiostatically grown at 0.900 V vs. SCE to various 
charges in the presence of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD. DA was 
released upon application of -0.900 V vs. SCE for 30 min. 
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Figure 4.21: DA release as a function of the charge consumed during the release of DA 
where polymers were potentiostatically grown at 0.900 V vs. SCE to various charges in 
the presence of 0.20 mol dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD. DA was released upon 
application of 0.100 V vs. SCE for 60 min. 
 
However, an unusual observation was made with the thicker polymer films; a 
shift in the absorption peak of DA from 280 nm to about 298 nm was identified 
with polymers which were potentiostatically grown to charges ≥ 4.0 C cm-2. 
This peak shift is reported to be due to the presence of the oxidised species of 
DA, as discussed previously in Section 4.3.1.28 
 
To understand this phenomenon several additional experiments were 
performed. The first possibility that was considered, and subsequently ruled 
out, was an interaction between the pyrrole monomer and the DA. During 
polymerisation of thick polymer films some monomer may remain entrapped 
within the matrix which could then potentially come into contact with the 
incorporated DA. Accordingly, a mixture of both the pyrrole monomer and the 
DA dissolved in water, were placed in an electrochemical cell in the UV 
spectrophotometer, and an anodic potential of 0.200 V vs. SCE was applied to 
the system for 10 min. Figure 4.22 shows the UV data obtained. It is clear from 
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these data that there is no shift between the spectra taken before and after the 
application of the anodic potential. 
 
 
 
Figure 4.22: UV data obtained for a mixture of pyrrole and DA obtained ♦ before and 
♦ after an application of an anodic potential of 0.200 V vs. SCE for 10 min. 
 
It was then thought that the solutions contained too much oxygen and so, 
nitrogen gas was bubbled through all solutions; during the growth of the 
PPy/Sβ-CD films as well as the incorporation and release of the DA, (results not 
shown). The absorption peak shift was still evident, and so DA oxidation by 
dissolved oxygen was ruled out. 
 
Consequently, hydrogen evolution was considered. During electrochemical 
reactions at a bare platinum working electrode, hydrogen evolution is evident at 
potentials closely related to the reduction potentials applied during the 
incorporation of the DA. If the rate of hydrogen evolution was high at the 
electrode surface during incorporation of the DA cation, it is possible that a local 
alkaline region may be created at the electrode surface. A local alkaline region in 
contact with the DA during incorporation could subsequently oxidise the DA 
upon uptake. However, Figure 4.23 shows CV data of a bare platinum electrode 
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and a modified PPy/Sβ-CD electrode cycled in 0.10 mol dm-3 DA from -1.000 to 
0.650 V vs. SCE at a scan rate of 50 mV s-1. It is apparent from this figure that the 
hydrogen evolution occurring at the higher reduction potentials is considerably 
suppressed in the presence of the modified polymer. This result also rules out 
the involvement of the hydrogen evolution reaction in this event.  
 
Another reason thought to be causing this event was the oxidation of the DA at 
the counter electrode. In the electrochemical cell the counter electrode (CE) 
allows current to flow through the analyte solution without passing current into 
or out of the reference electrode. Thus IR drop and electrode polarisation are 
eliminated.38 However, if a reaction takes place at the CE, the species produced 
can easily diffuse throughout the electrochemical cell. It has been shown 
previously in Section 4.3.1, that DA oxidises at potentials > 0.200 V. Therefore, if 
the DA was being oxidised at the CE, coupled with the fact that the WE and CE 
are in close proximity to each other, the oxidised DA species may be 
incorporated into the film and consequently released.  
 
 
 
Figure 4.23: CV data recorded in 0.10 mol dm-3 DA in the supporting electrolyte, 0.10 
mol dm-3 Na2SO4, at ♦ bare platinum ♦ PPy/Sβ-CD film. Scan rate was 50 mV s-1. 
Highlighted is the region where hydrogen evolution readily occurs. 
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In general, a common way of eliminating the possibility of contaminating the 
electrochemical cell with the product of the chemical reactions taking place at 
the CE is the introduction of a salt bridge. A salt bridge allows for the flow of 
ions between two solutions while preventing mixing.38 Therefore, a KNO3 salt 
bridge was prepared in U-tubes, as outlined in Section 4.2.2.5.2, where, the CE 
was separated from the electrochemical cell. A schematic of which is illustrated 
in Figure 4.24.  
 
Using this set up the incorporation and release of DA at the thicker PPy/Sβ-CD 
films was investigated. PPy/Sβ-CD films were synthesised at 0.900 V vs. SCE to a 
charge of 10.0 C cm-2, where the DA was incorporated and released as normal 
using the set up shown in Figure 4.24. Figure 4.25 illustrates the absorbance as 
a function of wavelength for the release of DA at 0.100 V vs. SCE for 60 min. 
However, as is evident from Figure 4.25, the DA is still being released in its 
oxidised state. 
 
 
 
 
Figure 4.24: A schematic of the electrochemical set up using the salt bridge. 
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Figure 4.25: Absorbance as a function of wavelength for the release of DA, from a 
PPy/Sβ-CD film synthesised electrochemically onto a platinum wire at 0.900 V vs. SCE 
to 10.0 C cm-2, where the DA was incorporated at -0.900 V vs. SCE and subsequently 
released at 0.100 V vs. SCE for 60 min using the salt bridge set up, shown in Figure 
4.22. 
 
 
The final suggestion for this phenomenon, and the one that appears to fit, is the 
possibility of localised capacitance.  Capacitance, which is a build up of charge, 
can occur in areas where conjugation is not ideal and the current flow is 
suppressed. During the release of DA, from the polymer matrix, an anodic 
potential of 0.100 V vs. SCE is generally applied. A capacitive charge build up, 
due to the application of these potentials, can be present where the DA is bound. 
At a certain point, the capacitance charge can overcome the resistance of the 
conducting medium. This can lead to a build up of a greater amount of potential 
at capacitive regions, than that applied to the polymer system. DA can 
potentially (i) donate two electrons and (ii) act as a conducting medium, due to 
the presence of the protonated amine group. However, instead of acting like a 
normal ion which would carry the current, the DA may get oxidised. This event 
is not seen in thin polymer films because electrolyte ions can penetrate the 
0.0
0.1
0.2
0.3
0.4
0.5
200 280 360 440 520
A
b
so
rb
a
n
ce
Wavelength / nm
Polypyrrole and drug delivery  Chapter 4 
- 152 - 
polymer layer easily and conjugation is not restricted, so a capacitive charge 
build up does not occur.  
 
Although this problem has not been pinpointed, it can be overcome through 
limiting the polymer growth to < 4.0 C cm-2. With this thickness limitation, the 
next step investigated in the optimisation of this drug delivery system was the 
incorporation step of the DA. 
 
4.3.4.1.3 Uptake and release of DA from PPy/Sβ-CD films synthesised in the 
presence of a supporting electrolyte 
As already stated, there has been very little research reported in using Sβ-CD as 
a dopant for the polymerisation of pyrrole. In the experiments reported here, 
the electropolymerisation of pyrrole is carried out in the presence of Sβ-CD 
only. Therefore, it can be confirmed that it is the only anion doping the polymer 
film. Similar to this research, Bidan et al.34 and Reece et al.39 are the only groups 
found that carried out the same type of electropolymerisation in the presence, 
only, of the Sβ-CD anion. However, the other literature surveyed demonstrated 
the electropolymerisation of pyrrole in the presence of Sβ-CD and another 
supporting electrolyte.40 These authors state that the large immobile anion is 
preferentially used to dope the polymer over the small mobile anion. 
Accordingly,  this lead to a number of experiments being performed where the 
polymers were electrochemically deposited in the presence of a mixture of Sβ-
CD and a supporting electrolyte, Na2SO4, and hence investigated for their uptake 
and release of DA. 
 
Figure 4.26 shows the release of DA, from two different PPy films, as a function 
of time. Both polymers were electrochemically deposited at 0.900 V vs. SCE until 
a charge of 1.0 C cm-2 was reached. In the first instance, the polymer was 
polymerised in the presence of Sβ-CD with 0.10 mol dm-3 Na2SO4 supporting 
electrolyte, where as in the second case, the polymer was deposited, as normal, 
without any supporting electrolyte. In both systems the DA was incorporated 
and released as detailed in Section 4.2.2.5.1.  
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Figure 4.26: DA release as a function of time. Polymer films were synthesised in the 
presence of 0.20 mol dm-3 pyrrole and 0.01 Sβ-CD (i) ♦ in 0.10 mol dm-3 Na2SO4 and (ii)   
 in water.  
 
 
It is evident that there is more DA released from the polymer synthesised 
without the Na2SO4 supporting electrolyte. However, in comparison to the 
amount released from a PPy/SO4 polymer film, under the same conditions, there 
is a significant difference. For a PPy/SO4 polymer film the DA released over a 
period of 60 min is ~ 100 nmol cm-2, compared to ~ 1700 nmol cm-2 from the 
combined PPy/SO4, Sβ-CD system. If it were the case that the more mobile anion 
was doping the polymer then ideally similar results should be observed with the 
PPy/SO4 and PPy/SO4, Sβ-CD systems. However, this is not the case as the 
amount of DA released has increased more than 10 fold. This would suggest that 
the large immobile anionic cyclodextrin is indeed preferentially doping the 
polymer film over the smaller anion; there is only a small reduction in the 
amount of DA released when the mixed dopant system is used. 
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4.3.4.2 Influence of varying the incorporation step 
4.3.4.2.1 Influence of varying the incorporation potential 
The influence of the application of the reduction potential applied was 
investigated. We observe, from the EQCM data shown in Chapter 3, Figure 3.18, 
as well as the CV data shown in Figure 4.16, that the redox properties of the 
PPy/Sβ-CD films show a cathodic peak at ~ - 0.5 V. It is at this stage that the 
cations are taken up into the film. Figure 4.27 shows a typical current-time 
transient for the reduction of a PPy/Sβ-CD film in the presence of 0.10 mol dm-3 
DA in a supporting electrolyte of 0.10 mol dm-3 Na2SO4. The current decays over 
the 200 s period, as the polypyrrole film is converted from the oxidised to the 
reduced state. 
 
Figure 4.28 shows the amount of DA released as a function of the potential 
applied during the incorporation step. The PPy/Sβ-CD films were prepared as 
outlined in Section 4.2.2.5.2, where the DA was incorporated at various applied 
reduction potentials and subsequently released upon application of an anodic 
potential of 0.100 V vs. SCE for 60 min.  
 
 
Figure 4.27: Current as a function of time for the reduction of the PPy/Sβ-CD film at      
-0.800 V vs. SCE in the DA solution. 
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Figure 4.28: DA release as a function of the potential applied during the incorporation 
of DA.  Films were grown at 0.900 V vs. SCE to 2.0 C cm-2 in the presence of 0.20 mol 
dm-3 pyrrole and 0.01 mol dm-3 Sβ-CD, where DA was released upon application of 
0.100 V vs. SCE for 60 min. 
 
It is clear from this figure that at potentials more anodic than -0.500 V vs. SCE 
less DA is taken up into the film. It is also evident that there is little difference 
observed when the DA is incorporated at potentials in the range of -0.600 to        
-0.800 V vs. SCE. These findings are in good agreement with the redox 
properties of the PPy/Sβ-CD films, where the polymer is reduced at -0.556 V vs. 
SCE, Figure 4.16. However, at a potential of -0.900 V vs. SCE there is less DA 
released which correlates to less DA incorporated. This may be connected with 
the competing reduction of hydrogen ions at this potential. 
 
Another experiment examined was the possibility of the uptake of DA through 
diffusion, where no potential was applied. The prepared polymers were 
immersed in a 1.0 x 10-3 mol dm-3 DA solution and left standing over night. In 
order to eliminate the possibility of the DA oxidising during this experiment, a 
lower concentration was used, and the solutions were degassed with nitrogen 
gas and left with a blanket of N2 overnight. After the set up was left to stand 
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overnight, the polymer was washed with distilled water and placed in a fresh, 
0.10 mol dm-3 Na2SO4 solution and monitored for release without applying a 
potential for 60 min. After this, an oxidation potential of 0.100 V vs. SCE was 
applied to investigate the release at an applied potential over a 120 min period. 
Figure 4.29 shows the DA concentration, expressed as absorbance, released 
over the total period of 180 min. From this figure the first observation is that DA 
was incorporated, while being immersed in a DA solution over night, without 
the application of a reduction potential. It also shows the DA is released slowly 
without the application of an oxidation potential. And finally, it demonstrates 
that there is a considerable rise, as highlighted on the figure at the 60 min time 
interval, in the amount released upon application of an oxidation potential. 
However, these absorbance values are low and correspond to DA levels of 200 
nmol cm-2. In summary, reduction of the polymer is required for the ingress of 
high amounts of DA and an oxidation potential is essential for the efficient 
release of the DA.  
 
  
 
Figure 4.29: Absorbance at 280 nm as a function of time, where a PPy/Sβ-CD was 
electrodeposited onto the platinum wire at 0.900 V vs. SCE to 1.0 C cm-2. DA was 
incorporated under open-circuit conditions for 12 hrs. DA release ♦ 1st 60 min under 
open-circuit conditions,  a further 180 min at 0.100 V vs. SCE. 
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4.3.4.2.2 Influence of varying incorporating time 
Throughout the incorporation step a reduction potential is applied in order to 
uptake the DA cations into the polymer film. As shown in Figure 4.27, reduction 
of the polymer is not instantaneous, but takes place relatively slowly over time. 
In this section the period of this reduction step, or incorporation step, was 
varied.  PPy films were deposited onto a platinum wire using the Sβ-CD as the 
dopant. The DA was then incorporated upon application of a reduction potential 
of -0.900 V vs. SCE for a varying amount of time. After the incorporation step, 
the polymers were subjected to the release step by applying an oxidation 
potential of 0.100 V vs. SCE for 60 min. Figure 4.30 shows the results obtained, 
the DA release is expressed in nmol cm-2 and is shown as a function of the 
reduction or incorporation period. It is clear from this figure that the amount of 
DA liberated from the polymer films, increases with an increase in the timescale 
for the incorporation step, particularly during the first 30 min. 
 
 
 
 
Figure 4.30: DA release as a function of the DA incorporation period at -0.900 V vs. 
SCE for PPy/Sβ-CD films that were grown at 0.900 V vs. SCE to 3.0 C cm-2, where DA 
was released upon application of 0.100 V vs. SCE for 60 min. 
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4.3.4.2.3 Influence of varying supporting electrolyte concentration 
One issue that might arise during this incorporation step, in the presence of a 
supporting electrolyte, is competition between the cations. In order to 
determine the level of competition between DA and Na+, the supporting 
electrolyte concentration was varied. Polymers were synthesised at 0.900 V vs. 
SCE to 3.0 C cm-2, then reduced in a 0.10 mol dm-3 DA solution in the presence of 
varying concentrations of Na2SO4. The incorporation of DA was achieved at          
-0.900 V vs. SCE for 30 min. Consequently, DA was released from the polymer 
film through an oxidation step, by applying an anodic potential of 0.100 V vs. 
SCE for 60 min. Figure 4.31 shows the amount of DA released as a function of 
the supporting electrolyte concentration. Although a substantial amount of DA 
is released when the DA is incorporated from water, indicating competition at 
low Na+ concentrations, more efficient release is achieved in the presence of 0.1 
mol dm-3 Na2SO4. This can be explained in terms of the more efficient reduction 
of the polymer in the more conducting electrolyte solution. 
 
 
 
Figure 4.31: DA release as a function of the Na2SO4 electrolyte concentration used in 
the DA incorporation step from 0.10 mol dm-3 DA for PPy/Sβ-CD films grown at 0.900 
V vs. SCE to 3.0 C cm-2, where DA was released upon application of 0.100 V vs. SCE for 
60 min. 
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4.3.4.3 Influence of varying the release step 
4.3.4.3.1 Influence of the release potential 
Finally, the release step was examined for its influence on the delivery of DA. As 
discussed earlier in Section 4.3.1, DA oxidises under anodic conditions. Miller et 
al.23 also suggested limiting the applied release, or anodic potential, of PPy films 
for the release of DA to ≤ 0.600 V. To investigate the influence of the release 
potentials applied in this PPy/Sβ-CD system, polymers were prepared 
electrochemically, as outlined in Section 4.2.2.5.3, and the DA was incorporated 
during the reduction of the polymer films at a potential of -0.900 V vs. SCE for 
30 min. Figure 4.32 shows the UV spectra of the DA released after various 
oxidation potentials were applied to the film, in order to release the drug. From 
these data it is apparent that potentials > 0.200 V vs. SCE are not suitable for 
this release system, as there was clear evidence of the oxidation product of DA 
being formed, particularly at 0.300 V vs. SCE. This result is in agreement with 
the results previously shown in Section 4.3.3.3 for the release of DA from the 
PPy/SO4 system. It can be understood that, at these anodic potentials, the DA is 
being oxidised and so the potential must be limited to ≤ 0.100 V vs. SCE to 
achieve release of the pure DA species.  
 
As shown in Figure 4.16, oxidation of the PPy/Sβ-CD films occurs in the vicinity 
of -0.300 V vs. SCE. As this correlates with the release of the cations, the release 
potentials were varied from ≥ -0.300 V vs. SCE to 0.100 V vs. SCE to achieve the 
release of the DA from the PPy/Sβ-CD system. The PPy/Sβ-CD films were 
electrochemically deposited at 0.900 V vs. SCE to 3.0 C cm-2, and then reduced in 
0.10 mol dm-3 DA solution in the presence of 0.10 mol dm-3 Na2SO4 at -0.900 V 
vs. SCE for 30 min. DA was released from the polymer film through the 
application of an oxidation step, which was varied from -0.300 to 0.100 V vs. 
SCE for 60 min. Figure 4.33 shows the amount of DA released as a function of 
the release potential applied. From this figure it can be seen that there is no 
significant change in the amount of DA released upon application of the various 
release potentials. However, there is a gradual increase in the amount released 
as the potential is increased, from -0.100 to 0.100 V vs. SCE. 
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Figure 4.32: UV spectra of DA release from polymers grown to 2.0 C cm-2 from 0.20 
mol dm-3 Py and 0.01 mol dm-3 Sβ-CD at 0.600 V vs. SCE. Release of the DA was achieved 
by applying ♦0.100 ♦0.200 ♦0.300 V vs. SCE for 60 min. 
 
 
Figure 4.33: DA release as a function of the potential applied during release for 
polymers that were grown at 0.900 V vs. SCE to 3.0 C cm-2, DA was incorporated at        
-0.900 V vs. SCE for 30 min in a 0.10 mol dm-3 DA and 0.10 mol dm-3 Na2SO4 solution. 
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4.3.4.3.2 Kinetics of the release process 
Finally, the release of the DA was examined as a function of time. It must be 
pointed out however, that DA is light and air sensitive and so, there were 
limitations to investigating longer time periods. The films were grown at a 
constant potential and DA was incorporated and released as described in 
Section 4.2.2.5.3. The amount of DA released was monitored as a function of 
time where the polymers were subjected to the 0.100 V vs. SCE release 
potential. Figure 4.34 displays the release of DA from a number of polymers as a 
function of time. Evidently from this figure it can be seen that more DA is 
released when polymers are monitored over longer release times. 
 
 
 
 
Figure 4.34: DA release as a function of the release time at 0.100 V vs. SCE. Polymers 
were grown at 0.900 V vs. SCE to 3.0 C cm-2, DA was incorporated at -0.900 V vs. SCE 
for 30 min in a 0.10 mol dm-3 DA and 0.1 mol dm-3 Na2SO4 solution. 
 
 
Figure 4.35 shows the release of DA as a function of time over a period of 120 
min. Monitoring this more closely, it was observed that there was a higher rate 
of release during the early release times, giving a rate of release of 39.53 nmol 
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cm-2 min-1, compared to the lower rate of release at longer release times, 1.63 
nmol cm-2 min-1. 
 
 
 
Figure 4.35: DA release as a function of time at 0.100 V vs. SCE. The polymer was 
grown at 0.900 V vs. SCE to 3.0 C cm-2, DA was incorporated at -0.900 V vs. SCE for 30 
min in a 0.10 mol dm-3 DA and 0.1 mol dm-3 Na2SO4 solution. 
 
4.3.4.3.3 Electrochemical stimulation 
The most attractive feature regarding the use of conducting films for the uptake 
and release of a number of compounds is the manner in which the polymers can 
be stimulated using an applied potential, i.e. electrochemical stimulation. 
Indeed, many groups have investigated the use of electrochemical potentials to 
release different types of anionic and cationic species from various composite 
polymer films.6, 10, 13, 26, 31, 34, 41, 42  
 
As shown in Figure 4.33, DA is released over a wide potential window and in 
order to explore this release in more detail, the release stimulated on the 
application of an oxidation potential was compared to the release observed in 
the absence of electrochemical stimulation. Polymers were grown and DA was 
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incorporated as outlined in Section 4.2.2.5.3. The release of DA was then 
investigated where a potential of 0.100 V vs. SCE was applied and compared to 
the release of DA from the polymer film under open-circuit conditions (OCP). 
Figure 4.36 compares the release of DA with electrochemical stimulation at 
0.100 V vs. SCE and under OCP conditions. It is obvious that the amount of DA 
released, when a potential of 0.100 V vs. SCE is applied, is considerably higher; 
almost 80 % of an increase compared to the data obtained under OCP 
conditions. Also, it is evident that the rate of release during the first 30 min has 
significantly increased with the application of the electrical stimulus. This is due 
to the fact that the polymer film at OCP conditions is in a reduced state after the 
incorporation of the DA at -0.900 V vs. SCE. The film therefore would need some 
chemical or electrochemical oxidant in order to oxidise the film and allow for 
the liberation of the DA. Figure 4.37 is a typical potential-time transient, for the 
measurement of OCP conditions, of a PPy/Sβ-CD film during release of DA. It can 
be seen from this figure that in the time frame, where the DA release is 
monitored, the polymer remains in a reduced state.  
 
 
Figure 4.36: DA release as a function of time for polymers stimulated at  0.100 V vs. 
SCE and ♦ under open-circuit conditions.  Polymers were grown at 0.900 V vs. SCE to 
3.0 C cm-2. DA was incorporated at -0.900 V vs. SCE for 30 min in 0.10 mol dm-3 DA and 
0.10 mol dm-3 Na2SO4 solution.  
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Figure 4.37: OCP conditions monitored over 60 min, of a PPy/Sβ-CD film where 
growth was obtained at 0.900 V vs. SCE to 3.0 C cm-2 and DA was incorporated at           
-0.900 V vs. SCE for 30 min in 0.10 mol dm-3 DA and 0.10 mol dm-3 Na2SO4 solution. 
OCP was monitored in a 0.10 mol dm-3 Na2SO4 solution for 60 min. 
 
 
Zhou and colleagues37 commented on the affect of the OCP conditions during the 
release of dimethlydopamine from PMP/PSS films. They also reported that the 
application of a constant or pulse potential was required, in comparison to OCP.  
 
Many other groups have shown the release of various compounds using 
electrical stimulation. Kontturi et al.31 demonstrated the release of salicylate 
from PPy films, up to 130 nmol cm-2, while Zinger and Miller43 confirmed the 
release of glutamate from PPy films to be ~ 27 nmol cm-2, with respect to a 5 µm 
thick PPy film. Pyo and Reynolds27 showed ATP release from PPy films in the 
region of 65 nmol cm-2 from films 0.5 µm thick. In comparing these amounts 
with some of the results presented here for the PPy/Sβ-CD system, where DA 
levels in the region of 2500 nmol cm-2 were released, it is clear that the PPy/Sβ-
CD system is more superior to the other PPy system reported to date. 
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To the best of our knowledge the only other paper reporting the release of DA, 
using PPy films, was published by Miller and Zhou23 in 1987. They used CV to 
monitor the release of DA and determined the DA released from the PPy films, 
grown galvanostatically to a charge of 0.6 C, to be 110 nmol cm-2. In comparing 
this value to the values obtained where PPy/Sβ-CD films were synthesised to 1.0 
C cm-2 system, this result is 20 times smaller than the typical release of DA, 
shown in these studies. 
 
4.3.5 EQCM 
4.3.5.1 EQCM measurements for the incorporation of DA 
Due to the little knowledge previously reported about these PPy/Sβ-CD films, 
preliminary results show that these films are exceptionally good in taking up 
and releasing cations. Temsamani and co-workers40 show the uptake and 
release of K+ and Na+ ions from PPy/Sβ-CD films synthesised in the presence of 
a supporting electrolyte, (LiClO4). They demonstrated that the uptake of the K+ 
and Na+ ions was achieved during an open-circuit potential, through a slow 
release controlled ion exchange, and also under potential control at a reduction 
potential of -0.500 V. They also reported almost 100 % release of the cations 
upon application of an oxidation potential of 1.400 V. However, as discussed in 
Chapter 3, their application of high oxidation potentials applied during 
electrochemical deposition of the PPy films creates over-oxidation of the 
polymers and therefore, uncertainties over their findings. Despite this, Bidan et 
al.44 who successfully synthesised PPy films in aqueous solutions of Sβ-CD also 
proved the release of a neutral drug, N-methylphenothiazine (NMP) upon 
application of a suitable potential, reinforcing the point made in this chapter 
that the application of appropriate potentials to the PPy/Sβ-CD films 
considerably increases the rate of uptake and release of cations. 
 
EQCM measurements were used to show the uptake and release of DA using 
both PPy/SO4 and PPy/Sβ-CD films. In Chapter 3, Figure 3.19, EQCM data were 
examined during cycling of the PPy/Sβ-CD film in a supporting electrolyte.  A 
Polypyrrole and drug delivery  Chapter 4 
- 166 - 
mass increase was observed for the uptake of sodium cations upon application 
of a reduction potential, reaching a maximum value at -0.600 V vs. SCE. These 
results observed exemplified the region that was to be concentrated on for the 
uptake of the DA cations.  
 
Figure 4.38 shows the EQCM data obtained for the uptake of DA from a 0.10 mol 
dm-3 DA solution on applying -0.900 V vs. SCE to a  PPy/SO4 film. The polymers 
were previously prepared from a 0.20 mol dm-3 Py and 0.10 mol dm-3 Na2SO4 
solution at 0.700 V vs. SCE until a charge of 1.5 x 10-2 C cm2 was passed. It is 
evident from this plot that the simultaneous frequency decrease and mass 
increase is due to the uptake of DA cations into the reduced polymer film in 
order to neutralise the charge.  
 
Figure 4.39 shows similar EQCM data obtained for the uptake of DA from a 0.10 
mol dm-3 DA solution on applying -0.900 V vs. SCE to the PPy/Sβ-CD film. The 
polymers were previously prepared from a 0.20 mol dm-3 Py and 0.01 mol dm-3 
Sβ-CD solution at 0.700 V vs. SCE until a charge of 1.5 x 10-2 C cm-2 was passed. 
Again, there is a clear decrease in the frequency and an increase in the mass due 
to the uptake of DA cations into the reduced polymer film. In comparing both 
figures, Figure 4.35 and 4.36, it shows that the cations are incorporated into the 
PPy/Sβ-CD polymer films at a faster rate than the PPy/SO4 system. 
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Figure 4.38: Frequency(♦) and mass change (♦) as a function of time on reduction of a 
PPy/SO4 film at -0.900 V vs. SCE, the film was prepared from 0.20 mol dm-3 Py and 0.10 
mol dm-3 Na2SO4 at 0.700 V vs. SCE, to 1.5 x 10-2 C cm-2.  
 
 
 
Figure 4.39: Frequency(♦) and mass change (♦) as a function of time on reduction of a 
PPy/ Sβ-CD film at -0.900 V vs. SCE, the film was prepared from 0.20 mol dm-3 Py and 
0.10 mol dm-3 Sβ-CD at 0.700 V vs. SCE, to 1.5 x 10-2 C cm-2.  
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4.3.5.2 EQCM data for the release of DA 
Release of DA was also monitored using the EQCM technique. The mass changes 
attributed to the change in frequency were measured during the application of 
0.100 V vs. SCE to a polymer prepared using Sβ-CD as the dopant, where the DA 
was incorporated at a potential of -0.900 V vs. SCE. Figure 4.40 shows the 
frequency and corresponding mass changes for the release of DA as a function of 
time from a PPy/Sβ-CD film previously prepared and consequently loaded with 
the DA cations.  The mass decreases rapidly during the first 20 s and then 
reaches a near constant mass after about 100 s. This is consistent with the loss 
of DA from the film. 
 
 
 
Figure 4.40: Frequency(♦) and mass change (♦) as a function of time obtained on the 
application of 0.100 V vs. SCE to the PPy/Sβ-CD film loaded with DA. Film was 
prepared from a 0.20 mol dm-3 Py and 0.01 mol dm-3 Sβ-CD aqueous solution at 0.700 V 
vs. SCE until a charge of 3.6 x 10-2 C cm-2 was passed.  
 
The EQCM measurements were also utilised to quantify the amount of DA 
released from these thin polymer films. Figure 4.41 shows the mass changes 
measured when a PPy/Sβ-CD film was firstly polarised to promote the intake of 
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DA and then subsequently polarised to release DA. The comparison between the 
uptake and release is illustrated in this figure. These data were recorded for a 
thin polymer film, where the incorporation and the release were attained over a 
period of 100 s. In examining the data, where the polymers were prepared as 
outlined in Section 4.2.2.6, the uptake and release was monitored for either 100 
(shown in Figure 4.41) or 600 s. The % amount of DA released over 100 s for 
polymers grown to a charge of 1.5 x 10-2 and 3.6 x 10-2 C, was on average     
10.97 % and 17.57 %, respectively, of the initial amount incorporated. However, 
relating these thin polymers to the larger polymers used in the bulk system is 
not straightforward, as the thinner polymers are more compact and less porous 
and this could affect the % of DA released.  
 
 
 
 
Figure 4.41: Mass change as a function of time for the uptake(♦) and release (♦) of DA, 
obtained for a PPy/Sβ-CD film prepared from a 0.20 mol dm-3 Py and 0.01 mol  dm-3 Sβ-
CD aqueous solution at 0.700 V vs. SCE until a charge of 3.6 x 10-2 C cm-2 was passed. 
Constant potentials of -0.900 V vs. SCE and 0.100 V vs. SCE were applied to 
incorporate and release the DA, respectively.  
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The switching of the polymer between its reduced and oxidised state during the 
uptake and release of DA was also examined using EQCM. Figure 4.42 shows the 
frequency data as a function of time recorded for the first 1200 s at a polymer 
prepared at 0.700 V vs. SCE in the presence of 0.01 mol dm-3 Sβ-CD and 0.20 mol 
dm-3 pyrrole which was subsequently, immersed in a 0.10 mol dm-3 DA aqueous 
solution and switched from -0.900 to 0.100 V vs. SCE every 100 s. The first 100 s 
period corresponds to the intake of DA, while the second 100 s period gives the 
release of DA. On application of the release potential, there is a clear gradual 
increase in the frequency, corresponding to a gradual decrease in mass and loss 
of the DA. This is seen with all the release steps.   
 
The mass changes involved during the oxidation processes were also recorded 
as a function of time and are shown in Figure 4.43. It is clear that the overall 
mass of the polymer increases with time. From the inset, the difference between 
the start and finish of each 100 s, oxidative process, was plotted as a function of 
time and it can be seen that the mass decreases slightly over time as the DA was 
released. This is due to the observation made earlier; that only ~ 11 % of the DA 
was released during the subsequent oxidation step. Therefore, throughout this 
experiment, stepping the potential from one state to the next results in an 
overall mass increase as only ~ 11 % of the DA originally incorporated is 
released. 
 
Hepel and Mahdavi25 also carried out similar experiments to examine the 
uptake and release of chlorpromazine (CPZ) from a PPy/melanin composite 
films. They also observed an overall increase in the mass of the polymer and 
verified faster uptake than release of the drug, stepping the potential from           
-0.800 to 0.200 V vs. SCE every 2 min. 
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Figure 4.42: Frequency change as a function of time recorded upon pulsed potential 
steps from -0.900 V vs. SCE to 0.100 V vs. SCE in a solution of 0.10 mol dm-3 DA, in a 
supporting 0.10 mol dm-3 Na2SO4 electrolyte solution, at a PPy/Sβ-CD film 
electrodeposited onto an EQCM gold electrode.  
 
 
Figure 4.43: Mass changes as a function of time recorded upon pulsed potential steps 
from -0.900 V vs. SCE to 0.100 V vs. SCE in a solution of 0.10 mol dm-3 DA solution in a 
supporting 0.10 mol dm-3 Na2SO4 electrolyte solution, at a PPy/Sβ-CD film 
electrodeposited onto an EQCM gold electrode.  
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4.3.6 Comparing PPy/SO4 to PPy/Sβ-CD  
In comparing the PPy/SO4 and PPy/Sβ-CD films for the uptake and release of 
DA, it can be concluded that there is a considerable difference between both 
systems. Clearly, the PPy/Sβ-CD films are capable of binding more DA and are 
more efficient in the release of DA, giving better release profiles. These results 
can only be attributed to the presence of the Sβ-CD anion, which is immobile 
and permanently incorporated within the polypyrrole backbone. However, as 
shown in Figure 4.14, other large dopants, such as PTS, are considerably poorer 
than the Sβ-CD system in the uptake and release of DA.  The cyclodextrin family 
is well known to form inclusion complexes and this unique property of the Sβ-
CD dopant may be a factor in the significant increase in the uptake and 
subsequent release of DA. An investigation into the complexation of DA was 
therefore performed using a variety of techniques. These results are presented 
and discussed in Chapter 5. 
 
4.4 Summary of results 
The use of the electroactive PPy film for the binding and delivery of the DA 
cations was investigated in this chapter. Varying the dopant anion upon 
polymerisation of the pyrrole monomer and subsequently using these 
composite films for the uptake and release of DA lead to some interesting 
results. The DA was successfully released from all the polymer systems.  
However, DA release profiles obtained for the PPy/Sβ-CD system were 
considerably higher than the release obtained from the other polymer systems.  
 
It was confirmed that the application of anodic potentials higher than 0.100 V 
vs. SCE, to the electrochemical system, resulted in the oxidation of DA. It was 
also observed that polymers synthesised to a charge ≥ 4.0 C cm-2 resulted in the 
oxidation of the DA. Many reasons were suggested, the majority of which were 
ruled out. However, this unusual effect could be eliminated by synthesising 
thinner polymer films. It was also shown that the application of an appropriate 
potential to release the drug is an important parameter, with both the rate of 
release and the amount released increasing with higher release potentials. In 
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comparison to the release of DA under applied potentials, OCP showed a slow 
release with very little DA liberated, as the polymer does not reach its oxidising 
potentials over the time monitored. 
 
The results obtained for the PPy/Sβ-CD system were intriguing and so lead to an 
investigation into why this large anion might possibly increase the release of DA 
in comparison to a polymer doped with other anions. A common characteristic 
of the cyclodextrin family is the fact that they can form inclusion complexes in 
solution with a variety of organic and inorganic compounds. In the following 
chapter, Chapter 5, an exhaustive investigation into the inclusion properties of 
Sβ-CD in the presence of DA will be examined. This inclusion complexation 
between the cyclodextrin and DA could be a potential benefit in the delivery of 
DA, giving a distinct increase in the uptake and release, in comparison to other 
anionic dopants.  
 
The world of Nanotechnology is also coming alive at present and the idea of 
increasing the surface area of polymer films in order to increase the amount of 
drug incorporated and released is a promising field for these biomedical 
applications. With this said an investigation into increasing the surface area of 
the PPy/Sβ-CD polymer films and subsequent uptake and release properties of 
these polymers was carried out. These results are described in Chapter 6. 
 
Although these polymer composite films were only shown here to deliver DA, 
this can be regarded as a model cationic species, and so this model system leads 
the way for various other biomolecules and drugs to be delivered in this fashion.  
The ability to control the release through electrical stimulation provides more 
flexibility than other release systems that rely on polymer degradation for 
delivery.  
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5.1 Introduction 
From the results obtained in Chapter 4 it was interesting to note that the release 
of dopamine (DA) increased significantly when sulfonated β-cyclodextrin (Sβ-
CD) was used as the dopant for the polymer system. As described in Chapter 1, 
cyclodextrin (CD) molecules are commonly known as ‘hosts’. The presence of an 
internal cavity allows guest molecules, which can be inorganic, organic or ionic, 
to enter the cavity and form non-covalent host-guest inclusion complexes.1 It is 
this key property that we investigate in this chapter, with the view to 
establishing the reasons why the polymer doped with the sulfonated β-CD gives 
the best release profile for DA. 
 
The effects of cyclodextrin encapsulation on the electrochemical and chemical 
properties of guest molecules have been widely investigated, as discussed in 
Chapter 1.2-7 When forming inclusion complexes the host and guest redox 
properties can change, and this allows us to study the host-guest interactions 
spectroscopically and electrochemically. Inclusion complexation depends on 
many factors, including the size of the CD cavity. As described in Chapter 1, α, β, 
and γ CD cavities have different diameters and, therefore, the size of the guest 
molecule is equally important.8  
 
In this chapter, results are presented and discussed on the inclusion of a DA 
guest molecule within sulfonated β-cyclodextrin host in aqueous solution. The 
complexation was investigated using UV, CV, RDV and 1H NMR. The binding 
stoichiometry was determined by a continuous variation method or Job’s 
method using CV, UV and 1H NMR and these methods were also used to evaluate 
the stability constant, Kf, of the DA-Sβ-CD complex. 
 
The inclusion of DA with a neutral β-cyclodextrin has been reported by Zhou et 
al.4 with a stability constant, Kf, of 95.06. However, to the best of our knowledge 
there are no published data on the interaction of DA and Sβ-CD and their host-
guest complexation. In this chapter reports are made on the interactions of DA 
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with Sβ-CD, along with some of the factors that influence the complexation, 
including a comparison of the inclusion abilities of sulfonated α-cyclodextrin 
(Sα-CD). In addition, a study on the factors that influence complexation 
including cavity size, pH and supporting electrolyte was carried out. 
 
5.2  Experimental 
5.2.1 Materials 
5.2.1.1 Reagents 
Dopamine hydrochloric salt, sulfonated β-cyclodextrin, sodium salt and 
sulfonated α-cyclodextrin sodium salt were purchased from Sigma, and D2O     
(> 99.92 % isotopic purity) was purchased from Apollo Scientific. All other 
reagents were of analytical grade either from Sigma-Aldrich or Riedel de–Haen 
and were used as received. Distilled water was used throughout the study.  In 
the majority of electrochemical and spectroscopy experiments, a citrate-
phosphate buffer was utilised for pH ranges 3-6. In the case of pH~1, 0.1 mol 
dm-3 H2SO4 was used. In the NMR titrations and Job’s measurements, 0.1 mol  
dm-3 KCl was used to buffer the ionic strength, since the Sβ-CD is highly charged. 
 
5.2.1.2 Electrodes and Instruments 
CV and RDV measurements were carried out using a Solartron Model SI 1285 
potentiostat. All measurements were made at room temperature. Gold, platinum 
and glassy carbon (GC) flat disc electrodes were prepared, as detailed in Section 
2.2.3, and used to investigate the electrochemical studies of the complexation. 
Details on the instruments used in the UV and 1H-NMR studies are provided in 
Section 2.5.2 and 2.5.6, respectively. 
 
5.2.1.3 Buffer solutions 
A citrate-phosphate buffer was used in all measurements, except for the studies 
at pH values of 1.0. Table 5.1 shows the volumes used to obtain the required pH 
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for the citrate-phosphate buffers in 100 mL volumes. In the case of the acidic 
electrolytes, at pH values close to 1.0, a 0.1 mol dm-3 H2SO4 solution was used. 
 
Table 5.1: Volumes of stock solution required to obtain pH values for 100 mL of the 
citrate-phosphate buffers. 
 
Desired 
pH 
H2SO4 / 0.1 mol dm-3 
(mL) 
Na2HPO4 / 0.2 mol dm-3 
(mL) 
C6H8O7 / 0.1 mol dm-3 
(mL) 
1 100 - - 
3 - 20.5 79.5 
4 - 37.0 63.0 
5 - 49.3 50.7 
6 - 62.1 37.9 
 
5.2.2 Procedures 
5.2.2.1 Determination of the stoichiometry of Sβ-CD and DA 
The stoichiometry of the Sβ-CD and DA complex was determined by using the 
well known Job’s plot or continuous variation method.9 This method was 
employed for both UV and CV techniques. For the UV data two stock solutions of 
1.0 x 10-4 mol dm-3 DA and 1.0 x 10-4 mol dm-3 Sβ-CD in water were prepared. A 
series of solutions were prepared in which the sum of the number of moles, of 
DA and Sβ-CD, was kept constant, but the relative amount of the two was 
systematically varied, according to Table 5.2. The UV absorption spectrum of 
each solution was obtained, using distilled water as a reference. For the CV data, 
two stock solutions of 1.0 x 10-2 mol dm-3 DA and 1.0 x 10-2 mol dm-3 Sβ-CD in 
citrate-phosphate buffer at pH 5.0 were prepared. Different volumes of the two 
stock solutions were combined, keeping the final volume constant at 10.0 mL, 
shown in Table 5.3. For the CV studies, a GC electrode was used as the working 
electrode, while a SCE and a platinum wire served as the reference and the 
counter electrodes, respectively. The CVs were recorded in the -0.250 to 0.800 V 
vs. SCE interval by applying a potential scan rate of 50 mV s-1. 
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Table 5.2: The solution composition for the UV Job’s plot measurements (total volume 
is 3.0 mL). 
 
Solution 1 x 10-4 mol dm-3 Sβ-CD 
(mL) 
1 x 10-4 mol dm-3 DA 
(mL) 
[DA]/([DA]+[Sβ-CD]) 
Mole fraction 
1 3.0 0.0 0.0 
2 2.7 0.3 0.1 
3 2.4 0.6 0.2 
4 2.1 0.9 0.3 
5 1.8 1.2 0.4 
6 1.5 1.5 0.5 
7 1.2 1.8 0.6 
8 0.9 2.1 0.7 
9 0.6 2.4 0.8 
10 0.3 2.7 0.9 
11 0.0 3.0 1.0 
 
Table 5.3.The solution composition for the CV Job’s plot measurements (total volume 
is 10.0 mL). 
 
Solution 1 x 10-2 mol dm-3 Sβ-CD 
(mL) 
1 x 10-2 mol dm-3 DA 
(mL) 
[DA]/([DA]+[Sβ-CD]) 
Mole fraction 
1 10.0 0.0 0.0 
2 9.0 1.0 0.1 
3 8.0 2.0 0.2 
4 7.0 3.0 0.3 
5 6.0 4.0 0.4 
6 5.0 5.0 0.5 
7 4.0 6.0 0.6 
8 3.0 7.0 0.7 
9 2.0 8.0 0.8 
10 1.0 9.0 0.9 
11 0.0 10.0 1.0 
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5.2.2.2 Determination of the stability constant of Sβ-CD and DA 
Both spectroscopic and electrochemical methods were used to determine the 
stability constant of the DA-Sβ-CD complex. For the UV method the DA guest 
was kept at a constant concentration of 5.00 x 10-4 mol dm-3 in a citrate-
phosphate buffer (pH of 6.0), while the concentration of the Sβ-CD host was 
varied over the range of 5.65 x 10-4 to 2.00 x 10-2 mol dm-3. The UV absorption 
spectrum of each sample was obtained and the data were analysed at 280 nm 
(λmax of DA). The Sβ-CD does absorb slightly at 280 nm. Accordingly, all 
measurements made at 280 nm, to follow the DA inclusion events were 
corrected by subtracting the corresponding Sβ-CD solution absorbance at 280 
nm. The Kf value was determined for the complex based on the absorbance 
changes of the different DA/Sβ-CD mixtures.  
 
For the CV method the DA guest was kept at a constant concentration of 5.00 x 
10-4 mol dm-3 in a citrate-phosphate buffer (pH of 6.0), while the concentration 
of the Sβ-CD host was varied over the range of 3.12 x 10-4 to 2.00 x 10-2 mol   
dm-3. The cyclic voltammograms were recorded using a GC working electrode in 
the potential range of -0.500 to 0.800 V vs. SCE at a potential scan rate of 50 mV 
s-1. CVs were also recorded where the scan rate was varied between 50, 100, 
150, 200, 300, 400 and 500 mV s-1.  
 
RDV data were recorded using the same electrochemical set-up as CV, except a 
GC rotating disc electrode was used. For the RDV method, the DA guest was kept 
at a constant concentration of 5.00 x 10-4 mol dm-3 in a citrate-phosphate buffer 
(pH of 6.0), while the concentration of the Sβ-CD host was varied over the range 
of 6.25 x 10-4 to 2.00 x 10-2 mol dm-3. The rotations were varied from 50 to 700 
rpm.  
 
5.2.2.3 NMR analysis 
To obtain a stoichiometric value for the complex, the Job’s method was applied 
to chemical shift data collected by NMR. The mole fraction of DA was varied 
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from 0.0 to 1.0 in increments of 0.1. Each DA/Sβ-CD solution was prepared from 
a 1.0 x 10-2 mol dm-3 DA or Sβ-CD stock solution in the presence of 0.1 mol dm-3 
KCl/D20 in order to maintain a constant pH and ionic strength. The volume of 
each stock solution used to give the required mole fraction values are shown in 
Table 5.4.  
 
Verification of the formation of an inclusion complex was achieved by adding 
varying amounts of Sβ-CD to 0.5 mL volumes of a 5.00 x 10-4 mol dm-3 DA stock 
solution made up in 0.1 mol dm-3 KCl/D20, such that samples with final Sβ-CD 
concentrations ranging from 1.00 x 10-4 to 2.50 x 10-3 mol dm-3 were produced. 
The samples were allowed to equilibrate for 60 min before acquiring their 1H 
NMR spectrum. Due to the complexity of the Sβ-CD spectra the aromatic 
spectral region of the DA was used to monitor chemical shift variations. The Kf 
value for host-guest complexation was determined using a non-linear curve 
fitting programme. Finally, this information was used to analyse and obtain 
information on the geometry of the complex.  
 
 
Table 5.4: The volumes of stock solutions used for the NMR Job’s plot measurements. 
Total volume is 0.5 mL in 0.1 mol dm-3 KCl /D20.  
 
Solution 1 x 10-2 mol dm-3 Sβ-
CD (mL) 
1 x 10-2 mol dm-3 
DA (mL) 
[DA]/([DA]+[Sβ-CD]) 
1 0.50 0.00 0.0 
2 0.45 0.05 0.1 
3 0.40 0.10 0.2 
4 0.35 0.15 0.3 
5 0.30 0.20 0.4 
6 0.25 0.25 0.5 
7 0.20 0.30 0.6 
8 0.15 0.35 0.7 
9 0.10 0.40 0.8 
10 0.05 0.45 0.9 
11 0.00 0.50 1.0 
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5.2.2.4 Varying the pH 
The binding constants between DA and Sβ-CD were determined as a function of 
pH. Firstly, acid-base titrations were employed in order to investigate if the 
change in pH affected the ionisation of the sulfonated groups on the Sβ-CD. 
Stock solutions of 0.02 mol dm-3 NaOH in the absence and presence of 5.00 x   
10-3 mol dm-3 Sβ-CD were prepared and the pH was varied by adding a dilute 
solution of H2SO4. The conductivity and pH were recorded simultaneously using 
a Jenway 4510 conductivity meter and an Orion model 720A pH meter, 
respectively. 
 
In the pH studies, citrate-phosphate buffers were used to achieve pH values 
between 3.0 and 6.0, while 0.1 mol dm-3 H2SO4 was used to further reduce the 
pH value to 1.4. The DA concentrations were held constant at 5.00 x 10-4 mol 
dm-3 and the absorption spectra of DA (λmax =280 nm) in the absence and 
presence of Sβ-CD concentrations, which were varied in the range of 5.65 x 10-4 
to 2.00 x 10-2 mol dm-3, were recorded. Accordingly, all measurements made at 
280 nm, to follow the DA absorption, were corrected by subtracting the 
corresponding Sβ-CD solution absorbance at 280 nm.  
 
CV experiments were also performed at pH values of 1.36, 3.20, 4.01, 5.01 and 
6.06. Again, the solutions were prepared using a citrate-phosphate buffer for pH 
values in the region of 3.20 to 6.06, while H2SO4 was used for solutions of pH 
1.36. Data were obtained for DA, 5.00 x 10-4 mol dm-3, in the absence and 
presence of varying concentrations of Sβ-CD, ranging from 2.00 x 10-2 to 3.12 x 
10-4 mol dm-3 for each pH. The CVs were recorded as detailed in Section 5.2.2.1.  
 
5.2.2.5 Varying the electrolyte 
Supporting electrolytes sodium chloride, calcium chloride, ammonium chloride, 
potassium chloride, sodium sulfate, sodium citrate and disodium hydrogen 
phosphate were obtained from Aldrich and used without further purification. 
0.2 mol dm-3 stock solutions of the various electrolytes were prepared (Table 
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5.5). HCl, H2SO4, NaH2PO4 and [C(OH)(CH2CO2)2(CO2)] were used to adjust the 
pH to ~ 5.  CV data were first obtained for a 5.00 x 10-4 mol dm-3 DA solution in 
the presence of the electrolyte and subsequently for a 5.00 x 10-4 mol dm-3 
DA/2.00 x 10-2 mol dm-3 Sβ-CD solution. The CVs were recorded using the 
procedure outlined in Section 5.2.2.1. 
 
 
Table 5.5: Electrolytes used to investigate the presence of a supporting electrolyte in 
Sβ-CD complexation. 
 
 
Electrolyte / 0.2 mol dm-3 
 
pH 
 
NaCl 5.09 
KCl 4.99 
CaCl2 4.93 
NH4Cl 5.10 
Na2SO4 4.96 
Na2HPO4 4.98 
[C(OH)(CH2CO2)2(CO2)] 5.03 
 
 
5.2.2.6 Varying the size of the cavity  
The Sα-CD was obtained from Aldrich and used without further purification. DA 
was kept at a constant concentration of 5.00 x 10-4 mol dm-3 in a citrate-
phosphate buffer (pH of 5.0), while the Sα-CD was maintained in excess. The Sα-
CD concentrations which were prepared in a citrate-phosphate buffer, were 
varied from 2.00 x 10-2 mol dm-3 to 3.12 x 10-4 mol dm-3. CV measurements were 
employed as detailed in Section 5.2.2.1.  
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5.2.2.7 Complexation studies of levodopa and tyrosine with Sβ-CD 
The stoichiometry of the complexes formed between levodopa (L-dopa) and Sβ-
CD and between tyrosine (Tyr) and Sβ-CD were determined by applying the 
Job’s method to UV absorption spectra of mixtures of Sβ-CD and either L-dopa 
or Tyr. Two stock solutions of 1.0 x 10-4 mol dm-3 for L-dopa and Tyr were 
prepared in 0.1 mol dm-3 H2SO4 and 1.0 x 10-4 mol dm-3 Sβ-CD. A series of 
solutions was prepared, in which the sums of the number of moles of L-dopa or 
Tyr and Sβ-CD were kept constant, but the relative amount of either guest 
molecule was systematically varied, as given in Table 5.2 for DA.  In each case, 
0.1 mol dm-3 H2SO4 was used as a reference. 
 
The stability constant for the L-dopa and Sβ-CD complexation was determined 
using UV-visible spectroscopy. L-dopa was kept at a constant concentration of 
5.00 x 10-4 mol dm-3 in a citrate-phosphate buffer (pH of 2.3), while the Sβ-CD 
was maintained in excess and varied from 2.00 x 10-2 mol dm-3 to 1.25 x 10-3 
mol dm-3. Absorption spectra of all samples were obtained and the data were 
analysed at 280 nm (λmax of L-dopa). The contribution of Sβ-CD at 280 nm was 
eliminated by the use of an Sβ-CD concentration calibration curve generated at 
280 nm. 
 
CV was used to determine Tyr-Sβ-CD complexation at pH values of 2.44 and 
12.1. Experiments were carried out at these pH values in order to eliminate the 
presence of Tyr zwitterions.  CV was employed as detailed in Section 5.2.2.1. 
 
5.2.3 Evaluation of the stability constants 
The theory behind each of the equations presented below is described in 
Chapter 2. The assumptions and values for each parameter are also shown in 
Chapter 2. Here, a short synopsis of the equations used to evaluate the stability 
constant for each of the techniques studied is provided. The Kf value for the 
inclusion complex was calculated from the absorption spectra data using the 
modified Heildebrand Benesi, Equation 5.1.7, 10, 11 
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The Kf  value for the inclusion complex was calculated from the CV data using  
Equation 5.2,10, 12, 13, while the RDV data were analysed using Equation 5.3. The 
Levich equation, Equation 5.4, was used to determine Dc and Df: 
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The Koutecky-Levich equation was applied to evaluate the apparent rate 
constant, kDA, for the oxidation of DA in the presence and absence of Sβ-CD: 
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where iK is given by the expression in Equation 5.6. 
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The NMR spectra were analysed using Equation 5.7. The Kf value was evaluated 
from a non-linear analysis using the relationships in Equation 5.714 
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5.3  Results and Discussion 
5.3.1 Determination of the stoichiometry of Sβ-CD and DA 
5.3.1.1 UV data 
The UV spectra of 1.0 x 10-4 mol dm-3 solutions of DA and Sβ-CD are overlaid in 
Figure 5.1. The band centred at approximately 280 nm results from the 
absorption of DA, while that centred at approximately 256 nm is from Sβ-CD. 
Figure 5.1 reveals an approximate 4 times greater extinction coefficient for DA 
compared to Sβ-CD. Although Sβ-CD exhibits a minimal absorption at 280 nm, 
spectral intensity at 280 nm from a DA/ Sβ-CD mixture would be expected to 
result overwhelmingly from DA absorption. In the interest of accuracy, however, 
all measurements made at 280 nm for DA/ Sβ-CD solutions were corrected by 
subtracting the corresponding absorption resulting from Sβ-CD. 
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Figure 5.1: UV spectra of ♦1.0  x  10-4 mol dm-3 DA, λmax = 280 nm and ♦ 1.0 x 10-4 mol 
dm-3 Sβ-CD, λmax = 256 nm. 
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Absorption spectra of DA/Sβ-CD of varying mole fractions are overlaid in Figure 
5.2, whereby the DA band intensity increases with increasing DA mole fraction. 
For example, the absorbance at 280 nm was 0.04 for a DA mole fraction of 0.1, 
while the absorbance increased to 0.19 when the mole fraction of DA was 0.7. 
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Figure 5.2: UV spectra for the Job’s plot titration curve with Sβ-CD and DA. From low to 
high absorbance values, the value of [DA]/([DA]+[ Sβ-CD]) increases from 0.0 to 1.0, in 
increments of 0.1. 
 
 
For the UV analysis the Job’s plot was generated from the change of the 
absorbance at a wavelength of 280 nm relative to that of an equal concentration 
of free DA using the equation: 
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where A0 and A are the absorbance values for DA in the absence and presence of 
Sβ-CD, respectively. These ∆A values were then multiplied by the corresponding 
mole fraction and the product was plotted as a function of the DA mole fraction. 
Figure 5.3 shows the Job’s plot of the UV absorbance change at 280 nm of the 
complex when varying the DA mole fraction of the DA/Sβ-CD solutions. The 
maximum absorbance value was achieved at the 0.5 mole fraction and this is 
evidence that there exists a 1:1 DA:Sβ-CD complex stoichiometry. 
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Figure 5.3: Job’s plot curve of UV absorbance change (280 nm) of DA upon the addition 
of Sβ-CD, indicating the formation of 1:1 host-guest complex. 
 
5.3.1.2 CV data 
Cyclic voltammetry is a technique commonly employed to investigate the 
interactions between the host and guest molecules or ions; as long as either the 
host or guest is electroactive.15, 16 DA is electroactive and its electrochemical 
behaviour has been previously investigated.17, 18 There is much debate over the 
exact steps in the electrochemical oxidation of DA. Wen et al.18 suggest it to be 
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an ECC process, where two consecutive one electron transfer reactions occur, as 
shown in Scheme 5.1. The successive two electron transfer from protonated DA 
1 generates the DA ortho-quinone 2. However, Chen and co-workers17 state that 
it is a direct two-electron transfer process of DA to DA ortho-quinone. For the 
purpose of these CV experiments, DA (pKa = 8.92)19 was taken to exhibit a quasi 
reversible two electron redox process.  
 
 
 
 
 
Scheme 5.1: Oxidation reaction of DA. 
 
 
Figure 5.4 shows cyclic voltammograms of 1.0 x 10-2 mol dm-3 Sβ-CD (A) and 1.0 
x 10-4 mol dm-3 DA (B) at each electrode surface. The GC flat disc electrode was 
chosen for the electrochemical studies of the complexation analysis; not only 
did it show no electroactivity in the presence of 1.0 x 10-2 mol dm-3 Sβ-CD in 
citrate-phosphate buffer, as shown in Figure 5.4(A), but it also gave the best 
defined peak for the oxidation of a 1.0 x 10-4 mol dm-3 DA solution, as evident 
from Figure 5.4(B).  
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Figure 5.4: The cyclic voltammograms recorded in a citrate-phosphate buffer (pH = 
3.17) at various electrode surfaces;     GC    gold and   platinum.  The potential was 
swept from -0.250 to 0.700 V vs. SCE at 50 mV s-1. A) Data recorded in 1.0 x 10-2 mol 
dm-3 Sβ-CD and B) data recorded in 1.0 x 10-4 mol dm-3 DA. 
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The electrochemical properties of DA solution of 5.0 x 10-4 mol dm-3 in aqueous 
citrate-phosphate buffer solutions (pH of 5.0) are shown in Figure 5.5. This 
typical voltammogram in the potential range of -0.250 to 0.800 V vs. SCE, at a GC 
electrode shows a well defined pair of redox peaks for DA. An anodic peak, Epa, 
appears at 0.323 V vs. SCE, which corresponds to the oxidation of the 
protonated DA to the ortho-quinone. Upon reversal of the potential, a cathodic 
peak, Epc, at 0.193 V vs. SCE is observed and is associated with the reduction of 
ortho-quinone back to DA.  
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Figure 5.5: Cyclic voltammogram of DA (5.0 x 10−4 mol dm-3) on GC in citrate 
phosphate buffer pH=5.0. Scan rate 50 mV s-1. 
 
 
Figure 5.6 shows cyclic voltammograms of DA at different potential scan rates, 
(v). The peak currents for both the anodic and cathodic reactions are directly 
proportional to the scan rate and vary linearly with the square root of scan rate, 
as seen in Figure 5.7 which plots the peak current, ip, as a function of the square 
root of the scan rate, v1/2. R2 values of 0.999 and 0.995 for the anodic and 
Complexation studies  Chapter 5 
 
- 193 - 
 
cathodic peak currents, respectively, were achieved. Figure 5.7 shows that the 
reaction is diffusion-controlled. Consequently, an electrochemical approach is 
ideal for probing the complexation between DA and the Sβ-CD. Furthermore, the 
Sβ-CD is not electroactive and only the electrochemistry of the DA is observed in 
this electrochemical approach. Bersier et al.20 stated that in these voltammetric 
methods the transport of the electroactive species should be diffusion 
controlled. With this confirmed, the electrochemical approach was used to study 
the complexation of DA with the Sβ-CD. 
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Figure 5.6: Cyclic voltammograms of DA (5.0 x 10−4 mol dm-3) on GC in citrate 
phosphate buffer pH=5.0. Scan rate ν/mV s−1: (1) 50; (2) 100; (3) 150; (4) 200; (5) 300. 
Currents vary in the order (1) < (2) < (3) < (4) < (5). 
 
Figure 5.8 shows the cyclic voltammograms of DA in the presence of Sβ-CD.  From 
Figure 5.8 it can be seen that the peak current increases with increasing DA 
mole fraction. For example, the peak current for 0.1 mole fraction was            
1.11 x 10-4 A cm-2, in comparison to 1.29 x 10-3 A cm-2 for the mole fraction value 
of 1.0. 
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Figure 5.7: The plot of ip versus ν1/2 of DA (5.0 x 10−4 mol dm-3) on GC in citrate 
phosphate buffer pH=5.0.  
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Figure 5.8: Cyclic voltammograms used to construct the Job’s plot titration curve of Sβ-
CD and DA in a citrate-phosphate buffer, pH = 5.0.  From bottom to top, the DA mole 
fraction increases from 0.0 to 1.0, in increments of 0.1.  
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To generate the Job’s plot from the CV analysis the continuous variation method 
was used to follow the changes in the peak current of DA using the equation  
 
C#    #    #E 
          
where ip0 and ipx are the peak currents of DA in the absence and presence of Sβ-
CD, respectively. These ∆ip values were then multiplied by the corresponding 
mole fraction (∆ip x mole fraction) and the product was plotted as a function of 
the mole fraction ([DA]/([DA]+[Sβ-CD])). 
 
Figure 5.9 shows a Job’s plot generated from the data presented in Figure 5.8. 
The Job’s plot reaches a maximum value at 0.50 mole fraction, confirming the 
formation of a 1:1 DA/Sβ-CD complex.  This is in excellent agreement with the 
spectroscopy measurements, Figure 5.3. 
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Figure 5.9: Job’s plot curve of a change in peak current of DA upon the addition of      
Sβ-CD, as a function of the mole fraction of DA, indicating the formation of 1:1 host-
guest complex.  
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5.3.2 DA-Sβ-CD complex stability constant 
5.3.2.1 Determination of Kf by UV 
The absorption spectra of DA (λmax =280 nm) in the absence and presence of 
varying concentrations of Sβ-CD are overlaid in Figure 5.10. From Figure 5.10 it 
can be seen that increasing the concentrations of Sβ-CD gives rise to an overall 
decrease in band intensity at 280 nm, or a hypochromic effect. This 
hypochromic effect is shown in Figure 5.11, which plots the absorbance value 
against the concentration of Sβ-CD present in the sample solution. Additional to 
this hypochromic effect, a shift in the wavelengths of the absorption bands was 
observed. This red shift of the DA spectral band to longer wavelengths, or 
bathochromic effect, has been reported previously and is due to an influence of 
substitution or to a change in environment. 21, 22 In our case there is a change in 
the environment due to complex formation, giving rise to the observed red shift.  
Both hypochromic and bathochromic effects were clearly present in all DA-Sβ-CD 
complex UV spectra as greater amounts of Sβ-CD were added. Similar 
bathochromic effects to that seen here were reported  by  Taraszewska et al.23 for 
flutamide and Zhang and co-workers for cresyl blue in the complexation studies 
with β-cyclodextrin.22 Ramaraj and co-workers also reported an overall increase 
in the intensity of the absorption band for the inclusion studies of various 
aromatic amines and nitro-compounds with β-cyclodextrin.24 The changes in 
the absorption spectrum of DA upon addition of Sβ-CD are consistent with the 
formation of an inclusion complex between DA and Sβ-CD.  
 
Figure 5.11 shows the change in the absorbance at 280 nm with increasing Sβ-
CD concentration. The absorbance becomes smaller at higher concentrations of 
Sβ-CD, suggesting that the DA is completely included within the cavity when an 
excess of the Sβ-CD is present in solution. A similar observation was made by 
Yanez et al.12 for the complexation of Nicardipine (NC) with β-CD. 
 
 
Complexation studies  Chapter 5 
 
- 197 - 
 
 
1.20
1.25
1.30
1.35
1.40
270 280 290
A
b
so
r
b
a
n
ce
Wavelength / nm
 
 
Figure 5.10: UV spectra of DA (5.00 x 10-4 mol dm-3) in the absence (black trace) and 
presence of varying amounts of Sβ-CD in a citrate–phosphate buffer, pH=6.0 (red 
traces) (Sβ-CD concentrations were varied from 5.65 x 10-4 to 2.00 x 10-2 mol dm-3). 
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Figure 5.11: UV data of DA (5.0 x 10-4 mol dm-3) at its λmax = 280 nm as a function of 
increasing amounts of Sβ-CD in a citrate–phosphate buffer, pH=6.0.        
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In calculating the value of Kf, Equation 5.1 assumes that a 1:1 inclusion complex 
is formed between DA and Sβ-CD (Section 5.3.1), and that an excess of Sβ-CD is 
present. Figure 5.12 shows a Heildebrand-Benesi plot constructed using Figure 
5.10, showing a linear relationship with a correlation coefficient of 0.997. This 
linear relationship is further support for a 1:1 complex stoichiometry.4  
 
From the intercept and slope of Figure 5.12, a Kf  value of 336.92 ± 24.83 was 
computed using Equation 5.1. This is considerably higher than the value 
reported for the inclusion complex between DA and neutral β-CD.7 
 
 
 
 
Figure 5.12: Plot of (A0/A0-A) as a function of (1/[Sβ-CD]) for the evaluation of the 
stability constant, (Kf), for DA inclusion within Sβ-CD. 
 
5.3.2.2 Determination of Kf by CV 
The inclusion phenomenon was also investigated using electrochemical 
methods. The CV and RDV techniques were chosen for their sensitivity and 
because they allow data to be retrieved at low concentrations of the 
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electroactive species.6, 10 Section 5.3.1.2 reveals that DA is electroactive, quasi-
reversible and under diffusion control.  
 
Figure 5.13 shows the cyclic voltammograms obtained for DA at a pH of 6.0 in 
the absence and presence of 2.00 x 10-2 mol dm-3 Sβ-CD. It is clear from this 
figure that the addition of Sβ-CD decreases the peak current and shifts the 
oxidation peak potential in the positive direction.  
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Figure 5.13: Cyclic voltammograms of DA (5.0 x 10-4 mol dm-3) a) in the absence and b) 
in the presence of 2.0 x 10-2 mol dm-3 Sβ-CD at pH=6.0 citrate-phosphate buffer. The 
potential was swept from -0.250 to 0.800 V vs. SCE at 50 mV s-1. 
 
 
The influence of the Sβ-CD can be seen more evidently in the cyclic 
voltammograms of DA in Figure 5.14, recorded with increasing concentrations 
of Sβ-CD ranging from 3.12 x 10-4 to 2.00 x 10-2 mol dm-3.  Although the 
voltammograms recorded in the presence of the Sβ-CD have similar 
characteristics to that recorded in a pure DA solution, there is a significant 
a) 
b) 
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difference in the oxidation of DA. The inset of Figure 5.14 shows a plot of the 
peak potential, Ep, for the oxidation of DA as a function of Sβ-CD concentration 
and reveals a gradual increase in the peak potential with increasing 
concentration of Sβ-CD. This indicates that DA is more difficult to oxidise in the 
presence of Sβ-CD and is consistent with the formation of an inclusion complex.  
Figure 5.14 also shows a decrease in the peak current, with increasing 
concentration of Sβ-CD, which is attributable to the change in the diffusion 
coefficient of DA. A lower diffusion coefficient is expected when a guest is 
included within the bulky cyclodextrin cavity, as has been shown in several 
other works with a variety of electroactive guests.16, 25, 26 
 
 
 
Figure 5.14: Cyclic voltammograms of 5.0 x 10-4 mol dm-3 DA in a citrate-phosphate 
buffer, pH=6.0, at a GC electrode in the absence and in the presence of increasing 
concentrations of Sβ-CD. The potential is swept from -0.250 to 0.800 V vs. SCE at 50 mV 
s-1 for 10 cycles. Inset shows the anodic peak potential as a function of [Sβ-CD]. 
 
 
Similar changes in the peak currents and potentials observed here are well 
represented within the literature and are indicative of inclusion complex 
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formation.6, 25, 27 Dang et al.7, 25 reported similar results for the complexation of 
benzoquinone and anthraquinone with β-CD. This trend was also observed by Li 
and co-workers in the investigation into the interactions of Basic Brown G with 
β-CD.3 While, Gao et al.26 investigated the inclusion complexation of another 
catecholamine, adrenaline (AD), and found that a similar increase in the shift of 
the oxidation potential was observed. They reported that it was due to the AD 
being more strongly bound to the hydrophobic cavity than of it’s reduced state. 
  
Figure 5.15 plots the peak potentials for the cathodic peak resulting from the 
reduction of quinone and it is interesting to note that there is no significant 
change in the peak potentials. This would suggest that the quinone is not 
included in the cavity.  From this it seems likely that once the DA becomes 
oxidised it is expelled from the cavity.  
 
 
 
Figure 5.15: The cathodic peak potential plotted as a function of [Sβ-CD] in a 5.0 x 10-4 
mol dm-3 solution of DA in a citrate-phosphate buffer, pH=6.0, at a GC electrode in the 
presence of increasing concentrations of Sβ-CD.   
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Figure 5.16 shows the peak current for the oxidation of 5.00 x 10−4 mol dm-3 DA 
and the corresponding reduction of the quinone as a function of the square root 
of the scan rate, in the absence and presence of 2.00 x 10-2 mol dm-3 Sβ-CD. 
These plots have a good linear relationship with correlation coefficients of 0.999 
and 0.998 for DA in the absence and presence of Sβ-CD, respectively, for the 
anodic peak. The diffusion coefficients were evaluated from the slopes of these 
plots using the Randles-Sevcik equation, Equation 5.10, 
 
FG   8 .//!  /! 2 H /!  
                                                  
where k has a value of 2.69 x 105, Ip is the peak current density, c is the 
concentration of DA in mol cm-3 and v is the scan rate of the potential in V s-1. 28 
Ip is linearly proportional to the bulk concentration, c, of the electroactive 
species and the square root of the scan rate, v1/2. 
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Figure 5.16: The plot of Ip versus v1/2 (cyclic voltammograms) on a GC disc electrode in 
citrate-phosphate buffer, pH=5, for 5.0 x 10−4 mol dm-3 DA in the absence ♦ and 
presence ♦ of 2.0 x 10-2 mol dm-3 Sβ-CD.  
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Table 5.6 gives a summary of the diffusion coefficients obtained for DA alone 
and in the presence of a large excess of Sβ-CD. From these linear relationships in 
Figure 5.16 it can be seen that the diffusion coefficient of DA in the presence of 
the Sβ-CD decreases. It is known that β-CD could cause an increase in the 
viscosity of the solution and, therefore, a decrease in the diffusion coefficient. 
However, according to the literature no change in β-CD viscosity was detected 
over the concentration range 0.00 to 1.00 x 10-2 mol dm-3.16, 25, 26 Therefore, with 
respect to that of free DA, this decrease can be attributed to the DA inside the 
cavity and the formation of an inclusion complex. The sulfonated CD is very 
large compared to DA and this will influence the diffusion of DA when DA is 
confined within the cavity of the CD. 
 
 
Table 5.6: The diffusion coefficients obtained for the oxidation of DA in the absence 
and presence of Sβ-CD using the Randles-Sevcik equation. 
 
 Slope / A cm2 V-1/2s1/2 Diffusion coefficient / cm2 s-1 
DA 6.32 x 10-4 2.76 x 10-6 
Sβ-CD+DA 3.41 x 10-4 8.05 x 10-7 
 
 
Figure 5.17 shows a plot of the experimental data, 1/[Sβ-CD] vs. 1/(1-i/i0) 
which gives a linear relationship with a correlation coefficient of 0.999.  
According to Equation 5.2 such linear plots not only confirm the existence of a 
1:1 complex,29 but can also be used to calculate the stability constant. 
Accordingly, the Kf value was calculated as 255.88 ± 7.97. Again, this is in good 
agreement with the value obtained from UV analysis, Section 5.3.2.1. 
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Figure 5.17: Plot of 1/[Sβ-CD] as a function of 1/(1-i/i0) for the evaluation of the 
stability constant, (Kf), for DA in citrate phosphate buffer, pH=6.0. 
 
5.3.2.3 Determination of Kf by RDV 
It has been suggested that as the peak potential shifts to more positive 
potentials, due to an increase in the presence of cyclodextrins, the shift can be 
used to determine the Kf of the complex.16 To undertake these experiments an 
excess of Sβ-CD is needed and the experiments should be performed at slow 
scan rates. RDV is thought to be more suited for these studies because it 
provides enhanced conditions for a reversible charge-transfer.6  
 
Figure 5.18 shows the RDV voltammograms for DA (5.00 × 10−4 mol dm-3) as a 
function of the rotation speed. The data obtained at the GC rotating disc 
electrode show that the limiting current (iL) of DA increases with increasing 
rotation frequencies. There is a clear linear relationship between the limiting 
current and the square root of the rotation speed, as shown by the inset of 
Figure 5.18, indicating that the system follows the Levich equation (Equation 
5.5). It also indicates that the limiting current is mass transport controlled.  
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Figure 5.18: RDV voltammograms of DA (5.0 x 10−4 mol dm-3) on a GC disc electrode in 
a citrate-phosphate buffer pH=6.0. Rotation frequency, rpm: (1) 200; (2) 300; (3) 400; 
(4) 500; (5) 600; (6) 700. The inset shows a plot of iL versus ω1/2. 
 
 
Figure 5.19 shows the effect of Sβ−CD concentration on the RDV 
voltammograms of DA. As the Sβ-CD concentration is increased the half-wave 
potentials (E1/2) for DA oxidation continue to shift to more positive potentials, 
as shown in the inset of Figure 5.19. Additional experiments were carried out 
where the limiting current for the oxidation of DA was measured as a function of 
the rotation speed both alone and in the presence of varying concentrations of 
Sβ-CD.  
 
Levich plots, where the limiting current is plotted as a function of the square 
root of the rotation speed are shown in Figure 4.20. Good linear relationships 
are observed with correlation coefficients exceeding 0.986, indicating that the 
system is indeed under diffusion control. 
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Figure 5.19: Effect of Sβ-CD concentration on the rotating-disc voltammograms of DA 
(5 x 10−4 mol dm-3) on a GC disc electrode in citrate-phosphate buffer (pH=6.0). [Sβ-
CD]/ mol dm-3: (1) 0.000; (2) 0.005; (3) 0.010; (4) 0.020. Rotation frequency 500 rpm 
(ν = 50 mV s−1). The inset shows a plot of E1/2 versus [Sβ-CD].  
 
 
The slopes of the Levich plots for free DA and for DA in the presence of 0.02 mol 
dm-3 Sβ-CD were used with Equation 5.5, to evaluate the diffusion coefficients, 
Df and Dc. A decrease in the diffusion coefficient was found with increasing 
concentration of Sβ-CD, as is evident from the inset in Figure 5.20. A Df value of 
5.11 x 10-6 cm2 s−1 was found for free DA, while the diffusion coefficient of the 
complexed species, Dc, was evaluated as 2.44 x 10-6 cm2 s−1. Again, this is 
attributed to the formation of a DA-Sβ-CD inclusion complex, which has a slower 
diffusion rate due to the large size of the cyclodextrin. These values are in 
general agreement with the diffusion coefficients calculated using CV (Table 
5.6). However, the RDV diffusion coefficient values are considered to be more 
accurate because of the elimination of mass transport related kinetic 
restrictions. A Dc/Df  value of 0.47 was obtained and this is in very good 
agreement with ratios found in the literature for the complexation of ferrocenes 
with CDs.6, 16  
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Figure 5.20: Plot of iL versus ω1/2 at rotating-disc voltammograms of DA (5.0 x 10−4 mol 
dm-3) on a GC disc electrode in citrate-phosphate buffer, (pH=6), in the presence of 
varying amounts of [Sβ-CD] / mol dm-3. 1) 0.00 2) 1.25 x 10-3 3) 2.50 x 10-3 4) 5.00 x   
10-3 5) 1.00 x 10-2 and 6) 2.00 x 10-2. The inset shows a plot of the diffusion coefficients 
as a function of increasing Sβ-CD concentrations. 
 
 
Using Equation 5.3 and the Dc/Df value of 0.47, the Kf value for the DA-Sβ-CD 
inclusion complex was calculated as 331.28 ± 5.85. Equation 5.3 is valid when 
the concentration of the cyclodextrin is larger than the total concentration of the 
guest. The kinematic viscosity of the system was taken to be 0.92 x 10-6 m2 s-1.30 
The diffusion coefficient evaluated for DA is in close agreement with values 
reported in the literature in the range of 1.9 x 10-6 to 6.3 x 10-6 cm2 s-1.31-33 Also, 
both the CV and RDV methods in computing the diffusion coefficient are in good 
accordance with each other.  
 
Additionally, from these data the Koutecky-Levich equation (Equation 5.6) was 
used to calculate the heterogeneous charge transfer rate constant, k, for DA in 
the absence and presence of the varying concentrations of Sβ-CD. Figure 5.21 
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shows the Koutecky-Levich plots (iL-1 vs. ω-1/2) for DA alone and in the presence 
of varying concentration of Sβ-CD. For each Sβ-CD concentration a linear 
Koutecky-Levich relationship was observed and from the y-intercept of each 
plot the k values were obtained and are presented in Table 5.7. From the inset in 
Figure 5.21 it is evident that the rate constant for the oxidation of DA decreased 
as the concentration of Sβ-CD increased. This decrease in rate constant can be 
attributed to the formation of an inclusion complex. It is reasonable to expect 
that the rate of the electron-transfer reaction will be higher when the DA is free 
in solution, compared to when it is complexed within the cavity of the CD 
species. Using Marcus theory34, this can be explained in terms of the 
reorganisation energy. In the semi-classical Marcus theory, the rate of electron 
transfer is given by the equation 
 
k  2πh  
HDA2
√4πλRT  e-
>ΔG0
λB2
4λRT     5.11 
 
 
where HDA is the electronic coupling matrix element, ∆Go is the Gibbs energy 
change and λ is the re-organisation energy, which is the energy associated with 
relaxing the geometry of the system after the electron-transfer step. This 
reorganisation energy is likely to be higher when the DA is confined within the 
cavity of the Sβ-CD, leading to a lower rate constant, in accordance with 
Equation 5.11.  
 
Typical rate constants for the oxidation  of DA in the literature are in the range 
of 1.3 x 10-2 cm s-1 to 3.88 x 10-3 cm s-1 on different materials and the higher 
values are in good agreement with the values obtained in Table 5.7.33, 35-37  
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Figure 5.21: Koutecky-Levich plots for DA in the absence and presence of varying 
concentrations of [Sβ-CD] / mol dm-3. 1) 0.00 2) 1.25 x 10-3 3) 2.50 x 10-3 4) 5.00 x 10-3 
5) 1.00 x 10-2 and 6) 2.00 x 10-2. Experiments were carried out in a citrate-phosphate 
buffer (pH=6.0). Current was read at +0.700 V. The inset shows the rate constant as a 
function of increasing Sβ-CD concentrations. 
 
 
Table 5.8 shows the stability constants obtained using the three techniques 
discussed here. In all cases the data were obtained in a citrate-phosphate 
aqueous buffer with a pH of 6.0. From Table 5.8 the stability constants are in 
close agreement, validating both the different methods and the stability 
constants obtained. In comparing these values with the values obtained with the 
neutral β-cyclodextrin (Kf = 95.06)4 we can confirm that the presence of the 
sulfonated groups on the cyclodextrin aids complexation. This could be due to 
the fact that one of the main driving forces in complexation is electrostatic 
interactions38 and as the DA in solution is protonated there is a strong 
electrostatic interaction between the protonated N atom on the DA and the 
negatively charged sulfonated groups on the CD. This in turn allows the 
aromatic moiety of the DA to enter the cavity.38 
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Table 5.7: The effect of the concentration of Sβ-CD on the rate constant, k, evaluated 
using the Koutecky-Levich equation. 
 
[Sβ-CD] / mol dm-3 rate constant, k / cm s-1 R2 
0.00 1.26 x 10-2 0.992 
1.25 x 10-3 1.11 x 10-2 0.996 
2.50 x 10-3 9.79 x 10-3 0.997 
5.00 x 10-3 8.39 x 10-3 0.997 
1.00 x 10-2 6.31 x 10-3 0.993 
2.00 x 10-2 5.37 x 10-3 0.986 
 
 
Table 5.8: The stability constants obtained from UV, CV and RDV. 
 
Formation constants of DA and Sβ-CD pH~6.0 
Kf  by UV spectra Kf by CV Kf  by RDV 
336.92 ± 24.83 255.88 ± 7.97 331.28 ± 5.85 
 
 
These results are consistent with the formation of an inclusion complex, 
according to the equilibrium, 
 
Guest + CD  V     Guest-CD 
 
where the Guest-CD represents the inclusion complex of DA with Sβ-CD.  
 
In the next section NMR is used to investigate the structural relationship 
between DA and Sβ-CD and a proposed structure for the inclusion complex is 
presented and discussed. 
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5.3.3 Analysis of the DA-Sβ-CD complex by NMR 
NMR spectroscopy is a sensitive technique for monitoring the interactions 
between molecules and it has been widely used to study complexes between 
CDs and a variety of guests to give structural information on a range of 
complexes.39, 40 In this study, chemical shifts generated from complexation were 
used to estimate the apparent complexation constants and confirm a 1:1 
DA:Sβ−CD complex stoichiometry.  
 
5.3.3.1 Determination of the DA-Sβ-CD complex molecular structure by NMR  
NMR is a very appropriate tool for the structural analysis of the complexation 
mechanism by comparison of the DA spectra in the absence and presence of 
Sβ−CD. In general, cyclodextrins have an overall cylindrical truncated cone 
shape, which has a predominantly hydrophobic internal cavity due to the 
presence of the lone pairs of glycosidic oxygen atoms.41 This cavity is open at 
both ends, which have different diameters, and these ends are referred to as the 
primary and secondary ends due to the presence of the primary and secondary 
hydroxyl groups.8 Generally, in the NMR process of determining the geometric 
factor between the host and guest, the host protons H3 and H5 are monitored 
because they face the internal cavity and are located near the secondary and 
primary ends, respectively. They can, therefore, be used to explore the internal 
cavity of cyclodextrins for the presence of a guest molecule and identify the 
nature of its interaction.40 Unfortunately, in the case of Sβ-CD, the NMR spectra 
are too complicated (the Sβ-CD sample is a structure of substituted CDs, with 
the degrees of substitution varying between 7 and 11) to follow the chemical 
shifts of these protons and so analysis of the guest protons was necessary. 
 
Figure 5.22 shows the chemical structure of DA; it has five types of hydrogen:   
a-H, b-H, c-H, d-H and e-H. The protons designated as a-H, b-H and c-H 
correspond to the aromatic protons, while the protons d-H and e-H correspond 
to the methylene (-CH2-) group protons. 
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Figure 5.23 shows a 1H NMR spectra of 5 x 10-3 mol dm-3 DA in 0.1 mol dm-3 KCl 
in D2O. In this figure, the two proton regions are highlighted. The red region 
corresponds to the aromatic protons a-H, b-H and c-H and the blue region 
corresponds to the d-H and e-H 2-CH2 group protons, as illustrated in Figure 
5.22.  
HO
HO
NH2
a
b
c d
e
 
 
Figure 5.22: Chemical structure of DA. The protons are designated with letters. 
 
a c b d e
 
 
Figure 5.23: 1H NMR spectra of 5 x 10-3 mol dm-3 DA in 0.1 mol dm-3 KCl in D2O. DA 1H 
NMR (300 MHz, D2O): δ 6.79 (1H, d, J=8.1, a-H), 6.64 (1H, dd, J=1.3, 8.0, b-H), 
6.74 (1H, d, J=2.1, c-H), 3.11 (2H, t, J=7.2, d-H), 2.76 (2H, t, J=7.2, e-H).  
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The main interest of the NMR technique is that a change in the chemical shift 
indicates complexation. As Sβ-CD does not interfere with the aromatic region 
(Figure 5.24) it was easy to monitor the chemical shift change in DA. This 
information can be used to approximate which moiety of the molecule was 
included and, hence, the structural identity of the complex. In Figure 5.24 the 
aromatic region of the 1H NMR spectra of 2.0 x 10-2 mol dm-3 Sβ−CD, 5.0 x 10-3 
mol dm-3 DA and a mixture of DA-Sβ−CD are shown. In Figure 5.22 the coloured 
letters represent each aromatic proton; these colours are shown in Figure 5.24 
to illustrate the shift of each individual proton in the presence of Sβ-CD. 
 
 
Ha
Hc Ha
Hc
Hb
Hb
 
 
Figure 5.24: 1H NMR spectra of the aromatic region, Sβ-CD (green), DA (red), and DA in 
the presence Sβ-CD (blue) in buffered D2O solutions. The corresponding protons are 
colour coded to differentiate the chemical shift. 
 
Comparing the 1H NMR spectra of DA in the absence and presence of Sβ-CD the 
protons implied in the inclusion process can be located. It is evident from Figure 
5.24 that the chemical shift of the a-H proton of DA is significant. Also evident 
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from Figure 5.24 is that the b-H proton also experiences a moderate shift, while 
the c-H proton’s chemical shift is only slightly affected, suggesting that it 
remains outside the CD cavity. It should be noted that all these chemical shifts 
are in the same upfield direction. A summary of the changes observed for the 
protons of DA in the presence and absence of Sβ-CD is given in Table 5.9.   
 
 
Table 5.9: 1H NMR chemical shifts (ppm) of DA in the absence and presence of Sβ-CD. 
 
DA δ without Sβ-CD δ with Sβ-CD ∆δ 
Ha 6.7932 6.6873 -0.1058 
Hb 6.6472 6.6299 -0.0173 
 
 
The significant upfield or low frequency shift of the aromatic protons indicates a 
shielding effect, which is possibly due to the increase in the electron density 
inside the cavity from the non-bonding electron pairs of the glycosidic oxygen 
bridges.8 This is further evidence that the aromatic ring is penetrating the 
cavity. The complex illustrated in Figure 5.25 is consistent with the findings 
presented in Table 5.9. 
 
The region of the aromatic ring that enters the Sβ-CD cavity can be deduced 
from the observed chemical shift in Figure 5.24 and this process is illustrated in 
Figure 5.25.  Bratu et al.42 observed shifts of a similar nature for Fenbufen (FEN) 
in the presence of neutral β-CD. They observed that the methylene groups of the 
FEN remained outside the cavity and the FEN molecule entered from the larger 
side or the secondary opening of the β-CD ring. Also Chao and co-workers43 
demonstrated with NMR that the aromatic ring of caffeic acid, a molecule with 
similarities to DA, lay inside the β-CD cavity while the more polar groups 
remained outside.  
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Figure 5.25: A proposed structural representation deduced from the NMR data. The 
aromatic protons are differentiated with a colour code: a-H, b-H, c-H.  
 
5.3.3.2 Determination of complex stoichiometry by NMR 
NMR is also often used to determine the stoichiometry of the complex by the 
well known continuous variation method (Job’s method), in which 
stoichiometry can be determined by the position of highest point.9, 44, 45 Most 
current stoichiometric ratios between β-CD and guest molecules reported in the 
literature are 1:1, 1:2 and 2:1. 7, 40, 43 As shown previously in Section 5.3.1, a 
stoichiometric value of 1:1 for the Sβ-CD and DA complex was determined using 
both spectrophotometric and electrochemical procedures. 
 
The NMR spectra of each solution, given in Table 5.4, were recorded and Figure 
5.26 shows a comparison plot of all 11 samples. The experimentally observed 
parameter in this case is the chemical shift of the aromatic protons of the DA, 
where an upfield shift of proton a-H and b-H was observed. For example, the 
chemical shift for a-H was 6.87 ppm when the mole fraction of DA was 1.0 and it 
changed to 6.74 ppm for a DA mole fraction of 0.1.  
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Figure 5.26: 1H NMR spectra (aromatic region) in 0.1 mol dm-3 KCl/D2O. This is the 
spectra obtained for the Job’s method where the mole fraction was varied from 0.0 to 
1.0, as shown on the diagram. 
 
 
To generate the Job’s plot and establish the stoichiometry of the complex, the 
continuous variation method was used to follow the changes in chemical shifts 
of the DA aromatic protons a-H and b-H that showed the most distinct 
variations. The Job’s plot was created by evaluating the change of the chemical 
shift, Δδ, from that of an equal concentration of DA using the equation:  
 
∆δ = δ0 - δc 
 
where δ0 and δc are the chemical shift values for DA in the absence and presence 
of Sβ-CD, respectively. These Δδ values were then multiplied by the 
corresponding mole fraction (Δδ x mole fraction) and the product was plotted 
as a function of the mole fraction ([DA]/([DA]+[Sβ-CD])).  
 
5.12 
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The results for the a-H proton are shown in Figure 5.27. The maximum value of 
the Job’s plot for the a-H proton (Figure 5.27) occurs at a DA mole fraction of 
0.5. A similar Job’s plot to that of Figure 5.27 resulted from the chemical shift 
changes of the b-H proton (data not shown) with a maximum at 0.5 DA mole 
fraction. Taken together this is strong evidence for a 1:1 complex stoichiometry. 
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Figure 5.27: The Job’s plot for the determination of the stoichiometry of the a-H proton 
of the DA.  
 
 
5.3.3.3 Determination of the Kf value by NMR 
A NMR titration experiment was performed to obtain host-guest binding 
information on the DA/ Sβ-CD system. The spectrum of the DA in a deuterated 
solvent was first measured, small aliquots of Sβ-CD were then added and the 
spectrum was recorded. In all these experiments, the concentration of the DA, 
guest, was kept constant and the concentration of Sβ-CD, host, was varied. 
During the complexation procedure of DA with Sβ-CD a change in the chemical 
shift was observed, as shown in Figure 5.28. This figure shows a typical upfield 
shift of the aromatic protons of DA in the presence of Sβ-CD.  
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Figure 5.28: 1H NMR spectra (aromatic region) in 0.1 mol dm-3 KCl/D2O of a) DA 
b) DA in the presence of Sβ-CD. 
 
 
Figure 5.29 plots the Δδ of the a-H, b-H and c-H protons of DA as a function of 
the Sβ-CD molar ratio using a non-linear curve fitting method (Chapter 2), and 
from this the evaluation of the Kf value for each proton was determined using 
Equation 5.7 and these constants are presented in Table 5.10. There is very 
good agreement between the Kf values evaluated for both a-H and b-H protons, 
while the constant evaluated using c-H is somewhat lower. This is probably 
connected to the small variations in the chemical shifts observed for the c-H 
proton. 
 
b) 
 
 
 
 
 
 
 
a) 
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Figure 5.29: Difference in the observed chemical shift in the absence and presence of 
Sβ-CD for each of the DA aromatic protons. ♦a-H♦b-H. 
 
 
Table 5.10: Stability constants, Kf, of DA-Sβ-CD complex evaluated using the non-linear 
curve data for the NMR technique. 
 
Proton Stability constant, Kf 
Ha 384.48 
Hb 394.39 
 
Table 5.11 gives the results obtained for the stability constant of DA in the 
presence of Sβ-CD using the techniques outlined in this chapter. The NMR data 
for DA are thus in good agreement with UV, CV and RDV results and confirm 
inclusion of the aromatic ring of DA within the cavity of the Sβ-CD molecule. 
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Table 5.11: Stability constants, Kf, of DA-Sβ-CD complex evaluated using UV, CV, RDV 
and NMR. 
 
Formation constants of DA and Sβ-CD pH~6 
Kf  by UV spectra Kf by CV Kf  by RDV Kf  by NMR 
336.92 ± 24.83 255.88 ± 7.97 331.28 ± 5.85 384.48 ± 164.81 
 
5.3.4 Factors that influence DA-Sβ-CD Complexation 
In addition to the geometry of the inclusion complex, the driving forces leading 
to the complexation are also of importance. The interactions between charged 
cyclodextrins and guest molecules are still very much absent in the literature.46 
For this reason it is difficult to establish what specific interactions are involved 
in complexation, with charged cyclodextrins. Nevertheless, some potential 
factors involved are discussed in this section, including electrostatic interaction, 
the influence of supporting electrolyte and cavity size of the host. 
 
5.3.4.1 Influence of pH 
In terms of electrostatic interaction, three types are of most importance, i.e. ion-
ion interaction, ion-dipole interaction, and dipole-dipole interaction.47 The aim 
of this study was to alter the charge on the DA molecule, by varying the pH of 
the solution between a pH of 1.4 and 6.0 and then to determine the influence of 
the charge of DA (level of protonation) on the magnitude of the complexation 
constant. Unfortunately, higher pH values could not be employed, as it was too 
difficult to prevent the oxidation of DA, which is well known to be unstable in 
the presence of oxygen at higher pH values.35-37 
 
In addition to the charged DA guest, the sulfonate groups on the Sβ-CD are also 
ionised. Although sulfonated groups tend to be fully ionised (sulfonic acids are 
considered strong acids, with dissociation constants of about 10-2) 48 an 
experiment was designed to establish if significant changes in pH would alter 
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the charge on the Sβ-CD. This involved an acid-base titration which served to 
give rise to variations in the pH of the solution, while simultaneous 
measurements on the conductivity of the solution gave an indication of the 
number of charged species. Figure 5.30 shows the conductivity as a function of 
pH for the Sβ-CD initially dissolved in a NaOH solution (to give a pH of 
approximately 12.0). The conductivity is also plotted for an equivalent 
concentration of NaOH, but in the absence of the Sβ-CD. The conductivity of the 
Sβ-CD containing NaOH solution is much higher than the pure NaOH solution, 
which clearly shows that the Sβ-CD is contributing to the conductivity 
measured. Indeed, the conductivity of the Sβ-CD is high, similar to that of a 
0.020 mol dm-3 NaOH solution, indicating a very high degree of dissociation of 
the sulfonated groups. By comparing the difference between the conductivity of 
the NaOH and the NaOH solution containing the Sβ-CD, it is clear that the Sβ-CD 
contributes a near constant conductivity to the solution, over the entire pH 
range from 3.0 to about 11.0, confirming that the extent of dissociation is not 
affected by the pH of the solution. 
 
In order to study the complexation between DA and the Sβ-CD as a function of 
pH, both UV and CV methods were employed. For the spectrophotometric data 
the measurements were performed at three pH values, pH 6.0, 3.0 and 1.4. As 
discussed previously in Section 5.3.2.1, increasing the concentrations of Sβ-CD 
gave rise to a shift in the λmax from 280 to 283 nm. An overall increase in the 
intensity was observed as an excess of Sβ-CD, was added but a decrease in 
absorbance intensity at 280 nm was observed. Based on the variation in the 
absorbance at λmax = 280 nm, the formation constant (Kf) of the inclusion 
complex was evaluated using the Heildebrand-Benesi relationship, Equation 5.1. 
The formation constant was determined for the complex based on the 
absorbance changes, ∆A. ∆A values were computed using Equation 5.10 and 
then A0/∆A was plotted as a function of 1/[Sβ-CD], as demonstrated in Figure 
5.31. The plot shows a good linear relationship for all of the experimental data.  
Correlation coefficients of 0.997, 0.997and 0.992 were obtained for pH values of 
6.0, 3.0 and 1.4, respectively. 
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The formation constants were determined from the slope and the intercept of 
the straight line plots, in Figure 5.31 in association with Equation 5.1. The 
formation constants evaluated for each pH studied are correlated in Table 5.12. 
From these data the formation constants show little variation at different pH 
values. It is noted that the constants of the DA-Sβ-CD complex are somewhat 
stronger in acidic media, than in more neutral media in the citrate-phosphate 
buffer system. 
 
 
 
 
Figure 5.30: Conductivity as a function of pH for a solution of 0.020 mol dm-3 NaOH in 
the absence ♦  and presence ♦of 0.005 mol dm-3 Sβ-CD.  
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Figure 5.31: Linear relationship of A0/A-A0 as a function of 1/[Sβ-CD] for 5.0 x 10-4 mol 
dm-3 DA in the presence of varying concentrations of Sβ-CD at the following pH values, 
♦pH=1.4 in H2SO4 and pH=3.0 •pH=6.0 in citrate phosphate buffers. 
 
 
Table 5.12: Stability constants for the inclusion complex formed at the various pH 
values obtained from UV spectroscopy. 
 
pH Stability Constant, Kf R2 
1.4 261.87 ± 28.61 0.992 
3.0 452.68 ± 12.45 0.997 
6.0 336.93 ± 24.82 0.993 
 
The ratio of DA in the neutral and protonated states can be obtained by 
considering the Henderson Hasselbalch equation given below and using HA+ to 
represent the protonated DA and A to indicate the neutral form (HA+ V H+ + A). 
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This relationship can be arranged to give Equation 5.13, providing the ratio of 
the neutral to the protonated DA in terms of the pH and pKa value of DA, which 
is 8.9. 
10#	#4"  ::]           5.13 
 
Using this relationship, the ratio of protonated DA to the neutral DA can be 
computed as 3 x 107, 7 x 105 and 7 x 103 at pH values of 1.4, 3.0 and 6.0, 
respectively, indicating a slightly higher proportion of neutral DA molecules at 
pH 6.0 compared to pH 3.0, which may be connected to the increase in the Kf 
value as the pH is varied from 6.0 to 3.0, Table 5.12. 
 
The pH study was also investigated using CV. It is well documented that the 
peak potential, Ep, is dependent on pH and decreases with increasing pH.17, 49, 50 
Figure 5.32 shows a plot of the oxidation peak, Ep, of DA as a function of pH. 
Both citrate-phosphate buffer solutions for the range of pH 2.0 - 7.0 and H2SO4 
for lower pH solutions were used to prepare the solutions. These results show 
that the DA is becoming harder to oxidise at lower pH values. This pH 
dependence indicates that protons are directly involved in the rate-determining 
step for the oxidation of DA. The equation relating peak potential with pH, over 
the pH range 3.1 to 7.0, is Ep = 0.536 – 0.037 pH. The slope value of 37 mV is 
consistent with the overall reaction being a two-electron and two proton 
process. 
 
Complexation studies using CV were performed at various pH values using 
solutions of 5.00 x 10-4 mol dm-3 DA in the presence of increasing amounts of 
Sβ-CD. The change in the peak oxidation potential of DA as a function of the pH 
for DA in the absence and presence of a large excess of Sβ-CD, 2.00 x 10-2 mol 
dm-3, was obtained and is expressed in Figure 5.33. From these results it is seen 
that the potential difference between DA and DA in the presence of Sβ-CD 
increases as the pH increases.  There is a significant difference between pH 
values close to 1.4 and those in the range 3.0 to 6.0. However, this may be due to 
the presence of different anions in the two solutions. As detailed in Section 
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5.2.1.3 sulfate anions are used in the preparation of the solutions at a pH of 1.4, 
while the citrate/phosphate anions are present at pH values between 3.0 and 
6.0. This will be discussed later in Section 5.3.4.2. 
 
Using Equation 5.2, the stability constants, Kf were evaluated as a function of pH 
and are shown in Table 5.13 and plotted in Figure 5.34. There is a significant 
increase in the Kf value as the pH is increased from 1.4 to 3.0. This is consistent 
with the small shift in the peak potential observed at a pH of 1.4, compared to 
that obtained at a pH of 3.0, Figure 5.33. These data are also in good agreement 
with the spectroscopic measurements, Table 5.12, and show a decrease in the 
magnitude of Kf  as the pH is increased from 3.20 to 6.06. 
 
 
 
Figure 5.32: The peak oxidation potential of 5.00 x 10-4 mol dm-3 DA as a function of 
pH. Potential was swept from -0.250 to 0.800 V vs. SCE at 50 mV s-1. 
 
 
Nevertheless, there is less agreement between the potential shifts observed in 
Figure 5.33 and the computed Kf values shown in Table 5.12 and Figure 5.34 at 
higher pH values. There is a small increase in the ∆Ep values with increasing pH 
from 3.0 to 6.0 in Figure 5.33, However there is a decrease in the magnitude of 
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Kf as the solution is brought to higher pH values, as shown in Table 5.13.  This 
may be connected to the manner in which the stability constants were 
calculated; only the peak currents and Equation 5.2 was used  to calculate the Kf 
value.  
 
 
 
Figure 5.33: The change in the oxidation peak potential, ∆Ep of 5.00 x 10-4 mol dm-3 DA 
in the absence and presence of 2.0 x 10-2 mol dm-3 Sβ-CD as a function of pH. Potential 
was swept from -0.250 to 0.800 V vs. SCE at 50 mV s-1. 
 
Table 5.13: Stability constants for the inclusion complex formed at the various pH 
values. Data were obtained from CV measurements. 
 
pH Stability constant, Kf 
1.36 372.62 ± 32.52 
3.20 673.84 ± 12.64 
4.01 489.99 ± 140.50 
5.01 238.57 ± 278.47 
6.06 255.88 ± 7.97 
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Figure 5.34: Stability constants obtained for the DA-Sβ-CD complex using 5.00 x 10-4 
mol dm-3 DA in the presence of varying concentrations of Sβ-CD as a function of pH.  
 
 
These findings are in good agreement with other investigations which have 
been carried out with charged guests. For example, Li et al.51 suggest that the 
relief of conformational strain and electrostatic forces are the main driving 
forces for complexation. Rajewski and co-workers52, 53 investigated the role of 
charge by comparing the binding of neutral and charged cyclodextrins with 
neutral and charged guests. They found that in the case of complexing with 
neutral species that the negatively charged sulfobutyl ether β-CD had a higher 
binding affinity than neutral β-CD. In the case of a protonated species, 
papaverine, the binding constant was evaluated in the presence of the neutral β-
CD and the negatively charged β-CD and values of 10 and 570 were obtained, 
respectively. They found the presence of charge on the cyclodextrin gave a 
further site of interaction for the guest molecule in comparison to the neutral 
cyclodextrin. However, they also stated that the complexation of the negatively 
charged CD, sulfobutyl ether β-CD, with the positively charged species is highly 
dependent on the solution electrolyte concentration which is important in the 
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charge interactions of the complex. Indeed, this is consistent with the variations 
observed between the sulfate and the citrate/phosphate systems described 
here. It appears from the stability constants that the citrate/phosphate species 
promote the formation of the inclusion complex. 
 
These results are also in very good agreement with Zia et al.52 who stated that as 
the positive charge is increased it has an encouraging effect on the binding 
constants. Wenz et al.46 also stated that the orientation of the guest inside the 
cavity is influenced by interactions with functional groups on the cyclodextrin. 
In view of Wenz’s statement it could be said that because of the presence of the 
positive and negative charges the interaction between the two components 
could have some affect on the geometrical factors of the complex. As shown in 
Section 5.3.3, the aromatic ring of the DA was inside the cavity while the 
protonated amine group was predicted to remain outside the cavity. This 
orientation may differ slightly once the pH ranges from 1.4 to 6.0, but it is likely 
that the polar amine group will remain outside the cavity and bind 
electrostatically with the anionic sulfonated groups.  
 
5.3.4.2 Influence of counter ions 
Although the variation of the stability constant with pH, Table 5.13, is in 
agreement with charge considerations, there is a significant difference between 
the stability constants at pH 1.4 and 3.0, which cannot be explained fully in 
terms of charge. The fraction of DA molecules in the neutral state at pH 1.4 and 
3.0 can be estimated using the analysis presented in Equations 5.14 to 5.16. The 
degree of dissociation, α, can be represented in accordance with Equation 5.14. 
 
            W\      V      
   W\
      1  α     V    ^  
    ^  
 
Accordingly, α can be expressed in terms of both the pH and pKa values, as 
shown in Equations 5.15 to 5.17, and finally the % ionisation can be expressed 
in terms of Equation 5.18. 
 
5.14 
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Using this analysis, the % of non-ionised, protonated DA molecules is close to 
100% both at pH 1.4 and 3.0. As the supporting electrolyte is different in the pH 
1.4 and 3.0 studies, this may point to an influence of the counter ions.  
Accordingly, experiments were carried out to establish if the sulfate and citrate 
anions had any role to play in the complexation of DA with the Sβ-CD. In 
addition, the influence of cations was investigated by using chloride salts of 
sodium, ammonium, potassium and calcium. The ammonium cation was 
selected as the NH4+ can be related to the protonated DA and may compete with 
the electrostatic interactions between protonated DA and the sulfonated groups 
on the Sβ-CD. 
 
The presence of a supporting electrolyte in solution could alter the interaction 
between the host and guest. A change in the activity coefficient of ions could 
influence the equilibrium constants and therefore the ability to generate an 
inclusion complex.15 In solution, ions can vary the dielectric constant and the 
water activity; in the case of charged molecules like DA, ions can also be directly 
involved in the formation of non-covalent bindings.54 
 
CV experiments of 5.00 x 10-4 mol dm-3 DA were carried out in the absence and 
presence of 2.00 x 10-2 mol dm-3 Sβ-CD in each supporting electrolyte. The pH 
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was maintained in the range of 4.96 to 5.10. Regarding the influence of the 
cations, the anion was kept constant; only chloride salts were used. Figure 5.35 
shows the CV data obtained for the oxidation of DA in each supporting 
electrolyte; 0.20 mol dm-3 solutions of NaCl, KCl, CaCl2 and NH4Cl. In the case of 
these supporting electrolytes upon the addition of an excess of Sβ-CD a 
substantial shift in the peak current of the DA oxidation was noticed. A 
summary of the peak current and the peak potential ratios obtained for DA in 
the absence and presence of Sβ-CD are specified in Table 5.14. As can be seen no 
significant difference was observed. This clearly shows that the cations, Na+, K+, 
Ca2+ and NH4+ exert no influence on the complexation between DA and the      
Sβ-CD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.35: Cyclic voltammograms of 5.00 x 10-4 mol dm-3 DA in the ♦absence and 
♦presence of 0.02 mol dm-3 of Sβ-CD and 0.20 mol dm-3 supporting electrolyte. A. NaCl. 
B. KCl C. CaCl2. D. NH4Cl. Potential was swept -0.250 to 0.800 V vs. SCE at 50 mV s-1 
using a GC electrode. 
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Table 5.14: A summary of the data obtained for the CV in 5.00 x 10-4 mol dm-3 DA in the 
absence and presence of 2.00 x 10-2 mol dm-3 Sβ-CD with each supporting electrolyte. 
 
 
Cation 
 0.20 mol dm-3 
 
ip (DA)/ 
ip (DA+Sβ-CD) 
 
Ep (DA)/ 
Ep(DA+Sβ-CD) 
NaCl 1.610 1.023 
KCl 1.591 0.995 
CaCl2 1.593 1.012 
NH4Cl 1.611 0.968 
 
 
However, it is well known that the composition of the electrolyte can influence 
the manner in which an electroactive species is oxidised or reduced. For 
example, Wang et al.55 in investigating the effect of supporting electrolytes 
found that in one particular buffer, the reduction peak of the molecule being 
detected showed a more clear and sensitive peak. As the data obtained with the 
citrate/phosphate buffer and the sulfate electrolyte cannot be explained in 
terms of pH alone, additional experiments were carried out in an attempt to 
obtain information on the role of the anions. 
 
CV experiments were carried in a similar manner as described above to 
investigate the influence of the anions. The supporting electrolytes were sodium 
chloride, sodium sulfate and citrate-phosphate buffer. The data obtained are 
summarised in Table 5.15. It can be clearly seen that there is a significant 
change in the peak current ratios as well as the peak potential ratios. This 
clearly shows that the anions do have a significant influence on the degree of 
complexation between DA and the Sβ-CD. 
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Table 5.15: A summary of the data obtained for the CV of 5.00 x 10-4 mol dm-3 DA in the 
absence and presence of 2.00 x 10-2 mol dm-3 Sβ-CD with each supporting electrolyte. 
 
 
Anion  
 0.2 mol dm-3 
 
ip (DA)/ 
ip (DA+Sβ-CD) 
 
Ep (DA)/ 
Ep (DA+Sβ-CD) 
NaCl 1.610 1.023 
Na2SO4 1.773 0.834 
Citrate phosphate 1.915 0.747 
 
 
Firstly, it was thought that the ionic strength may have a major influence on the 
complexation. The ionic strength of each solution was computed using Equation 
5.19, where cA is the molar concentration of ion A (mol dm-3), zA is the charge 
number of that ion, and the sum is taken over all ions in the solution.  
 
F'   12 Σceze
!  
                     
It was found that the ionic strength varied in the order: citrate/phosphate > 
Na2SO4 > NaCl. So in order to investigate if it was indeed ionic strength that 
influenced the degree of complexation, NaCl solutions were prepared at various 
ionic strengths to match the corresponding ionic strength of the other anions 
and the CV experiments were repeated. These data are summarised in Table 
5.16. While ionic strength is clearly important in electrochemistry, it can be seen 
that ionic strength has no influence on the complexation of DA in the presence 
of Sβ-CD when the ionic strength is varied between 0.2 and 0.9 mol dm-3.  
 
The only other explanation for this phenomenon is that the anion has an 
influence. Therefore, additional CV experiments with the sodium chloride, 
sodium sulfate and the two components of the citrate phosphate buffer, sodium 
citrate and sodium phosphate, individually prepared at a concentration of        
0.2 mol dm-3 solution, were completed. In each case the oxidation of DA, at a 
5.19 
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concentration of 5.00 x 10-4 mol dm-3, was followed in the absence and presence 
of 2.00 x 10-2 mol dm-3 Sβ-CD.  
 
Table 5.16: A summary of the data obtained for the CV of 5.00 x 10-4 mol dm-3 DA in the 
absence and presence of 2.00 x 10-2 mol dm-3 Sβ-CD in NaCl where the ionic strength 
was varied. 
 
 
NaCl 
Ionic strength/ mol dm-3 
 
ip (DA)/ 
ip (DA+Sβ-CD) 
 
Ep (DA)/ 
Ep (DA+Sβ-CD) 
0.2 1.61 1.02 
0.3 1.56 1.05 
0.9 1.48 1.06 
 
 
After analysing the CV data of DA it was observed that in the absence of Sβ-CD 
the anion contributing to each supporting electrolyte had an influence on the 
oxidation potential of DA. Figure 5.36 shows the redox peak potential of          
5.00 x 10-4 mol dm-3 DA in 0.20 mol dm-3 of each supporting electrolyte, at the 
bare GC electrode. This figure indicates that the electrochemical oxidation of DA 
was more strongly suppressed when NaCl was used as a supporting electrolyte 
than in the case where sodium phosphate, sulfate or citrate were used. The peak 
oxidation potential shifted to higher potentials in the following order: NaCl > 
Na2SO4 > Na2H(C3H5O(COO)3) > Na2HPO4. These results are shown in Table 5.17, 
and indicate that the presence of the larger anionic groups in the phosphate and 
citrate media promote the electrochemical oxidation of DA.  
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Figure 5.36: Cyclic voltammograms of 5.00 x 10-4 mol dm-3 DA in 0.20 mol dm-3 
     NaCl      Na2SO4      Na2H(C3H5O(COO)3)     Na2HPO4. Potential was swept -0.250 to 
0.800 V vs. SCE at 50 mV s-1 using a GC electrode. 
 
 
These observations can be explained in terms of the size and polarisability of 
the anions. The small chloride anions have a stronger electrostatic binding with 
the protonated DA, making it more difficult to oxidise the DA molecule. The 
larger more diffuse anions, where the negative charge can be delocalised, have a 
lower attraction for the protonated DA, enabling the oxidation of DA at a slightly 
lower potential. This analysis can also be used to explain the more efficient 
formation of the inclusion complex in the citrate/phosphate media, as evident 
from Figure 5.34. The equilibrium between the free DA and the DA included 
within the cavity of the Sβ-CD, is shown below. 
 
DA + Sβ-CD  V     DA- Sβ-CD 
 
It is well known from the literature that the main driving force for complex 
formation (and a shift in the equilibrium to favour the complex), is the 
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displacement of water molecules from the cavity by more hydrophobic guest 
molecules, assuming that there is a fit between the size of the guest and the 
cavity of the cyclodextrin1, 46, 56, 57. The energetically favourable interactions are 
the displacement of the polar water molecules from the hydrophobic cavity. 
Once outside the cavity, the displaced water forms hydrogen bonds with the 
neighbouring water molecules. On the other hand, the repulsive interactions 
between the guest and the aqueous environment are reduced as the guest 
enters the cavity. Accordingly, in the presence of the chloride and sulfate (SO42- 
and HSO4-) anions, the DA is stabilised in the solution and the equilibrium lies to 
the left in favour of the un-complexed species. In contrast, the larger 
citrate/phosphate species have a lower stabilisation effect on the protonated DA 
and it is now the formation of the complex that is more energetically favoured. 
This in turn leads to slightly higher stability constants in the phosphate/citrate 
buffer compared to that obtained with the sulfate anions as the supporting 
electrolyte. 
 
 
Table 5.17: A summary of the data obtained for the CV of 5.00 x 10-4 mol dm-3 DA only 
in the presence of each supporting electrolyte. 
 
 
Anion / 0.2 mol dm-3 
 
ip DA / A cm-2 
 
Ep DA / V vs. SCE 
Na2HPO4 1.329 x 10-4 0.368 
[C(OH)(CH2CO2)2(CO2)] 1.287 x 10-4 0.411 
Na2SO4 1.075 x 10-4 0.475 
NaCl 1.086 x 10-4 0.524 
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5.3.4.3 Varying the size of the Cavity 
An investigation into the complexation of DA with Sα-CD was also carried out. 
As previously discussed in Chapter 1, the α-CD has similar complexing 
properties to the β-CD. One of the major characteristic differences between the 
two cyclodextrins is the number of glucose rings which affects the diameter of 
the cavity; the diameter of the α-CD is smaller than the β-CD cavity, as it only 
contains 6 glucose rings where as the β-CD has 7 rings. Connors et al.1 reported 
that cavity size was an important parameter in complexation. Therefore, in this 
study the Sα-CD was selected to explore the influence of the size of the cavity. 
 
Using CV, the complexation between DA and Sα-CD was investigated.  The DA 
concentration was kept constant at 5.00 x 10-4 mol dm-3 and using a citrate 
phosphate buffer, the pH was maintained at 5.0.  The Sα-CD concentrations 
were varied from 2.00 x 10-2 mol dm-3 to 3.12 x 10-4 mol dm-3. The results 
obtained are shown in Figure 5.37.  There is little evidence of any change in the 
voltammograms on the addition of the Sα-CD. The anodic peak potentials of DA 
in the absence and presence of 2.00 x 10-2 mol dm-3 of Sα-CD were 0.441 V vs. 
SCE and 0.448 V vs. SCE, respectively. Also, peak currents of 8.25 x 10-5 and 8.52 
x 10-5 A cm-2, in the absence and presence of 2.00 x 10-2 mol dm-3 Sα-CD are 
similar. These results are very different to those presented in Section 5.3.1.2, 
where a shift in the peak potentials and a decrease in the peak currents were 
observed when Sβ-CD was added to the DA solution. These shifts were 
attributed to complexation. The results obtained here in the presence of Sα-CD 
suggest that no complexation has transpired. If little or no complexation is 
occurring in the case of the Sα-CD it can only be assumed that this is due to the 
difference in the diameter of the cavities of the α and β sulfonated CDs.  
 
The approximate diameters of both the neutral α- and β- CD cavities are shown 
in Figure 5.38.56, 58, 59 Wang et al.60 have reported that the sulfonated β-
cyclodextrin and other derivatised cyclodextrins have the same ring structure, 
as β-cyclodextrin. The only difference between them is the substituents on the 
rim of the cyclodextrin ring. Due to this statement we can assume that the 
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diameters of the cavities with and without the sulfonated groups are 
approximately the same.  
 
It is also noted that the diameter decreases in width from the secondary 
hydroxyl rim to the primary rim.1 In order to investigate if in fact the DA is 
structurally able to fit inside the α-CD cavity, the diameter of DA was first 
calculated using a Quantum mechanical calculation using density functional 
theory (DFT). This method considers the electron density at a point and 
optimises the geometry from which the diameter can be calculated. Illustrations 
of both the face and side geometry of DA are shown in Figure 5.39. The total 
diameter is taken from the O-H group on the aromatic ring to the hydrogen on 
the nitrogen atom, as illustrated in the figure. A total diameter of 8.95 Å was 
obtained.  
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Figure 5.37: Cyclic voltammograms of DA (5.00 x 10-4 mol dm-3) in the absence and 
presence of varying amounts of Sα-CD at pH=5.0 in a citrate-phosphate buffer. The 
potential was swept from -0.250 to 0.800 V vs. SCE at 50 mV s-1. 
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It is also interesting to note the orientation of the NH2 group in the molecule. 
The bulk of the molecule is planar except for the amine group which extends out 
almost perpendicular to the rest of the molecule. This orientation could bare 
some connotations to the complexation in the CD cavity.  From the models 
shown, the diameter of DA was evaluated to be approximately 9.0 Å. Therefore, 
it would not be possible for the DA to completely fit inside either cavity; as the 
diameter of the α and β-CD cavities are 4.9 and 6.2 Å, respectively. The width of 
the aromatic ring with the hydroxyl groups was calculated to be ~ 6.05 Å, as 
shown in Figure 5.39. 
 
Based on this analysis it is clear that DA cannot form an inclusion complex with 
Sα-CD due to the fact that the diameter of the Sα-CD is not sufficiently large for 
the DA to fit inside the cavity. It is this reason why there is little or no 
complexation observed in the electrochemical studies between DA and Sα-CD. It 
has been reported that benzene can fully fit inside the α-CD cavity;1 however in 
the case of DA, the presence of the hydroxyl groups and the side chain could be 
inhibiting complexation due to their size.  
 
 
 
 
Figure 5.38: An illustration of the diameters of the cavity for neutral α and β CDs.  
α = 4.9 Å
β = 6.2 Å
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Figure 5.39: Illustration of the DA molecule and its orientation using DFT. The 
intermolecular distances from the furthest points are shown. Also shown is the 
proposed geometry of DA inside the Sβ-CD cavity. 
 
For the Sβ-CD, the cavity is just the right diameter to fit the aromatic ring only 
and this consolidates the NMR results presented in Section 5.3.3. This proposed 
structure can also support the electrostatic interactions discussed in Section 
5.3.4.1 where the protonated amine group is interacting with the negatively 
charged sulfonate groups on the secondary rim of the cyclodextrin. It has been 
previously reported that the β-CD is more suitable for the complexation of 
guests than the α-CD due to the size of the cavity. Terekhova et al.61 found that 
the formation constants for the complexation of aminobenzoic acid (ABA), with 
α-CD and β-CD differed due to the ABA guest entering the cavities at different 
depths. 
6.05 Å 
 
 
 
6.44 Å 
 
8.95 Å 
2.73 Å 
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5.3.5 Complexation studies of a related structure to DA 
5.3.5.1 Levodopa 
There are various molecules related to the DA structure. One such molecule is 
Levodopa (L-dopa or 3,4 dihyroxy-L-phenylalanine). Due to its similarity in 
structure to DA, as seen in Figure 5.40 its complexation with Sβ-CD was 
investigated using UV.  
 
 
Figure 5.40: The chemical structure of Levodopa. 
 
 
As the pH is changed, the L-dopa characteristics change. An intra-molecular 
neutralisation reaction leads to a salt-like ion called a zwitterion. At pH < 2.32, 
the amine group is protonated and the carboxylic group is un-dissociated to 
generate a positively charged species.  At pH > 8.11, the carboxyl group can lose 
a hydrogen ion to become negatively charged. Figure 5.41 demonstrates this 
concept, which is characteristic of all amino acids. 
 
 
pKa(COOH) = 2.32               pKa(NH3+) = 8.11 
 
pH < 2.32      2.32 < pH > 8.11       pH > 8.11 
Positive charge       Negative charge 
 
Figure 5.41: Schematic showing the cationic, zwitterionic and anionic forms of 
levodopa.62 
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It is documented in the literature that L-dopa exists as a zwitterion between pH 
2.32 and 8.11.63 In order to generate the protonated species, pH values less than 
a pH of 2.32 were used.  
 
Firstly, UV spectra were used to confirm a 1:1 inclusion complex stoichiometry 
with L-dopa and Sβ-CD.  UV spectra of 1.0 x 10-4 mol dm-3 L-dopa and 1.0 x 10-4 
mol dm-3 Sβ-CD are shown in Figure 5.42. L-dopa and Sβ-CD have a λmax of 280 
and 256 nm, respectively. As discussed previously, Section 5.3.1.1, the 
absorbance from 200 to 260 nm can be attributed to Sβ-CD. Accordingly, all 
measurements made at 280 nm, to follow the L-dopa inclusion events, were 
corrected by subtracting the absorbance of the corresponding Sβ-CD solution at 
280 nm. 
 
 
 
 
Figure 5.42: UV spectra of     1.0 x 10-4 mol dm-3 L-dopa and       1.0 x 10-4 mol dm-3      
Sβ-CD. 
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For this study, the solutions were prepared in a 0.1 mol dm-3 H2SO4 to give a pH 
of 2.0. Equimolar solutions of 1.0 x 10-4 mol dm-3 sβ-CD and 1.0 x 10-4 mol dm-3 
L-dopa were prepared. The UV data were recorded with 11 different solutions, 
where the mole fraction of L-dopa varied from 0.0 to 1.0, in increments of 0.1. 
The Job’s plot was obtained from the absorbance changes at 280 nm in the 
mixtures of Sβ-CD and L-dopa. The UV spectrum of each solution was recorded. 
Typical spectra are shown in Figure 5.43. An increase in complex absorbance 
was observed on increasing the mole fraction of L-dopa. For example, the 
absorbance at 280 nm was 0.032 for an L-dopa mole fraction of 0.1, while the 
absorbance increased to 0.255 when the mole fraction of L-dopa was 0.8. To 
generate the Job’s plot shown in Figure 5.44, the change in the absorbance at a 
wavelength of 280 nm (from that of an equal concentration of free guest) was 
computed using Equation 5.8. 
 
These ∆A values were then multiplied by the corresponding mole fraction, ∆A x 
mole fraction, and the product was plotted as a function of the mole fraction  
([L-dopa]/([L-dopa]+[Sβ-CD])), as shown in Figure 5.44. The maximum 
absorbance value was achieved at the 0.5 mole fraction and this proves that 
these complexes are formed with 1:1, Sβ-CD:L-dopa stoichiometry.  
 
The determination of the formation constant for the complex was computed on 
the same basis as previously calculated for the DA-Sβ-CD complex, Section 
5.3.2.1. Based on the variation in the absorbance at λmax = 280 nm of L-dopa in 
the absence and presence of varying concentrations of Sβ-CD, the formation 
constant (Kf) of the inclusion complex was evaluated using the Heildebrand-
Benesi relationship, Equation 5.1. 
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Figure 5.43: UV spectra for the Job’s plot titration curve with Sβ-CD and L-dopa. From 
low to high absorbance values, the value of [L-dopa]/([ L-dopa]+[ Sβ-CD]) increases 
from 0.0 to 1.0, in increments of 0.1. 
 
  
 
Figure 5.44: Job’s plot curve of UV absorbance change (280 nm) of L-dopa upon the 
addition of Sβ-CD, indicating the formation of 1:1 host-guest complex. 
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A Heildebrand-Benesi plot for the experimental data is demonstrated in Figure 
5.45 showing a good linear relationship with a correlation coefficient of 0.984. 
The linear relationship obtained based on the Hildebrand-Benesi equation, is 
further support for a 1:1 stoichiometry.4 According to Equation 5.1, A0/(A-A0) 
vs. 1/[Sβ-CD] plot, the ratio of the intercept to the slope was used to give a 
formation constant of Kf = 321.02 ± 92.52 in a solution of pH~1. This value is 
close to that obtained with DA, Tables 5.12 and 5.13. This is not surprising as 
the structures are related and it is likely that the aromatic ring resides inside the 
cavity while the protonated amine group is bound electrostatically to the 
anionic sulfonated groups on the rim of the CD. 
 
 
 
 
Figure 5.45: Plot of (A0/A0-A) vs. (1/[Sβ-CD]) for the evaluation of the stability 
constant, (Kf), for L-dopa. Experiments were carried out at pH=1.3. 
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5.3.5.2 Tyrosine 
Tyrosine (Tyr) is an amino acid and similarly to L-dopa exists as a zwitterion. Its 
structure, shown in Figure 5.46, has similarities to DA. Unlike DA and L-dopa, 
Tyr does not readily oxidise at neutral and alkaline pH values. Figure 5.47 
shows its form in the cationic, zwitterionic and anionic form.  
 
 
 
Figure 5.46: The chemical structure of tyrosine. 
 
 
pKa(COOH) = 2.21               pKa(NH3+) = 9.21 
 
 
 
 
pH < 2.21      2.21 < pH > 9.21       pH > 9.21 
Positive charge       Negative charge 
 
 
Figure 5.47: Schematic showing the cationic, zwitterionic and anionic forms of 
Tyrosine.62 
 
 
To investigate the influence of electrostatic interactions, experiments were 
carried out in both acidic and alkaline pH values out of the range where Tyr can 
exist as a zwitterion. Similar to DA and L-dopa, Tyr absorbs in the UV region 
with a λmax = 275 nm. This property allowed the Job’s method to be applied in 
order to confirm stoichiometry of the complex. The UV spectrum of each 
solution was recorded. An increase in complex absorbance was observed on 
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increasing the mole fraction. Figure 5.48 shows the Job’s plot obtained from the 
absorbance changes at 275 nm in the mixtures of Sβ-CD and Tyr. The maximum 
absorbance value was achieved at the 0.5 mole fraction and confirms that these 
complexes are formed with 1:1 (Sβ-CD to Tyr) stoichiometry.  
 
 
 
 
Figure 5.48: Job’s plot curve of UV absorbance change (275 nm) of tyrosine upon the 
addition of Sβ-CD, indicating the formation of 1:1 host-guest complex. pH was 1.44. 
 
 
CV data were obtained at both acidic and alkaline solutions, pH 2.44 and 12.1, 
respectively. Using Equation 5.18 the amount of Tyr protonated at pH 12.1 is 
negligible. Figure 5.49 shows the cyclic voltammogram recorded for 5.00 x 10-4 
mol dm-3 Tyr in the absence and presence of 2.00 x 10-2 mol dm-3 Sβ-CD at pH 
12.1. It is evident from these data that no complexation occurs at this pH as 
there is no shift in the current or the potential at which the Tyr is oxidised. This 
can be explained easily in terms of the charge on the Tyr. At pH 12.1, the 
carboxylate group is dissociated, giving the Tyr a negative charge. It is unlikely 
that this negatively charge Tyr molecule could approach the negatively charged 
sulfonated groups and form an inclusion complex. 
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Figure 5.49: Cyclic voltammograms of Tyr (5.00 x 10−4 mol dm-3) in the absence ♦ and 
presence ♦ of 2.00 x 10-2 mol dm-3 Sβ-CD on GC pH=12.1. Scan rate 50 mV s-1. 
 
 
However, as shown in Figure 5.50 there is evidence for the formation of an 
inclusion complex when the pH is reduced to 2.44. In this figure, there is a 
substantial shift in the peak current and a slight shift in the peak potential. At 
this pH, the Tyr is protonated through the amine group and the carboxylate 
group remains un-dissociated to give a positively charged Tyr species, Figure 
5.47. Accordingly, the Tyr is attracted to the negatively charged Sβ-CD and it is 
likely that the aromatic ring fits inside the cavity while the protonated amine 
binds with the sulfonated groups on the rim of the CD. 
 
In examining these compounds which have similar structures to DA some 
insight into the inclusion complexation of DA with the Sβ-CD can be obtained. 
The stability constant for L-dopa was found to be in good agreement with the 
binding constant values obtained for DA with Sβ-CD in acidified solutions. 
However, it is the results obtained with the Tyr that highlight the contribution 
that electrostatic interactions play in the complexation of DA with Sβ-CD. As it is 
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impossible to study the electrochemistry of DA at pH values of 12, Tyr was 
chosen and the experiments with Tyr clearly show that the protonated Tyr 
species form an inclusion complex, while the anionic Tyr is unable to include 
inside the cavity of the Sβ-CD.  
 
 
 
 
Figure 5.50: Cyclic voltammograms of Tyr (5.00 x 10−4 mol dm-3) in the absence ♦ and 
presence ♦ of 2.00 x 10-2 mol dm-3 Sβ-CD on GC pH=2.44. Scan rate 50 mV s-1. 
 
5.4  Summary of results 
It was demonstrated using spectrophotometric studies that DA can be included 
in Sβ−CD and, in turn, forms an inclusion complex with a 1:1 stoichiometry.    UV 
spectra showed a shift in the wavelength of the DA in the presence of Sβ−CD 
confirming a change in the environment of the DA. The Heildebrand-Benesi 
equation was utilised to evaluate stability constants. The formation of the 
complex and the stoichiometry of DA and Sβ-CD were further confirmed by 
electrochemical studies. The DA oxidation potentials shifted to more elevated 
potentials upon the addition of Sβ-CD, while the potential of the corresponding 
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reduction wave was not influenced by the presence of the Sβ-CD. This means 
that DA is bound more strongly to the host in comparison to the quinone form. 
There was a noticeable change in the peak currents; a decrease as the CD 
concentration was increased. Again this can be attributed to the formation of an 
inclusion complex due to the decrease in the diffusion coefficient of DA. 
Structural information on the inclusion complex was obtained from NMR 
studies. The NMR experiments confirmed the 1:1 inclusion complex and showed 
that the aromatic DA ring was included inside the cavity, while the protonated 
amine was bound through electrostatic interactions to the sulfonated groups on 
the rim of the CD.  
 
The electrochemical, spectroscopic and structural analysis in determining the 
formation constants at a pH of 6.0 are in very close agreement, validating our 
results. Accordingly, any of the methods examined here for the formation of an 
inclusion complex can be recommended as a reliable option to determining the 
formation constants of the inclusion complex of Sβ−CD, with a guest.  
 
The role of charge interactions with the negatively charged CD and the cationic 
DA was investigated using UV and CV by altering the pH. DA at more acidic pH 
displayed a larger binding affinity to Sβ-CD compared to that at higher pH 
values. This is probably due to the charge-charge interaction between the 
negatively charge CD and positively charged guest. In comparing the data 
obtained in these experiments to data found in the literature for the neutral β-
CD, it can be concluded that the negatively charged sulfonate groups on the CD 
play an important role in the complexation and increase the binding affinities in 
the case of protonated DA.  
 
The influence of supporting electrolyte was examined and subsequent analysis 
of CV experiments established that a change in the cation has no influence on 
the DA-Sβ-CD complexation. However, it was verified using CV that a change in 
the anion was significant. The influence of the size of the cavity was also 
considered and after approximate measurements of the diameter of DA using a 
Complexation studies  Chapter 5 
 
- 250 - 
 
DFT method, it was concluded that the DA molecule is too large to fit inside the 
cavity of the Sα-CD cavity but it is sufficient in size for most of it to fit inside the 
Sβ-CD cavity. The CV data of DA in the presence of Sα-CD confirmed this 
analysis. 
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6.1 Introduction 
It is well known that Poly(D,L – lactide-co-glycolide) (PLGA) copolymers can 
facilitate tissue engineering and, in particular, the electrospun nanofiber mat 
has been reported to be an excellent tissue engineering mat.1-4 PLGA was also 
chosen for this study because it, firstly, has been studied extensively for 
biomedical applications due to its biocompatibility and biodegradability 
properties and, secondly, its rate of degradation can be controlled by adjusting 
the ratio of lactic to glycolic acid units.5 However, in the interest of drug delivery 
the use of PLGA offers a great potential, either as a drug delivery system itself 6-8 
or in conjunction with a controlled release device.9  
 
In Chapter 4, the use of polypyrrole (PPy) as a drug delivery system was 
investigated; in this chapter the influence of introducing biodegradable PLGA 
nanofibers under the PPy matrix is explored. Nanostructures offer an increase 
in the surface area compared to their bulk counterparts. For this reason, the 
introduction of the nanofibers was investigated for a potential improvement on 
the uptake and release of dopamine (DA).  
 
The aim of this chapter was to introduce nanotechnology by the formation of 
nanofibers, using the technique of electrospinning. The work presented here 
describes the fabrication and characterisation of the electrospun PLGA fibers 
and the electrochemical deposition of PPy onto the formed substrates. These 
PLGA/PPy electrodes were then used for application in a drug delivery system 
for the controlled release of DA. The PLGA nanofibers were electrospun onto Au 
mylar. The structures were examined using both SEM and optical microscopy. 
PPy was electrochemically and chemically deposited onto the PLGA Au coated 
mylar electrodes which were then characterised using electrochemical 
measurements. The uptake and release of DA was performed using the same 
parameters as previously described in Chapter 3. The release of the drug was 
monitored using UV-visible spectroscopy.  
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6.2 Experimental 
6.2.1 Materials 
6.2.1.1 Reagents 
Poly(D,L – lactide-co-glycolide) (PLGA 50:50) copolymer with an inherent 
viscosity (the ratio of the natural logarithm of the relative viscosity, to the mass 
concentration of the polymer) of 0.59 dL g-1 was kindly donated by Dr. Kerry 
Gilmore, from the IPRI, in the University of Wollongong. The solvents, 
chloroform (CHCl3), N, N dimethylforamide (DMF) and 1,1,1,3,3,3 
hexafluroisopropanol (HFIP) and analytical reagents sodium sulfate (Na2SO4), 
sulfonated β-cyclodextrin (Sβ-CD) and dopamine hydrochloride salt were 
purchased from Aldrich and used as received. Pyrrole (Py) and para-toluene-4-
sulfonic acid sodium salt (PTS, C7H7NaO3S) were obtained from Merck and 
distilled prior to experimental use. Distilled Py was stored in the fridge at low 
temperature in the dark. Potassium ferricyanide (K3FeCN6) was obtained from 
Ajax. 40% Fe(III)/PTS in ethanol was obtained from Dr.Jun Chen from the IPRI, 
in the University of Wollongong. 
 
6.2.1.2 Electrodes and Instruments 
The electrospinning apparatus consisted of a number of pieces of equipment: a 
high voltage power source which was connected to the metallic needle, a digital 
syringe pump and an electrically grounded collector plate made of galvanised 
iron mounted on a stand. A schematic of the experimental set up is shown in 
Figure 6.1. The fibers were electrospun onto 5 x 5 cm cut squares of Au mylar. 
Au mylar was purchased from CPFilms Inc (USA). This material was selected for 
these studies as it is a good conducting substrate, easy to use, and a specific area 
of the deposited fibers can be cut into the dimensions needed for experimental 
analysis. A digital syringe pump (Kd Scientific Pump) and high voltage power 
supply (Gamma High Voltage) were used.  
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Figure 6.1: Schematic diagram of the electrospinning set-up. 
 
Optical Microscopy and SEM were used to study the morphology of the fibers 
obtained and were preformed on a Leica DMEP DFC-280 and a Leica Stereoscan 
440 SEM. The SEM samples were sputtered using an Emitech K550x Gold 
Sputter Coater. These electrospun samples were then cut into strips and an area 
of 5 x 5 mm of the PLGA fibers was exposed. Electrochemical analysis of the 
samples, as well as electropolymerisation of Py using galvanostatic (constant 
current), potentiostatic (constant potential) and cyclic voltammetry (CV) was 
carried out using an Electrochemical EDAQ Potentiostat Model EA160 and a 
Solartron Model SI 1285 potentiostat. UV studies on the release of the DA were 
carried out on a Shimadzu UV – 1601 and a Varian Instruments Cary 50 Conc 
UV-visible spectrophotometer using a 1 cm path length quartz crystal cuvette. 
Finally, a study on the vapour phase deposition of PPy onto the electrospun 
PLGA fibers was performed using a Model WS-400B-6NPP/LITE Spinning 
machine. 
6.2.2 Procedures 
6.2.2.1 Formation of PLGA nanofibers by electrospinning 
For the formation of PLGA fibers, the structure of which is illustrated in Figure 
6.2; solutions of 50:50 PLGA at various concentrations, in the range of 12% to 
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25% by weight, with different ratios of the organic solvents, CHCl3, DMF and 
HFIP (neat CHCl3, CHCl3:DMF at 70:30, neat HFIP by vol%) were prepared and 
left to stir overnight to dissolve. The polymer solution was then placed in the 
syringe and delivered by the syringe pump at various flow rates in the range of 
0.1 – 1.0 mL h-1. The distance from the needle to the collector plate (ground 
electrode) was in the range of 3 – 15 cm; while the positive voltage applied to 
the polymer solution was in the range of 5 – 20 kV. The amount of time used for 
the electrospinning process was varied from 1 to 10 min. A flow of dry air was 
also turned on during electrospinning to minimise bead formation. All 
experiments were carried out at room temperature. For the electrospinning of 
the PLGA fibers onto the Au mylar substrate, a metal iron template was welded 
to the collector plate and 5 x 5 cm samples of Au coated mylar were cut out, 
washed with acetone, dried, and clipped onto the template with the conducting 
side facing the needle. It is also important to note that the electrospun PLGA 
fibers are non-conducting. 
 
 
 
 
Figure 6.2: Structure of PLGA. 
 
6.2.2.2 Formation of electrospun fibers containing DA 
From a 20% PLGA in HFIP solution, 1 mL was transferred to a clean vile and 1 
wt % (0.01 g) DA was added and left to stir on heat for ~ 24 hr to dissolve. This 
solution was then placed in the electrospinning set up, and using a flow rate of 
0.2 mL h-1 at a distance of 7 cm from the needle to the collector plate (ground 
electrode), a positive voltage of 20 kV was applied to the polymer solution. The 
samples were then cut into 5 x 5 mm areas and placed in a 1 mL artificial 
cerebrospinal fluid (CSF) and left at 22 0C. The solution was monitored over 
time using UV-visible spectroscopy, for the presence of DA. 
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6.2.2.3 Optical microscopy and SEM sample preparation and imaging 
The image processing and analysis to study the formation of fibers as a function 
of the various parameters applied were performed using optical and SEM 
imaging techniques. Samples were electrospun where a variety of parameters 
were altered and images were taken using both techniques. For the optical 
images, PLGA fibers were electrospun onto both glass slides and Au mylar. In 
the case of SEM, the Au mylar substrate was sputtered with a thin coat of gold 
prior to analysis. Images were also taken before and after the polymerisation of 
Py onto the fibers. 
 
6.2.2.4 Electrochemical analysis 
Electrochemical experiments were preformed using an EDAQ system, with a 
conventional three-electrode system. An Ag/AgCl (3.0 mol dm-3 NaCl) and a 
platinum wire mesh electrode were used as reference and auxiliary electrode, 
respectively. Electrospun samples mounted on the Au mylar substrate were 
used as the working electrode. These samples were electrospun from a 20 % 
PLGA in HFIP solution at a distance of 7 cm, diameter of the needle of 0.49 mm, 
at a feeding rate of 0.2 and 0.8 mL h-1 and at potentials of 5, 10, 15 and 20 kV. In 
addition, the difference between fibers spun for 1 min and for 15 min was 
examined. The nanofibers on Au coated mylar were cut into strips with a 
diameter of 5 mm. A surface area of 5 x 5 mm was subjected to the solution and 
the samples were swept through a potential of –0.600 to 0.600 V vs. Ag/AgCl at 
a scan rate of 100 mV s-1. For comparative studies, bare Au mylar was used. CV 
was used to investigate the electrochemical properties of the PLGA fibers. In all 
cases, a 0.25 cm2 surface area of the sample was immersed in the electrolyte 
solution, 0.01 mol dm-3 K3FeCN6 in 0.10 mol dm-3 KCl, where the potential was 
swept from -0.600 to 0.600 V vs. Ag/AgCl at 100 mV s-1. In order to determine 
the stability of the substrate, electrospun PLGA fiber samples were cycled 
between -0.300 to 0.900 V vs. Ag/AgCl for 100 cycles in 0.01 mol dm-3 K3FeCN6 
in a 0.10 mol dm-3 KCl, supporting electrolyte. 
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6.2.2.5 Polymerisation of pyrrole 
The synthesis of PPy was carried out using an electro-synthesis method, which 
deposited the polymer film at the working electrode. In order to investigate 
which polymerisation technique maintained the greatest nanofiber morphology 
on the PLGA fiber mat, polymers were prepared using different electrochemical 
deposition approaches in a 0.10 mol dm-3 para-toluene-4-sulfonic (PTS) acid 
sodium salt solution containing 0.20 mol dm-3 Py. PPy was grown in a 
conventional three-electrode cell where a Ag/AgCl (3.0 mol dm-3 NaCl) and a 
platinum wire mesh electrode were used as reference and auxiliary electrode, 
respectively, and the working electrode was bare Au coated mylar or Au coated 
mylar with electrospun PLGA fibers, with an electrode surface area of 0.25 cm2. 
The various techniques employed included constant potential (V), constant 
current (I) and CV. For constant potential polymerisation, 0.700 V vs. Ag/AgCl 
was applied until a sufficient charge was passed. In the constant current 
experiments a current of 1 mA cm-2 was applied, and for CV, the potential was 
swept between 0.000 to 0.800 V vs. Ag/AgCl at 50 mV s-1, where the cycle 
number was varied. For the uptake and release of DA, the polymers were 
prepared using 1.00 x 10-2 mol dm-3 sulfonated β−cyclodextrin solution 
containing 0.20 mol dm-3 Py using various parameters depending on the 
technique used. 
 
The vapourisation phase polymerisation of Py was also investigated. In using 
this method two systems were studied. The first was where the oxidant was 
added to the polymer solution prior to electrospinning. In this case, 0.5 mL of 
20% PLGA in HFIP and 0.02 mL of the oxidant, 40% Fe(III)/PTS in ethanol, were 
mixed and left to stand for 60 min before electrospinning. Then, the fibers were 
electrospun using the same conditions outlined in Section 6.2.2.1. The second 
method involved previously electrospun 20 % PLGA samples from HFIP at a 
flow rate of 0.2 mL h-1, at 20 kV and at a distance of 7 cm for 1 min. These 
samples were subjected to two drops of the oxidant and spin coated at 1000 
rpm for 5 s; the oxidant was then flashed off using a hot plate and placed in a 
chamber containing 5 mL of the Py monomer. After 20 min the samples were 
removed and left to dry for 60 min. The samples were then placed in ethanol for 
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20 min in order to wash off any of the oxidant remaining on the sample and 
were allowed to dry prior to analysis using optical microscopy. 
 
6.2.2.6 Incorporation and release of DA 
The samples electrospun for use in these experiments are as follows: 20 % 
PLGA in 1,1,1,3,3,3 hexafluroisopropanol (HFIP) and electrospun onto Au mylar 
at 0.2 mL h-1 at 20 kV at a diameter of 0.49 mm and a distance of ~ 7 cm for 1 
min. In all cases, a 5 x 5 mm sample dimension was used giving a 0.25 cm2 
surface area. The electrochemical deposition of PPy was achieved using cyclic 
voltammetry, where the potential was swept in a 0.2 mol dm-3 Py and 0.01 mol 
dm-3 Sβ-CD solutions, from 0.000 to 0.800 V vs. Ag/AgCl, at various scan rates, 
for a numerous number of cycles ranging from 5 to 100 cycles. 
 
These prepared polymers were then immersed in a 0.10 mol dm-3 DA solution in 
a supporting electrolyte of 0.10 mol dm-3 Na2SO4 solution and reduced at a 
potential of –0.900 V vs. Ag/AgCl for 30 min. This gave rise to the incorporation 
of DA, as detailed in Chapter 4. The sample was then transferred to a 0.10 mol 
dm-3 Na2SO4 solution and held at a reduction potential, –0.900 V vs. Ag/AgCl, in 
order to remove any excess DA on the surface. The sample was finally 
transferred to an electrochemical cell, containing 25 mL of 0.10 mol dm-3 
Na2SO4 solution and a stirring bead, and an oxidation potential of 0.100 V vs. 
Ag/AgCl was applied to stimulate the release of the incorporated DA. A sample 
of the solution was removed every 10 min for the 60 min and monitored using 
UV-visible spectroscopy to give the concentration of DA released from the 
polymer/fiber sample.  
6.3 Results and Discussion 
6.3.1 Electrospinning of PLGA fibers 
Over the past 20 years extensive efforts have been made to develop a controlled 
drug release system using biocompatible polymers. In this study, as well as 
using PPy which is biocompatible10, the use of poly(lactide-co-glycolide) (PLGA) 
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was chosen for its biodegradability properties, its biocompatibility and its 
approval by the Food and Drug Administration (FDA).11-13  
 
Electrospinning involves the application of an applied voltage to a needle or 
capillary connected to a syringe or reservoir containing the polymer solution. 
Upon application of an electric field, a conical shaped cone develops at the 
needle tip which is known as the Taylor cone. A schematic is shown in Figure 
6.1. After a critical point, the electrostatic forces overcome the surface tension 
and a charged jet is ejected. This charged jet then undergoes a whipping 
process, leading to the formation of a fiber at the grounded electrode collector. 
 
In order to obtain a uniform film, a stable continuous flow is required. In the 
formation of the electrospun PLGA fibers, a number of parameters were varied 
in order to achieve the optimum electrospinning system and to yield uniform 
nanofibers. The parameters that were varied included the solvent system, the 
applied voltage, the flow rate and the distance from the needle to the collector 
and the substrate. The main defect that is common and undesirable is 
beading.14-16 The formation of beads reduces the otherwise large surface area, 
which is the desired feature, in the creation of nanoscale structures. 
 
Here, results are presented on the influence of varying the solvent, the applied 
voltage, the flow rate, and the distance from the needle to the collector and the 
substrate, as well as elimination of the bead formation. 
 
6.3.1.1 Varying the voltage applied 
When a high voltage is subjected to the polymer solution, which is retained by 
its surface tension, repulsion charges opposite to the surface tension give rise to 
what is well known as the Taylor cone.17-20 After a critical point, where the 
surface tension is overcome, a charged jet of the polymer solution is ejected 
from the needle tip of the cone. Generally, it has been established that increasing 
the applied voltage increases the deposition rate due to the higher mass flow 
from the needle tip.21 
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A 25% PLGA (50:50) polymer solution in 70:30 CHCl3:DMF solvent mix was 
prepared and placed in the syringe. The diameter of the syringe was 0.49 mm 
and the distance from the syringe tip to the collector plate was ~ 8 cm. In each 
case the sample was electrospun for 1 min on a glass slide, in the presence of 
air, and analysed under an optical microscope. In Figure 6.3 images were 
attained at a feeding rate of 0.2 mL h-1, where the voltage was varied from 5-20 
kV. On analysing the images it was observed that as the voltage was increased 
there was a significant increase in the amount of fibers collected on the sample. 
It is also significant that as the voltage increased the diameter of the fibers 
decreased. The formation of beads also changed as evident from image (B) and 
image (D) of Figure 6.3. As the voltage was increased the fiber diameter 
decreased due to the simultaneous stretching effect of the charged fibers. This 
also affected the shape of the bead as the stretching of the jet revealed a spindle 
shape. At these higher voltages the surface tension is no longer dominant in the 
fiber formation shape. It is also reported that the application of higher voltages 
leads to a higher electrostatic repulsion force between the needle tip and the 
collector, which serves to increase the drawing tension and thus decreases the 
beading size.22 It is evident from Figure 6.3 that as the voltage was increased the 
extent of the bead formation decreased.  
 
These results are in good agreement with literature reports as it is well 
documented that increasing the applied voltage in the electrospinning process 
produces thinner fibers.23-26 Li et al.26 reported that initially with an increase of 
applied voltage, the nanofiber diameter of Polyvinylalcohol (PVA) decreased but 
at a certain point, began to increase again. Deitzel et al.23 investigated the 
parameters involved in electrospinning poly(ethylene oxide) (PEO). They 
reported that the flow rate, voltage, solution concentration, and surface tension 
were all major factors in the electrospinning process of this polymer solution. In 
the case of applied voltage they found that as the voltage was increased a 
change in the originating droplet shape was observed. This change 
corresponded to a decrease in the stability of the liquid jet, and therefore 
increasing the applied voltage lead to an increase in the number of bead defects 
that formed along the fibers. 
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Figure 6.3: Optical images of 1 min electrospun 25 % PLGA (50:50) in 70:30 
CHCl3:DMF on a glass slide at 0.2 mL h-1, diameter of 0.49 mm and a distance of ~ 8 cm 
at an applied voltage of A) 5 kV B)  10 kV C)  15 kV D)  20 kV. Highlighted areas mark 
beading. 
 
 
The authors overcame the presence of beading by creating more viscous 
solutions (i.e. higher concentrations of PEO). Contrary to Dietzel and co-
workers, Zuo and colleagues reported that increasing the applied voltage leads 
to smaller beads and at a critical point elimination of beading altogether.14 
Baumgart27 while electrospinning acrylic fibers observed an increase in fiber 
length with an increase in applied voltage, while Zong and co-workers 
confirmed that an increase in the applied electrospinning voltage altered the 
shape of the initial droplet.28  
 
A B
C D
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6.3.1.2 Varying the solvent and solution concentration 
The solvent must be a volatile liquid, as when the process is taking place, the 
solvent must evaporate in order to form the solid fiber on the collector plate.25 
As the charged jet leaves the needle tip the increase in surface area enhances 
the rate of evaporation of the volatile solvent which results in a charged, solid 
polymer fiber. However, if the rate of evaporation is too high, i.e., the solvent is 
very volatile, the evaporation process occurs too fast on the outer surface of the 
polymer jet. This gives rise to a fixed outer polymer surface before the solvent 
content is entirely lost.29 
 
A 20% PLGA solution in chloroform was used for the electrospinning process. 
However, in this case at no point was a continuous jet of fiber obtained. You et 
al.30 suggest that the viscosity of PLGA is important. The authors state that at 
~15 % PLGA, the viscosity stabilises the polymer solution expelled and allows 
the fibers to form as the solvent disperses. In light of this, the polymer solution 
was diluted down to ~17 % PLGA with chloroform, but once again no fibers 
were formed. Contrary to You and co-workers30, this suggests that chloroform 
was not a suitable solvent for this PLGA system.  
 
Another solvent was introduced, N, N dimethylforamide (DMF), which has a 
lower vapour pressure than chloroform (3.7 mm Hg compared to 190.2 mm Hg 
for chloroform). Shawon and Sung31 believe that the vapour pressure of the 
solvent is important as it is an indication of a liquid's evaporation rate. The 
higher the vapour pressure at normal temperature the greater the evaporation 
rate of the solvent. They found that in the electrospinning process of 
polycarbonate the higher ratios of THF to DMF solvent mixtures gave rise to 
rapid solvent evaporation. This was attributed to the vapour pressure of THF, 
and the authors reported that the capability to generate more fibers than beads, 
was lost. 
 
Subsequently, with evaporation rates taken into account, a 12 % PLGA (50:50) 
polymer solution in 70:30 CHCl3:DMF was prepared. This time the 
electrospinning observed was promising and a continuous uniform flow of the 
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polymer material was observed which yielded the formation of fibers, as shown 
in Figure 6.4. This sample was achieved using a feeding rate of 0.6 mL h-1, a 
distance ~ 10 cm, diameter of 0.49 mm and a voltage of 15 kV on a glass slide. 
When the sample was examined under the optical microscope, particles were 
observed. The observation of particles on the optical image has been well 
documented and indicated that the polymer concentration, and therefore the 
viscosity, was still not high enough.15, 30 
 
Consequently, the concentration of the polymer solution was increased to 25 % 
PLGA (50:50) in 70:30 CHCl3:DMF. This polymer solution was electrospun 
under the following conditions: the feeding rate was varied from 1.0 to 0.15 mL 
h-1, distance ~ 10 cm, diameter 0.49 mm and a voltage of 15 kV. Although fibers 
were formed there was a significant amount of beading, as shown in Figure 6.5 
(A). Another sample was obtained at a higher flow rate of 0.3 mL h-1 at 15 kV in 
the presence of air, Figure 6.5 (B), where the formation of beading was reduced 
slightly. 
 
 
 
 
Figure 6.4: An optical image taken of 12% PLGA in 70:30 CHCl3:DMF on glass at a flow 
rate of of 0.6 mL h-1, at 15 kV. 
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Figure 6.5: Optical images of 25 % PLGA in 70:30 CHCl3:DMF on a glass slide, A) at a 
flow rate of 0.15 mL h-1 at 15 kV. B) at a flow rate of 0.3 mL h-1 in the presence of air at 
15 kV. 
 
 
As beading was still present with all the electrospun fibers, a third solvent 
system was chosen. In this case, the solvent, HFIP, was used to prepare a 15 % 
PLGA (50:50) solution. HFIP was chosen as a fellow colleague was working on a 
similar electrospinning process and found this solvent system formed the 
optimum fibers. Fibers were electrospun at a flow rate of 0.4 mL h-1 at a 
distance of 8 cm, diameter 0.49 mm at 15 kV in the presence of air. However, 
particles were observed once again, as seen in Figure 6.6, and so the 
concentration was increased to 20 % PLGA (50:50) in HFIP. From the 20 % 
PLGA (50:50) in HFIP, samples were obtained as shown in Figure 6.7. In this 
instance a constant flow rate of 0.4 mL h-1 was used and the voltage applied was 
varied. In all circumstances beading was observed. However, as the applied 
voltage was increased the extent of bead formation decreased, as shown from a 
comparison of images (A) and (D) in Figure 6.7. The reason for this has been 
previously discussed in Section 6.3.1.1. 
 
It is evident in the literature that the concentration of the polymer solution 
influences the morphology and structure of the electrospun fibers.23, 28 Taking a 
look at the difference between 15% and 20% PLGA in HFIP using the same 
parameters, Figure 6.6 (B) and Figure 6.7 (C), respectively it is evident that a 
considerable change in the morphology is observed.  
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Similar to the results obtained here by varying the concentration of the PLGA 
polymer solution, Zong et al.28 observed extreme morphology changes as the 
concentration of poly(D,L-lactic acid) (PDLA) was increased. They found that 
the concentration or viscosity was the most effective parameter in controlling 
the morphology of the electrospun fibers. 
 
Beading is a common problem in the electrospinning of fibers.15, 23 Fong et al.15 
also found that viscosity, surface tension and the net charges all influenced the 
morphology of electrospun PEO fibers. The authors demonstrated that an 
increase in the net charge density favours formation of small diameter fibers. 
 
 
 
 
Figure 6.6: Optical images for 1 min of electrospun 15 % PLGA (50:50) in HFIP on glass 
at 15 kV and a distance of 8 cm and a feeding rate of A) 0.2 mL h-1 B) 0.4 mL h-1. 
 
However, further work on the HFIP solvent system gave rise to bead-free fibers. 
Figure 6.8 shows SEM images of both 70:30 CHCl3:DMF and HFIP solvent 
systems. Beading is prominent in the case of the 70:30 CHCl3:DMF solvent mix, 
where  as in the presence of HFIP, an improved fiber mat was obtained. In these 
cases a high applied voltage of 20 kV was used with a flow rate of 0.2 mL h-1. It 
appears that the HFIP solvent system at low flow rates gives rise to the 
optimum conditions (viscosity, volatility, surface tension etc,) needed to 
generate the bead free fibers. 
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Figure 6.7: Optical images for 1 min of electrospun 20 % PLGA (50:50) in HFIP on glass 
at a constant feeding rate of 0.4 mL h-1, a distance of 8 cm and a voltage of A) 5 kV B) 10 
kV C) 15 kV D) 20 kV. 
 
 
 
 
Figure 6.8: SEM images of 1 min electrospun 20 % PLGA (50:50) on a Au coated mylar 
at 7 cm distance, applied potential of 20 kV and a flow rate of 0.2 mL h-1, A) 70:30 
CHCl3:DMF, B) HFIP. 
 
 
With this new solvent system the feeding rate, the distance between the tip and 
collector and the substrate at which the fibers were collected was investigated. 
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6.3.1.3 Varying the feeding rate  
In order to form a Taylor cone a certain minimum volume of solution is required 
at the tip of the needle.28 Variation of the solution volume facilitates the 
generation of polymer fibers with different morphologies. In keeping with the 
applied voltage of 20 kV, fibers were electrospun from a 20 % PLGA (50:50) in 
HFIP solution on a glass slide at a diameter of 0.49 mm and a distance of ~ 7 cm, 
the flow rate was varied from 0.2 mL h-1 to 0.8 mL h-1. Figure 6.9 shows 
representative images for each sample generated. At a feeding rate of 0.2 mL h-1, 
a fiber diameter of < 0.8 µm was obtained while at a feeding rate of 0.8 mL h-1, a 
fiber diameter of ~ 1.0 µm was generated. Also, an increase in the amount of 
beading as the flow rate was increased was evident. Significant beading at       
0.4 mL h-1 was observed. Overall, a feeding rate of 0.2 mL h-1 achieved the best 
fibrous network, with a high density of fibers.  
 
It is well documented in the literature that the flow rate has an influence on the 
diameter of the fibers produced. Son and co-workers32 investigated many 
parameters in the electrospinning of cellulose acetate (CA). They found in the 
case of varying the flow rate that the average fiber diameter increased with 
increasing flow rate. Li et al.25 also stated that the higher the feeding rate, the 
greater the thickness of the fibers formed. 
 
These experiments were a good way of optimising the fiber formation; however, 
beading was still present. In examining the applied voltage and the feeding rate 
it appears that an applied voltage in the range of 15 to 20 kV and the feeding or 
flow rate of 0.2 mL h-1 produces the best fibrous mat. 
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Figure 6.9: Optical images of 1 min electrospun 20 % PLGA (50:50) in HFIP on a glass 
slide at 20 kV, diameter of 0.49 mm and a distance of ~ 7 cm at a flow rate of A) 0.2 mL 
h-1 B) 0.4 mL h-1 C) 0.6 mL h-1 D) 0.8 mL h-1. 
 
6.3.1.4 Varying the distance from needle tip to collector  
To continue on in the variation of parameters, Figure 6.10 shows the influence 
of the distance from the needle to the collector plate on fiber formation. Samples 
were electrospun at a constant flow rate of 0.2 mL h-1 at 15 kV. In terms of these 
results a significant difference was observed. As the distance between the 
collector plate and the needle tip was decreased to 3 cm, a thicker film was 
acquired. A significant amount of beading was observed at needle to collector 
distances of 14 and 10 cm, while more fibers and less beading were evident at 7 
cm. This result is consistent with the results obtained by Zuo and co-workers14, 
and Lee and colleagues22 in the electrospinning of poly(hydroxybutyrate-co-
valerate) (PHBV) and polystyrene (PS), respectively. As the tip to collector 
distance, is increased the electrostatic force decreases, giving rise to a higher 
bead formation.22 
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Figure 6.10: Optical images for 1 min of electrospun 20 % PLGA (50:50) in HFIP on 
glass at a constant flow rate of 0.2 mL h-1 at 15 kV where the distance was A) 14 cm B) 
10 cm C) 7 cm D) 3 cm. 
 
6.3.1.5 Varying the substrate 
Finally, an investigation into the substrate on which the fibers were collected 
was examined. Initially samples were collected on glass slides. In order to 
achieve electrochemical polymerisation of Py and uptake and release of DA, a 
conductive substrate was needed. In this case Au coated mylar was chosen as 
the substrate. In comparing the samples obtained on glass slides, which are non-
conducting, to the Au coated mylar which is conducting, 20 % PLGA (50:50) in 
HFIP polymer solution electrospun samples were obtained and analysed. Figure 
6.11 show the optical images of 1 min electrospun 20 % PLGA in HFIP at a 
distance of 7 cm and at an applied potential of 20 kV on glass and Au mylar. No 
beading was observed at the Au mylar substrate. Figure 6.11 (A) and (C) show 
electrospun fibers on glass slides at different flow rates, and it is clear that the 
beading persists; it is also evident that at the higher flow rate, the presence of 
beading in more prominent. Again, this feature was previously discussed in 
Section 6.3.1.2.  
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Figure 6.11: Optical images of 1 min electrospun 20 % PLGA in HFIP at a distance of 7 
cm at 0.2 mL h-1 at an applied potential of 20 kV on A) glass and B) Au mylar, and 0.8 
mL h-1 on C) glass and D) Au mylar. 
 
 
The absence of the beading on the electrospun Au mylar samples clearly 
demonstrate that the substrate has a significant affect on the nature of the fibers 
formed. This feature correlates with results obtained by Liu et al.33, who 
examined the effect of the collectors (substrates) on the nature of the fibers 
formed when electrospinning cellulose acetate (CA). The authors reported that 
the nature of the collector can affect the diffusion and evaporation of the 
residual solvent which influences the fiber structure. They also state that an 
electrically conducting collector is more favourable than a non-conducting 
substrate as it leads to a more tightly packed and thick membrane structure. 
Conducting substrates provide a sink for generated electric charges, which 
reduces inter-fiber repulsion and yields a more loosely packed fibrous network. 
Similar interpretations have been reported in the electrospinning of PEO, that is, 
more fibers are collected when a metal screen is used as a collector in 
comparison to those collected on cloth.18 These results demonstrate that the 
fiber morphology and arrangement can be controlled by varying the 
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conductivity and geometry of the collector and they are consistent with the data 
presented here for the PLGA system. Figure 6.12 shows SEM images of 20 % 
PLGA in HFIP electrospun onto Au coated mylar at a distance of 7 cm, at a 
feeding rate of 0.8 mL h-1, and a potential of 20 kV for 15 min. In the case of 
Figure 6.12 (B) the diameter of the fiber was calculated using the SEM software 
to be approximately 300 nm.  
 
 
 
Figure 6.12: SEM micrographs of 20 % PLGA in HFIP electrospun onto Au coated mylar 
at a distance of 7 cm, at a feeding rate of 0.8 mL h-1, and a potential of 20 kV, for 15 min. 
 
6.3.2 Incorporation of DA into the polymer solution prior to 
electrospinning 
In the past decade electrospinning has been used to prepare membranes for 
biomedical applications, such as tissue engineering, drug delivery and wound 
healing. 34-38  
 
The initial aim of these experiments was to, (i) compare the fibers formed via 
electrospinning of 20% PLGA in HFIP in the absence and presence of 5 wt % DA 
hydrochloride salt and, (ii) to monitor the natural degradation of the 
electrospun polymer mat to establish if the DA is incorporated during the 
electrospinning process. Figure 6.13 shows the optical images taken after 20% 
PLGA in HFIP was electrospun at a feeding rate of 0.2 mL h-1 at 20 kV in the 
absence and presence of 5 wt % DA hydrochloride salt. Figure 6.14 shows the 
corresponding SEM images. From the image presented in Figure 6.14 (B), a 
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coating was observed in various areas around the sample. After analysis of the 
electrospun samples it was concluded that these observations were from the 
change in the composition of the polymer solution due to the addition of the 
salt, which decreased the stability of the fiber spinning process.30 
 
 
 
 
Figure 6.13: Optical images of electrospun 20 % PLGA in HFIP electrospun at a feeding 
rate of 0.2 mL h-1 at 20 kV on Au mylar for 1 min.  A) in the absence and B) presence of 
5 wt % DA. 
 
 
 
Figure 6.14: SEM images of electrospun 20 % PLGA in HFIP at a feeding rate of 0.2 mL 
h-1 at 20 kV shown in A) absence and B) presence of 5 wt % DA hydrochloride salt. 
 
 
Nevertheless, an experiment monitoring the degradation of the fibers over one 
month was conducted. The degradation of the polymer was monitored using 
A B
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UV-visible spectroscopy. As shown previously, in Chapter 4, DA absorbs in the 
UV region and has a λmax = 280 nm.  Figure 6.15 shows the UV data obtained for 
DL Lactic acid, a degradation product of the PLGA polymer, which also shows 
absorbance in the same region as DA. Figure 6.16 is the absorbance as a function 
of time observed from the samples at 256 nm. From this figure it is evident that 
the degradation process of the fibers was initiated. Figure 6.17 is the 
absorbance as a function of time observed from the samples at 280 nm. From 
this figure, the absorbance observed over time is due to the degradation of the 
electrospun PLGA fibers; there was no evidence to suggest any DA was 
encapsulated in the electrospun fibers. Contrary, to these results, it is well 
documented in the literature that encapsulation and release of drug-loaded 
electrospun samples is a promising field.28, 35, 39 
 
The incorporation of DA during the electrospinning process may not be a viable 
option. This can be attributed to the fact that DA is highly soluble in water and, 
consequently, insoluble in non-polar organic solvents. The PLGA polymer 
solution is dissolved in HFIP and after addition of the solid DA, remnants of 
undissolved DA powder is evident in the solution. 
 
 
 
Figure 6.15: UV spectrum of DL Lactic acid. 
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Figure 6.16: Absorbance recorded at 256 nm for an electrospun sample of 20 % PLGA 
in HFIP. The samples were immersed in 1 mL of CSF where the UV spectra were taken 
over a number of days. 
 
 
Figure 6.17: Absorbance as a function of time for an electrospun sample of 20 % PLGA 
in HFIP in the absence and presence of DA. The samples were immersed in 1 mL of CSF 
where the UV spectra were taken over a number of days. ♦is PLGA in the absence and 
 in the presence of DA. 
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Liao et al.40 studied the encapsulation and release studies of rhodamine B in 
electrospun PLGA fiber mats. Rhodamine B was dissolved firstly in distilled 
water then added dropwise to the solvent mixture of CHCl3:DMF with stirring. 
The authors successfully monitored rhodamine B release using fluorescence, 
and thus, a type of tissue engineering scaffold was created with desirable and 
controllable drug encapsulation/release properties. Kenawy and co-workers 
also achieved release of tetracycline from electrospun mats of PEVA, PLA and 
blends of these polymers. Tetracycline was solubilised in methanol and added 
to the polymer solutions prior to electrospinning. They achieved drug release 
over 5 days.39 
 
All of the above mentioned literature reports focused on the drug loaded 
composite nanofibers electrospun using a mixture of the drug and the polymer, 
both of which were dissolved in the same solvent. This method can lead to 
problems in the release of the drug, as the drug particles tend to situate on the 
fiber surface due to rapid evaporation of the solvent.6 In contrast, a technique 
involving the electrochemical deposition of PPy onto the electrospun fibers was 
investigated. It has previously been shown in Chapter 3, as well as in the 
literature, that PPy is an appropriate material for the uptake and release of 
compounds due to its redox properties.41, 42 This can stimulate more effective 
drug release. The presence of the electrospun nanofiber matrix should enhance 
the surface area which, in turn, may increase the amount of drug released. 
Firstly, electrochemical characterisation on the PLGA nanofiber mats was 
carried out in order to clarify if the electrochemical deposition of PPy would be 
possible, at these non-conducting fibers. 
 
6.3.3 Electrochemical Characterisation 
CV is a technique commonly used to study the electrochemical behaviour and 
properties of many new materials. Once the parameters of the electrospun 
samples had been optimised, the electrochemical behaviour of the Au mylar 
with the electrospun PLGA nanofibers were studied using the voltammetric 
response of potassium ferricyanide. The one electron reduction of ferricyanide 
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to ferrocyanide is a standard used to demonstrate the electrochemical 
properties of many substrates, as reported in the literature. This redox couple 
demonstrates nearly reversible electrode kinetics, without any complications. 
CV in 0.01 mol dm-3 K3FeCN6 solution was performed to characterise the 
electrochemical reactivity of the films. In Figure 6.18, the CV data for the 
reduction of ferricyanide (0.01 mol dm-3) to ferrocyanide in the supporting 
electrolyte solution of KCl (0.10 mol dm-3) at a Au mylar substrate with 
electrospun PLGA nanofibers are shown. The resistance or conductivity of the 
working electrode will determine the position of the oxidation and reduction 
peaks. As evident from the data shown in this figure, this material holds good 
electronic properties. This voltammogram in the potential range of -0.600 to 
0.600 V vs. Ag/AgCl shows a well defined pair of redox peaks. The Ip(a)/Ip(c) was 
almost unity and the anodic peak, Epa, appears at ~ 0.26 V vs. Ag/AgCl which 
corresponds to the oxidation of the ferrocyanide to ferricyanide. Upon reversal 
of the potential, a cathodic peak, Epc, at ~ 0.15 V vs. Ag/AgCl is observed and is 
associated with the reduction of ferricyanide back to ferrocyanide, as shown in 
Scheme 6.1. The ∆Ep value of 112 mV is somewhat higher than the value of 95 
and 99 mV which has been reported for the ferricyanide/ferrocyanide system at 
bare and modified gold electrodes, respectively.43, 44 Nevertheless, the Au 
mylar/electrospun fiber substrate shows good reversibility for the 
ferricyanide/ferrocyanide system. 
 
[Fe(CN)6]3- + e-   [Fe(CN)6]4- 
 
    ferricyanide Fe(III)     ferrocyanide Fe(II)   
 
Scheme 6.1: Reduction of ferricyanide to ferrocyanide. 
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Figure 6.18: Cyclic voltammogram of K3FeCN6 (1.0 x 10−2 mol dm-3) on electrospun 
PLGA fibers on Au mylar. The potential was swept from –0.600 to 0.600 V vs. Ag/AgCl 
at a scan rate 100 mV s-1. 
 
 
Figure 6.19 shows the affect of the thickness of the PLGA electrospun fibers, on 
the Au mylar. This figure shows results of CV data for two samples which were 
electrospun for 1 and 15 min. As seen in this figure, there is a significant drop in 
the current between a sample electrospun for 1 min and one electrospun for 15 
min. For example, the anodic peak current has dropped from 1.156 x 10-3 to 
3.458 x 10-4 A cm-2 on changing from a 1 to 15 min electrospun sample, 
respectively. These data confirm that time has a significant influence on the 
thickness of the fibers obtained on the substrate, and the more time subjected to 
electrospinning process, the thicker the PLGA fibrous mat. Longer spinning 
periods increase the thickness of the fibers and decrease the porosity of the mat. 
This inhibits the electrochemical activity of the fiber coated Au mylar and the 
insulating properties of the PLGA fibers are accentuated. 
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Figure 6.19: Cyclic voltammograms of K3FeCN6 (1.0 x 10−2 mol dm-3) in KCl (0.1 mol 
dm-3). The potential was swept from –0.600 to 0.600 V vs. Ag/AgCl at a scan rate 100 
mV s-1. Samples were electrospun at 0.8 mL h-1 at 20 kV for        1 min          15 min. 
        
In order to verify experimental reproducibility, a number of samples were 
fabricated and investigated. Figure 6.20 shows CV data for two separate 
samples of electrospun PLGA onto Au mylar at 0.2 mL h-1 at 20 kV for 1 min. The 
samples were subsequently cycled in 1.0 x 10−2 mol dm-3 K3FeCN6 in 0.10 mol  
dm-3 KCl where the potential was swept from –0.600 to 0.600 V vs. Ag/AgCl at a 
scan rate 100 mV s-1. As evident from this figure similar results were obtained 
for each sample. However, in some cases CV data were found to deviate when 
electrospun samples were taken from different electrode areas. Therefore, care 
was taken in all subsequent experiments and an appropriate area from the 
centre of the electrospun fibers was cut. 
 
In order to determine the stability of the substrate, a sample was cycled 
between -0.300 to 0.900 V vs. Ag/AgCl for 100 cycles at a scan rate 100 mV s-1. 
Figure 6.21 shows an electrospun sample cycled in 1.0 x 10−2 mol dm-3 K3FeCN6 
in 0.10 mol dm-3 KCl. In this figure, cycle 10 and 90 are shown; no change in 
redox properties was observed.  
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Figure 6.20: Cyclic voltammograms of K3FeCN6 (1.0 x 10−2 mol dm-3) in KCl (0.10 mol 
dm-3). The potential was swept from –0.600 to 0.600 V vs. Ag/AgCl at a scan rate 100 
mV s-1. Both samples were electrospun at 0.2 mL h-1 at 20 kV for 1 min. 
 
 
Figure 6.21: Cyclic voltammograms of K3FeCN6 (1.0 x 10−2 mol dm-3) in KCl (1.0 x 10−1 
mol dm-3). The potential was swept from –0.300 to 0.900 V vs. Ag/AgCl at a scan rate of 
100 mV s-1 for 100 cycles. Samples were electrospun from 20 % PLGA in HFIP at 0.2 mL 
h-1 at 20 kV for 1 min.          Cycle 10      Cycle 90. 
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In increasing the potential window however, as shown in Figure 6.22, where a 
sample was swept between -0.300 to 1.100 V vs. Ag/AgCl for 20 cycles at a scan 
rate of 100 mV s-1, all electrochemical activity was lost after 5 cycles. If the 
nanofibers degraded after 5 cycles, we would expect a corresponding increase 
in the FeCN63-/4- peak currents. This is justified in that a larger surface area of Au 
mylar should be available for the electrochemical reaction to take place. 
However, the peak current diminishes until it disappears suggesting that at 
these high oxidation potentials there is oxidation at the gold and loss of the gold 
surface from the mylar. This is probably due to the oxygen evolution at the 
electrode surface affecting the Au coated layer on the mylar. Indeed, this is 
consistent with the sharp increase in current at potentials higher than about 
0.900 V vs. Ag/AgCl, Figure 6.22. 
 
 
 
 
Figure 6.22: Cyclic voltammograms of K3FeCN6 (1.0 x 10−2 mol dm-3) in KCl (1.0 x 10−1 
mol dm-3). The potential was swept from –0.300 to 1.100 V vs. Ag/AgCl at a scan rate of 
100 mV s-1 for 20 cycles. Samples were electrospun from 20 % PLGA in HFIP at 0.2 mL 
h-1 at 20 kV for 1 min. 
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In Figure 6.23 the influence of the reduction potential is considered where the 
potential was swept from –1.100 to 0.600 V vs. Ag/AgCl at a scan rate of 100 mV 
s-1 for 20 cycles. This figure shows as the cycle number increases the peak 
currents also increase. This is possibly due to the occurrence of the hydrogen 
evolution reaction at more negative potentials which takes place at the 
electrode surface and destroys the electrospun fibers, therefore giving rise to a 
greater gold coated surface area which accounts for the increase in the peak 
currents. Alternatively, the electro-reduction of gold oxides at these negative 
potentials and the detachment of the fibers may take place leading to a higher 
surface area of gold.  
 
 
 
Figure 6.23: Cyclic voltammograms of K3FeCN6 (1.0 x 10−2 mol dm-3) in KCl (0.10 mol 
dm-3).   corresponds to          cycle 2,        cycle 7 and          cycle 18. The potential was 
swept from –1.100 to 0.600 V vs. Ag/AgCl at a scan rate of 100 mV s-1 for 20 cycles. 
Samples were electrospun from 20 % PLGA in HFIP at 0.2 mL h-1 at 20 kV for 1 min. 
 
 
The final analysis was performed to assess the stability of the nanofibers in a  
1.0 x 10−2 mol dm-3 ferrocyanide in 0.10 mol dm-3 KCl solution over a number of 
minutes. Samples were prepared and immersed in the solution and the potential 
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was swept from –0.300 to 0.600 V vs. Ag/AgCl at a scan rate of 100 mV s-1 for 20 
cycles every 60 min for 480 min. Figure 6.24 presents the results of the peak 
currents obtained as a function of time. The peak current observed after 60 min 
is lower than that observed in previous experiments, because a thicker sample 
was used to monitor the sample over a long period of time. An increase in the 
peak currents was observed the longer the fibers were left in the solution; this 
suggests that the adherence of the fibers to the Au mylar is lost as time elapses. 
The greatest increase in current is observed during the first 180 min of 
immersion. 
 
 
 
Figure 6.24: Peak current as a function of time for electrospun samples immersed and 
cycled every hour in 1.0 x 10−2 mol dm-3 ferrocyanide in 0.10 mol dm-3 KCl. The 
potential was swept from –0.300 to 0.600 V at a scan rate of 100 mV s-1 for 20 cycles.  
 
 
Overall, the Au mylar substrates with PLGA electrospun fibers are stable in the 
potential window where Py can be polymerised and the uptake and release of 
DA can be achieved. The current profiles also show that the non conducting 
fibers do not inhibit the redox behaviour of the ferrocyanide/ferricyanide 
system allowing electron transfer to occur at the Au substrate. However, fibers 
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degrade with time; therefore, the amount of time the fibers are immersed in 
solution should be kept to a minimum. An investigation into the best technique 
for the polymerisation of Py onto the fiber mats was performed.  
 
6.3.4 Polymerisation of pyrrole onto the nanofibers 
6.3.4.1 Polymerisation using electrochemical methods 
Many groups have used conducting polymers for a variety of applications, 
including drug delivery.9, 45 Conducting polymers are of substantial interest for 
many biomedical applications and PPy in particular has been shown to be 
biocompatible and has been used for several of these applications.9, 46-49 
However, polymerisation of Py onto electrospun PLGA fibers is a new approach 
with only one other group reporting this.9 
 
In this section a range of techniques were employed for the electrochemical 
polymerisation of Py onto the electrospun fibers including CV, galvanostatic and 
potentiostatic depositions. As shown in Section 6.3.3, there is enough 
conducting gold interface for the standard redox couple of ferricyanide to occur 
and therefore enough to electrochemically deposit PPy. The effects of various 
deposition methods on maintaining the fibrous structure of the PLGA substrates 
were investigated. All experimental work in this section was performed using 
electropsun PLGA fiber samples on Au coated mylar, these samples were 
fabricated from a 20% PLGA in HFIP solution, at a flow rate of 0.2 mL h-1, at a 
distance of 7 cm from the needle to the collector plate and the positive voltage 
applied to the polymer solution was 20 kV for 1 min. After the preparation of 
the PLGA fibers, PPy doped with PTS was electrochemically formed on the 
electrode surfaces. It was observed during the electrochemical polymerisation 
that PPy nucleated from the Au mylar and grew around the PLGA nanoscale 
fibers creating a 3D mesh of PPy nanoscale fibers. The polymer formed around 
the fibrous mat and not from the insulating PLGA electrospun fibers. 
 
Figure 6.25 shows optical images obtained when each technique was employed 
on the electrospun samples. The corresponding SEM micrographs are shown in 
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Figure 6.25. In the case of constant current, a current of 1 mA cm-2 was applied 
until 0.5 C was passed. For the constant potential deposition, 0.700 V vs. 
Ag/AgCl was applied until a sufficient charge of 0.5 C cm-2 was passed and for 
CV deposition, the potential was swept between 0.000 - 0.800 V vs. Ag/AgCl at 
50 mV s-1, and the cycle number was varied in the range of 5 to 100 cycles. After 
some preliminary experiments and observations from the optical and SEM 
analysis of various polymer samples, polymer growth using CV was shown to 
maintain, to a large extent, the underlying nanofiber structure. Constant 
potential and constant current methods are known to promote aggressive 
nucleation of the polymer leading to rapid polymer growth, as shown in Figure 
6.26 (B) and (D). Accordingly, the CV method was chosen and used to deposit 
PPy onto the electrospun fibers in the subsequent experiments.  
 
 
 
Figure 6.25: Optical images obtained from a sample electrospun at 0.2 mL h-1 at 20 kV 
on Au mylar where various electrochemical polymerisation techniques were employed 
in the presence of 0.2 mol dm-3 Py and 0.1 mol dm-3 PTS. A) constant current 1 mA cm-2 
to 0.5 C, B) constant potential of 0.700 V vs. Ag/AgCl to 0.5 C and C) CV growth for 10 
cycles where the potential was swept from 0.000 to 0.800 V vs. Ag/AgCl. 
A B
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Figure 6.26: SEM images of PPy electrochemically deposited on electrospun PLGA 
fibers using 0.2 mol dm-3 Py and 0.1 mol dm-3 PTS A) –B) Constant current of 1 mA cm-2 
to 0.5 C, C) – D) Constant potential of 0.700 V vs. Ag/AgCl to 0.5 C and E) - F) CV growth 
for 10 cycles where the potential was swept from 0.000 to 0.800 V vs. Ag/AgCl. 
 
6.3.4.2 Polymerisation using CV 
To ensure the nanofiber network was maintained PPy was deposited using CV. 
For the uptake and release of DA, sulfonated β-cyclodextrin was used as the 
dopant. Figure 6.27 shows a typical plot of current as a function of potential for 
A B
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the CV polymerisation of Py in the presence of 0.01 mol dm-3 Sβ-CD on a sample 
of electrospun PLGA fibers. The increase of the anodic current at approximately 
0.500 V vs. Ag/AgCl is associated with the oxidation of the Py monomer. The 
current increases with increasing cycle number, indicating the formation of a 
conducting film, even though the underlying fibers are insulating. 
 
 
 
Figure 6.27: CV growth of PPy on a sample of PLGA fibers in HFIP electrospun at 0.2 
mL h-1 at 20 kV on Au mylar in the presence of 0.20 mol dm-3 Py and 0.01 mol dm-3 Sβ-
CD. The potential was swept from 0.000-0.800 V vs. Ag/AgCl at a scan rate of 50 mV s-1 
for 20 cycles. 
 
Various electrospun samples were taken where PPy was electrodeposited onto 
the substrates as a function of the cycle number. Optical images were taken 
before polymerisation and after each subsequent amount of CV growth. Figure 
6.28 shows an electrospun sample which was imaged prior to 10 cycles of CV 
growth and then subsequently imaged again. The sample was further subjected 
to another 5 cycles of CV growth and imaged. This method was repeated in 
increments of 5 cycles until 25 cycles of CV growth were obtained. It is clear 
from these images that the deposition of PPy increases with increasing cycle 
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number. It is also evident that the nanofiber structure becomes less dominant 
with increasing amounts of deposited PPy, as highlighted in Figure 6.28 (E). 
 
 
 
 
Figure 6.28: Optical images of a sample electrospun at 0.2 mL h-1 at 20 kV for 1 min on 
Au mylar where CV growth was obtained in the presence of 0.2 mol dm-3 Py and 0.01 
mol dm-3 Sβ-CD. A) prior to CV growth B) after 10 cycles C) 15 cycles D) 20 cycles and 
E) 25 cycles of polymer growth and the potential was swept from 0.000 to 0.800 V vs. 
Ag/AgCl at 50 mV s-1. 
 
A B
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SEM images of samples of electrospun PLGA with and without PPy are shown in 
Figure 6.29 and 6.30, respectively. CV growth was performed for a total of 20 
cycles using a potential window of 0.000 to 0.800 V vs. Ag/AgCl at 50 mV s-1. 
From the images it can be clearly observed that the nanofiber structure is being 
maintained, as highlighted in Figure 6.30 (B). The polymer is growing over the 
fibers. The cauliflower morphology of the PPy was also evident, as highlighted in 
Figure 6.30 (E). 
 
 
 
 
Figure 6.29: SEM images at various magnification of electrospun 20% PLGA (50:50) in 
HFIP at a feeding rate of 0.2 mL h-1 at 20 kV for 1 min. A) 1000 B) 3000 C) 6000 D) 
10000 magnification. 
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Figure 6.30: SEM images at various magnification of electrospun 20% PLGA (50:50) in 
HFIP at a feeding rate of 0.2 mL h-1 at 20 kV for 1 min where PPy was electrodeposited 
using CV for 20 cycles swept between 0.000-0.800 V vs. Ag/AgCl at 50 mV  s-1.  a) 1000 
b) 2000 c) 3000 d) 6000 e) 10000 f) 20000  magnification. 
 
 
Abidian et al.9 produced conducting polymer nanotubes using PLGA nanofibers 
as a template. Once the polymers were electropolymerised onto the surface the 
electrospun fibers were removed by soaking them in DMF. 
 
After investigating three electrochemical methods for the deposition of PPy 
onto the electrospun mats; another method known as vapour phase 
polymerisation was examined and compared to the electrochemical approaches. 
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6.3.4.3 Vapour phase polymerisation of pyrrole 
The most common approach in the incorporation of molecules into PPy is 
during the electrochemical polymerisation process. However, some reports 
have shown that in industry this can be a slow process and so chemical 
deposition using vapour phase polymerisation of Py has been investigated.50 
Vapour phase polymerisation was investigated for the chemical deposition of 
Py. This technique was tried in two ways: (i) the oxidant was added to the 
electrospinning polymer solution and once the fibers were successfully 
electrospun, the samples were placed in a chamber containing the monomer 
solution; (ii) the fibers were electrospun and the oxidant was spin coated onto 
the sample and the samples were once again placed into the Py monomer 
chamber. 
 
6.3.4.3.1 Incorporation of the oxidant prior to electrospinning 
As outlined in Section 6.2.2.5, 0.5 mL of 20% PLGA (50:50) in HFIP was added to 
0.02 mL of the oxidant, 40% Fe(III)/PTS in ethanol. The solution was placed in 
the syringe and samples were electrospun onto Au mylar. Figure 6.31 shows 
two optical images; both samples were electrospun at a distance of ~7 cm, 
image (A) was electrospun at 0.5 mL h-1 at 15 kV and image (B) was electrospun 
at 1 mL h-1 at an applied voltage of 18 kV. 
 
 
 
 
Figure 6.31: Optical images of electrospun PLGA in HFIP in the presence of the oxidant 
40% Fe(III)/PTS in ethanol A) at 0.5 mL h-1 at 15 kV B) 1 mL h-1 at 18 kV. 
A B
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These electrospun samples were then placed in a monomer chamber containing 
3 mL of the Py monomer for 30 min to allow vapour phase polymerisation of Py 
to occur. After polymerisation the samples were washed in ethanol for 20 min 
to eliminate any excess oxidant. Figure 6.32 shows SEM micrographs of the 
samples. Figure 6.32 (A) shows a SEM of the electrospun fibers from the 
PLGA/oxidant solution at 0.5 mL h-1 at 15 kV prior to vapour phase 
polymerisation. Figure 6.33 (B) shows a SEM image after 30 min of vapour 
phase and washing in ethanol for 20 min. There are particles present which 
represent the crystals formed from the evaporation of the oxidant. It is essential 
that once the fibers are electrospun they are placed straight into the monomer 
chamber. From Figure 6.32 (A) the electrospun fibers obtained are extremely 
promising especially after the addition of the oxidant. These images were used 
to try to confirm the growth of PPy. However, from these preliminary 
experiments it was hard to say if PPy was present, or if only shorter chain 
oligomers were formed. 
 
 
 
 
Figure 6.32: SEM image of electrospun PLGA in HFIP with the oxidant at 0.5 mL h-1 at 
15 kV A) prior to vapor phase polymerisation. B) after 30 min vapor phase 
polymerisation and 20 min washing with ethanol. 
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6.3.4.3.2 Vapour phase polymerisation on previously electrospun PLGA fibers 
The second attempt of vapour phase polymerisation of Py included the spin 
coating of the oxidant, 40% Fe(III)/PTS in ethanol, onto previously electrospun 
samples of 20 % PLGA in HFIP. The samples were then placed into the monomer 
chamber containing Py for 20 min, removed and left to dry before washing with 
ethanol for 20 min.  
 
Figure 6.33 shows optical images of 5 min electrospun PLGA fibers before and 
after 20 min vapour phase polymerisation and washing in ethanol. It is evident 
that the fibers are not present after the vapour phase process. A valid reason for 
this is the fact that at a rotation speed of 1000 rpm during the spin coating of 
the oxidant, the adherence of the fibers on the Au mylar substrate is lost and all 
that is left is the flat Au mylar surface. This is also evident in the sample shown 
in Figure 6.34. This sample was electrospun for 10 min and the same 
procedures were carried out. In Figure 6.34 (B) the presence of some fibers are 
highlighted however, the SEM image (C) shows lines of crystal structures which 
could be attributed to the crystallisation of the oxidant. 
 
 
 
Figure 6.33: Optical images of an electrospun 20 % PLGA fiber sample in HFIP for 5 
min at a feeding rate of 0.2 mL h-1 and an applied potential of 20 kV and a distance of ~ 
7 cm (A) prior to and (B) after 20 min vapour phase polymerisation and 20 min 
washing with ethanol.  
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Figure 6.34: Optical and SEM
HFIP for 10 min at a feeding rate of 0.2 mL h
distance of ~ 7 cm (A) prior to and (B)
20 min washing with ethanol. 
of Py and washing in ethanol. 
 
 
Cyclic voltammetry is often used to study conducting polymer films. This 
technique is widely used for investigating the electroactivity of conducting 
polymers as it follows the electron transfer.
used to determine if PPy was formed during the vapour phase polymerisation. 
Electrospun samples after the vapou
a three electrode set up in the presence of 0.1 mol dm
observe the redox potentials of PPy the potential was swept from 
0.800 V vs. Ag/AgCl at 50 mV s
redox peaks, an oxidation peak at  0.094 V
0.496 V vs. Ag/AgCl which can be related to the PPy matrix. These values are 
  
- 295 - 
 images of an electrospun 20 % PLGA fiber sample in 
-1 and an applied potential of 20 kV and a 
 after 20 min vapour phase polymerisation and 
(C) SEM image after 20 min vapour phase polymerisation
 
51 Therefore, the CV technique was 
r phase polymerisation step were placed in 
-3 Na2SO4
-1 for 20 cycles. In Figure 6.35, the CV shows two 
 vs. Ag/AgCl and a reduction peak at 
Chapter 6 
 
 
. In order to 
-0.800 to 
-
Electrospinning and drug delivery  Chapter 6 
- 296 - 
similar to values obtained in the literature. However, the signals were lost as the 
cycle number increased. This indicates a loss in the conducting properties of the 
deposited PPy. However, these data confirm the presence of polypyrrole. 
 
 
 
Figure 6.35: CV data of an electrospun 20 % PLGA fiber sample in HFIP at a feeding 
rate of 0.2 mL h-1 and an applied potential of 20 kV and a distance of ~ 7 cm after 20 
min vapour phase polymerisation washing in ethanol. Samples were cycled in 0.1 mol 
dm-3 Na2SO4 from -0.800 to 0.800 V vs. Ag/AgCl at 50 mV s-1.  
 
Clearly, this vapour phase technique has the potential to deposit the polymer 
either prior to or after electrospinning. However, one significant problem was 
loss of the fibers upon spin coating of the oxidant at the high rotation speeds. As 
well as that, the amount of polymer deposited was not consistent. Due to the 
inconsistency of this method, PPy polymers used in the uptake and release of 
DA were generated using cyclic voltammetry from a pyrrole-sulfonated β-
cyclodextrin solution. All parameters were kept as described in Section 6.3.4.2 
where the number of cycles was varied. For comparative studies polymers were 
electrochemically synthesised on bare Au mylar to investigate if the presence of 
the electrospun PLGA nanofibers had an influence on the amount of DA released 
from the system. 
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6.3.5 Incorporation and release of DA 
It has been documented that a promising characteristic of conducting polymers 
is their ability to use their redox properties to incorporate and release ions 
under applied potentials.50, 52-54 Due to this characteristic the polymer films can 
be used to deliver small amounts of DA as described in Chapter 4. With the 
addition of the PLGA nanofibers two types of delivery could be achieved, firstly 
through degradation of the PLGA network which could potentially lead to the 
overall degradation of the polymer matrix and subsequent release of the DA. 
Secondly, and the technique that was examined here, by actively applying the 
redox properties to the drug loaded polymer matrices using an applied 
potential. Using UV-visible spectroscopy, the release profile of DA was 
monitored. As previously demonstrated in Chapter 4, DA absorbs at λmax = 280 
nm. 
 
Once the electrospun fibers with deposited PPy doped with Sβ-CD had been 
prepared, these polymers were investigated for the uptake and release of DA. As 
illustrated in Figure 6.36 during the reduction of the PPy-CD polymer matrix the 
cationic DA is injected into the polymer and the negative charges of the 
immobilised cyclodextrin are compensated. Here, overall charge neutrality is 
maintained. Upon application of a positive potential the positively charged DA 
molecules are expelled into the solution. 55, 56 
 
 
 
Figure 6.36: Schematic of the concept of the DA uptake and release. 
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6.3.5.1 Uptake and release of DA using electrochemical means 
Figure 6.37, shows UV spectra for the release of DA from a sample where PPy 
was deposited onto the electrospun PLGA nanofibers using CV for 30 cycles. In 
this case a potential of 0.100 V vs. Ag/AgCl was applied to the sample in order to 
release the DA. This figure illustrates that the amount of DA released increases 
over time upon an application of an oxidation potential. 
 
 
 
 
Figure 6.37: Absorbance as a function of wavelength of the release of DA upon 
application of 0.100 V vs. Ag/AgCl over a 2 h period on a sample where PLGA was 
electrospun at 0.2 mL h-1 at 20 kV for 1 min and PPy was electrochemically deposited 
using CV for 30 cycles. 
 
 
In Figure 6.38 the release profiles are expressed as a function of time. In all 
cases, PPy was electrochemically formed using CV growth swept between 
0.000-0.800 V vs. Ag/AgCl at 50 mV s-1 for 30 cycles. PPy was also deposited 
onto a bare Au mylar electrode for comparison. From the results it can be 
clearly seen that the presence of the nanofibers on the substrate increases the 
amount of DA incorporated and subsequently released. 
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Figure 6.38: Absorbance as a function of time for the release of DA at 0.100 V vs. 
Ag/AgCl for 2 h where PPy was electrodeposited in the presence of 0.2 mol dm-3 Py 
and 0.01 mol dm-3 Sβ-CD for 30 cycles of CV growth at a potential of 0.000-0.800 V vs. 
Ag/AgCl and at a scan rate of 50 mV s-1 on ♦ Electrospun PLGA present  Bare Au. 
 
 
In Figure 6.39 the maximum absorbance of DA at 280 nm after 120 min of 
applying an oxidation potential was recorded and plotted as a function of the 
number of cycles applied during polymerisation. In each case all the parameters 
were the same except for the number of cycles applied during CV growth. An 
application of an oxidation potential of 0.100 V vs. Ag/AgCl over 120 min was 
applied in order to release the DA. Again in all cases the samples where PLGA 
fibers were present show a greater release for DA.  For some reason the 
polymer grown to 30 cycles observed the best release profile. This is probably 
related to the fact that with further cycles more PPy is electrochemically 
deposited and the nanofiber structure is lost. At this point the deposited 
polymer has the characteristic cauliflower structure and gives a DA release 
profile similar to pure PPy, as shown at 50 cycles, Figure 6.39. 
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Figure 6.39: The absorbance of DA at 280 nm as a function of the number of cycles 
applied during polymerisation of PPy. PPy was electrodeposited in the presence of 0.2 
mol dm-3 Py and 0.01 mol dm-3 Sβ-CD on ♦ Electrospun PLGA present  Bare Au. 
 
 
It is interesting to note that the release profile at 50 cycles for PPy deposited 
onto both the bare Au mylar and the PLGA fiber coated substrate give very 
similar release profiles. This is more clearly shown in Figure 6.40 where the PPy 
gold and PPy fiber gold electrodes are compared for the release of DA. In both 
cases the polymer was grown using 50 cycles between 0.000 and 0.800 V vs. 
Ag/AgCl. Similar absorbance values are recorded for both electrodes, showing 
no difference between the release profiles. 
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Figure 6.40: Absorbance as a function of time for the release of DA at 0.100 V vs. 
Ag/AgCl for 120 min where PPy was electrodeposited in the presence of 0.2 mol dm-3 
Py and 0.01 mol dm-3 Sβ-CD for 50 cycles of CV growth at a potential of 0.000-0.800 V 
and a scan rate of 50 mV s-1 on ♦Electrospun PLGA present  Bare Au. 
 
6.3.5.2 Comparison of applying a potential for release 
Another experiment attempted was the release of DA over time without the use 
of electrochemical stimulation in order to evaluate how much more DA is being 
released with the application of an oxidation potential. 
 
In the results shown in Figure 6.41 both polymers were grown on electrospun 
fibers using CV growth for 30 cycles where once again the potential was swept 
between 0.000-0.800 V vs. Ag/AgCl at 50 mV s-1. The normal incorporation and 
washing procedures were applied in both cases, however, in terms of release 
the results shown are where an applied potential of 0.100 V vs. Ag/AgCl and no 
electrical stimulation was applied over 120 min. From these data, the 
significance of the electrical stimulation is apparent and it clearly shows the 
benefit in applying stimulation instead of relying on slow release to take place, 
confirming that electrical stimulation is an important factor in the release of the 
0.000
0.005
0.010
0.015
0.020
0.025
0 20 40 60 80 100 120
A
b
so
rb
a
n
ce
 
Time / min
Electrospinning and drug delivery  Chapter 6 
- 302 - 
drug from the polymer. It is also interesting to note that the rate of release is 
slower in when no potential is applied in comparison to the application of an 
electrical stimulation. This result was also observed in the bulk system 
discussed in Chapter 4, Section 4.3.4.3. 
 
 
 
 
Figure 6.41: The release of DA monitored at 280 nm as a function time. The DA was 
released using ♦0.100 V vs. Ag/AgCl  no electrochemical stimulation over 120 min. 
 
 
In order to calculate the amount of DA being released the calibration curve and 
subsequent equation demonstrated in Chapter 2 was used. The concentration of 
DA was evaluated and expressed in nmol cm-2. The amount of DA released upon 
applying a potential in comparison to no potential was 4335 to 887 nmol cm-2, 
respectively. This corresponds to a 79.52 % increase in the release of the drug 
when the electrical stimulation was applied. As shown in Chapter 4, similar 
results were obtained for the bulk system. 
 
Abidan et al.9 demonstrated the release of dexamethasone (DEX) from 
electrospun PLGA nanofibers covered with an electroactive polymer, poly(3,4-
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rthylenedioxythiophene), (PEDOT). In monitoring the drug release of the DEX, 
the electrospun fibers were removed or allowed to slowly degrade, where, the 
PEDOT maintained its nanofibrous structure. They observed a significant 
increase in the amount of drug released when an electrical stimulation was 
applied in comparison to no potential. This verifies the point made in Chapter 4 
and by other authors53, that the application of an applied potential presents a 
way of controlling the release of the drug. 
 
6.3.5.3 Comparing the release of DA  
It is clear from Figure 6.38 that the nanofiber substrate provides better release 
of DA. However, with the increasing amounts of PPy, this enhancement is lost, as 
observed from the data shown in Figure 6.40, where DA release was monitored 
from PPy films electrochemically deposited for 50 cycles in the presence and 
absence of electrospun fibers substrates. Figure 6.42 summaries data obtained 
from bare Au coated mylar samples (no electrospun PLGA), where PPy was 
electrochemically deposited using CV at 50 mV s-1.  
 
 
Figure 6.42: The amount of DA release upon applying 0.100 V vs. Ag/AgCl for 120 min 
as a function of time from polymers generated using CV where the amount of cycles 
was varied. Cycles of PPy growth were ♦5, ♦10, ♦20, ♦30, ♦and 50 at 50 mV s-1. 
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This figure demonstrates what was shown, previously, in Chapter 4 that as the 
thickness, or the amount, of polymer on the working electrode increased; an 
increase in the amount of DA released was obtained. This makes a direct 
comparison of the results obtained in this chapter with Chapter 4 impossible. 
However, it can be concluded that the PLGA nanofibers give rise to a higher 
release of DA. 
 
6.4 Summary of results 
Neat chloroform is not a suitable solvent for the electrospinning of PLGA 
(50:50).  The voltage applied during the formation of fibers has a significant 
affect on the amount of fibers produced. As the voltage is increased more fibers 
are formed therefore giving thicker films on the substrate. Also, if an increase in 
flow rate is applied during electrospinning more beading is observed. The 
collector plate has a significant affect on the samples taken in terms of beading. 
In the case of the 20 % PLGA in HFIP beading was observed when samples were 
collected on a glass slide but when samples were collected on Au coated mylar 
bead formation was reduced substantially. 
 
Investigation by CV of PLGA fibers indicates that this material exhibits good 
electronic properties. Film thickness and voltage applied in forming the 
nanostructured material have a significant affect on the electrochemistry of the 
samples. The application of oxidation potentials above 1.100 V shows a 
significant affect on the redox properties of the substrate and leads to the loss of 
gold from the gold coated mylar substrate. The application of low reduction 
potentials increases the amount of hydrogen evolution and therefore, an 
increase in the oxidation peak currents were observed due to the loss of the 
fibers from the electrode surface. The stability of the PLGA fibers on the Au 
mylar decreases significantly over time when left immersed in the electrolyte 
solution. 
 
PPy can successfully be electrochemically polymerised onto the nanofibers 
using various techniques; however, it was confirmed that CV growth was the 
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best technique in maintaining the nanostructured material. DA was successfully 
incorporated and released from the polymer composite of nanofibers and PPy. 
UV-visible spectroscopy was a feasible technique to monitor the release. It was 
also confirmed that the application of an electrical stimulation to the drug-
incorporated polymers released ~80 % more drug than allowing the drug to 
undergo slow release. Electrospun PLGA nanofibers have been successfully used 
as substrates for the polymerisation of PPy and subsequently the uptake and 
release of DA. It is also evident that an increase of the DA release was obtained 
in the presence of the electrospun PLGA fiber/PPy matrix. 
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7.1  Conclusions 
The work described in this thesis addressed the need to develop a controllable 
device, for a cationic species. PPy, a conducting polymer, is an attractive 
material extensively researched in the area of biomedical devices. In the studies 
presented in this research, it successfully served as a controllable material for 
delivery of dopamine, DA, a cationic species. 
 
The results obtained in Chapter 3, described the formation and characterisation 
of the polymers in the presence of various electrolytes. Attention was focused 
on the large sulfonated β-cyclodextrin (Sβ-CD) for the doping of the PPy films.  
Due to their large size, these dopants were found to remain immobilised in the 
polymer matrix and act predominantly as cation exchangers. Conductivity 
measurements performed on the Sβ-CD in water, confirmed that the Sβ-CD was 
a sufficiently strong electrolyte for the polymerisation of pyrrole. Moreover, no 
other supporting electrolyte was required, contrary to reports by other research 
groups.1-3 The growth, morphology and doping levels of these films were also 
examined and showed that the PPy-Sβ-CD films could successfully be prepared 
electrochemically using both potentiostatic and potentiodynamic methods. The 
CV experiments demonstrated that the pyrrole monomer oxidised at lower 
potentials in the presence of the Sβ-CD, in comparison to other dopants like the 
Cl- anion. Additionally, the growth kinetics demonstrated a 4-fold increase in the 
rate of oxidation of PPy-Sβ-CD films, contrary to PPy-Cl films. Simultaneous, 
EQCM and CV experiments were used to measure the redox properties of these 
films and demonstrated not only the well defined redox properties of the PPy-
Sβ-CD films, but the main cationic movement associated with the electroactivity 
of these films. SEM confirmed polymer growth and illustrated an oriented and 
organised manner in which the polymer was deposited, while EDAX 
measurements confirmed the presence of the Sβ-CD anion. The influence of the 
fluxes, cation and solvent, as a function of the potential, were also explored 
during CV measurements. EQCM measurements showed that a considerable 
amount of solvent, water was taken up into the film during redox switching.  
 
Conclusions  Chapter 7 
- 310 - 
We also report for the first time, the application of this simple modified 
electrode for the drug delivery of DA. Chapter 4 demonstrated the impressive 
release of DA from polymers synthesised in the presence of Sβ-CD in 
comparison to smaller, more mobile, dopants. Various parameters, including, 
the application of potential during the incorporation and release process of the 
drug, as well as, polymer thickness were optimised. The electrochemical 
stimulated release of DA from these films was successfully obtained. The release 
was shown to be dependent on the potential as, at open-circuit potentials, the 
polymer film does not reach the potentials required, over the time monitored, 
for oxidation of the polymer film and subsequent release of the DA. Results also 
provided some limitations in these systems, the first, that the application of 
anodic potentials higher than 0.100 V vs. SCE, to the electrochemical system, 
resulted in the oxidation of DA. Secondly, polymers synthesised to a charge ≥ 
4.0 C cm-2 resulted in the oxidation of the DA. 
 
The question of inclusion phenomena was introduced and exhaustively 
examined in Chapter 5 and showed that indeed the DA was forming an inclusion 
complex with the CD in solution. This can be attributed to the significant 
increase in the release of DA. Although, there is a difference in analysing the 
complexation properties of CDs in solution and on the surface, many papers 
have examined both these processes and have attained similar observations.4, 5 
Damos et al.4 demonstrated the simple process of self assembled monolayer’s 
(SAM) of CDs on gold. They showed that when the CDs are immobilised onto the 
surface they retain their strong inclusion complexation properties with 
[Fe(CN)6]3-/4-. In Chapter 3, it was shown that the pyrrole monomer did not form 
an inclusion complex with the Sβ-CD. If the radical cations and the CD formed an 
inclusion complex, a decrease in the rate of polymerisation would be evident; 
however, in this case the opposite was observed. Therefore, there is no evidence 
to suggest an inclusion complex with the PPy, leaving a large number of cavities 
available for complexation of DA. We can safely say that the DA is forming an 
inclusion complex with the Sβ-CD. Also, in the analysis performed in Chapter 3 
on the doping levels of the CD with the polymer, it was presented that if all of 
the negative sulfonated groups were involved with the polymerisation for the 
Conclusions  Chapter 7 
- 311 - 
polymer, it could lead to a considerable strain on the polymer system. 
Therefore, it can be assumed that there are free negative groups around the 
ring. Chapter 5 revealed that the presence of the sulfonated groups enhanced 
complexation. In the case of the polymer, if some of the sulfonate groups are not 
involved in the doping then this would favour the complexation of the DA and, 
therefore, include more DA.   
 
The inclusion complexation of DA with Sβ-CD was dealt with in Chapter 5. 
Techniques including UV, NMR, CV and RDV were all used to demonstrate not 
only the 1:1 stoichiometry but evaluate the apparent formation constants. UV 
spectra showed a distinct shift in the wavelength and an increase in the 
intensity of the DA, in the presence of excess Sβ−CD, confirming a change in the 
environment of the DA and verifying complexation. In the electrochemical 
studies, the DA oxidation potentials shifted to higher potentials, while, the peak 
current decreased upon the addition of Sβ-CD. These traits were once more 
attributed to the formation of an inclusion complex due to the DA being harder 
to oxidise inside the cavity and the decrease in the diffusion coefficient of DA 
due to the less mobile bulky complex. Structural information on the inclusion 
complex was obtained from NMR studies and concluded that the aromatic DA 
ring was included inside the cavity, while the protonated amine was bound 
through electrostatic interactions to the sulfonated groups on the rim of the CD.  
 
In all techniques the formation constants evaluated were in very close 
agreement, which not only validated the results, but confirmed that the methods 
examined for the complexation could be recommended as a reliable option in 
determining the formation constants of the inclusion complex of Sβ−CD, with 
other guest molecules. In comparing the data obtained in these experiments to 
data found in the literature for the neutral β-CD, 95.06,6 it can be concluded that 
the negatively charged sulfonate groups on the CD play an important role in the 
complexation and increase the binding affinities in the case of protonated DA. 
Examinations on the influence of supporting electrolyte established that a 
change in the anion had an influence on the DA-Sβ-CD complexation while no 
change was observed for the cation. Complexation of DA with a smaller CD, 
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sulfonated α-CD showed no complexation and it was concluded that this was 
due to the size of the DA being too large to fit inside the cavity of the Sα-CD but 
it is sufficient in size for most of it to fit inside the Sβ-CD cavity.  
 
Finally, poly(D,L – lactide-co-glycolide) (PLGA) nanofibers were successfully 
deposited onto a Au mylar substrate using a technique known as 
electrospinning. During the electrospinning process a number of parameters 
were varied in order to form bead free nanofibers, including solvent, polymer 
concentration, potential and feeding rate. After successful fibers were attained, 
PPy films were both chemically and electrochemically deposited using vapour 
phase polymerisation and potentiostatic, galvanostatic and potentiodynamic 
methods, respectively. From SEM images, it was established that the 
electrochemical technique, CV, was the best technique employed enabling the 
formation of uniform conducting films, while still maintaining the nano-fibrous 
structure of the PLGA fibers. DA was again effectively incorporated and 
delivered from these new materials using electrical stimulation. 
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7.1  Conclusions 
The work described in this thesis addressed the need to develop a controllable 
device, for a cationic species. PPy, a conducting polymer, is an attractive 
material extensively researched in the area of biomedical devices. In the studies 
presented in this research, it successfully served as a controllable material for 
delivery of dopamine, DA, a cationic species. 
 
The results obtained in Chapter 3, described the formation and characterisation 
of the polymers in the presence of various electrolytes. Attention was focused 
on the large sulfonated β-cyclodextrin (Sβ-CD) for the doping of the PPy films.  
Due to their large size, these dopants were found to remain immobilised in the 
polymer matrix and act predominantly as cation exchangers. Conductivity 
measurements performed on the Sβ-CD in water, confirmed that the Sβ-CD was 
a sufficiently strong electrolyte for the polymerisation of pyrrole. Moreover, no 
other supporting electrolyte was required, contrary to reports by other research 
groups.1-3 The growth, morphology and doping levels of these films were also 
examined and showed that the PPy-Sβ-CD films could successfully be prepared 
electrochemically using both potentiostatic and potentiodynamic methods. The 
CV experiments demonstrated that the pyrrole monomer oxidised at lower 
potentials in the presence of the Sβ-CD, in comparison to other dopants like the 
Cl- anion. Additionally, the growth kinetics demonstrated a 4-fold increase in the 
rate of oxidation of PPy-Sβ-CD films, contrary to PPy-Cl films. Simultaneous, 
EQCM and CV experiments were used to measure the redox properties of these 
films and demonstrated not only the well defined redox properties of the PPy-
Sβ-CD films, but the main cationic movement associated with the electroactivity 
of these films. SEM confirmed polymer growth and illustrated an oriented and 
organised manner in which the polymer was deposited, while EDAX 
measurements confirmed the presence of the Sβ-CD anion. The influence of the 
fluxes, cation and solvent, as a function of the potential, were also explored 
during CV measurements. EQCM measurements showed that a considerable 
amount of solvent, water was taken up into the film during redox switching.  
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We also report for the first time, the application of this simple modified 
electrode for the drug delivery of DA. Chapter 4 demonstrated the impressive 
release of DA from polymers synthesised in the presence of Sβ-CD in 
comparison to smaller, more mobile, dopants. Various parameters, including, 
the application of potential during the incorporation and release process of the 
drug, as well as, polymer thickness were optimised. The electrochemical 
stimulated release of DA from these films was successfully obtained. The release 
was shown to be dependent on the potential as, at open-circuit potentials, the 
polymer film does not reach the potentials required, over the time monitored, 
for oxidation of the polymer film and subsequent release of the DA. Results also 
provided some limitations in these systems, the first, that the application of 
anodic potentials higher than 0.100 V vs. SCE, to the electrochemical system, 
resulted in the oxidation of DA. Secondly, polymers synthesised to a charge ≥ 
4.0 C cm-2 resulted in the oxidation of the DA. 
 
The question of inclusion phenomena was introduced and exhaustively 
examined in Chapter 5 and showed that indeed the DA was forming an inclusion 
complex with the CD in solution. This can be attributed to the significant 
increase in the release of DA. Although, there is a difference in analysing the 
complexation properties of CDs in solution and on the surface, many papers 
have examined both these processes and have attained similar observations.4, 5 
Damos et al.4 demonstrated the simple process of self assembled monolayer’s 
(SAM) of CDs on gold. They showed that when the CDs are immobilised onto the 
surface they retain their strong inclusion complexation properties with 
[Fe(CN)6]3-/4-. In Chapter 3, it was shown that the pyrrole monomer did not form 
an inclusion complex with the Sβ-CD. If the radical cations and the CD formed an 
inclusion complex, a decrease in the rate of polymerisation would be evident; 
however, in this case the opposite was observed. Therefore, there is no evidence 
to suggest an inclusion complex with the PPy, leaving a large number of cavities 
available for complexation of DA. We can safely say that the DA is forming an 
inclusion complex with the Sβ-CD. Also, in the analysis performed in Chapter 3 
on the doping levels of the CD with the polymer, it was presented that if all of 
the negative sulfonated groups were involved with the polymerisation for the 
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polymer, it could lead to a considerable strain on the polymer system. 
Therefore, it can be assumed that there are free negative groups around the 
ring. Chapter 5 revealed that the presence of the sulfonated groups enhanced 
complexation. In the case of the polymer, if some of the sulfonate groups are not 
involved in the doping then this would favour the complexation of the DA and, 
therefore, include more DA.   
 
The inclusion complexation of DA with Sβ-CD was dealt with in Chapter 5. 
Techniques including UV, NMR, CV and RDV were all used to demonstrate not 
only the 1:1 stoichiometry but evaluate the apparent formation constants. UV 
spectra showed a distinct shift in the wavelength and an increase in the 
intensity of the DA, in the presence of excess Sβ−CD, confirming a change in the 
environment of the DA and verifying complexation. In the electrochemical 
studies, the DA oxidation potentials shifted to higher potentials, while, the peak 
current decreased upon the addition of Sβ-CD. These traits were once more 
attributed to the formation of an inclusion complex due to the DA being harder 
to oxidise inside the cavity and the decrease in the diffusion coefficient of DA 
due to the less mobile bulky complex. Structural information on the inclusion 
complex was obtained from NMR studies and concluded that the aromatic DA 
ring was included inside the cavity, while the protonated amine was bound 
through electrostatic interactions to the sulfonated groups on the rim of the CD.  
 
In all techniques the formation constants evaluated were in very close 
agreement, which not only validated the results, but confirmed that the methods 
examined for the complexation could be recommended as a reliable option in 
determining the formation constants of the inclusion complex of Sβ−CD, with 
other guest molecules. In comparing the data obtained in these experiments to 
data found in the literature for the neutral β-CD, 95.06,6 it can be concluded that 
the negatively charged sulfonate groups on the CD play an important role in the 
complexation and increase the binding affinities in the case of protonated DA. 
Examinations on the influence of supporting electrolyte established that a 
change in the anion had an influence on the DA-Sβ-CD complexation while no 
change was observed for the cation. Complexation of DA with a smaller CD, 
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sulfonated α-CD showed no complexation and it was concluded that this was 
due to the size of the DA being too large to fit inside the cavity of the Sα-CD but 
it is sufficient in size for most of it to fit inside the Sβ-CD cavity.  
 
Finally, poly(D,L – lactide-co-glycolide) (PLGA) nanofibers were successfully 
deposited onto a Au mylar substrate using a technique known as 
electrospinning. During the electrospinning process a number of parameters 
were varied in order to form bead free nanofibers, including solvent, polymer 
concentration, potential and feeding rate. After successful fibers were attained, 
PPy films were both chemically and electrochemically deposited using vapour 
phase polymerisation and potentiostatic, galvanostatic and potentiodynamic 
methods, respectively. From SEM images, it was established that the 
electrochemical technique, CV, was the best technique employed enabling the 
formation of uniform conducting films, while still maintaining the nano-fibrous 
structure of the PLGA fibers. DA was again effectively incorporated and 
delivered from these new materials using electrical stimulation. 
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7.1  Conclusions 
The work described in this thesis addressed the need to develop a controllable 
device, for a cationic species. PPy, a conducting polymer, is an attractive 
material extensively researched in the area of biomedical devices. In the studies 
presented in this research, it successfully served as a controllable material for 
delivery of dopamine, DA, a cationic species. 
 
The results obtained in Chapter 3, described the formation and characterisation 
of the polymers in the presence of various electrolytes. Attention was focused 
on the large sulfonated β-cyclodextrin (Sβ-CD) for the doping of the PPy films.  
Due to their large size, these dopants were found to remain immobilised in the 
polymer matrix and act predominantly as cation exchangers. Conductivity 
measurements performed on the Sβ-CD in water, confirmed that the Sβ-CD was 
a sufficiently strong electrolyte for the polymerisation of pyrrole. Moreover, no 
other supporting electrolyte was required, contrary to reports by other research 
groups.1-3 The growth, morphology and doping levels of these films were also 
examined and showed that the PPy-Sβ-CD films could successfully be prepared 
electrochemically using both potentiostatic and potentiodynamic methods. The 
CV experiments demonstrated that the pyrrole monomer oxidised at lower 
potentials in the presence of the Sβ-CD, in comparison to other dopants like the 
Cl- anion. Additionally, the growth kinetics demonstrated a 4-fold increase in the 
rate of oxidation of PPy-Sβ-CD films, contrary to PPy-Cl films. Simultaneous, 
EQCM and CV experiments were used to measure the redox properties of these 
films and demonstrated not only the well defined redox properties of the PPy-
Sβ-CD films, but the main cationic movement associated with the electroactivity 
of these films. SEM confirmed polymer growth and illustrated an oriented and 
organised manner in which the polymer was deposited, while EDAX 
measurements confirmed the presence of the Sβ-CD anion. The influence of the 
fluxes, cation and solvent, as a function of the potential, were also explored 
during CV measurements. EQCM measurements showed that a considerable 
amount of solvent, water was taken up into the film during redox switching.  
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We also report for the first time, the application of this simple modified 
electrode for the drug delivery of DA. Chapter 4 demonstrated the impressive 
release of DA from polymers synthesised in the presence of Sβ-CD in 
comparison to smaller, more mobile, dopants. Various parameters, including, 
the application of potential during the incorporation and release process of the 
drug, as well as, polymer thickness were optimised. The electrochemical 
stimulated release of DA from these films was successfully obtained. The release 
was shown to be dependent on the potential as, at open-circuit potentials, the 
polymer film does not reach the potentials required, over the time monitored, 
for oxidation of the polymer film and subsequent release of the DA. Results also 
provided some limitations in these systems, the first, that the application of 
anodic potentials higher than 0.100 V vs. SCE, to the electrochemical system, 
resulted in the oxidation of DA. Secondly, polymers synthesised to a charge ≥ 
4.0 C cm-2 resulted in the oxidation of the DA. 
 
The question of inclusion phenomena was introduced and exhaustively 
examined in Chapter 5 and showed that indeed the DA was forming an inclusion 
complex with the CD in solution. This can be attributed to the significant 
increase in the release of DA. Although, there is a difference in analysing the 
complexation properties of CDs in solution and on the surface, many papers 
have examined both these processes and have attained similar observations.4, 5 
Damos et al.4 demonstrated the simple process of self assembled monolayer’s 
(SAM) of CDs on gold. They showed that when the CDs are immobilised onto the 
surface they retain their strong inclusion complexation properties with 
[Fe(CN)6]3-/4-. In Chapter 3, it was shown that the pyrrole monomer did not form 
an inclusion complex with the Sβ-CD. If the radical cations and the CD formed an 
inclusion complex, a decrease in the rate of polymerisation would be evident; 
however, in this case the opposite was observed. Therefore, there is no evidence 
to suggest an inclusion complex with the PPy, leaving a large number of cavities 
available for complexation of DA. We can safely say that the DA is forming an 
inclusion complex with the Sβ-CD. Also, in the analysis performed in Chapter 3 
on the doping levels of the CD with the polymer, it was presented that if all of 
the negative sulfonated groups were involved with the polymerisation for the 
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polymer, it could lead to a considerable strain on the polymer system. 
Therefore, it can be assumed that there are free negative groups around the 
ring. Chapter 5 revealed that the presence of the sulfonated groups enhanced 
complexation. In the case of the polymer, if some of the sulfonate groups are not 
involved in the doping then this would favour the complexation of the DA and, 
therefore, include more DA.   
 
The inclusion complexation of DA with Sβ-CD was dealt with in Chapter 5. 
Techniques including UV, NMR, CV and RDV were all used to demonstrate not 
only the 1:1 stoichiometry but evaluate the apparent formation constants. UV 
spectra showed a distinct shift in the wavelength and an increase in the 
intensity of the DA, in the presence of excess Sβ−CD, confirming a change in the 
environment of the DA and verifying complexation. In the electrochemical 
studies, the DA oxidation potentials shifted to higher potentials, while, the peak 
current decreased upon the addition of Sβ-CD. These traits were once more 
attributed to the formation of an inclusion complex due to the DA being harder 
to oxidise inside the cavity and the decrease in the diffusion coefficient of DA 
due to the less mobile bulky complex. Structural information on the inclusion 
complex was obtained from NMR studies and concluded that the aromatic DA 
ring was included inside the cavity, while the protonated amine was bound 
through electrostatic interactions to the sulfonated groups on the rim of the CD.  
 
In all techniques the formation constants evaluated were in very close 
agreement, which not only validated the results, but confirmed that the methods 
examined for the complexation could be recommended as a reliable option in 
determining the formation constants of the inclusion complex of Sβ−CD, with 
other guest molecules. In comparing the data obtained in these experiments to 
data found in the literature for the neutral β-CD, 95.06,6 it can be concluded that 
the negatively charged sulfonate groups on the CD play an important role in the 
complexation and increase the binding affinities in the case of protonated DA. 
Examinations on the influence of supporting electrolyte established that a 
change in the anion had an influence on the DA-Sβ-CD complexation while no 
change was observed for the cation. Complexation of DA with a smaller CD, 
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sulfonated α-CD showed no complexation and it was concluded that this was 
due to the size of the DA being too large to fit inside the cavity of the Sα-CD but 
it is sufficient in size for most of it to fit inside the Sβ-CD cavity.  
 
Finally, poly(D,L – lactide-co-glycolide) (PLGA) nanofibers were successfully 
deposited onto a Au mylar substrate using a technique known as 
electrospinning. During the electrospinning process a number of parameters 
were varied in order to form bead free nanofibers, including solvent, polymer 
concentration, potential and feeding rate. After successful fibers were attained, 
PPy films were both chemically and electrochemically deposited using vapour 
phase polymerisation and potentiostatic, galvanostatic and potentiodynamic 
methods, respectively. From SEM images, it was established that the 
electrochemical technique, CV, was the best technique employed enabling the 
formation of uniform conducting films, while still maintaining the nano-fibrous 
structure of the PLGA fibers. DA was again effectively incorporated and 
delivered from these new materials using electrical stimulation. 
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7.1  Conclusions 
The work described in this thesis addressed the need to develop a controllable 
device, for a cationic species. PPy, a conducting polymer, is an attractive 
material extensively researched in the area of biomedical devices. In the studies 
presented in this research, it successfully served as a controllable material for 
delivery of dopamine, DA, a cationic species. 
 
The results obtained in Chapter 3, described the formation and characterisation 
of the polymers in the presence of various electrolytes. Attention was focused 
on the large sulfonated β-cyclodextrin (Sβ-CD) for the doping of the PPy films.  
Due to their large size, these dopants were found to remain immobilised in the 
polymer matrix and act predominantly as cation exchangers. Conductivity 
measurements performed on the Sβ-CD in water, confirmed that the Sβ-CD was 
a sufficiently strong electrolyte for the polymerisation of pyrrole. Moreover, no 
other supporting electrolyte was required, contrary to reports by other research 
groups.1-3 The growth, morphology and doping levels of these films were also 
examined and showed that the PPy-Sβ-CD films could successfully be prepared 
electrochemically using both potentiostatic and potentiodynamic methods. The 
CV experiments demonstrated that the pyrrole monomer oxidised at lower 
potentials in the presence of the Sβ-CD, in comparison to other dopants like the 
Cl- anion. Additionally, the growth kinetics demonstrated a 4-fold increase in the 
rate of oxidation of PPy-Sβ-CD films, contrary to PPy-Cl films. Simultaneous, 
EQCM and CV experiments were used to measure the redox properties of these 
films and demonstrated not only the well defined redox properties of the PPy-
Sβ-CD films, but the main cationic movement associated with the electroactivity 
of these films. SEM confirmed polymer growth and illustrated an oriented and 
organised manner in which the polymer was deposited, while EDAX 
measurements confirmed the presence of the Sβ-CD anion. The influence of the 
fluxes, cation and solvent, as a function of the potential, were also explored 
during CV measurements. EQCM measurements showed that a considerable 
amount of solvent, water was taken up into the film during redox switching.  
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We also report for the first time, the application of this simple modified 
electrode for the drug delivery of DA. Chapter 4 demonstrated the impressive 
release of DA from polymers synthesised in the presence of Sβ-CD in 
comparison to smaller, more mobile, dopants. Various parameters, including, 
the application of potential during the incorporation and release process of the 
drug, as well as, polymer thickness were optimised. The electrochemical 
stimulated release of DA from these films was successfully obtained. The release 
was shown to be dependent on the potential as, at open-circuit potentials, the 
polymer film does not reach the potentials required, over the time monitored, 
for oxidation of the polymer film and subsequent release of the DA. Results also 
provided some limitations in these systems, the first, that the application of 
anodic potentials higher than 0.100 V vs. SCE, to the electrochemical system, 
resulted in the oxidation of DA. Secondly, polymers synthesised to a charge ≥ 
4.0 C cm-2 resulted in the oxidation of the DA. 
 
The question of inclusion phenomena was introduced and exhaustively 
examined in Chapter 5 and showed that indeed the DA was forming an inclusion 
complex with the CD in solution. This can be attributed to the significant 
increase in the release of DA. Although, there is a difference in analysing the 
complexation properties of CDs in solution and on the surface, many papers 
have examined both these processes and have attained similar observations.4, 5 
Damos et al.4 demonstrated the simple process of self assembled monolayer’s 
(SAM) of CDs on gold. They showed that when the CDs are immobilised onto the 
surface they retain their strong inclusion complexation properties with 
[Fe(CN)6]3-/4-. In Chapter 3, it was shown that the pyrrole monomer did not form 
an inclusion complex with the Sβ-CD. If the radical cations and the CD formed an 
inclusion complex, a decrease in the rate of polymerisation would be evident; 
however, in this case the opposite was observed. Therefore, there is no evidence 
to suggest an inclusion complex with the PPy, leaving a large number of cavities 
available for complexation of DA. We can safely say that the DA is forming an 
inclusion complex with the Sβ-CD. Also, in the analysis performed in Chapter 3 
on the doping levels of the CD with the polymer, it was presented that if all of 
the negative sulfonated groups were involved with the polymerisation for the 
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polymer, it could lead to a considerable strain on the polymer system. 
Therefore, it can be assumed that there are free negative groups around the 
ring. Chapter 5 revealed that the presence of the sulfonated groups enhanced 
complexation. In the case of the polymer, if some of the sulfonate groups are not 
involved in the doping then this would favour the complexation of the DA and, 
therefore, include more DA.   
 
The inclusion complexation of DA with Sβ-CD was dealt with in Chapter 5. 
Techniques including UV, NMR, CV and RDV were all used to demonstrate not 
only the 1:1 stoichiometry but evaluate the apparent formation constants. UV 
spectra showed a distinct shift in the wavelength and an increase in the 
intensity of the DA, in the presence of excess Sβ−CD, confirming a change in the 
environment of the DA and verifying complexation. In the electrochemical 
studies, the DA oxidation potentials shifted to higher potentials, while, the peak 
current decreased upon the addition of Sβ-CD. These traits were once more 
attributed to the formation of an inclusion complex due to the DA being harder 
to oxidise inside the cavity and the decrease in the diffusion coefficient of DA 
due to the less mobile bulky complex. Structural information on the inclusion 
complex was obtained from NMR studies and concluded that the aromatic DA 
ring was included inside the cavity, while the protonated amine was bound 
through electrostatic interactions to the sulfonated groups on the rim of the CD.  
 
In all techniques the formation constants evaluated were in very close 
agreement, which not only validated the results, but confirmed that the methods 
examined for the complexation could be recommended as a reliable option in 
determining the formation constants of the inclusion complex of Sβ−CD, with 
other guest molecules. In comparing the data obtained in these experiments to 
data found in the literature for the neutral β-CD, 95.06,6 it can be concluded that 
the negatively charged sulfonate groups on the CD play an important role in the 
complexation and increase the binding affinities in the case of protonated DA. 
Examinations on the influence of supporting electrolyte established that a 
change in the anion had an influence on the DA-Sβ-CD complexation while no 
change was observed for the cation. Complexation of DA with a smaller CD, 
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sulfonated α-CD showed no complexation and it was concluded that this was 
due to the size of the DA being too large to fit inside the cavity of the Sα-CD but 
it is sufficient in size for most of it to fit inside the Sβ-CD cavity.  
 
Finally, poly(D,L – lactide-co-glycolide) (PLGA) nanofibers were successfully 
deposited onto a Au mylar substrate using a technique known as 
electrospinning. During the electrospinning process a number of parameters 
were varied in order to form bead free nanofibers, including solvent, polymer 
concentration, potential and feeding rate. After successful fibers were attained, 
PPy films were both chemically and electrochemically deposited using vapour 
phase polymerisation and potentiostatic, galvanostatic and potentiodynamic 
methods, respectively. From SEM images, it was established that the 
electrochemical technique, CV, was the best technique employed enabling the 
formation of uniform conducting films, while still maintaining the nano-fibrous 
structure of the PLGA fibers. DA was again effectively incorporated and 
delivered from these new materials using electrical stimulation. 
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drug delivery of dopamine. ISE, 1st Regional Symposium on 
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Electrochemistry of South-East Europe, Rovinj, Croatia, 4–8th May 2008. 
[Poster Presentation]. 
 
 Gillian M. Hendy and Carmel B. Breslin, Polypyrrole, Its application in the 
delivery of dopamine. 215th ECS Meeting, San Francisco, 24-29th May 
2009. [Poster Presentation]. 
 
 Gillian M. Hendy and Carmel B. Breslin, An electrochemical and 
spectrophotometric analysis on the inclusion complexation of dopamine 
and an anionic β-cyclodextrin. 215th ECS Meeting, San Francisco, 24-29th 
May 2009. [Oral Presentation]. 
 
7.3 Papers in preparation/submitted 
 Controlled release of dopamine from sulfonated β-cyclodextrin doped 
polypyrrole. 
 
 An Electrochemical Study in Aqueous Solutions on the Binding of 
Dopamine to a Sulfonated Cyclodextrin Host. 
 
 A Spectrophotometric and NMR Study on the Formation of an Inclusion 
Complex between Dopamine and a Sulfonated Cyclodextrin Host. 
 
 Electrochemical polymerisation of a sulfonated β-cyclodextrin doped 
polypyrrole film onto electrospun poly(D,L – lactide-co-glycolide) (PLGA) 
nanofibers. 
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